
<html lang="en"     class="pb-page"  data-request-id="9d35703b-f196-452b-b85f-c9d57d67a6e1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-22;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.8b00185;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics" /></meta><meta name="dc.Creator" content="Dnyandev&#xA;B.  Jarhad" /></meta><meta name="dc.Creator" content="Karishma K.  Mashelkar" /></meta><meta name="dc.Creator" content="Hong-Rae  Kim" /></meta><meta name="dc.Creator" content="Minsoo  Noh" /></meta><meta name="dc.Creator" content="Lak Shin  Jeong" /></meta><meta name="dc.Description" content="Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a member of an evolutionarily conserved family of protein kinases that belongs to the CMGC group of kinases. DYRK1A, encode..." /></meta><meta name="Description" content="Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a member of an evolutionarily conserved family of protein kinases that belongs to the CMGC group of kinases. DYRK1A, encode..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 9, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00185" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00185" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00185" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00185" /></link>
        
    
    

<title>Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00185" /></meta><meta property="og:title" content="Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0026.jpeg" /></meta><meta property="og:description" content="Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a member of an evolutionarily conserved family of protein kinases that belongs to the CMGC group of kinases. DYRK1A, encoded by a gene located in the human chromosome 21q22.2 region, has attracted attention due to its association with both neuropathological phenotypes and cancer susceptibility in patients with Down syndrome (DS). Inhibition of DYRK1A attenuates cognitive dysfunctions in animal models for both DS and Alzheimer’s disease (AD). Furthermore, DYRK1A has been studied as a potential cancer therapeutic target because of its role in the regulation of cell cycle progression by affecting both tumor suppressors and oncogenes. Consequently, selective synthetic inhibitors have been developed to determine the role of DYRK1A in various human diseases. Our perspective includes a comprehensive review of potent and selective DYRK1A inhibitors and their forthcoming therapeutic applications." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a member of an evolutionarily conserved family of protein kinases that belongs to the CMGC group of kinases. DYRK1A, encoded by a gene located in the human chromosome 21q22.2 region, has attracted attention due to its association with both neuropathological phenotypes and cancer susceptibility in patients with Down syndrome (DS). Inhibition of DYRK1A attenuates cognitive dysfunctions in animal models for both DS and Alzheimer’s disease (AD). Furthermore, DYRK1A has been studied as a potential cancer therapeutic target because of its role in the regulation of cell cycle progression by affecting both tumor suppressors and oncogenes. Consequently, selective synthetic inhibitors have been developed to determine the role of DYRK1A in various human diseases. Our perspective includes a comprehensive review of potent and selective DYRK1A inhibitors and their forthcoming therapeutic applications." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0026.jpeg" /></meta><meta name="twitter:title" content="Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00185"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00185">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00185&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00185&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00185&amp;href=/doi/10.1021/acs.jmedchem.8b00185" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9791-9810</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b00294" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Dnyandev B. Jarhad</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dnyandev B. Jarhad</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dnyandev%0AB.++Jarhad">Dnyandev B. Jarhad</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karishma K. Mashelkar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karishma K. Mashelkar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karishma+K.++Mashelkar">Karishma K. Mashelkar</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hong-Rae Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong-Rae Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong-Rae++Kim">Hong-Rae Kim</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Minsoo Noh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Minsoo Noh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Minsoo++Noh">Minsoo Noh</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Lak Shin Jeong</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lak Shin Jeong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Korea</div></div><span class="conrtib-corresp"><strong>*</strong>Phone, 82-2-880-7850. E-mail: <a href="/cdn-cgi/l/email-protection#48242923222d27262f083b263d66292b66233a"><span class="__cf_email__" data-cfemail="0b676a60616e64656c4b78657e256a68256079">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lak+Shin++Jeong">Lak Shin Jeong</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3441-707X" title="Orcid link">http://orcid.org/0000-0002-3441-707X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00185&amp;href=/doi/10.1021%2Facs.jmedchem.8b00185" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9791–9810</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 9, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 February 2018</li><li><span class="item_label"><b>Published</b> online</span>9 July 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 21 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00185" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00185</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9791%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDnyandev%250AB.%2BJarhad%252C%2BKarishma%2BK.%2BMashelkar%252C%2BHong-Rae%2BKim%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D22%26contentID%3Dacs.jmedchem.8b00185%26title%3DDual-Specificity%2BTyrosine%2BPhosphorylation-Regulated%2BKinase%2B1A%2B%2528DYRK1A%2529%2BInhibitors%2Bas%2BPotential%2BTherapeutics%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9810%26publicationDate%3DNovember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00185"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4038</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00185" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dnyandev\nB.&quot;,&quot;last_name&quot;:&quot;Jarhad&quot;},{&quot;first_name&quot;:&quot;Karishma&quot;,&quot;last_name&quot;:&quot;K. Mashelkar&quot;},{&quot;first_name&quot;:&quot;Hong-Rae&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Minsoo&quot;,&quot;last_name&quot;:&quot;Noh&quot;},{&quot;first_name&quot;:&quot;Lak&quot;,&quot;last_name&quot;:&quot;Shin Jeong&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9791-9810&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00185&quot;},&quot;abstract&quot;:&quot;Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a member of an evolutionarily conserved family of protein kinases that belongs to the CMGC group of kinases. DYRK1A, encoded by a gene located in the human chromosome 21q22.2 region, has attracted attention due to its association with both neuropathological phenotypes and cancer susceptibility in patients with Down syndrome (DS). Inhibition of DYRK1A attenuates cognitive dysfunctions in animal models for both DS and Alzheimer’s disease (AD). Furthermore, DYRK1A has been studied as a potential cancer therapeutic target because of its role in the regulation of cell cycle progression by affecting both tumor suppressors and oncogenes. Consequently, selective synthetic inhibitors have been developed to determine the role of DYRK1A in various human diseases. Our perspective includes a comprehensive review of potent and selective DYRK1A inhibitors and their forthcoming therapeutic applications.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00185&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00185" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00185&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00185" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00185&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00185" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00185&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00185&amp;href=/doi/10.1021/acs.jmedchem.8b00185" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00185" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00185" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00185%26sid%3Dliteratum%253Aachs%26pmid%3D29985601%26genre%3Darticle%26aulast%3DJarhad%26date%3D2018%26atitle%3DDual-Specificity%2BTyrosine%2BPhosphorylation-Regulated%2BKinase%2B1A%2B%2528DYRK1A%2529%2BInhibitors%2Bas%2BPotential%2BTherapeutics%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D22%26spage%3D9791%26epage%3D9810%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/22" title="Go to Volume 61, Issue 22"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/jmcmar.2018.61.issue-22/20181121/jmcmar.2018.61.issue-22.largecover.jpg" alt="Go to Volume 61, Issue 22"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a member of an evolutionarily conserved family of protein kinases that belongs to the CMGC group of kinases. DYRK1A, encoded by a gene located in the human chromosome 21q22.2 region, has attracted attention due to its association with both neuropathological phenotypes and cancer susceptibility in patients with Down syndrome (DS). Inhibition of DYRK1A attenuates cognitive dysfunctions in animal models for both DS and Alzheimer’s disease (AD). Furthermore, DYRK1A has been studied as a potential cancer therapeutic target because of its role in the regulation of cell cycle progression by affecting both tumor suppressors and oncogenes. Consequently, selective synthetic inhibitors have been developed to determine the role of DYRK1A in various human diseases. Our perspective includes a comprehensive review of potent and selective DYRK1A inhibitors and their forthcoming therapeutic applications.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61872" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61872" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein kinases constitute one of the largest superfamily of proteins in eukaryotes and have evolved as key enzymes for the regulation of basic cellular functions and processes involving the chemical addition of phosphate groups to the proteins, a process known as phosphorylation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Dual-specificity tyrosine-regulated kinases (DYRKs) constitute an evolutionarily conserved family of protein kinases and belong to the CMGC (named after the initials of some of its members) group of kinases, which also includes other kinase families such as cyclin-dependent kinases (CDKs), mitogen-activated protein kinases (MAPKs), glycogen synthase kinase-3 (GSK3), and CDK-like kinases (CLKs).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> DYRKs have been identified in organisms such as baker’s yeast (YAK1), fission yeast (POM1), and <i>Drosophila</i> (minibrain, mnb).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Two major classes of its mammalian homologue DYRK have been recognized: class I DYRKs, which include DYRK1A and DYRK1B, and class II DYRKs, which include DYRK2, DYRK3, and DYRK4.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> DYRK-related kinases have distinct structural and enzymatic features<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and play diverse roles in cell cycle control and cell differentiation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p last">Among the mammalian DYRKs, DYRK1A has attracted therapeutic attention because of its genetic locus in human chromosome 21q22.2, covering the Down syndrome critical region. DYRK possesses dual specificity because of its capability to autophosphorylate tyrosine residue Y321 in its own activation loop as well as to phosphorylate its substrates at serine or threonine residues.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> In addition to the role of DYRK1A in apoptosis, cell cycle regulation, splicing, and signaling pathways, it has also been shown to be involved in brain growth,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> neuronal development,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and synaptic transmission.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Hyperactivity of DYRK1A has been correlated with abnormal brain development, neurodegeneration, cancer, cognitive disabilities, and early onset Alzheimer’s disease (AD) in individuals with Down syndrome (DS).<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11−14)</a> Studies have shown that the loss-of-function mutations of DYRK1A are responsible for the syndromic form of intellectual disabilities with microcephaly, epilepsy, and autistic troubles, which is generally referred as autosomal dominant mental retardation 7 syndrome (MRD7).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> As estimated by the Centers for Disease Control and Prevention, approximately 5 million people suffer from Alzheimer’s disease in the United States alone, the country with the highest aging population, and approximately 83000 people die from this condition each year. Thus the need for DYRK1A inhibitors has become a major concern and has motivated scientists to develop potential therapeutic inhibitors for applications in DS,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> AD,<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> cancer,<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> and diabetes.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a> Herein, we present a comprehensive review of the literature on the currently available potent and selective DYRK1A inhibitors and their forthcoming therapeutic applications.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Role of DYRK1A Activity in Various Diseases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Neurodegenerative Diseases</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5"> Alzheimer’s Disease</h4><div class="NLM_p last">Alzheimer’s disease is a neurodegenerative disease known to be caused by β-amyloid protein deposits, called amyloid plaques, and neurofibrillary tangles (NFTs).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> It is one of the leading causes of deaths worldwide as the aging population increases. NFTs are formed as a result of hyperphosphorylation of the microtubule-binding protein Tau and its intracellular aggregation in the brain.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Researchers have postulated that DYRK1A phosphorylates Tau protein at Thr212 in neuroblastoma cells, which leads to the formation of NFTs.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> It has also been found that DYRK1A phosphorylates amyloid precursor protein (APP) at the Thr668 residue in vitro.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Thus, the overexpression of DYRK1A enhances the levels of phospho-APP, and hence β-amyloid, in the brain. A greater than theoretically expected (1.5-fold) overexpression of the APP gene in DS has been observed, thereby causing an increase in β-amyloid production. This could explain the appearance of early onset AD-like pathologies in DS patients.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> As yet, no cure or effective treatment has been found for Alzheimer’s disease despite intense research since its discovery in 1906. A potent inhibitor of DYRK1A, harmine, inhibits the DYRK1A-mediated phosphorylation of Tau, with an IC<sub>50</sub> value of 0.7 μM.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> Down Syndrome</h4><div class="NLM_p last">Down syndrome (DS) is a common genetic disorder that causes retardation in physical growth and neuronal abnormalities in DS individuals. Down syndrome is likely to be related with the trisomy of human chromosome 21, which arises from chromosomal nondisjunction during meiotic cell division.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> DYRK1A maps to human chromosomal region 21q22.2 and is therefore associated with this disease.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The overexpression of DYRK1A has been observed in patients with DS, causing splicing aberrations and leading to changes in mRNA expression levels.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> However, the mechanism by which trisomy 21 is actually responsible for DS is not yet understood in detail. Similar to AD, an effective treatment for DS has not yet been reported; therefore, DYRK1A is an attractive therapeutic target for this disease.</div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Cancer</h3><div class="NLM_p last">As mentioned earlier, DYRK1A plays an important role in cell cycle control. Hence, the overexpression of DYRK1A may cause deregulation of the cell cycle. Examination of tumor cells showed overexpression of kinases such as DYRK and CLK. Sprouty2 (Spry2) protein negatively modulates epidermal growth factor receptor (EGFR) signaling, whose mutation might promote oncogenesis. However, DYRK1A phosphorylates T75 on spry2 and thus prevents EGFR degradation.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In addition, DYRK1A increases the expression of the antiapoptotic enzyme Bcl-X<sub>L</sub>, thereby contributing to cancer.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> DYRK1A phosphorylates CDK inhibitor p27Kip1 (CDKN1B) and cyclin D1 (CCND1), which has been investigated in cancer cell cycle progression, and thus, regulates cell proliferation.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Caspase 9, which is associated with apoptosis processing, is also known to be phosphorylated by DYRK1A at Thr 125 which interrupts apoptosis.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Most solid tumors are resistant to pro-apoptotic stimuli and are therefore resistant to chemotherapy, as in the case of leukemias, melanomas, and glioblastomas.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Diabetes</h3><div class="NLM_p">Approximately 5% of the world’s population suffers from diabetes. The diabetic condition (type I) arises from a deficiency of insulin-secreting β-cells. NFATc (nuclear factor of activated T-cells, cytoplasmic) plays a crucial role in the activation of human β-cell proliferation. DYRK1A phosphorylates NFAT, which is further phosphorylated by GSK3β and CK1 (casein kinase 1); its removal from the nucleus leads to its inactivation. Inhibition of DYRK1A prompts translocation of NFAT into the nucleus, which promotes β-cell proliferation.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Harmine, a DYRK1A inhibitor, has been known to induce β-cell proliferation.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p last">Because higher than normal levels of DYRK1A have adverse effects on human health, its consequences cannot be neglected. Thus, it is important to design a potent and specific DYRK1A inhibitor for the benefit of appropriate patients.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Activation and Inhibition of DYRK1A</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">DYRK1A kinases must be activated before they can phosphorylate their substrates. During translation, DYRK1A activates itself by intramolecular (<i>Cis</i>) autophosphorylation at the conserved tyrosine (Y321) residue<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> in its activation loop, as demonstrated by the mutation of Mg<sup>2+</sup> ATP-binding lysine in the catalytic domain.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This binding leads to the formation of a transient protein intermediate,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> which produces an active conformation of DYRK1A. This active form is believed to be stabilized by Y321, which is the primary mediator of a network of interactions.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Interestingly, in vitro studies have shown that Y321 cannot be rephosphorylated after phosphatase activity.<a onclick="showRef(event, 'ref6 ref41'); return false;" href="javascript:void(0);" class="ref ref6 ref41">(6,41)</a> DYRK1A kinase activity is no longer influenced by tyrosine phosphorylation once the protein is completely translated, as dephosphorylating Y321 in the active kinase does not significantly decrease its kinase activity in vitro.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Matured and active DYRK1A kinase phosphorylates its substrates only at serine (S) and threonine (T) residues that have a proline residue situated carboxyl-terminal to the target site,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> thereby expressing its activity in diverse biological functions. Substitution of the second Y321 in the activation domain by phenylalanine, histidine, or glutamine resulted in a substantial decrease of DYRK1A activity by >80%.<a onclick="showRef(event, 'ref6 ref43'); return false;" href="javascript:void(0);" class="ref ref6 ref43">(6,43)</a></div><div class="NLM_p">Although intense efforts have been made to develop DYRK1A inhibitors, highly potent and specific inhibitors are still lacking. Many inhibitors of DYRK1A from natural and synthetic sources have been reviewed.<a onclick="showRef(event, 'ref18 ref21 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref18 ref21 ref44 ref45 ref46">(18,21,44−46)</a> However, it is difficult to design a rationale for the chemical synthesis of an inhibitor because its exact mechanism of action is still unclear. Small cell-permeant molecules are important from a medicinal chemistry point of view in determining the molecular interactions of molecules with the target enzyme. To interpret its mechanism of action, different docking and co-crystallization experiments were performed with competitive ATP inhibitors that gave insight into the necessary interactions between the amino acid residues of DYRK1A and the inhibitors.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Currently, it appears that most of the inhibitors suppress DYRK1A kinase activity by interacting with residues in the ATP-binding site, resulting in the prevention of protein autophosphorylation or inhibition of mature protein activity. The activity of inhibitors against DYRK1A and their mode of action can now be analyzed using a simple and rapid ELISA DYRK1A nonradioactive kinase assay.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p">The crystal structure analysis of DYRK1A has been reported by co-crystallization with various inhibitors such as harmine<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and INDY<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> ((<i>Z</i>)-1-(3-ethyl-5-hydroxy-2(3<i>H</i>)-benzothiazolylidene)-2-proanone)). Recently, Elkins and colleagues reported the crystal structure of DYRK1A complexed with ATP-mimetic inhibitor <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Compound <b>1</b> binds to the ATP binding site and interacts with the hinge backbone through three hydrogen bonds. The primary amine of <b>1</b> forms two additional hydrogen bonds with the side chains of Asn292 and the DFG motif aspartate Asp307.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Compound <b>1</b> was also found to interact with Asp307 through electrostatic interaction between the amide nitrogen of the inhibitor and the nitrogen of Asp307 via an ion (modeled as chloride). Moreover, hydrogen bonding occurs with the backbone carbonyl of Glu291 via a water molecule. The reader is referred to the original reference describing the detailed binding interactions of inhibitor <b>1</b> with the DYRK1A kinase domain for further clarification.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of DYRK1A inhibitor <b>1</b> that has been co-crystallized with DYRK1A kinase.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Surprisingly, the potent natural polyphenol epigallocatechin gallate (EGCG, <b>2</b>) is noncompetitive with ATP,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and its mechanism of action is still uncertain.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Classification of DYRK1A Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16378" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16378" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several DYRK1A inhibitors were initially designed or postulated to specifically target other protein kinases. Nevertheless, over the years, several classes of DYRK1A inhibitors have been reported, and a few are used as pharmacological tools. Kinase inhibitors in general are categorized as type I, type II, or type III inhibitors. Type I inhibitors, known as ATP competitors, bind to the ATP binding site of the kinase domain when the activation loop is phosphorylated. However, type II and III are non-ATP competitors. Type II inhibitors bind to the ATP binding site but partially bind to an allosteric pocket, whereas type III inhibitors particularly bind to an allosteric pocket. Type II and III inhibitors induce conformational changes in the target enzyme that result in the loss of kinase activity. The alkaloid compound, harmine (an ATP competitor) has been identified as the conventional DYRK1A inhibitor.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p last">Herein, we have classified the DYRK1A inhibitors into two classes: (i) natural DYRK1A inhibitors and their derivatives and (ii) synthetic DYRK1A inhibitors. In addition, the synthetic inhibitors are further divided into subclasses based on their heterocyclic skeleton.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Naturally Occurring DYRK1A Inhibitors and Their Derivatives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37281" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37281" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There are various DYRK1A inhibitors obtained from natural sources, and these inhibitors mainly contain either nitrogen heterocycles or polyphenols. Selective profiling studies against a panel of kinases have identified two natural compounds (<b>2</b> and <b>3</b>) as DYRK1A inhibitors. The potent and selective inhibitors of DYRK1A are described below.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Epigallocatechin Gallate</h3><div class="NLM_p">The antioxidant, anti-inflammatory, and antitumor properties of polyphenols make them a unique class of phytochemicals. Compound <b>2</b>, a catechin derivative, was extracted as a major component from green tea and has been identified as the first DYRK inhibitor in animals and humans (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Bain and colleagues identified that <b>2</b> specifically inhibited DYRK1A (IC<sub>50</sub> = 330 nM) from among 29 tested kinases that were structurally and functionally related to DYRK1A.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> However, it does not selectively inhibit DYRK1A. It also inhibits p38-regulated/activated kinase (PRAK) (IC<sub>50</sub> = 1 μM) activity by binding to PRAK, resulting in inhibition of PRAK activation.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In 2006, Adayev et al., using a combination of biochemical and genetic studies, postulated that <b>2</b> inhibits DYRK1A by binding to a site in/around the kinase domain and identified it as a non-ATP-competitor.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> DYRK1A-overexpressing transgenic mice, fed on a green tea diet from incubation to adulthood, displayed brain structure development (brain weight and thalamus–hypothalamus volume), and improved cognitive deficits in long- and short-term memory.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of EGCG (<b>2</b>) as a DYRK1A inhibitor that contains bis-catechol PAINS motifs (shown in red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, compound <b>2</b> also exhibits anticancer activity, and several mechanisms of action have been suggested to describe its anticancer effect.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> However, it has disadvantages for use in cell and animal experiments due to poor bioavailability, complex pharmacokinetic properties, and heterogeneous effects on signaling pathways.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Although several preclinical studies and clinical trials have revealed that <b>2</b> has improved some DS-associated phenotypes by inhibiting DYRK1A, the beneficial effects of <b>2</b> have been questioned due to inconsistent results and a lack of necessary controls.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> For example, DYRK1A expression differs over the lifespan in DS mouse models, but little attention has been given to these developmental changes in preclinical therapeutic treatments targeting DYRK1A.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55,56)</a> There was significant heterogeneity observed in behavioral outcomes when various compositions and doses of <b>2</b> or <b>2</b>-containing supplements were administered to transgenic DYRK1A or Ts65Dn mice, as well as when different mouse models, ages, and routes of administration were employed.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Therefore, the necessity of controlling or monitoring the administered dose or composition of <b>2</b> in all studies is of great importance. Additionally, the identification of the effective dose and the level of EGCG accumulation in subjects over time remain important questions. However, there is no definitive proof that any of the observed improvement of some DS-associated phenotypes was a result of DYRK1A inhibition.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Several studies have used <b>2</b>-containing supplements as the source of <b>2</b> for administration. However, these supplements also contain other components, such as catechins (epigallocatechin, epicatechin gallate, epigallate, and epicatechin), sucrose, and/or caffeine, that could have acted separately or synergistically with <b>2</b>.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> For instance, different supplements containing <b>2</b> showed differences in degradation, polyphenol content, and effects on trisomic bone.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Thus, it is essential to precisely evaluate the dose of <b>2</b> and the composition of the EGCG-containing supplements used in different experiments.</div><div class="NLM_p last">Importantly, compound <b>2</b> has been classified as a promiscuous pan-assay interference compound (PAINS) due to its interference in biological assays leading to false positive results.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> It undergoes oxidative degradation in cell culture methods, forming oxidized degradation products that are more toxic than the parent EGCG molecule, which can be the reason for the cytotoxicity of <b>2</b>.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> It is known that the PAINS motif catechol readily undergoes oxidation to form the highly reactive orthoquinone, which binds covalently to proteins, and it has even been shown to chelate metals.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Compound <b>2</b> contains bis-catechol (pyrogallol), which is an additional PAINS motif and thus may interfere in assays. Furthermore, the moiety is known to cause nonspecific membrane perturbation rather than specific protein binding, thereby interfering in ion channel assays.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> As a consequence of this detrimental effect, it can activate several different pathways in cells and exhibits diverse biological activities. Unfortunately, it is being reported in the literature extensively as a “promising DYRK1A inhibitor” in spite of these well-known promiscuous effects in unrelated cell-based assays and target-based assays.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Harmine and Its Derivatives</h3><div class="NLM_p">Compound <b>3</b> belongs to a β-carboline alkaloid with a pyrido[3,4-<i>b</i>]indole ring and was first isolated from the South American vine <i>Banisteriopsis caapi</i> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). It was initially used in 1928 in the treatment of Parkinson’s disease patients for improving the mental status of the patients.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Compound <b>3</b> was found to be a potent inhibitor of DYRK1A (IC<sub>50</sub> = 80 nM) in vitro and specifically inhibited DYRK1A among 69 protein kinases. However, it also strongly inhibited other DYRKs (IC<sub>50</sub> = 0.9 μM for DYRK2, 0.8 μM for DYRK3).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Studies based on molecular docking and the co-crystal structure of <b>3</b> with the DYRK1A kinase domain have shown that it binds to the ATP binding site of DYRK1A and inhibits the serine/threonine phosphorylation activity by competing directly with ATP.<a onclick="showRef(event, 'ref46 ref63'); return false;" href="javascript:void(0);" class="ref ref46 ref63">(46,63)</a> A study has shown that <b>3</b> inhibits the tyrosine autophosphorylation of DYRK1A in vitro, although a higher concentration was required to inhibit the autophosphorylation in vivo.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General structures of harmine (<b>3</b>) and its analogues (<b>4</b>–<b>8</b>) as potent DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>3</b> significantly inhibits endogenous DYRK1A in HeLa cells with an IC<sub>50</sub> of 48 nM.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> In addition, <b>3</b> was found to be cytostatic and/or cytotoxic against cancer cells<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a> and to possess antidiabetic activity.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Although <b>3</b> has been considered to be a potent and orally bioavailable inhibitor of DYRK1A, it also exhibited an even stronger inhibition of monoamine oxidase (MAO)-A, causing side effects that led to a significant limitation of its potential therapeutic application.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> However, despite this limitation in terms of DYRK1A inhibition, it may find other therapeutic uses. For example, <i>N</i>,<i>N</i>-dimethyltryptamine (DMT), a hallucinogen, is rapidly degraded by MAO-A enzymes via the deamination metabolic pathway in the liver and gut when ingested in the absence of <b>3</b>.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Remarkably, when DMT is co-administered with <b>3</b>, the degradation of DMT is effectively prevented, thus enabling its transfer into the bloodstream to induce the desired psychoactive effects. Therefore, the synergistic interaction between DMT and <b>3</b> is necessary for the enhancement of the psychoactive effects from DMT oral consumption.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div class="NLM_p">To overcome the hallucinogenic and toxic effect observed with <b>3</b>, several harmine and β-carboline analogues, <b>4</b>–<b>8</b>, have been synthesized as potent DYRK1A inhibitors. Demethylation of a methoxy group resulted in harmol (<b>4</b>), which showed low inhibition of MAO-A; however, it also showed only a slight effect on DYRK1A inhibition.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Compound <b>4</b> inhibited DYRK1A-mediated phosphorylation of Tau (IC<sub>50</sub> = 90 nM) with a greater potency than <b>3</b> (IC<sub>50</sub> = 700 nM). A similar inhibition was shown by 9-ethylharmine (<b>5</b>), with an IC<sub>50</sub> value of 400 nM.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In 2014, Drung et al. synthesized various β-carboline derivatives, evaluated them for DYRK1A activity, and concluded that compound <b>6</b> was more effective than <b>3</b>.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Compound <b>6</b> (IC<sub>50</sub> = 130 nM) displayed a 97% inhibition of DYRK1A at 10 μM and inhibited MAO-A to a lesser extent (34% inhibition at 10 μM), whereas <b>3</b> showed complete inhibition of MAO-A (103% inhibition at 1 μM). The higher inhibition of MAO-A in the case of <b>3</b> revealed that the amine of the central ring is essential for MAO-A binding but not for DYRK1A binding.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Interestingly, compound <b>6</b> inhibited DYRK1A (85% inhibition at 1 μM) specifically among other DYRKs and cyclin-like kinases.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div><div class="NLM_p last">To enhance the activity against DYRK1A while reducing the activity of MAO-A, harmine analogues <b>7a</b> and <b>7b</b> were synthesized and their activities were compared with <b>3</b> using a kinase-GLO assay.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The results showed a greater than 60% inhibition of DYRK1A by inhibitor <b>3</b> at 1 μM, whereas <b>7a</b> (IC<sub>50</sub> = 81 nM) and <b>7b</b> (IC<sub>50</sub> = 181 nM) showed improved inhibition (8% and 10% uninhibited control, respectively). Compound <b>7a</b> inhibited MAO-A to a far lesser extent (IC<sub>50</sub> = 3.24 μM), whereas compound <b>7b</b> showed a significant drop in MAO-A inhibition (IC<sub>50</sub> > 10 μM). Similar behavior was shown by compound <b>8</b>. Replacing the methyl group at the 1-position for a trifluoromethyl or chloro group resulted in the complete loss of the activity against MAO-A while retaining the activity against DYRK1A, demonstrating that the 1-position of the β-carboline plays an important role in discriminating DYRK1A and MAO-A inhibition.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The effect of <b>7b</b> on the tyrosine autophosphorylation during translation of DYRK1A and the threonine (Thr434) phosphorylation in substrate protein splicing factor 3b1 (SF3B1) was evaluated in a coupled in vitro transcription–translation system.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Compound <b>7b</b> inhibited the tyrosine autophosphorylation of DYRK1A at concentrations >1 μM, whereas higher concentrations of <b>7b</b> were required to inhibit threonine phosphorylation in SF3B1.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Strikingly, in the peptide assay, preferential inhibition of threonine phosphorylation over tyrosine autophosphorylation of DYRK1A was observed, owing to the fact that autophosphorylation assays in the in vitro translation mix cannot be performed under conditions of substrate saturation.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Acrifoline</h3><div class="NLM_p">In 2014, an alkaloid termed acrifoline (compound <b>9)</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) was isolated from the stem bark of <i>Glycosmis chlorosperma</i> along with other acridone alkaloids such as chlorospermines A and B and atalaphyllidine.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Compound <b>9</b> showed potent inhibition (IC<sub>50</sub> = 75 nM) against DYRK1A, with an inhibitory activity comparable to that of <b>3</b> but provided a better molecular scaffold against DYRK1A. The evaluation of the selectivity profile against 14 protein kinases on the basis of IC<sub>50</sub> values revealed that compound <b>9</b> had selectivity toward DYRK1A. Molecular docking studies revealed that the strong interactions of <b>9</b>, with both conserved Lys188 and backbone atoms in the hinge region (Glu239 and/or Leu241), were key interactions for enhanced biological activity.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Natural alkaloid <b>9</b> as a potent DYRK1A inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Leucettines</h3><div class="NLM_p">Leucettines appear to be promising drug candidates for the inhibition of DYRK1A and its closely related kinases, CLKs. The natural product leucettamine B (<b>10</b>) was isolated from the marine calcareous sponge <i>Leucetta microraphis</i>,<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> and leucettine L41 (<b>11</b>) was derived from alkaloid <b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Compound <b>10</b> inhibited protein kinases such as DYRK1A (IC<sub>50</sub> = 420 nM), DYRK2 (IC<sub>50</sub> = 0.49 μM), CLK1 (IC<sub>50</sub> = 0.1 μM), and CLK2 (IC<sub>50</sub> = 0.91 μM) in the micromolar/submicromolar range,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> which are associated with Alzheimer’s disease at different stages of disease progression.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> However, compound <b>11</b> specifically inhibited DYRKs (preferentially DYRK1A, IC<sub>50</sub> = 32 nM)<a onclick="showRef(event, 'cit78a'); return false;" href="javascript:void(0);" class="ref cit78a">(78a)</a> and CLKs (IC<sub>50</sub> = 60–70 nM), but unlike <b>10</b>, it also inhibited GSK-3 (IC<sub>50</sub> = 0.41 μM), PIM1 (proto-oncogene serine/threonine-protein kinase, IC<sub>50</sub> = 4.1 μM), and CK2 (IC<sub>50</sub> = 0.32 μM).<a onclick="showRef(event, 'cit78b'); return false;" href="javascript:void(0);" class="ref cit78b">(78b)</a> Interestingly, compound <b>11</b> targets only DYRK1A in the mouse brain, as analyzed by affinity chromatography.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Additionally, it showed better affinity and potency than <b>10</b>, likely for two reasons. First, the phenyl ring being less flexible probably increases the stabilizing hydrophobic interactions with residues of the Gly loop. Second, the secondary amine adjacent to the phenyl group is involved in hydrogen bonding. Thus, leucettines (2-aminoimidazolones) appear to serve as important moieties for designing potent DYRK1A inhibitors.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Although initial results showed promising activity, leucettines should be carefully examined when developed as DYRK1A inhibitors. Their structure contains an unsaturated enone, which is typically regarded as a PAINS chemotype; therefore, it may be prone to react with biological nucleophiles, such as cysteines, via Michael addition.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> In particular, the exocyclic double bond is considered to be a potent Michael acceptor that binds covalently with cellular structures and modifies the protein. In addition, leucettines may interfere with biochemical assays due to the aggregate-based inhibition of enzymes.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of leucettamine B (<b>10</b>) and leucettine L41 (<b>11</b>) as potent DYRK1A inhibitors, containing a Michael acceptor that is recognized as a PAINS motif.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Meridianins</h3><div class="NLM_p">Meridianins are naturally occurring compounds that have 3-(pyrimidin-4-yl)-1<i>H</i>-indole as a core structure. They were isolated from a marine source, the south Atlantic tunicate <i>Aplidium meridianum</i>.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Meridianins were found to be active against various protein kinases<a onclick="showRef(event, 'cit82a'); return false;" href="javascript:void(0);" class="ref cit82a">(82a)</a> and to possess antitumor activity.<a onclick="showRef(event, 'cit82b'); return false;" href="javascript:void(0);" class="ref cit82b">(82b)</a></div><div class="NLM_p">The meridianin series (<b>12a</b>–<b>14a</b>) and its synthetic derivatives, the meridianin-like series (<b>12b</b>–<b>14b</b>), were tested against DYRK1A (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) and other kinases such as CDK5/p25, CK1δ/ε, GSK-3R/β, and CLK1.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Compounds <b>14a</b>, <b>13b</b>, and <b>14b</b> were remarkably active against DYRK1A (IC<sub>50</sub> = 0.068, 0.34, and 0.039 μM, respectively) and CLK1 (IC<sub>50</sub> = 0.065, 0.032, and 0.042 μM, respectively). Variolin B (<b>15</b>), a marine natural product extracted from the Antarctic sponge <i>Kirkpatrickia variolosa</i>, structurally resembles meridianins.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> It was found to be cytotoxic to various human cancer cell lines.<a onclick="showRef(event, 'cit85a'); return false;" href="javascript:void(0);" class="ref cit85a">(85a)</a> Surprisingly, it exerted a profound inhibitory activity against CK1 (IC<sub>50</sub> = 5 nM) and DYRK1A (IC<sub>50</sub> = 80 nM).<a onclick="showRef(event, 'cit85b'); return false;" href="javascript:void(0);" class="ref cit85b">(85b)</a> However, it has limited use in clinical trials due to its low solubility in water and complex pharmacokinetic properties.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Meridianins <b>12a</b>–<b>14b</b> and their structural analogue variolin B (<b>15</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>16</b>, prepared from <b>14b</b> by Suzuki coupling, displayed submicromolar activity against DYRK1A but was less active than <b>14b</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The <i>N</i>-acylated meridianin <b>17</b> showed an improved inhibition of DYRK1A (IC<sub>50</sub> = 0.5 μM) over DYRK2 (IC<sub>50</sub> = 1.4 μM) and DYRK3 (IC<sub>50</sub> = 2.2 μM) and exhibited no cytotoxicity up to 100 μM in human neuroblastoma SH-SY5Y cells.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> It displayed a 56.7% inhibition of DYRK1A, similar to <b>12a</b>. The authors proposed that the meridianin pyrimidine <i>N</i>-1 and the 2-amino group of the pyrimidine ring interacted with the hinge region of DYRK1A and facilitated the binding of meridianins to the ATP binding site, while the indole ring was involved in π–π interactions with the phenylalanine gatekeeper.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Compound <b>17</b> also showed similar interactions as the parent meridianins. In addition to a carbonyl group interaction with the ATP binding pocket, a bulky bromine interacted with Asp307 and Lys188 side chains through hydrophobic and ionic interactions.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Meriolin (<b>18</b>) showed DYRK1A inhibition with an IC<sub>50</sub> value of 0.029 μM; however, it also showed potent inhibition of CDK9 (IC<sub>50</sub> = 0.006 μM).<a onclick="showRef(event, 'cit85b'); return false;" href="javascript:void(0);" class="ref cit85b">(85b)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structurally modified meridianins <b>16</b> and <b>17</b> and their aza-analogue meriolin (<b>18</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Staurosporine</h3><div class="NLM_p">Staurosporine (<b>19</b>), with an indolocarbazole ring, was isolated from the bacterium <i>Streptomyces staurosporeus</i> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). It showed potent activity against DYRK1A (IC<sub>50</sub> = 19 nM) but induced toxicity, as it also inhibited many other kinases such as AurA, AurB, Chk1, Ftl3, FGFR1, HGK, Ikkb, Jak2, KDR, and SYK.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Nevertheless, it has been used as an ideal control molecule for the screening of DYRK1A inhibitors. Compound <b>20</b> also showed potent inhibition of DYRK1A but was nonselective, which limited its development as a therapeutic agent.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of the DYRK1A inhibitors <b>19</b> and <b>20</b> with an indolocarbazole ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Synthetic Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75755" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75755" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Despite the substantial efforts accomplished so far by derivatizing naturally occurring DYRK1A inhibitors, the search for highly potent and selective DYRK1A inhibitors remains a priority. To overcome the disadvantages of natural DYRK1A inhibitors, several synthetic inhibitors have been developed that mainly have a higher potency against serine and threonine phosphorylation than against autophosphorylation. We have categorized these compounds into several classes according to their heteroaromatic scaffolds: benzothiazoles, indole, carbazoles, azaindole, purines, β-carboline derivatives, naphthyridines, quinazolines, and polyphenols.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Benzothiazoles</h3><div class="NLM_p">There are many synthetic DYRK1A inhibitors with benzothiazole as their core structure such as <b>21</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). In 2010, Ogawa et al. reported that <b>21</b> is three times more potent (IC<sub>50</sub> = 240 nM) than TG003 (<b>22</b>), (<i>Z</i>)-1-(3-ethyl-5-methoxy-2,3-dihydrobenzothiazol-2-ylidene)propan-2-one) (IC<sub>50</sub> = 930 nM).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Compared to <b>3</b>, compound <b>21</b> exhibited equipotent activity and similar substrate selectivity, suggesting a similar structural mechanism of action. Remarkably, it did not have affinity for monoamine oxidase. However, <b>21</b> also inhibited other DYRK family members, such as DYRK1B, with comparable potency. The co-crystal structure of DYRK1A/<b>21</b> in complex revealed considerable hydrophobic interactions of <b>21</b> with the active site of DYRK1A, where the phenolic hydroxyl group and the carbonyl oxygen of <b>21</b> form hydrogen bonds with the hinge backbone amide NH of Leu241 and with the side chain NH<sub>2</sub> group of Lys188, respectively.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Further, the same group described the efficacy of an acetylated prodrug <b>23</b>, which was hydrolyzed in vivo to generate <b>21</b>, which restored the abnormal development of <i>Xenopus laevis</i> tadpoles.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative benzothiazole analogues as potent DYRK1A inhibitors, with recognized PAINS shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Rothweiler et al. reported benzothiazole derivatives <b>24</b>–<b>26</b>, with an acetamido group at the C2 position of the thiazole moiety, as novel DYRK1A inhibitors for neurodegenerative therapies.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> The structure–activity relationship (SAR) of the benzene ring of the benzothiazoles indicated the 5-hydroxy derivative <b>24</b> (IC<sub>50</sub> = 800 nM), 5-methoxy derivative <b>25</b> (IC<sub>50</sub> = 400 nM), and 6-nitro derivative <b>26</b> (IC<sub>50</sub> = 700 nM) to be the most potent inhibitors. Furthermore, a combination of X-ray crystallography, dynamic NMR, and computational simulation techniques were performed to interpret the binding interactions between fragment-sized variants of the benzothiazole scaffold and the DYRK1A kinase.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Benzofuro-fused INDY (<b>27</b>) ((<i>Z</i>)-1-(1-ethylbenzo[2,3]benzofuro[4,5-<i>d</i>]thiazol-2(1<i>H</i>)-ylidene)propan-2-one, referred to as BINDY) was reported as a novel DYRK1A inhibitor (IC<sub>50</sub> = 25.1 nM).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Compound <b>27</b> was designed and synthesized based on the crystal structure of the DYRK1A/<b>21</b> complex by replacing the phenol group of <b>21</b> with dibenzofuran. However, the presence of a Michael acceptor moiety in <b>21–23</b> and in <b>27</b> raises concern over false positive results in the assays, as discussed above.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><div class="NLM_p">In 2016, by examination of a synthetic chemical library, Kii et al. identified a folding intermediate-selective inhibitor of DYRK1A, compound <b>28</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), is referred to as FINDY ((<i>Z</i>)-5-(4-methoxy-3-((trimethylsilyl)ethynyl) benzylidene)-2-thioxothiazolidin-4-one) and was found to be a highly selective DYRK1A inhibitor compared to other DYRK family members such as DYRK1B and DYRK2.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> It precisely suppressed DYKR1A intramolecular Ser<sup>97</sup>-autophosphorylation (IC<sub>50</sub> = 110 nM), resulting in its degradation by proteasomes, but did not affect tyrosine phosphorylation. In addition, the structure of <b>28</b> is analogous to the competitive ATP inhibitor RD0392 ((<i>Z</i>)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one). Sonamoto et al. developed a bioluminescent reporter assay for evaluating DYRK1A inhibitors and identified <b>29</b> (<i>Z</i>)-5-[(2,3-dihydrobenzofuran-5-yl)methylene]-2-iminothiazolidin-4-one (referred to as CaNDY: CDC37 association inhibitor for DYRK1A) as a potent and selective inhibitor of the DYRK kinase family.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Compound <b>29</b> is a competitive ATP inhibitor that antagonizes the kinase-specific cochaperone CDC37 interaction with DYRK1A and inhibits the substrate phosphorylation of recombinant DYRK1A (IC<sub>50</sub> = 7.9 nM). It also displayed activity against DYRK1B (IC<sub>50</sub> = 24.1 nM), CLK1, CLK2, and haspin among a panel of 275 recombinant kinases. Replacement of the oxygen atom attached to the benzene ring of <b>29</b> by a NH group led to a decrease in inhibitory activity. This demonstrates that the oxygen atoms attached to the aromatic and iminothiazolidinone of <b>29</b> are key pharmacophores for the inhibitory activity against DYRK1A. Interestingly, <b>29</b> selectively destabilizes newly synthesized DYRK1A molecules in cells but does not decrease the level of preaccumulated DYRK1A. However, these compounds (<b>28</b> and <b>29</b>) may have associated PAINS, as their scaffolds contain the recognizable rhodanine PAINS motif or molecules containing rhodanine-related motifs.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Rhodanines can interact nonspecifically with target proteins to form aggregates. It also display multiple behaviors that could give false positive assay readouts such as Michael acceptor ability, metal chelation, and exertion of light-induced reactivity. The ALARM NMR (a La assay to detect reactive molecules by NMR) technique has been used to identify the reactivity of thiols toward rhodanine moiety-containing compounds.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Furthermore, the observed potency of rhodanine- and thiazolidine-2,4-dione-based analogues against a variety of targets reflects the role of exocyclic, thioxo groups present in rhodanines. In comparison with thiazolidine-2,4-dione, rhodanines have a capability to participate in several interactions because of the unique electronic properties of the exocyclic thioxo group.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of selective DYRK1A inhibitors that contain recognizable rhodanine PAINS motifs (red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Indoles and Carbazoles</h3><div class="NLM_p">Dichloroindolyl enaminonitrile (<b>30</b>) (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) was identified as a potent and highly specific non-ATP-competitive inhibitor of CLK kinases.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> It also displayed effective inhibition of DYRK1A, with an IC<sub>50</sub> of 55 nM in enzyme kinetic assays. Guillou et al. evaluated the inhibitory activity of paprotrain (<b>31</b>) on a panel of CNS kinases that were apparently involved in Alzheimer’s disease.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Compound <b>31</b> showed a moderate activity against DYRK1A kinase (IC<sub>50</sub> = 5.5 μM). In a further study inspired by the 6,5,6-fused tricyclic skeleton of <b>3</b>, they reported the synthesis of a series of cyclized pyridocarbazoles, such as <b>32</b> from <b>31</b>, which were screened against a panel of five protein kinases, including DYRK1A.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Among an array of final 11<i>H</i>-pyrido[4,3-<i>a</i>]carbazole derivatives, compound <b>32</b> exhibited high inhibitory activity against DYRK1A (IC<sub>50</sub> = 18 nM). However, it also showed equipotency against DYRK1B (IC<sub>50</sub> = 23 nM) and submicromolar values for CDK5 and GSK3. The SAR of <b>32</b> concluded that the presence of the nitrile group at the 6-position was essential for the strong inhibition of DYRK1A and CLK1. It was also suggested that the rigidity of the scaffold should be taken into consideration when designing CNS kinases inhibitors, particularly with DYRK1A and CLK1. Indirubin has been identified as a promising protein kinase inhibitor scaffold (represented by <b>33</b>).<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> The modified bis-indole derivative <b>33</b> displayed relatively higher inhibitory potencies against DYRK1A and DYRK2 versus other kinases such as CDK5, GSK3, and CK1. The simultaneous introduction of the carboxylate moiety at position 5′ and a bromine group at position 7 of the indirubin scaffold resulted in changing the nonselective bis-indole indirubin into a potent and selective DYRK inhibitor. The co-crystal structure of the <b>33</b>/DYRK2 complex revealed that the carboxylic acid group interacted with Lys178, whereas the bulky bromine created a steric clash between <b>33</b> and the kinase hinge region.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> However, the indirubin moiety-containing compounds should be treated with caution, as indirubin itself has been reported to behave as a promiscuous compound by forming aggregates, at least at micromolar concentrations.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures of representative indole and carbazole derivatives as DYRK1A inhibitors, with PAINS shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In 2012, Routier and colleagues demonstrated the utility of chromeno[3,4-<i>b</i>]indoles, represented by <b>34</b>, as DYRK1A inhibitors for the development of potent treatments for neurological or oncological disorders.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Chromenoindoles have been developed as Lamellarin isosters, which are potent anticancer agents and nonselective inhibitors of several kinases. The SAR analysis indicated that the presence of phenolic OH was essential for the kinase activity. Compound <b>34</b> was the most active DYRK1A inhibitor (IC<sub>50</sub> = 0.067 μM) in the library of chromeno[3,4-<i>b</i>]indoles. Furthermore, the same group described the biological evaluation of a V-shaped molecule library comprising 3-(6-hydroxyindol-2-yl)-5-(phenyl)-pyrazine and pyridine derivatives against DYRK1A, CDK5, and GSK3β.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> It was observed that compound <b>35</b> showed significant inhibitory activity against DYRK1A (IC<sub>50</sub> = 60 nM).</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Indazole</h3><div class="NLM_p">Bain and colleagues identified compound <b>36</b> (A-443654, (2<i>S</i>)-1-(1<i>H</i>-indol-3-yl)-3-[5-(3-methyl-2<i>H</i>-indazol-5-yl)pyridin-3-yl]oxypropan-2-amine) as a potent protein kinase B (PKB) inhibitor (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> This compound showed activity against DYRK1A, but with a lower potency and poor selectivity.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Indazole derivatives <b>36</b> and <b>37</b> as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">5-(Pyridin-3-yl)-1<i>H</i>-indazole (<b>37</b>), named as ALGERNON, is a selective inhibitor of the DYRK1A and CLK families.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Nakano-Kobayashi et al. demonstrated that <b>37</b> suppresses endogenous DYRK1A, as indicated by the suppression of phosphorylation of endogenous Tau in primary hippocampal neurons. Importantly, in a DS mice model, it prevented cognitive deficits by balancing DYRK1A activity and restoring the aberrant brain development caused by DYRK1A expression. DYRK1A negatively regulates neural stem cell (NSC) proliferation.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> The concentration of compound <b>37</b> used in the study showed an enhancement of NSC proliferation, both in vitro and in vivo, through inhibition of DYRK1A. Notably, compound <b>37</b> may serve as a better template than <b>2</b> or <b>3</b> because it does not contain a promiscuous profile. Moreover, a higher concentration was required to inhibit MAO-A than the concentration required to inhibit DYRK1A.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Benzimidazoles and Imidazopyridines</h3><div class="NLM_p">The tetrabromobenzimidazole derivatives such as <b>38a</b> (4,5,6,7-tetrabromo-1<i>H</i>-benzotriazole, TBB), <b>38b</b> (4,5,6,7-tetrabromo-1<i>H</i>-benzimidazole, TBI), and <b>38c</b> (2-dimethylamino-4,5,6,7-tetrabromo-1<i>H</i>-benzimidazole, DMAT) were first identified as casein kinase 2 (CK) inhibitors<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>). These compounds (<b>38a</b>–<b>38c</b>) showed inhibitory activity against DYRK1A (IC<sub>50</sub> = 4.36, 2.1, and 0.41 μM, respectively). Additionally, <b>38c</b> inhibited DYRK2 (IC<sub>50</sub> = 0.35 μM) with almost equimolar potency and had the highest affinity to CK2 (IC<sub>50</sub> = 0.13 μM). However, the promiscuous profile needs to be addressed to develop these compounds as tools for therapeutic use. Recently, a novel benzimidazole series was discovered to possess promising kinase inhibitory activities. Compound <b>39</b> displayed significant affinity for DYRK1A and Pim kinases.<a onclick="showRef(event, 'cit102b'); return false;" href="javascript:void(0);" class="ref cit102b">(102b)</a> In 2017, a series of imidazo[1,2-<i>a</i>]pyridines (<b>40</b>) and benzimidazoles (<b>41</b>) were reported as DYRK1A inhibitors.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Compound <b>41</b> exhibited a more potent inhibition against DYRK1A (60–100% inhibition at 10 μM) than did <b>40</b>. Recently, Branca et al. evaluated the effects of <b>41</b> against DYRK1A on the AD-like pathology developed by 3xTg-AD mice and established that DYRK1A inhibition decreased APP and insoluble Tau phosphorylation.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. General structures of benzimidazoles (<b>38</b>, <b>39</b>, and <b>41</b>) and imidazopyridine (<b>40</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2017, the novel imidazo[4.5-<i>b</i>]pyridine analogue <b>42</b> was reported to be a dual DYRK1A/CLK1 inhibitor (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Compound <b>42</b>, which is structurally similar to the V-shaped molecules, displayed potent inhibitory activity against DYRK1A (IC<sub>50</sub> = 4 nM) and CLK1 (IC<sub>50</sub> = 15 nM) in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Imidazo[4.5-<i>b</i>]pyridine analogue <b>42</b> as a dual DYRK1A/CLK1 kinase inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Azaindoles</h3><div class="NLM_p">Gourdain et al. demonstrated a series of 3,5-diaryl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridines for the inhibition of DYRK1A in vitro.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Compound <b>43a</b>, also called DANDY (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>), was the most potent inhibitor (IC<sub>50</sub> = 3 nM) of DYRK1A in this series. In addition to a strong affinity to CLK1 kinase, compounds with hydroxyl groups on the aryl moieties exhibited a high inhibitory potency (IC<sub>50</sub> = 3–20 nM). In further structure–activity relationship studies, fluoro analogues of <b>43a</b> have been recently synthesized and evaluated for their inhibitory activity against DYRK1A.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Replacing one or two of the phenolic OH groups of the DANDY derivatives by fluoride atoms had a minimal effect on DYRK1A inhibitory activity (compound <b>43b</b>, IC<sub>50</sub> = 20.7 nM). However, the introduction of methoxy or benzyloxy groups to <b>43b</b> in place of the free phenolic hydroxyl groups resulted in a significant loss of inhibitory potency against DYRK1A (e.g., <b>44</b>, 1.43 μM). These results suggest the possibility of pan-assay interference because catechol is recognized as a PAINS motif, as described earlier.<a onclick="showRef(event, 'ref58 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref58 ref60 ref61">(58,60,61)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. DYRK1A inhibitors based on the 6- and 7- azaindole scaffold and a prominent PAINS motif (catechol, shown in red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the basis of the potent inhibitory activity of <b>43a</b> with a 7-azaindole moiety, a library of novel 7-azaindole derivatives served as a lead for the development of DYRK1A inhibitors with submicromolar IC<sub>50</sub> values.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> This series was screened for anticancer efficacy in glioblastoma cell lines, among which <b>45</b> (IC<sub>50</sub> = 43 nM) and <b>46</b> (IC<sub>50</sub> = 6.6 nM) were found to be the most potent; however, submicromolar IC<sub>50</sub> values were determined for DYRK1B, DYRK2, and CLK1 kinases. Both compounds significantly decreased the viability, clonogenic survival, migration, and invasion of glioblastoma cells. Shaw et al. reported a series of meridianin-derived 6-azaindoles for the inhibition of DYRK1A and their effects on the transcription factor NFAT (nuclear factor of activated T cells) in the nucleus.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Compound <b>47</b> was the most potent inhibitor (IC<sub>50</sub> = 1 nM) of DYRK1A and exhibited potent activity (IC<sub>50</sub> = 2.98 μM) in NFAT translocation. The SAR study indicated that introduction of nitrogen at the 6-position of the indole scaffold resulted in strong DYRK1A binding with the inhibitor and an increased NFAT residence time in the nucleus. The increased biological activity arises primarily from the additional interaction between the azaindole nitrogen and the Lys-188 in the back pocket of the ATP binding site of DYRK1A.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Purine Derivatives</h3><div class="NLM_p">In the structure-based development and iterative biological evaluation of CDK1/2 inhibitors, Davies et al. showed that compound <b>48</b> (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) is a potent inhibitor of CDK1/2 (IC<sub>50</sub> = 9 and 6 nM, respectively) and possesses low inhibitory activity against DYRK1A (IC<sub>50</sub> = 0.9 μM) at higher (100 μM) concentrations of ATP.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> The 6-aminopurine analogues purvalanol A (<b>49</b>) and roscovitine (<b>50</b>) were originally developed as potent competitive ATP inhibitors of CDK1, CDK2, and CDK5, but they also showed moderate activity against DYRK1A, with IC<sub>50</sub> values of 0.3 and 3.1 μM, respectively, in cell-based assays.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Moreover, the use of <b>49</b> has assisted in the identification of DYRK1A, not CDK5, as being the kinase responsible for the phosphorylation of specific sites (S1392) in MAP1B (microtubule-associated protein 1B), whereas <b>50</b> only slightly reduced S1392 phosphorylation.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Compound <b>50</b> has entered into clinical trials against various cancers such as leukemia and nonsmall cell lung cancer. To improve the antitumor activity of <b>50</b>, Meijer et al. synthesized a bioisostere of roscovitine (<b>51</b>) and found that it was 2–3-fold more potent than <b>50</b>. Similarly, <b>51</b> had a higher affinity for CDKs than for DYRK1A (IC<sub>50</sub> = 1.3 μM).<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> On the basis of CDK/<b>50</b> co-crystallization structures, the same group designed and reported the more active <i>N</i><sup>6</sup>-biaryl-substituted purine analogue <b>52</b>, bearing a 2-pyridyl substituent on the <i>para</i> position of the phenyl ring.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> A kinase assay performed on a panel of 108 kinases demonstrated that <b>52</b> was a selective inhibitor of CDKs compared to DYRK1A (IC<sub>50</sub> = 0.9 μM). Remarkably, <b>52</b> caused apoptotic cell death, with an approximately 50-fold greater potency than compound <b>50</b>.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Meijer et al. also reported the tri/tetra-substituted imidazo[4,5-<i>b</i>]pyridines exemplified by compound <b>53</b> as CDK and DYRK1A inhibitors.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Among the tested derivatives, <b>53</b> exhibited the most potent activity (IC<sub>50</sub> = 2.8 μM) against DYRK1A.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Purine derivatives <b>48</b>–<b>53</b> as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Thiazolo[ 5,4-<i>f</i>]quinazoline Derivatives</h3><div class="NLM_p">Besson et al. reported the design and synthesis of thiazolo[5,4-<i>f</i>]quinazoline compounds as novel inhibitors of the DYRK family kinases.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> They described the effectiveness of thiazolo[5,4-<i>f</i>]quinazolines against DYRK1A and DYRK1B, and most of them displayed similar or better inhibitory activity than <b>3</b>. In this series, compounds <b>54</b>–<b>58</b> exhibited strong inhibitory activities against DYRK1A (IC<sub>50</sub> = 0.22–0.99 nM) and DYRK1B (IC<sub>50</sub> = 0.28–2.83 nM) (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>). Among these, <b>54</b> and <b>55</b> displayed the most potent and selective inhibition against DYRK1A and DYRK1B (IC<sub>50</sub> of 0.22/0.28 and 0.36/0.59 nM, respectively) among 339 tested kinases. They belong to the most potent and selective DYRK1<i>A</i>/1B inhibitors reported so far. Recent studies conducted by Coutadeur et al. suggest that <b>54</b> inhibits Tau phosphorylation at multiple AD-relevant sites induced by DYRK1A.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Hedou et al. evaluated a series of thiazolo[5,4-<i>f</i>]quinazolin-9(8<i>H</i>)-one derivatives, among which <b>59</b> exhibited potent inhibitory activities against CDK5, GSK-3, CLK1, CK1, and DYRK1A.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a><i>N</i><sup>8</sup>-Aminoquinazolin-9-ones exhibited poor inhibitory activities compared to the C9-amino-substituted quinazolines. These findings suggested that the presence of 3-, 4-, or 5-membered cycloalkyl groups linked to the front pocket is favorable for the development of further SAR studies. Compound <b>59</b> showed nanomolar activity against DYRK1A but also possessed strong affinity for CLK1. Debray et al. investigated the inhibitory activity of a library of heterocycle-fused quinazolin-4-ones against DYRK1A, CDK5, and GSK3 to highlight compound <b>60</b> as a selective inhibitor (IC<sub>50</sub> = 0.61 μM) of DYRK1A.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Thiazolo[5,4-<i>f</i>]quinazoline derivatives as the most potent inhibitors of DYRK1A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Naphthyridines</h3><div class="NLM_p">A series of naphthyridine derivatives exhibited potent inhibitory activity against DYRK1A and DYRK1B.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Among these, CX-4945 (<b>61</b>, (5-[(3-chlorophenyl)amino]benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic acid)) (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>) showed strong inhibitory activity against DYRK1A (IC<sub>50</sub> = 6.8 nM) and DYRK1B (IC<sub>50</sub> = 6.4 nM) and activity against casein kinase 2 (CK2) and Cdc2-like kinases (IC<sub>50</sub> = ∼3–10 nM), which regulate alternative splicing.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> This compound is currently in phase 1b/2 clinical trials as an anticancer agent and was approved as an orphan drug in the USA for the treatment of advanced cholangiocarcinoma. It was also reported that <b>61</b> could be used to prevent and treat degenerative brain diseases associated with DYRK1A.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> It serves as a potent competitive ATP inhibitor and was approximately 20 times more potent in vitro (IC<sub>50</sub> = 6.8 nM) than <b>3</b>, <b>21</b>, and <b>23</b>. Interestingly, the binding modes of <b>61</b> in relation to <b>3</b> with DYRK1A were remarkably identical, which highlighted the importance of tricyclic scaffolds to enhance the inhibitory activity against DYRK1A. As stated previously, <b>3</b> displayed potent inhibition of MAO-A. Thus, it would be important to evaluate the effects of <b>61</b> against MAO-A. Furthermore, <b>61</b> effectively reversed the abnormal phosphorylation of Tau, amyloid precursor protein (APP), and presenilin 1 (PS1) in mammalian cells.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> However, its oral administration apparently blocked Tau hyperphosphorylation in the hippocampus of DYRK1A-overexpressing mice. Hoffman-La Roche AG identified another 1,6-naphthrydine derivative (<b>62</b>) as a potent DYRK1<i>A</i>/1B inhibitor (IC<sub>50</sub> = 4.6 and 13.8 nM, respectively), which exhibited antitumor activity.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Naphthyridine derivatives <b>61</b> and <b>62</b> as potent inhibitors of DYRK1A and DYRK1B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> β-Carboline Derivatives</h3><div class="NLM_p">There has been considerable interest in the development of DYRK1A inhibitors based on the β-carboline scaffold. Falke et al. identified compound <b>63</b> as a potent DYRK1A inhibitor with considerable selectivity against DYRK1A (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Compound <b>63</b> selectively inhibited DYRK1A within the CMGC family of protein kinases. Remarkably, higher selectivity for DYRK1A over DYRK1B (IC<sub>50</sub> values of 6 and 600 nM, respectively) was observed, although the catalytic domains of these kinases have 85% amino acid sequence similarity. This study suggested that substituents at the C10 position of the parent scaffold induce a strong and selective inhibitory activity against DYRK1A: the 10-iodo atom forms a bond with Leu241 through a water molecule via hydrogen bonding in the hinge region, while the deprotonated carboxylic group forms a salt bridge to the conserved Lys188. As a result, the inhibitor is positioned in the ATP binding site of DYRK1A.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Currently, compound <b>63</b> appears to be one of the most selective and potent DYRK1A inhibitors. However, as this molecule contains a lipophilic, flat, aromatic structure, solubility and cell permeability are major drawbacks. Modification of the pyridine ring of <b>3</b> yielded 2,3,4,7-tetrahydro-1<i>H</i>-indolo[2,3-<i>c</i>]quinolinone (<b>64</b>) that inhibited DYRK1A to control Tau phosphorylation.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Compound <b>64</b> was tested for its effects on phosphorylated Tau, and the total Tau expression was compared with those of <b>3</b>–<b>5</b>. Compounds <b>3</b>–<b>5</b> showed remarkable effects in reducing total Tau and phosphorylated Tau levels at doses of ≥1 μM,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> whereas <b>64</b> significantly reduced Tau levels at 50 μM.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of β-carboline derivatives <b>63</b> and <b>64</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Quinoline Derivatives</h3><div class="NLM_p">Quinolines represent an important class of DYRK1A inhibitors. They have higher binding affinity toward the ATP binding site of proteins due to its structural similarities with the adenine moiety. A series of substituted 2-oxo-1,2-dihydro-quinoline analogues (<b>65</b>–<b>67</b>) as DYRK1<i>A</i>/1B inhibitors (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>) and their cellular activity against colorectal adenocarcinoma cell lines were reported by Hoffmann-La Roche AG.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Compounds <b>65</b>–<b>67</b> inhibited DYRK1A selectively in the nanomolar range, while compound <b>65</b> showed better inhibition of a cancer cell line, with an EC<sub>50</sub> of 0.306 μM. Compound <b>68</b> displayed inhibition of DYRK1A; however, it revealed good selectivity toward Pim-1 kinase, a proto-oncogene that encodes a serine/threonine kinase that is known to play a critical role in the control of cell growth and apoptosis.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Examples of quinoline derivatives <b>65</b>–<b>68</b> as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Quinazoline Derivatives</h3><div class="NLM_p">In a combination of in silico, in vitro, and cell-based screenings, 2,4-diamino-quinazoline derivative <b>69</b> inhibited DYRK1A substrate phosphorylation (8% at 10 μM) (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>).<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> It also exhibited activity against the autophosphorylation of DYRK1A, with an IC<sub>50</sub> value of 5 μM, but did not show significant anti-DYRK1A activity at this concentration. Thomas et al. found that <b>70</b> showed selective inhibition against CLK1, CLK4, and DYRK1A (IC<sub>50</sub> = 27 nM) in the screening of 402 kinases.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> The mechanism of action suggests that <b>70</b> inhibited the CLK isozymes by binding at the ATP binding domain. Subsequently, the same group also identified another quinazolin-4-amine derivative (<b>71</b>) as a selective inhibitor of DYRK1A, CLK1, and CLK4.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Interestingly, SAR studies emphasized that the presence of a benzo[1,3]dioxole ring at the C6 position is essential for the inhibitory activity. Compounds <b>70</b> and <b>71</b> displayed strong affinity and selectivity for DYRK1A (IC<sub>50</sub> = 14–27 nM), CLK1, and CLK4 compared to CLK2, CLK3, and DYRK1B. Recently Esvan et al. designed and synthesized a series of pyrido[3,4-<i>g</i>]quinazoline derivatives (exemplified by <b>72</b>) based on meridianin scaffolds by controlling the conformation between the aminopyrimidine and indole moieties and evaluated their activity against five members of the CMGC family kinases (CDK5/p25, CK1δ/ε, GSK-3α/β, CLK1, and DYRK1A).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Compound <b>72</b> displayed nanomolar potency against DYRK1A and CLK1. The X-ray co-crystal structure of <b>72</b> with the ATP binding site of CLK1 showed that the aminopyrimidine moiety is positioned in the hinge region, while the amino group is located toward the ribose pocket.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Quinazoline derivatives <b>69</b>–<b>72</b> as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Pyrimidine Derivatives</h3><div class="NLM_p">Routier et al. identified a group of 2,7-disubstituted pyrido[3,2-<i>d</i>]pyrimidine derivatives, represented by <b>73</b>, which were able to inhibit DYRK1A, CDK5, and GSK3 kinases.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> The SAR study disclosed that pyrido[3,2-<i>d</i>]pyrimidine derivatives selectively inhibited DYRK1A and CDK5 and had a low inhibitory activity toward GSK3. The amide link at the 7-position on the pyrido[3,2-<i>d</i>]pyrimidine core appears to be important for selectivity toward DYRK1A. Compound <b>73</b> exhibited inhibitory activity against DYRK1A, CDK5, and GSK3, with IC<sub>50</sub> values of 60 nM, 2.2 μM, and 4.6 μM, respectively. Compound <b>73</b> had the highest ligand and lipophilic efficacy among the screened pyrido[3,2-<i>d</i>]pyrimidine derivatives. The pyrrolo[2,3-<i>d</i>]pyrimidine derivatives illustrated by <b>74</b> also showed inhibitory effects on DYRK1A and CLK1.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Compound <b>74</b> inhibited DYRK1A, DYRK1B, and CDK9, with IC<sub>50</sub> values of 2.1, 8, and 10 nM, respectively (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>).</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Representative pyrido[3,2-<i>d</i>]pyrimidine (<b>73</b>), pyrrolo[2,3-<i>d</i>]pyrimidine (<b>74</b>), and pyrazolo[3,4-<i>d</i>]pyrimidine (<b>75</b>) as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Hoffman-La Roche AG evaluated a library of pyrazolo[3,4-<i>d</i>]pyrimidines derivatives, represented by <b>75</b>, for their inhibitory activity against DYRK1A and DYRK1B.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> This study mainly focused on the addition of an aromatic ring or lipophilic alkyl chains to the C3 and C6 positions of the pyrazolo[3,4-<i>d</i>]pyrimidine moiety. Compound <b>75</b> displayed a highly effective inhibition of DYRK1A and DYRK1B (IC<sub>50</sub> = 5.9 and 18.3 nM, respectively) compared to other screened pyrazolo[3,4-<i>d</i>]pyrimidines derivatives.</div><div class="NLM_p">The same group also synthesized the pyrido[2,3-<i>d</i>]pyrimidine analogues, represented by <b>76</b>, and evaluated their activity against DYRK1A and DYRK1B (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>), among which 18 compounds exhibited nanomolar inhibitory activity against DYRK1A and DYRK1B (IC<sub>50</sub> = 4.6–15 nM).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> However, selectivity among the two subtypes, DYRK1A and DYRK1B, was not achieved in this series. For instance, the best activity was achieved with <b>76</b> toward DYRK1A (IC<sub>50</sub> = 4.6 nM) versus DYRK1B (IC<sub>50</sub> = 10.5 nM).</div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Pyrido[2,3-<i>d</i>]pyrimidine derivative <b>76</b> as a potent inhibitor of DYRK1A and DYRK1B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Pyridazine Derivatives</h3><div class="NLM_p">Bendjeddou et al. described the inhibitory activity of various 3,6-disubstituted imidazo[1,2-<i>b</i>]pyridazine derivatives against CLKs, CDKs, and DYRKs.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> In this series, the oxime derivative <b>77</b> (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>) exhibited significant inhibitory activities against DYRK1A (IC<sub>50</sub> = 33 nM), DYRK1B (IC<sub>50</sub> = 170 nM), and CLK2 (IC<sub>50</sub> = 59 nM) as well as moderate activity for CDK1 (1.1 μM). Compound <b>78</b>, bearing a pyridine moiety at the 6-position on the pyridazin-3(2<i>H</i>)-one moiety, showed moderate inhibitory activity against DYRK1A (IC<sub>50</sub> = 0.61 μM).<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> However, no activity was observed against CDK5, GSK3, and PI3Kα kinases.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Pyridazine derivatives <b>77</b> and <b>78</b> as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Polyphenols</h3><div class="NLM_p">Polyphenols have by no means been completely explored in the study of DYRK1A, and much attention needs to be focused on these moieties. However, few polyphenolic compounds (<b>79</b>–<b>83</b>) showed inhibitory activity toward DYRK1A, as is illustrated in <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>. Compound <b>79</b> was found to be a potent inhibitor of CK2 (IC<sub>50</sub> = 0.37 μM), an enzyme that has been known to prevent programmed cell death.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Nevertheless, it also showed inhibition of DYRK1A (IC<sub>50</sub> = 15.0 μM) although to a lesser extent. Interestingly, compound <b>80</b>, replacing the nitro group at the 9-position of <b>79</b> with hydrogen, showed a remarkable increase in its activity against DYRK1A (IC<sub>50</sub> = 0.6 μM), while a loss of the binding affinity for CK2 was observed (IC<sub>50</sub> > 30 μM). Docking studies regarding CK2 and DYRK1A proposed that compound <b>80</b> was deeply buried in the binding cleft of DYRK1A compared to <b>79</b> to interact with both the hinge region and the phosphate binding region. The methyl group at C4 was positioned between Ile165 and Val173 and thus protected from the solvent. The C4 methyl of <b>80</b> was placed in the opposite direction from how it was oriented in the <b>79</b>–CK2 complex. This type of interaction suggests that the nitro group at C9 (<b>79</b>) is unfavorable for DYRK1A activity due to the restricted approach of the bulky group by the gatekeeper Phe238 in DYRK1A.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Polyphenols <b>79</b>–<b>83</b> as DYRK1A inhibitors, with recognized PAINS motifs highlighted in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Folmer et al. evaluated the effect of <b>81</b>, known as flavokavain A, on a panel of 52 protein kinases and found that at 50 μM it reduced the activity of DYRK1A, PRAK, and Aurora B by 90%, 91%, and 84%, respectively, in a kinase inhibition assay.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> In this study, protein kinase activities were reported as a percentage relative to untreated K562 cells (= 100%). The flavonoid derivative <b>82</b> was found to show anticancer activity by targeting DYRK1A (IC<sub>50</sub> = 0.62 μM).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> It also displayed less potency toward the inhibition of DYRK1B (IC<sub>50</sub> = 6.4 μM). Compound <b>83</b> decreased the activity of DYRK1A/1B and CLK1, with IC<sub>50</sub> values of 2.9, 2.3, and 1.9 μM, respectively.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Moreover, compounds <b>81</b> and <b>82</b> displayed features associated with frequent-hitters because they possessed a Michael acceptor and a flavonoid moiety in their respective structures. These groups can interfere in the assays, as they are covalent modifiers. These compounds seem to be highly susceptible to aggregation in biochemical assay conditions. Flavonoids are frequently identified as false positives in fluorescence- or absorbance-based assays due to their colored extracts or intrinsic fluorescence. Flavonoids have been reported to generate reactive oxygen species (ROS), causing cysteine oxidation.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Beause of the apparent involvement of DYRK1A in cancer, DS, AD, and other neurodegenerative diseases, DYRK1A inhibitors have been recommended for use as potential therapeutics because these molecules are capable of diffusing across the blood–brain barrier (BBB). The discovery of selective DYRK1A inhibitors has slowly evolved, and this process still largely relies on the development of competitive ATP inhibitors that act by binding within the DYRK1A kinase domain in its active conformation when the activation loop is phosphorylated. Most of the inhibitors developed to date possess chemical structures resembling an adenine moiety and include various nitrogen heterocyclic compounds such as imidazopyridines, purines, quinoline, and quinazolines. These heteroaromatic motifs, due to their shape and hydrophobic nature, usually involve multiple interactions with protein, resulting in highly efficient binding to the kinase domain. Moreover, the extent of target selectivity is derived from the rigidity of inhibitors and the hydrogen bonding potential from their heteroatoms. However, despite the advantages their physical properties bring, they also have a major limitation in their low aqueous solubility.</div><div class="NLM_p">From a medicinal chemistry perspective, it is rather complicated and difficult to draw conclusions from the extensive lists of natural and synthetic DYRK1A inhibitors reported so far to direct further design. Docking experiments and various three-dimensional structures of DYRK1A complexed with diverse competitive ATP inhibitors could suggest which DYRK1A amino acid residues are essential for binding interaction. Obviously, additional studies are required to clarify the exact mechanisms of DYRK1A kinase inhibition by various inhibitors. In short, a deeper understanding of multiple interactions between the DYRK1A substrate and different inhibitors will help develop the rationale for discovering and developing novel DYRK1A inhibitors.</div><div class="NLM_p">The majority of DYRK1A inhibitors discussed here were originally developed to target structurally related kinases such as other kinases in the DYRK family and CDKs. It has been observed that many DYRK1A inhibitors have a higher affinity for serine/threonine phosphorylation than for tyrosine autophosphorylation. One of these examples is harmine, which inhibits the substrate phosphorylation of DYRK1A with higher potency than tyrosine autophosphorylation.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Moreover, DYRK1A kinase activity is thoroughly controlled by two sequential conformational states, one of which has an immature transitory folding intermediate and the second has a mature conformation of the kinase. However, these processes are kinetically extremely different. The inhibitors that preferentially inhibit tyrosine autophosphorylation in contrast to serine and threonine phosphorylation of substrates induce conformational changes in DYRK1A, resulting in loss of function; these inhibitors might show a new direction for developing potent and specific inhibitors. For example, β-carboline DYRK1A inhibitor <b>7b</b> preferentially inhibits tyrosine autophosphorylation of DYRK1A at concentrations >1 μM, whereas higher concentrations of <b>7b</b> were required to inhibit threonine phosphorylation in SF3B1.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> In contrast, excessive inhibition of DYRK1A may be deleterious due to long-term function loss in other biological signaling pathways. On that account, in most of the cases, it would be more beneficial to design inhibitors that specifically inhibit substrate phosphorylation over tyrosine autophosphorylation.</div><div class="NLM_p">It is extremely challenging to achieve selectivity and specificity among the closely related kinases, such as the CMGC group of kinases, as these kinases share a high structural similarity in the ATP binding sites, with only slight differences. Notably, DYRK1B shares 85% identical amino acid sequence similarity in the N-terminal and catalytic domains of DYRK1A.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Designing selective DYRK1A inhibitors would be very useful to investigate the role of DYRK1A in pathobiochemical and physiological processes. The DYRK1A inhibitors known thus far show poor selectivity among other closely related protein kinases of the CMGC superfamily, which includes CDKs, MAP kinases (such as extracellular signal-regulated kinases, known as ERKs), GSK-3, and CDC-like kinases. As discussed earlier, most of the known DYRK1A inhibitors act by competing with ATP in the binding pocket of the kinase. Therefore, further studies should be directed toward exploring the interactions of DYRK1A inhibitors with the DYRK1A kinase conformations or kinase subfamilies that can help distinguish the target kinase from other kinases.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Additionally, the competitive ATP inhibitors must resolve the difficulties encountered from high intracellular ATP levels, which may cause inconsistencies between the IC<sub>50</sub> values measured by biochemical versus cellular assays. To overcome these problems, the design of non-ATP-competitive inhibitors provides an opportunity for the further development of selective and specific inhibitors with novel chemical scaffolds, as these inhibitors do not compete with the intracellular concentrations of ATP and are more specific than ATP-competitive inhibitors. It also targets more diverse regions or premature kinases; furthermore, the non-ATP-mimetic inhibitors interfere with the functionality of the ATP binding site by inducing a conformational shift in the target enzyme such that the kinase is no longer able to function. Nevertheless, some novel interesting compounds have been in development as selective and more specific inhibitors of DYRK1A. For example, we discussed novel compound <b>63</b> as a potent and selective inhibitor of DYRK1A compared to other DYRKs and members of the CLK kinase family.</div><div class="NLM_p">Currently, major efforts are being made in developing strong and selective DYRK1A inhibitors for therapies of neurodegenerative disorders, myeloid leukemias, and gliomas. Because the use of the most potent and orally bioavailable archetypical DYRK1A inhibitor (<b>3</b>), progressive changes have been made to this class of inhibitors over the past few years. Compound <b>3</b> exhibited potent activity against cell growth and tumorigenesis in myeloid leukemias and gliomas. Harmine analogues <b>7a</b> and <b>7b</b> could also be developed as chemical probes for DYRK1A in terms of selectivity and potency. Furthermore, considering the relevance of DYRK1A in cancer, it appears that newly reported DYRK1A inhibitors, which are mainly developed for their applicability in neurodegenerative diseases, could also be considered as anticancer agents for acute megakaryoblastic leukemia (AMKL) and glioblastoma multiforme (GBM). It is desirable to study the efficacy of DYRK1A inhibitors in other neural tumors that display overexpression of DYRK1A such as oligodendrogliomas.</div><div class="NLM_p">Harmine-inspired heterocyclic compound <b>61</b>, a potent DYRK1A inhibitor, has demonstrated its therapeutic potential for DYRK1A-associated diseases, and this molecule is currently in clinical trials (phase II) for cancer treatment. Therefore, it is foreseeable that more potent and selective DYRK1A drug candidates with different and new mechanisms of action will considerably increase in clinical trials in the near future.</div><div class="NLM_p">To determine the target of action in the treatment of animal models and patients with DYRK1A drug candidates, it is necessary to develop practical, sensitive detection methods that enable a rapid and accurate investigation of the effects of the inhibitors in cells, animals, and patients.</div><div class="NLM_p last">From a development perspective, the biggest challenge is to design DYRK1A inhibitors in such a way that it does not suppress the DYRK1A activity completely but only to a certain extent where it does not affect the healthy individual. For example, excessive inhibition of DYRK1A in the case of MRD7 caused loss-of-function mutations of DYRK1A.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inhibition of DYRK1A serves as an emerging area of investigation, and a large number of DYRK1A inhibitors have been actively discovered, mainly by targeting the ATP competitive binding site. Some of the discovered DYRK1A inhibitors have already entered clinical trials. Few DYRK1A inhibitors are specific for DYRK1A among the CMGC group of kinases; hence, the issues of selectivity and specificity need to be addressed to utilize DYRK1A inhibitors as tools for understanding the role of DYRK1A in physiological and pathological processes. These studies will lead to the validation of DYRK1A as a potential drug target, particularly in Down syndrome and Alzheimer’s disease.</div><div class="NLM_p last">In the future, we anticipate the possibility of substantial changes in the diagnosis and treatment of various neurodegenerative disorders.</div></div><div class="NLM_back"><div class="NLM_notes" id="notes-1">#<span class="title" id="d97552375e2287">Author Contributions</span><p class="last">J.D.B. and M.K.K. are co-first-authors and contributed equally to this work. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></div><div class="NLM_notes" id="notes-2"><p class="first last">The authors declare no competing financial interest.</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00185" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lak Shin Jeong</span> - <span class="hlFld-Affiliation affiliation">Research Institute of Pharmaceutical
Sciences, College of Pharmacy, Seoul National
University, Seoul 08826, Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3441-707X" title="Orcid link">http://orcid.org/0000-0002-3441-707X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#acc0cdc7c6c9c3c2cbecdfc2d982cdcf82c7de"><span class="__cf_email__" data-cfemail="660a070d0c0309080126150813480705480d14">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dnyandev
B. Jarhad</span> - <span class="hlFld-Affiliation affiliation">Research Institute of Pharmaceutical
Sciences, College of Pharmacy, Seoul National
University, Seoul 08826, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karishma K. Mashelkar</span> - <span class="hlFld-Affiliation affiliation">Research Institute of Pharmaceutical
Sciences, College of Pharmacy, Seoul National
University, Seoul 08826, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong-Rae Kim</span> - <span class="hlFld-Affiliation affiliation">Research Institute of Pharmaceutical
Sciences, College of Pharmacy, Seoul National
University, Seoul 08826, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minsoo Noh</span> - <span class="hlFld-Affiliation affiliation">Research Institute of Pharmaceutical
Sciences, College of Pharmacy, Seoul National
University, Seoul 08826, Korea</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.D.B. and M.K.K. are co-first-authors and contributed equally to this work. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30871" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30871" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Dnyandev
B. Jarhad</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=BIO-d7e2587-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Dnyandev B. Jarhad</b> received his Ph.D. degree in 2016 from Indian Institutes of Technology Bombay (IIT Bombay), India, where he worked with Professor V. K. Singh on the total synthesis of natural products and their analogues. Since 2016, he is pursuing postdoctoral research at Seoul National University under the guidance of Professor Lak Shin Jeong. His current research interests include development of therapeutic nucleosides, particularly antiviral and antitumor nucleosides.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Karishma K. Mashelkar</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=BIO-d7e2592-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Karishma K. Mashelkar</b> obtained her M.S. degree in Organic Chemistry from Goa University (India) and then she joined Syngenta research and development, India, as a Research Associate in their discovery group. She is currently pursuing her doctoral degree under the supervision of Prof. Lak Shin Jeong at Seoul National University. Her current research is related to the medicinal chemistry field and mainly focuses on the design and synthesis of nucleosides as kinase inhibitors.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Hong-Rae Kim</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=BIO-d7e2597-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Hong-Rae Kim</b> earned his bachelor’s degree in chemistry from the University of Washington, Seattle, USA, in 2012. He is currently pursuing his doctoral degree at Seoul National University under the supervision of professor Lak Shin Jeong. His current research focuses on the synthesis of bioactive modified nucleosides.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Minsoo Noh</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=BIO-d7e2602-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Professor Minsoo Noh</b> received his bachelor’s and master’s degrees from Seoul National University and completed his Ph.D. at the Massachusetts Institute of Technology, USA. After working at Bioscience & Skin Research Department of Amorepacific Corporation as a principal investigator for few years, he joined the College of Pharmacy, Ajou University, as a faculty member in 2010 and moved to the College of Pharmacy, Seoul National University, in 2013. He currently is an associate professor at Seoul National University where he is conducting active research.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Lak Shin Jeong</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=BIO-d7e2607-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Professor Lak Shin Jeong</b> received his B.S. (1984) and M.S. (1986) degrees from Seoul National University and a Ph.D. (1992) from the University of Georgia working under the direction of Prof. Chung K. Chu. After carrying out postdoctoral research at the National Cancer Institute, USA, he joined the faculty of the College of Pharmacy at Ewha Womans University as Assistant Professor (1995) and was promoted to full professor in 2002. In 2013, he moved to the College of Pharmacy, Seoul National University. His research interests include development of novel antiviral nucleosides using chiral templates, development of methodologies for antiviral and antitumor nucleosides, computer-aided drug design, synthesis of antisense oligonucleotides, development of adenosine receptor ligands, and development of novel next-generation 4′-selenonucleosides.</p></figure></div><div class="ack" id="ACK-d7e2612-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by the grants from Midcareer Research Program (2016R1A2B3010164) and the Ministry of Science, ICT & Future Planning (2017M3A9A8032086) of the National Research Foundation (NRF) of Korea</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ALARM NMR</td><td class="NLM_def"><p class="first last">a La assay to detect reactive molecules by nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">AMKL</td><td class="NLM_def"><p class="first last">acute megakaryoblastic leukemia</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">AurA</td><td class="NLM_def"><p class="first last">Aurora A kinase</p></td></tr><tr><td class="NLM_term">AurB</td><td class="NLM_def"><p class="first last">Aurora B kinase</p></td></tr><tr><td class="NLM_term">BINDY</td><td class="NLM_def"><p class="first last">benzofuro-fused inhibitor of DYRK</p></td></tr><tr><td class="NLM_term">CaNDY</td><td class="NLM_def"><p class="first last">CDC37 association inhibitor for DYRK1A</p></td></tr><tr><td class="NLM_term">Cdc2</td><td class="NLM_def"><p class="first last">cell division control protein 2 homologue</p></td></tr><tr><td class="NLM_term">CDKs</td><td class="NLM_def"><p class="first last">cyclin-dependent kinases</p></td></tr><tr><td class="NLM_term">Chk1</td><td class="NLM_def"><p class="first last">checkpoint kinase 1</p></td></tr><tr><td class="NLM_term">CK1/2</td><td class="NLM_def"><p class="first last">casein kinase 1/2</p></td></tr><tr><td class="NLM_term">CK5</td><td class="NLM_def"><p class="first last">casein kinase 5</p></td></tr><tr><td class="NLM_term">CLKs</td><td class="NLM_def"><p class="first last">cyclin-dependent-like kinases</p></td></tr><tr><td class="NLM_term">CMGC</td><td class="NLM_def"><p class="first last">cyclin-dependent kinases (CDKs), mitogen-activated protein kinases (MAP kinases), glycogen synthase kinases (GSK), and CDK-like kinases</p></td></tr><tr><td class="NLM_term">DANDY</td><td class="NLM_def"><p class="first last">diaryl-azaindole inhibitors of DYRK1A</p></td></tr><tr><td class="NLM_term">DMAT</td><td class="NLM_def"><p class="first last">2-dimethylamino-4,5,6,7-tetrabromo-1<i>H</i>-benzimidazole</p></td></tr><tr><td class="NLM_term">DMT</td><td class="NLM_def"><p class="first last"><i>N</i>, <i>N</i>-dimethyltryptamine</p></td></tr><tr><td class="NLM_term">DS</td><td class="NLM_def"><p class="first last">Down syndrome</p></td></tr><tr><td class="NLM_term">DYRK1A</td><td class="NLM_def"><p class="first last">dual-specificity tyrosine-regulated kinase 1A</p></td></tr><tr><td class="NLM_term">EGCG</td><td class="NLM_def"><p class="first last">epigallocatechin gallate</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">ERKs</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinases</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">FGFR1</td><td class="NLM_def"><p class="first last">fibroblast growth factor receptor 1</p></td></tr><tr><td class="NLM_term">Ftl3</td><td class="NLM_def"><p class="first last">fms like tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">GBM</td><td class="NLM_def"><p class="first last">glioblastoma multiforme</p></td></tr><tr><td class="NLM_term">GSK3</td><td class="NLM_def"><p class="first last">glycogen synthase kinase-3</p></td></tr><tr><td class="NLM_term">HGK</td><td class="NLM_def"><p class="first last">hepatocyte progenitor kinase-like/germinal center kinase-like kinase</p></td></tr><tr><td class="NLM_term">Ikkb</td><td class="NLM_def"><p class="first last">inhibitor of nuclear factor kappa-B kinase subunit beta</p></td></tr><tr><td class="NLM_term">INDY</td><td class="NLM_def"><p class="first last">inhibitor of DYRK</p></td></tr><tr><td class="NLM_term">Jak2</td><td class="NLM_def"><p class="first last">Janus kinase 2</p></td></tr><tr><td class="NLM_term">KDR</td><td class="NLM_def"><p class="first last">kinase insert domain receptor</p></td></tr><tr><td class="NLM_term">MAO-A</td><td class="NLM_def"><p class="first last">monoamine oxidase A</p></td></tr><tr><td class="NLM_term">MAP</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MAP1B</td><td class="NLM_def"><p class="first last">microtubule-associated protein</p></td></tr><tr><td class="NLM_term">MAPKs</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinases</p></td></tr><tr><td class="NLM_term">MRD7</td><td class="NLM_def"><p class="first last">mental retardation disease 7</p></td></tr><tr><td class="NLM_term">NFAT</td><td class="NLM_def"><p class="first last">nuclear factor of activated T-cells</p></td></tr><tr><td class="NLM_term">NFATc</td><td class="NLM_def"><p class="first last">nuclear factor of activated T-cells, cytoplasmic</p></td></tr><tr><td class="NLM_term">NFTs</td><td class="NLM_def"><p class="first last">neurofibrillary tangles</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan assay interfering compounds</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PIM1</td><td class="NLM_def"><p class="first last">proto-oncogene serine/threonine-protein kinase</p></td></tr><tr><td class="NLM_term">PKB</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">PRAK</td><td class="NLM_def"><p class="first last">p38 regulated/activated kinase</p></td></tr><tr><td class="NLM_term">PS1</td><td class="NLM_def"><p class="first last">presenilin 1</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SF3B1</td><td class="NLM_def"><p class="first last">splicing factor 3b1</p></td></tr><tr><td class="NLM_term">Spry2</td><td class="NLM_def"><p class="first last">Sprouty2</p></td></tr><tr><td class="NLM_term">SYK</td><td class="NLM_def"><p class="first last">spleen tyrosine kinase</p></td></tr><tr><td class="NLM_term">TBB</td><td class="NLM_def"><p class="first last">4,5,6,7-tetrabromo-1<i>H</i>-benzotriazole</p></td></tr><tr><td class="NLM_term">TBI</td><td class="NLM_def"><p class="first last">4,5,6,7-tetrabromo-1<i>H</i>-benzimidazole</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 142 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whyte, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudarsanam, S.</span></span> <span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span>,  <span class="NLM_fpage">1912</span>– <span class="NLM_lpage">1934</span>, <span class="refDoi"> DOI: 10.1126/science.1075762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome&doi=10.1126%2Fscience.1075762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0lhQ0ceIffy_2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934%26doi%3D10.1126%2Fscience.1075762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanks, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1096/fasebj.9.8.7768349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1096%2Ffasebj.9.8.7768349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=7768349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1ajsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=576-596&author=S.+K.+Hanksauthor=T.+Hunter&title=Protein+kinases+6.+The+eukaryotic+protein+kinase+superfamily%3A+kinase+%28catalytic%29+domain+structure+and+classification&doi=10.1096%2Ffasebj.9.8.7768349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases. 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</span></div><div class="casAuthors">Hanks, Steven K.; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">576-96</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 48 refs.  The eukaryotic protein kinases make up a large superfamily of homologous proteins.  They are related by virtue of their kinase domains (also known as catalytic domains), which consist of ∼250-300 amino acid residues.  The kinase domains that define this group of enzymes contain 12 conserved subdomains that fold into a common catalytic core structure, as revealed by the 3-dimensional structures of several protein-serine kinases.  There are 2 main subdivisions within the superfamily: the protein-serine/threonine kinases and the protein-tyrosine kinases.  A classification scheme can be founded on a kinase domain phylogeny, which reveals families of enzymes that have related substrate specificities and modes of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxv30nsEyVU7Vg90H21EOLACvtfcHk0ljX_bpkkNy4Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1ajsbc%253D&md5=869a3926ba04f288947f80616bdcfb98</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.9.8.7768349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.9.8.7768349%26sid%3Dliteratum%253Aachs%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DProtein%2520kinases%25206.%2520The%2520eukaryotic%2520protein%2520kinase%2520superfamily%253A%2520kinase%2520%2528catalytic%2529%2520domain%2520structure%2520and%2520classification%26jtitle%3DFASEB%2520J.%26date%3D1995%26volume%3D9%26spage%3D576%26epage%3D596%26doi%3D10.1096%2Ffasebj.9.8.7768349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soppa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">DYRK protein kinases</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">R488</span>– <span class="NLM_lpage">R489</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2015.02.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.cub.2015.02.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26079075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1SgurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=R488-R489&author=U.+Soppaauthor=W.+Becker&title=DYRK+protein+kinases&doi=10.1016%2Fj.cub.2015.02.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK protein kinases</span></div><div class="casAuthors">Soppa, Ulf; Becker, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">R488-R489</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjVfjs-P7fGbVg90H21EOLACvtfcHk0ljX_bpkkNy4Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1SgurfM&md5=671c9aa42a244c7cdf1b640bde8829e6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2015.02.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2015.02.067%26sid%3Dliteratum%253Aachs%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DDYRK%2520protein%2520kinases%26jtitle%3DCurr.%2520Biol.%26date%3D2015%26volume%3D25%26spage%3DR488%26epage%3DR489%26doi%3D10.1016%2Fj.cub.2015.02.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aranda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laguna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de La Luna, S.</span></span> <span> </span><span class="NLM_article-title">DYRK family of protein kinases: evolutionary relationships, biochemical properties and functional roles</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1096/fj.10-165837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1096%2Ffj.10-165837" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=449-462&author=S.+Arandaauthor=A.+Lagunaauthor=S.+de+La+Luna&title=DYRK+family+of+protein+kinases%3A+evolutionary+relationships%2C+biochemical+properties+and+functional+roles&doi=10.1096%2Ffj.10-165837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1096%2Ffj.10-165837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.10-165837%26sid%3Dliteratum%253Aachs%26aulast%3DAranda%26aufirst%3DS.%26aulast%3DLaguna%26aufirst%3DA.%26aulast%3Dde%2BLa%2BLuna%26aufirst%3DS.%26atitle%3DDYRK%2520family%2520of%2520protein%2520kinases%253A%2520evolutionary%2520relationships%252C%2520biochemical%2520properties%2520and%2520functional%2520roles%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D449%26epage%3D462%26doi%3D10.1096%2Ffj.10-165837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span> <span> </span><span class="NLM_article-title">Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity</span>. <i>Prog. Nucleic Acid Res. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/S0079-6603(08)60503-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2FS0079-6603%2808%2960503-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1998&pages=1-17&author=W.+Beckerauthor=H.+G.+Joost&title=Structural+and+functional+characteristics+of+Dyrk%2C+a+novel+subfamily+of+protein+kinases+with+dual+specificity&doi=10.1016%2FS0079-6603%2808%2960503-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0079-6603%2808%2960503-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6603%252808%252960503-6%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26atitle%3DStructural%2520and%2520functional%2520characteristics%2520of%2520Dyrk%252C%2520a%2520novel%2520subfamily%2520of%2520protein%2520kinases%2520with%2520dual%2520specificity%26jtitle%3DProg.%2520Nucleic%2520Acid%2520Res.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D62%26spage%3D1%26epage%3D17%26doi%3D10.1016%2FS0079-6603%2808%2960503-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Himpel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eirmbter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czajkowska, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packman, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kentrup, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">505</span>, <span class="refDoi"> DOI: 10.1042/bj3590497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1042%2Fbj3590497" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2001&pages=497-505&author=S.+Himpelauthor=P.+Panzerauthor=K.+Eirmbterauthor=H.+Czajkowskaauthor=M.+Sayedauthor=L.+C.+Packmanauthor=T.+Blundellauthor=H.+Kentrupauthor=J.+Grotzingerauthor=H.+G.+Joostauthor=W.+Becker&title=Identification+of+the+autophosphorylation+sites+and+characterization+of+their+effects+in+the+protein+kinase+DYRK1A&doi=10.1042%2Fbj3590497"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2Fbj3590497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3590497%26sid%3Dliteratum%253Aachs%26aulast%3DHimpel%26aufirst%3DS.%26aulast%3DPanzer%26aufirst%3DP.%26aulast%3DEirmbter%26aufirst%3DK.%26aulast%3DCzajkowska%26aufirst%3DH.%26aulast%3DSayed%26aufirst%3DM.%26aulast%3DPackman%26aufirst%3DL.%2BC.%26aulast%3DBlundell%26aufirst%3DT.%26aulast%3DKentrup%26aufirst%3DH.%26aulast%3DGrotzinger%26aufirst%3DJ.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520the%2520autophosphorylation%2520sites%2520and%2520characterization%2520of%2520their%2520effects%2520in%2520the%2520protein%2520kinase%2520DYRK1A%26jtitle%3DBiochem.%2520J.%26date%3D2001%26volume%3D359%26spage%3D497%26epage%3D505%26doi%3D10.1042%2Fbj3590497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lochhead, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibbet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrice, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleghon, V.</span></span> <span> </span><span class="NLM_article-title">Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2005.03.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.cell.2005.03.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=15960979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1GksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2005&pages=925-936&author=P.+Lochheadauthor=G.+Sibbetauthor=N.+Morriceauthor=V.+Cleghon&title=Activation-loop+autophosphorylation+is+mediated+by+a+novel+transitional+intermediate+form+of+DYRKs&doi=10.1016%2Fj.cell.2005.03.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs</span></div><div class="casAuthors">Lochhead, Pamela A.; Sibbet, Gary; Morrice, Nick; Cleghon, Vaughn</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">925-936</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autophosphorylation of a crit. residue in the activation loop of several protein kinases is an essential maturation event required for full enzyme activity.  However, the mol. mechanism by which this happens is unknown.  We addressed this question for two dual-specificity tyrosine-phosphorylation-regulated protein kinases (DYRKs), as they autophosphorylate their activation loop on an essential tyrosine but phosphorylate their substrates on serine and threonine.  Here we demonstrate that autophosphorylation of the crit. activation-loop tyrosine is intramol. and mediated by the nascent kinase passing through a transitory intermediate form.  This DYRK intermediate differs in residue and substrate specificity, as well as sensitivity to small-mol. inhibitors, compared with its mature counterpart.  The intermediate's characteristics are lost upon completion of translation, making the crit. tyrosine autophosphorylation a one-off inceptive event.  This mechanism is likely to be shared with other kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtQ1sZC9Uhg7Vg90H21EOLACvtfcHk0liT3qkvWUj7gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1GksL8%253D&md5=ff5e78400ba9b038cef11b2a5c9b1801</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.03.034%26sid%3Dliteratum%253Aachs%26aulast%3DLochhead%26aufirst%3DP.%26aulast%3DSibbet%26aufirst%3DG.%26aulast%3DMorrice%26aufirst%3DN.%26aulast%3DCleghon%26aufirst%3DV.%26atitle%3DActivation-loop%2520autophosphorylation%2520is%2520mediated%2520by%2520a%2520novel%2520transitional%2520intermediate%2520form%2520of%2520DYRKs%26jtitle%3DCell%26date%3D2005%26volume%3D121%26spage%3D925%26epage%3D936%26doi%3D10.1016%2Fj.cell.2005.03.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guedj, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes Pereira, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barallobre, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souchet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebrie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herault, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span> <span> </span><span class="NLM_article-title">DYRK1A: A master regulatory protein controlling brain growth</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2012.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.nbd.2012.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=22293606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ontb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=190-203&author=F.+Guedjauthor=P.+Lopes+Pereiraauthor=S.+Najasauthor=M.+J.+Barallobreauthor=C.+Chabertauthor=B.+Souchetauthor=C.+Sebrieauthor=C.+Verneyauthor=Y.+Heraultauthor=M.+Arbonesauthor=J.+M.+Delabar&title=DYRK1A%3A+A+master+regulatory+protein+controlling+brain+growth&doi=10.1016%2Fj.nbd.2012.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A: A master regulatory protein controlling brain growth</span></div><div class="casAuthors">Guedj, Faycal; Pereira, Patricia Lopes; Najas, Sonia; Barallobre, Maria-Jose; Chabert, Caroline; Souchet, Benoit; Sebrie, Catherine; Verney, Catherine; Herault, Yann; Arbones, Mariona; Delabar, Jean M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-203</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Copy no. variation in a small region of chromosome 21 contg. DYRK1A produces morphol. and cognitive alterations in human.  In mouse models, haploinsufficiency results in microcephaly, and a human DYRK1A gain-of-function model (three alleles) exhibits increased brain vol.  To investigate these developmental aspects, we used a murine BAC clone contg. the entire gene to construct an overexpression model driven by endogenous regulatory sequences.  We compared this new model to two other mouse models with three copies of Dyrk1a, YACtgDyrk1a and Ts65Dn, as well as the loss-of-function model with one copy (Dyrk1a +/-).  Growth, viability, brain wt., and brain vol. depended strongly upon gene copy no.  Brain region-specific variations obsd. in gain-of-function models mirror their counterparts in the loss-of-function model.  Some variations, such as increased vol. of the superior colliculus and ventricles, were obsd. in both the BAC transgenic and Ts65Dn mice.  Using unbiased stereol. we found that, in the cortex, neuron d. is inversely related to Dyrk1a copy no. but, in thalamic nuclei, neuron d. is directly related to copy no.  In addn., six genes involved either in cell division (Ccnd1 and pAkt) or in neuronal machinery (Gap43, Map2, Syp, Snap25) were regulated by Dyrk1a throughout development, from birth to adult.  These results imply that Dyrk1a expression alters different cellular processes during brain development.  Dyrk1a, then, has two roles in the development process: shaping the brain and controlling the structure of neuronal components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopV3riBNwb3rVg90H21EOLACvtfcHk0lilWKbrkVZubA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ontb8%253D&md5=ebf45820a2d4fa915f03a4d35fb8dacd</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2012.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2012.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DGuedj%26aufirst%3DF.%26aulast%3DLopes%2BPereira%26aufirst%3DP.%26aulast%3DNajas%26aufirst%3DS.%26aulast%3DBarallobre%26aufirst%3DM.%2BJ.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DSouchet%26aufirst%3DB.%26aulast%3DSebrie%26aufirst%3DC.%26aulast%3DVerney%26aufirst%3DC.%26aulast%3DHerault%26aufirst%3DY.%26aulast%3DArbones%26aufirst%3DM.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26atitle%3DDYRK1A%253A%2520A%2520master%2520regulatory%2520protein%2520controlling%2520brain%2520growth%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2012%26volume%3D46%26spage%3D190%26epage%3D203%26doi%3D10.1016%2Fj.nbd.2012.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerle, B.</span></span> <span> </span><span class="NLM_article-title">MNB/DYRK1A as a multiple regulator of neuronal development</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07954.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1742-4658.2010.07954.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=223-235&author=F.+J.+Tejedorauthor=B.+Hammerle&title=MNB%2FDYRK1A+as+a+multiple+regulator+of+neuronal+development&doi=10.1111%2Fj.1742-4658.2010.07954.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07954.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07954.x%26sid%3Dliteratum%253Aachs%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DHammerle%26aufirst%3DB.%26atitle%3DMNB%252FDYRK1A%2520as%2520a%2520multiple%2520regulator%2520of%2520neuronal%2520development%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D223%26epage%3D235%26doi%3D10.1111%2Fj.1742-4658.2010.07954.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Fernandez, J.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderrama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindreu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Luna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altafaj, X.</span></span> <span> </span><span class="NLM_article-title">DYRK1A-mediated phosphorylation of GluN2A at ser(1048) regulates the surface expression and channel activity of GluN1/GluN2A receptors</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">331</span>, <span class="refDoi"> DOI: 10.3389/fncel.2014.00331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.3389%2Ffncel.2014.00331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25368549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVynu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=331&author=C.+Grauauthor=K.+Aratoauthor=J.%0AM.+Fernandez-Fernandezauthor=A.+Valderramaauthor=C.+Sindreuauthor=C.+Fillatauthor=I.+Ferrerauthor=S.+de+la+Lunaauthor=X.+Altafaj&title=DYRK1A-mediated+phosphorylation+of+GluN2A+at+ser%281048%29+regulates+the+surface+expression+and+channel+activity+of+GluN1%2FGluN2A+receptors&doi=10.3389%2Ffncel.2014.00331"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A-mediated phosphorylation of GluN2A at Ser1048 regulates the surface expression and channel activity of GluN1/GluN2A receptors</span></div><div class="casAuthors">Grau, Cristina; Arato, Krisztina; Fernandez-Fernandez, Jose M.; Valderrama, Aitana; Sindreu, Carlos; Fillat, Cristina; Ferrer, Isidre; de la Luna, Susana; Altafaj, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">331/1-331/13</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate glutamate receptors (NMDARs) play a pivotal role in neural development and synaptic plasticity, as well as in neurol. disease.  Since NMDARs exert their function at the cell surface, their d. in the plasma membrane is finely tuned by a plethora of mols. that regulate their prodn., trafficking, docking and internalization in response to external stimuli.  In addn. to transcriptional regulation, the d. of NMDARs is also influenced by post-translational mechanisms like phosphorylation, a modification that also affects their biophys. properties.We previously described the increased surface expression of GluN1/GluN2A receptors in transgenic mice overexpressing the Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), suggesting that DYRK1A regulates NMDARs.  Here we have further investigated whether the d. and activity of NMDARs were modulated by DYRK1A phosphorylation.  Accordingly, we show that endogenous DYRK1A is recruited to GluN2A-contg. NMDARs in the adult mouse brain, and we identify a DYRK1A phosphorylation site at Ser1048 of GluN2A, within its intracellular C-terminal domain.  Mechanistically, the DYRK1A-dependent phosphorylation of GluN2A at Ser1048 hinders the internalization of GluN1/GluN2A, causing an increase of surface GluN1/GluN2A in heterologous systems, as well as in primary cortical neurons.  Furthermore, GluN2A phosphorylation at Ser1048 increases the c.d. and potentiates the gating of GluN1/GluN2A receptors.  We conclude that DYRK1A is a direct regulator of NMDA receptors and we propose a novel mechanism for the control of NMDAR activity in neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAkr-L6eNnULVg90H21EOLACvtfcHk0lilWKbrkVZubA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVynu7rE&md5=f3b39ef031a7d82dac155e5bf1ee5df0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2014.00331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2014.00331%26sid%3Dliteratum%253Aachs%26aulast%3DGrau%26aufirst%3DC.%26aulast%3DArato%26aufirst%3DK.%26aulast%3DFernandez-Fernandez%26aufirst%3DJ.%2BM.%26aulast%3DValderrama%26aufirst%3DA.%26aulast%3DSindreu%26aufirst%3DC.%26aulast%3DFillat%26aufirst%3DC.%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3Dde%2Bla%2BLuna%26aufirst%3DS.%26aulast%3DAltafaj%26aufirst%3DX.%26atitle%3DDYRK1A-mediated%2520phosphorylation%2520of%2520GluN2A%2520at%2520ser%25281048%2529%2520regulates%2520the%2520surface%2520expression%2520and%2520channel%2520activity%2520of%2520GluN1%252FGluN2A%2520receptors%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D331%26doi%3D10.3389%2Ffncel.2014.00331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbassi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, L.</span></span> <span> </span><span class="NLM_article-title">DYRK1A in neurodegeneration and cancer: molecular basis and clinical implications</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.pharmthera.2015.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25795597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2015&pages=87-98&author=R.+Abbassiauthor=T.+G.+Johnsauthor=M.+Kassiouauthor=L.+Munoz&title=DYRK1A+in+neurodegeneration+and+cancer%3A+molecular+basis+and+clinical+implications&doi=10.1016%2Fj.pharmthera.2015.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span></div><div class="casAuthors">Abbassi, Ramzi; Johns, Terrance G.; Kassiou, Michael; Munoz, Lenka</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Protein kinases are one of the most studied drug targets in current pharmacol. research, as evidenced by the vast no. of kinase-targeting agents enrolled in active clin. trials.  Dual-specificity Tyrosine phosphorylation-Regulated Kinase 1A (DYRK1A) has been much less studied compared to many other kinases.  DYRK1A primary function occurs during early development, where this protein regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells.  Although most extensively characterized for its role in brain development, DYRK1A is over-expressed in a variety of diseases including a no. of human malignancies, such as haematol. and brain cancers.  Here we review the accumulating mol. studies that support our understanding of how DYRK1A signalling could underlie these pathol. functions.  The relevance of DYRK1A in a no. of diseases is also substantiated with intensive drug discovery efforts to develop potent and selective inhibitors of DYRK1A.  Several classes of DYRK1A inhibitors have recently been disclosed and some mols. are promising leads to develop DYRK1A inhibitors as drugs for DYRK1A-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIdxPFd6Zn0LVg90H21EOLACvtfcHk0lg552GxR325jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D&md5=bbe08b211b477f0d4a279c34c6d36b42</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DAbbassi%26aufirst%3DR.%26aulast%3DJohns%26aufirst%3DT.%2BG.%26aulast%3DKassiou%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DL.%26atitle%3DDYRK1A%2520in%2520neurodegeneration%2520and%2520cancer%253A%2520molecular%2520basis%2520and%2520clinical%2520implications%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D151%26spage%3D87%26epage%3D98%26doi%3D10.1016%2Fj.pharmthera.2015.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span> <span> </span><span class="NLM_article-title">The role of DYRK1A in neurodegenerative diseases</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07955.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1742-4658.2010.07955.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21156028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=236-245&author=J.+Wegielauthor=C.+X.+Gongauthor=Y.+W.+Hwang&title=The+role+of+DYRK1A+in+neurodegenerative+diseases&doi=10.1111%2Fj.1742-4658.2010.07955.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of DYRK1A in neurodegenerative diseases</span></div><div class="casAuthors">Wegiel, Jerzy; Gong, Cheng-Xin; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-245</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Recent studies indicate that the dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene, which is located on chromosome 21q22.2 and is overexpressed in Down syndrome (DS), may play a significant role in developmental brain defects and in early onset neurodegeneration, neuronal loss and dementia in DS.  The identification of hundreds of genes deregulated by DYRK1A overexpression and numerous cytosolic, cytoskeletal and nuclear proteins, including transcription factors, phosphorylated by DYRK1A, indicates that DYRK1A overexpression is central for the deregulation of multiple pathways in the developing and aging DS brain, with structural and functional alterations including mental retardation and dementia.  DYRK1A overexpression in DS brains may contribute to early onset neurofibrillary degeneration directly through hyperphosphorylation of tau and indirectly through phosphorylation of alternative splicing factor, leading to an imbalance between 3R-tau and 4R-tau.  The several-fold increases in the no. of DYRK1A-pos. and 3R-tau-pos. neurofibrillary tangles in DS support this hypothesis.  Moreover, the enhanced phosphorylation of amyloid precursor protein by overexpressed DYRK1A facilitates amyloidogenic amyloid precursor protein cleavage elevating Aβ40 and 42 levels, and leading to brain β-amyloidosis.  Therefore, inhibiting DYRK1A activity in DS may serve to counteract the phenotypic effects of its overexpression and is a potential method of treatment of developmental defects and the prevention of age-assocd. neurodegeneration, including Alzheimer-type pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6EhMKZ0hzPbVg90H21EOLACvtfcHk0lg552GxR325jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D&md5=ac857b61ce21452dac070f1c26a75d38</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07955.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07955.x%26sid%3Dliteratum%253Aachs%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DThe%2520role%2520of%2520DYRK1A%2520in%2520neurodegenerative%2520diseases%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D236%26epage%3D245%26doi%3D10.1111%2Fj.1742-4658.2010.07955.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammerle, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elizalde, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galceran, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F. J.</span></span> <span> </span><span class="NLM_article-title">The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications</span>. <i>J. Neural Transm., Suppl.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1007/978-3-7091-6721-2_11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1007%2F978-3-7091-6721-2_11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2003&pages=129-137&author=B.+Hammerleauthor=C.+Elizaldeauthor=J.+Galceranauthor=W.+Beckerauthor=F.+J.+Tejedor&title=The+MNB%2FDYRK1A+protein+kinase%3A+neurobiological+functions+and+Down+syndrome+implications&doi=10.1007%2F978-3-7091-6721-2_11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-6721-2_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-6721-2_11%26sid%3Dliteratum%253Aachs%26aulast%3DHammerle%26aufirst%3DB.%26aulast%3DElizalde%26aufirst%3DC.%26aulast%3DGalceran%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520MNB%252FDYRK1A%2520protein%2520kinase%253A%2520neurobiological%2520functions%2520and%2520Down%2520syndrome%2520implications%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D2003%26volume%3D67%26spage%3D129%26epage%3D137%26doi%3D10.1007%2F978-3-7091-6721-2_11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altafaj, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierssen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baamonde, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martí, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimerà, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oset, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flórez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estivill, X.</span></span> <span> </span><span class="NLM_article-title">Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down’s syndrome</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1915</span>– <span class="NLM_lpage">1923</span>, <span class="refDoi"> DOI: 10.1093/hmg/10.18.1915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1093%2Fhmg%2F10.18.1915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=11555628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlSgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1915-1923&author=X.+Altafajauthor=M.+Dierssenauthor=C.+Baamondeauthor=E.+Mart%C3%ADauthor=J.+Visaauthor=J.+Guimer%C3%A0author=M.+Osetauthor=J.+R.+Gonz%C3%A1lezauthor=J.+Fl%C3%B3rezauthor=C.+Fillatauthor=X.+Estivill&title=Neurodevelopmental+delay%2C+motor+abnormalities+and+cognitive+deficits+in+transgenic+mice+overexpressing+Dyrk1A+%28minibrain%29%2C+a+murine+model+of+Down%E2%80%99s+syndrome&doi=10.1093%2Fhmg%2F10.18.1915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome</span></div><div class="casAuthors">Altafaj, Xavier; Dierssen, Mara; Baamonde, Carmela; Marti, Eulalia; Visa, Joana; Guimera, Jordi; Oset, Marta; Gonzalez, Juan Ramon; Florez, Jesus; Fillat, Cristina; Estivill, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1915-1923</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Down's syndrome (DS) is a major cause of mental retardation, hypotonia and delayed development.  Murine models of DS carrying large murine or human genomic fragments show motor alterations and memory deficits.  The specific genes responsible for these phenotypic alterations have not yet been defined.  DYRK1A, the human homolog of the Drosophila minibrain gene, maps to the DS crit. region of human chromosome 21 and is overexpressed in DS fetal brain.  DYRK1A encodes a serine-threonine kinase, probably involved in neuroblast proliferation.  Mutant Drosophila minibrain flies have a redn. in both optic lobes and central brain, showing learning deficits and hypoactivity.  We have generated transgenic mice (TgDyrk1A) overexpressing the full-length cDNA of Dyrk1A.  TgDyrk1A mice exhibit delayed craniocaudal maturation with functional consequences in neuromotor development.  TgDyrk1A mice also show altered motor skill acquisition and hyperactivity, which is maintained to adulthood.  In the Morris water maze, TgDyrk1A mice show a significant impairment in spatial learning and cognitive flexibility, indicative of hippocampal and prefrontal cortex dysfunction.  In the more complex repeated reversal learning paradigm, this defect turned out to be specifically related to ref. memory, whereas working memory was almost unimpaired.  These alterations are comparable with those found in the partial trisomy chromosome 16 murine models of DS and suggest a causative role of DYRK1A in mental retardation and in motor anomalies of DS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwXDiQutGJ07Vg90H21EOLACvtfcHk0lgZTN_z5QzZZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlSgsb0%253D&md5=f31c3a38ca72e9d5709a489f34732b6a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.18.1915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.18.1915%26sid%3Dliteratum%253Aachs%26aulast%3DAltafaj%26aufirst%3DX.%26aulast%3DDierssen%26aufirst%3DM.%26aulast%3DBaamonde%26aufirst%3DC.%26aulast%3DMart%25C3%25AD%26aufirst%3DE.%26aulast%3DVisa%26aufirst%3DJ.%26aulast%3DGuimer%25C3%25A0%26aufirst%3DJ.%26aulast%3DOset%26aufirst%3DM.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DJ.%2BR.%26aulast%3DFl%25C3%25B3rez%26aufirst%3DJ.%26aulast%3DFillat%26aufirst%3DC.%26aulast%3DEstivill%26aufirst%3DX.%26atitle%3DNeurodevelopmental%2520delay%252C%2520motor%2520abnormalities%2520and%2520cognitive%2520deficits%2520in%2520transgenic%2520mice%2520overexpressing%2520Dyrk1A%2520%2528minibrain%2529%252C%2520a%2520murine%2520model%2520of%2520Down%25E2%2580%2599s%2520syndrome%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1915%26epage%3D1923%26doi%3D10.1093%2Fhmg%2F10.18.1915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duchon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herault, Y.</span></span> <span> </span><span class="NLM_article-title">DYRK1A, a dosage-sensitive gene involved in neurodevelopment disorders, is a target for drug development in Down syndrome</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">104</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2016.00104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.3389%2Ffnbeh.2016.00104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27375444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVOjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=104&author=A.+Duchonauthor=Y.+Herault&title=DYRK1A%2C+a+dosage-sensitive+gene+involved+in+neurodevelopment+disorders%2C+is+a+target+for+drug+development+in+Down+syndrome&doi=10.3389%2Ffnbeh.2016.00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in down syndrome</span></div><div class="casAuthors">Duchon, Arnaud; Herault, Yann</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104/1-104/17</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Down syndrome (DS) is one of the leading causes of intellectual disability, and patients with DS face various health issues, including learning and memory deficits, congenital heart disease, Alzheimer's disease (AD), leukemia, and cancer, leading to huge medical and social costs.  Remarkable advances on DS research have been made in improving cognitive function in mouse models for future therapeutic approaches in patients.  Among the different approaches, DYRK1A inhibitors have emerged as promising therapeutics to reduce DS cognitive deficits.  DYRK1A is a dual-specificity kinase that is overexpressed in DS and plays a key role in neurogenesis, outgrowth of axons and dendrites, neuronal trafficking and aging.  Its pivotal role in the DS phenotype makes it a prime target for the development of therapeutics.  Recently, disruption of DYRK1A has been found in Autosomal Dominant Mental Retardation 7 (MRD7), resulting in severe mental deficiency.  Recent advances in the development of kinase inhibitors are expected, in the near future, to remove DS from the list of incurable diseases, providing certain conditions such as drug dosage and correct timing for the optimum long-term treatment.  In addn. the exact mol. and cellular mechanisms that are targeted by the inhibition of DYRK1A are still to be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7AgNJ5S7XmbVg90H21EOLACvtfcHk0lgZTN_z5QzZZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVOjtrc%253D&md5=c343957f33c6d2dddac430de1904791d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2016.00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2016.00104%26sid%3Dliteratum%253Aachs%26aulast%3DDuchon%26aufirst%3DA.%26aulast%3DHerault%26aufirst%3DY.%26atitle%3DDYRK1A%252C%2520a%2520dosage-sensitive%2520gene%2520involved%2520in%2520neurodevelopment%2520disorders%252C%2520is%2520a%2520target%2520for%2520drug%2520development%2520in%2520Down%2520syndrome%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2016%26volume%3D10%26spage%3D104%26doi%3D10.3389%2Ffnbeh.2016.00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bronicki, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drunat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passemard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thevenon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riviere, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isidor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francannet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aylsworth, A. S.</span></span> <span> </span><span class="NLM_article-title">Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A</span>. <i>Eur. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1482</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1038/ejhg.2015.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fejhg.2015.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25920557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFyjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1482-1487&author=L.+M.+Bronickiauthor=C.+Redinauthor=S.+Drunatauthor=A.+Pitonauthor=M.+Lyonsauthor=S.+Passemardauthor=C.+Baumannauthor=L.+Faivreauthor=J.+Thevenonauthor=J.+B.+Riviereauthor=B.+Isidorauthor=G.+Ganauthor=C.+Francannetauthor=M.+Willemsauthor=M.+Gunelauthor=J.+R.+Jonesauthor=J.+G.+Gleesonauthor=J.+L.+Mandelauthor=R.+E.+Stevensonauthor=M.+J.+Friezauthor=A.+S.+Aylsworth&title=Ten+new+cases+further+delineate+the+syndromic+intellectual+disability+phenotype+caused+by+mutations+in+DYRK1A&doi=10.1038%2Fejhg.2015.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A</span></div><div class="casAuthors">Bronicki, Lucas M.; Redin, Claire; Drunat, Severine; Piton, Amelie; Lyons, Michael; Passemard, Sandrine; Baumann, Clarisse; Faivre, Laurence; Thevenon, Julien; Riviere, Jean-Baptiste; Isidor, Bertrand; Gan, Grace; Francannet, Christine; Willems, Marjolaine; Gunel, Murat; Jones, Julie R.; Gleeson, Joseph G.; Mandel, Jean-Louis; Stevenson, Roger E.; Friez, Michael J.; Aylsworth, Arthur S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1482-1487</span>CODEN:
                <span class="NLM_cas:coden">EJHGEU</span>;
        ISSN:<span class="NLM_cas:issn">1018-4813</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) gene, located on chromosome 21q22.13 within the Down syndrome crit. region, has been implicated in syndromic intellectual disability assocd. with Down syndrome and autism.  DYRK1A has a crit. role in brain growth and development primarily by regulating cell proliferation, neurogenesis, neuronal plasticity and survival.  Several patients have been reported with chromosome 21 aberrations such as partial monosomy, involving multiple genes including DYRK1A.  In addn., seven other individuals have been described with chromosomal rearrangements, intragenic deletions or truncating mutations that disrupt specifically DYRK1A.  Most of these patients have microcephaly and all have significant intellectual disability.  In the present study, we report 10 unrelated individuals with DYRK1A-assocd. intellectual disability (ID) who display a recurrent pattern of clin. manifestations including primary or acquired microcephaly, ID ranging from mild to severe, speech delay or absence, seizures, autism, motor delay, deep-set eyes, poor feeding and poor wt. gain.  We identified unique truncating and non-synonymous mutations (three nonsense, four frameshift and two missense) in DYRK1A in nine patients and a large chromosomal deletion that encompassed DYRK1A in one patient.  On the basis of increasing identification of mutations in DYRK1A, we suggest that this gene be considered potentially causative in patients presenting with ID, primary or acquired microcephaly, feeding problems and absent or delayed speech with or without seizures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6MOK9bTJTGbVg90H21EOLACvtfcHk0lgZTN_z5QzZZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFyjsrg%253D&md5=ebf2ad7398ad34bdd2ab681d55613954</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fejhg.2015.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fejhg.2015.29%26sid%3Dliteratum%253Aachs%26aulast%3DBronicki%26aufirst%3DL.%2BM.%26aulast%3DRedin%26aufirst%3DC.%26aulast%3DDrunat%26aufirst%3DS.%26aulast%3DPiton%26aufirst%3DA.%26aulast%3DLyons%26aufirst%3DM.%26aulast%3DPassemard%26aufirst%3DS.%26aulast%3DBaumann%26aufirst%3DC.%26aulast%3DFaivre%26aufirst%3DL.%26aulast%3DThevenon%26aufirst%3DJ.%26aulast%3DRiviere%26aufirst%3DJ.%2BB.%26aulast%3DIsidor%26aufirst%3DB.%26aulast%3DGan%26aufirst%3DG.%26aulast%3DFrancannet%26aufirst%3DC.%26aulast%3DWillems%26aufirst%3DM.%26aulast%3DGunel%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DJ.%2BR.%26aulast%3DGleeson%26aufirst%3DJ.%2BG.%26aulast%3DMandel%26aufirst%3DJ.%2BL.%26aulast%3DStevenson%26aufirst%3DR.%2BE.%26aulast%3DFriez%26aufirst%3DM.%2BJ.%26aulast%3DAylsworth%26aufirst%3DA.%2BS.%26atitle%3DTen%2520new%2520cases%2520further%2520delineate%2520the%2520syndromic%2520intellectual%2520disability%2520phenotype%2520caused%2520by%2520mutations%2520in%2520DYRK1A%26jtitle%3DEur.%2520J.%2520Hum.%2520Genet.%26date%3D2015%26volume%3D23%26spage%3D1482%26epage%3D1487%26doi%3D10.1038%2Fejhg.2015.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Branca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfiore, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meechoovet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oddo, S.</span></span> <span> </span><span class="NLM_article-title">Dyrk1 inhibition improves Alzheimer’s disease-like pathology</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1146</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1111/acel.12648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Facel.12648" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=1146-1154&author=C.+Brancaauthor=D.+M.+Shawauthor=R.+Belfioreauthor=V.+Gokhaleauthor=A.+Y.+Shawauthor=C.+Foleyauthor=B.+Smithauthor=C.+Hulmeauthor=T.+Dunckleyauthor=B.+Meechoovetauthor=A.+Caccamoauthor=S.+Oddo&title=Dyrk1+inhibition+improves+Alzheimer%E2%80%99s+disease-like+pathology&doi=10.1111%2Facel.12648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Facel.12648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Facel.12648%26sid%3Dliteratum%253Aachs%26aulast%3DBranca%26aufirst%3DC.%26aulast%3DShaw%26aufirst%3DD.%2BM.%26aulast%3DBelfiore%26aufirst%3DR.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DShaw%26aufirst%3DA.%2BY.%26aulast%3DFoley%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DHulme%26aufirst%3DC.%26aulast%3DDunckley%26aufirst%3DT.%26aulast%3DMeechoovet%26aufirst%3DB.%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DOddo%26aufirst%3DS.%26atitle%3DDyrk1%2520inhibition%2520improves%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%26jtitle%3DAging%2520Cell%26date%3D2017%26volume%3D16%26spage%3D1146%26epage%3D1154%26doi%3D10.1111%2Facel.12648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stotani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medda, F.</span></span> <span> </span><span class="NLM_article-title">DYRK1A inhibition as potential treatment for Alzheimer’s disease</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.4155%2Ffmc-2016-0013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27073990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=681-696&author=S.+Stotaniauthor=F.+Giordanettoauthor=F.+Medda&title=DYRK1A+inhibition+as+potential+treatment+for+Alzheimer%E2%80%99s+disease&doi=10.4155%2Ffmc-2016-0013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A inhibition as potential treatment for Alzheimer's disease</span></div><div class="casAuthors">Stotani, Silvia; Giordanetto, Fabrizio; Medda, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">681-696</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">In total, 47,500,000 people worldwide are affected by dementia and this no. is estd. to double by 2030 and triple within 2050 resulting in a huge burden on public health.  Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the most common cause of dementia, accounting for 60-70% of all the cases.  The cause of AD is still poorly understood but several brain abnormalities (e.g., loss of neuronal connections and neuronal death) have been identified in affected patients.  In addn. to the accumulation of β-amyloid plaques in the brain tissue, aberrant phosphorylation of tau proteins has proved to increase neuronal death.  DYRK1A phosphorylates tau on 11 different Ser/Thr residues, resulting in the formation of aggregates called 'neurofibrillary tangles' which, together with amyloid plaques, could be responsible for dementia, neuronal degeneration and cell death.  Small mol. inhibition of DYRK1A could thus represent an interesting approach toward the treatment of Alzheimer's and other neurodegenerative diseases.  Herein we review the current progress in the identification and development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIkkQdSVqce7Vg90H21EOLACvtfcHk0ljgLtI7eCt-Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFSqsrY%253D&md5=7f90e6dc11edc4d395371d7ad07460d7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0013%26sid%3Dliteratum%253Aachs%26aulast%3DStotani%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMedda%26aufirst%3DF.%26atitle%3DDYRK1A%2520inhibition%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D681%26epage%3D696%26doi%3D10.4155%2Ffmc-2016-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanjappa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puttamallesh, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaji, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahasrabuddhe, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, T. S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santosh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukumar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Califano, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangarajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A.</span></span> <span> </span><span class="NLM_article-title">A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">36132</span>, <span class="refDoi"> DOI: 10.1038/srep36132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fsrep36132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27796319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSitLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=36132&author=A.+Radhakrishnanauthor=V.+Nanjappaauthor=R.+Rajaauthor=G.+Satheauthor=V.+N.+Puttamalleshauthor=A.+P.+Jainauthor=S.+M.+Pintoauthor=S.+A.+Balajiauthor=S.+Chavanauthor=N.+A.+Sahasrabuddheauthor=P.+P.+Mathurauthor=M.+M.+Kumarauthor=T.+S.+K.+Prasadauthor=V.+Santoshauthor=G.+Sukumarauthor=J.+A.+Califanoauthor=A.+Rangarajanauthor=D.+Sidranskyauthor=A.+Pandeyauthor=H.+Gowdaauthor=A.+Chatterjee&title=A+dual+specificity+kinase%2C+DYRK1A%2C+as+a+potential+therapeutic+target+for+head+and+neck+squamous+cell+carcinoma&doi=10.1038%2Fsrep36132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma</span></div><div class="casAuthors">Radhakrishnan, Aneesha; Nanjappa, Vishalakshi; Raja, Remya; Sathe, Gajanan; Puttamallesh, Vinuth N.; Jain, Ankit P.; Pinto, Sneha M.; Balaji, Sai A.; Chavan, Sandip; Sahasrabuddhe, Nandini A.; Mathur, Premendu P.; Kumar, Mahesh M.; Prasad, T. S. Keshava; Santosh, Vani; Sukumar, Geethanjali; Califano, Joseph A.; Rangarajan, Annapoorni; Sidransky, David; Pandey, Akhilesh; Gowda, Harsha; Chatterjee, Aditi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36132</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite advances in clin. management, 5-yr survival rate in patients with late-stage head and neck squamous cell carcinoma (HNSCC) has not improved significantly over the past decade.  Targeted therapies have emerged as one of the most promising approaches to treat several malignancies.  Though tyrosine phosphorylation accounts for a minority of total phosphorylation, it is crit. for activation of signaling pathways and plays a significant role in driving cancers.  To identify activated tyrosine kinase signaling pathways in HNSCC, we compared the phosphotyrosine profiles of a panel of HNSCC cell lines to a normal oral keratinocyte cell line.  Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A) was one of the kinases hyperphosphorylated at Tyr-321 in all HNSCC cell lines.  Inhibition of DYRK1A resulted in an increased apoptosis and decrease in invasion and colony formation ability of HNSCC cell lines.  Further, administration of the small mol. inhibitor against DYRK1A in mice bearing HNSCC xenograft tumors induced regression of tumor growth.  Immunohistochem. labeling of DYRK1A in primary tumor tissues using tissue microarrays revealed strong to moderate staining of DYRK1A in 97.5% (39/40) of HNSCC tissues analyzed.  Taken together our results suggest that DYRK1A could be a novel therapeutic target in HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFYbEnXY2yF7Vg90H21EOLACvtfcHk0ljgLtI7eCt-Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSitLrM&md5=e62722030bd916a48be15e20230d32ff</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsrep36132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep36132%26sid%3Dliteratum%253Aachs%26aulast%3DRadhakrishnan%26aufirst%3DA.%26aulast%3DNanjappa%26aufirst%3DV.%26aulast%3DRaja%26aufirst%3DR.%26aulast%3DSathe%26aufirst%3DG.%26aulast%3DPuttamallesh%26aufirst%3DV.%2BN.%26aulast%3DJain%26aufirst%3DA.%2BP.%26aulast%3DPinto%26aufirst%3DS.%2BM.%26aulast%3DBalaji%26aufirst%3DS.%2BA.%26aulast%3DChavan%26aufirst%3DS.%26aulast%3DSahasrabuddhe%26aufirst%3DN.%2BA.%26aulast%3DMathur%26aufirst%3DP.%2BP.%26aulast%3DKumar%26aufirst%3DM.%2BM.%26aulast%3DPrasad%26aufirst%3DT.%2BS.%2BK.%26aulast%3DSantosh%26aufirst%3DV.%26aulast%3DSukumar%26aufirst%3DG.%26aulast%3DCalifano%26aufirst%3DJ.%2BA.%26aulast%3DRangarajan%26aufirst%3DA.%26aulast%3DSidransky%26aufirst%3DD.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DGowda%26aufirst%3DH.%26aulast%3DChatterjee%26aufirst%3DA.%26atitle%3DA%2520dual%2520specificity%2520kinase%252C%2520DYRK1A%252C%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D36132%26doi%3D10.1038%2Fsrep36132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Martinez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahonero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Gomez, P.</span></span> <span> </span><span class="NLM_article-title">DYRK: the double-edge kinase as a protagonist in cell growth and tumorigenesis</span>. <i>Mol. Cell. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e970048</span>, <span class="refDoi"> DOI: 10.4161/23723548.2014.970048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.4161%2F23723548.2014.970048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27308401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=e970048&author=P.+Fernandez-Martinezauthor=C.+Zahoneroauthor=P.+Sanchez-Gomez&title=DYRK%3A+the+double-edge+kinase+as+a+protagonist+in+cell+growth+and+tumorigenesis&doi=10.4161%2F23723548.2014.970048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis</span></div><div class="casAuthors">Fernandez-Martinez, P.; Zahonero, C.; Sanchez-Gomez, P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e970048/1-e970048/11</span>CODEN:
                <span class="NLM_cas:coden">MCOOCO</span>;
        ISSN:<span class="NLM_cas:issn">2372-3556</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">DYRK1A (dual-specificity tyrosine-regulated kinase 1A) is a kinase with multiple implications for embryonic development, esp. in the nervous system where it regulates the balance between proliferation and differentiation of neural progenitors.  The DYRK1A gene is located in the Down syndrome crit. region and may play a significant role in the developmental brain defects, early neurodegeneration, and cancer susceptibility of individuals with this syndrome.  DYRK1A is also expressed in adults, where it might participate in the regulation of cell cycle, survival, and tumorigenesis, thus representing a potential therapeutic target for certain types of cancer.  However, the final readout of DYRK1A overexpression or inhibition depends strongly on the cellular context, as it has both tumor suppressor and oncogenic activities.  Here, we will discuss the functions and substrates of DYRK1A assocd. with the control of cell growth and tumorigenesis with a focus on the potential use of DYRK1A inhibitors in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OUDGl-nB87Vg90H21EOLACvtfcHk0lhQoUN4cy2awg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWqtr0%253D&md5=27153f30af11f2572ba271ee09dd9939</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4161%2F23723548.2014.970048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F23723548.2014.970048%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Martinez%26aufirst%3DP.%26aulast%3DZahonero%26aufirst%3DC.%26aulast%3DSanchez-Gomez%26aufirst%3DP.%26atitle%3DDYRK%253A%2520the%2520double-edge%2520kinase%2520as%2520a%2520protagonist%2520in%2520cell%2520growth%2520and%2520tumorigenesis%26jtitle%3DMol.%2520Cell.%2520Oncol.%26date%3D2015%26volume%3D2%26spage%3De970048%26doi%3D10.4161%2F23723548.2014.970048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ionescu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufrasne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelbcke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoral-Theys, D.</span></span> <span> </span><span class="NLM_article-title">DYRK1A kinase inhibitors with emphasis on cancer</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1315</span>– <span class="NLM_lpage">1329</span>, <span class="refDoi"> DOI: 10.2174/13895575112091315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.2174%2F13895575112091315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=23016545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1315-1329&author=A.+Ionescuauthor=F.+Dufrasneauthor=M.+Gelbckeauthor=I.+Jabinauthor=R.+Kissauthor=D.+Lamoral-Theys&title=DYRK1A+kinase+inhibitors+with+emphasis+on+cancer&doi=10.2174%2F13895575112091315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A kinase inhibitors with emphasis on cancer</span></div><div class="casAuthors">Ionescu, A.; Dufrasne, F.; Gelbcke, M.; Jabin, I.; Kiss, R.; Lamoral-Theys, D.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1315-1329</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Various types of cancers (including gliomas, melanomas, and esophageal, pancreas and non-small-cell lung cancers) display intrinsic resistance to pro-apoptotic stimuli, such as conventional chemotherapy and radiotherapy, and/or the activation of a multidrug resistance phenotype, which are major barriers to effective treatment and lead to poor patient prognosis.  The DYRK1A kinase is directly implicated in the resistance of cancer cells to pro-apoptotic stimuli and drives several pathways that enhance proliferation, migration, and the redn. of cell death, leading to very aggressive biol. behavior in cancer cell populations.  The DYRK1A kinase is also implicated in neurol. diseases and in neoangiogenic processes.  Thus, the DYRK1A kinase is of great interest for both cancer and neuroscience research.  During the last decade, numerous compds. that inhibit DYRK1A have been synthesized.  The present review discusses the available mols. known to interfere with DYRK1A activity and the implications of DYRK1A in cancer and other diseases and serves as a rational anal. for researchers who aim to improve the anti-DYRK1A activity of currently available compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxH4Qznig8rVg90H21EOLACvtfcHk0lhQoUN4cy2awg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI&md5=9acac0cacdc9fbfd558d6199ff4e3a96</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F13895575112091315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13895575112091315%26sid%3Dliteratum%253Aachs%26aulast%3DIonescu%26aufirst%3DA.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DGelbcke%26aufirst%3DM.%26aulast%3DJabin%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DLamoral-Theys%26aufirst%3DD.%26atitle%3DDYRK1A%2520kinase%2520inhibitors%2520with%2520emphasis%2520on%2520cancer%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D1315%26epage%3D1329%26doi%3D10.2174%2F13895575112091315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen-Tran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeusen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamireddy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swafford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursalaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiDonato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deaton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarez-Pinzon, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hering, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin Seidel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laffitte, B.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A and GSK3β induces human β-cell proliferation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8372</span>, <span class="refDoi"> DOI: 10.1038/ncomms9372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fncomms9372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26496802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslegu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8372&author=W.+Shenauthor=B.+Taylorauthor=Q.+Jinauthor=V.+Nguyen-Tranauthor=S.+Meeusenauthor=Y.+Q.+Zhangauthor=A.+Kamireddyauthor=A.+Swaffordauthor=A.+F.+Powersauthor=J.+Walkerauthor=J.+Lambauthor=B.+Bursalayaauthor=M.+DiDonatoauthor=G.+Harbauthor=M.+Qiuauthor=C.+M.+Filippiauthor=L.+Deatonauthor=C.+N.+Turkauthor=W.+L.+Suarez-Pinzonauthor=Y.+Liuauthor=X.+Haoauthor=T.+Moauthor=S.+Yanauthor=J.+Liauthor=A.+E.+Hermanauthor=B.+J.+Heringauthor=T.+Wuauthor=H.+Martin+Seidelauthor=P.+McNamaraauthor=R.+Glynneauthor=B.+Laffitte&title=Inhibition+of+DYRK1A+and+GSK3%CE%B2+induces+human+%CE%B2-cell+proliferation&doi=10.1038%2Fncomms9372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DYRK1A and GSK3B induces human β-cell proliferation</span></div><div class="casAuthors">Shen, Weijun; Taylor, Brandon; Jin, Qihui; Nguyen-Tran, Van; Meeusen, Shelly; Zhang, You-Qing; Kamireddy, Anwesh; Swafford, Austin; Powers, Andrew F.; Walker, John; Lamb, John; Bursalaya, Badry; DiDonato, Michael; Harb, George; Qiu, Minhua; Filippi, Christophe M.; Deaton, Lisa; Turk, Carolina N.; Suarez-Pinzon, Wilma L.; Liu, Yahu; Hao, Xueshi; Mo, Tingting; Yan, Shanshan; Li, Jing; Herman, Ann E.; Hering, Bernhard J.; Wu, Tom; Seidel, H. Martin; McNamara, Peter; Glynne, Richard; Laffitte, Bryan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8372</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Insufficient pancreatic β-cell mass or function results in diabetes mellitus.  While significant progress has been made in regulating insulin secretion from β-cells in diabetic patients, no pharmacol. agents have been described that increase β-cell replication in humans.  Here we report aminopyrazine compds. that stimulate robust β-cell proliferation in adult primary islets, most likely as a result of combined inhibition of DYRK1A and GSK3B.  Aminopyrazine-treated human islets retain functionality in vitro and after transplantation into diabetic mice.  Oral dosing of these compds. in diabetic mice induces β-cell proliferation, increases β-cell mass and insulin content, and improves glycemic control.  Biochem., genetic and cell biol. data point to Dyrk1a as the key mol. target.  This study supports the feasibility of treating diabetes with an oral therapy to restore β-cell mass, and highlights a tractable pathway for future drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVHzP-VkH5nrVg90H21EOLACvtfcHk0lhRtm2Vts2LLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslegu7%252FK&md5=5ef960af3bfd2795b9fdce52876e5d59</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fncomms9372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9372%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTaylor%26aufirst%3DB.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DNguyen-Tran%26aufirst%3DV.%26aulast%3DMeeusen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%2BQ.%26aulast%3DKamireddy%26aufirst%3DA.%26aulast%3DSwafford%26aufirst%3DA.%26aulast%3DPowers%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DJ.%26aulast%3DLamb%26aufirst%3DJ.%26aulast%3DBursalaya%26aufirst%3DB.%26aulast%3DDiDonato%26aufirst%3DM.%26aulast%3DHarb%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DM.%26aulast%3DFilippi%26aufirst%3DC.%2BM.%26aulast%3DDeaton%26aufirst%3DL.%26aulast%3DTurk%26aufirst%3DC.%2BN.%26aulast%3DSuarez-Pinzon%26aufirst%3DW.%2BL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DMo%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHerman%26aufirst%3DA.%2BE.%26aulast%3DHering%26aufirst%3DB.%2BJ.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DMartin%2BSeidel%26aufirst%3DH.%26aulast%3DMcNamara%26aufirst%3DP.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DLaffitte%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520DYRK1A%2520and%2520GSK3%25CE%25B2%2520induces%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8372%26doi%3D10.1038%2Fncomms9372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirice, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dančík, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A stimulated human β-cell proliferation</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1660</span>– <span class="NLM_lpage">1671</span>, <span class="refDoi"> DOI: 10.2337/db15-1127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.2337%2Fdb15-1127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1660-1671&author=E.+Diriceauthor=D.+Walpitaauthor=A.+Vetereauthor=B.+C.+Meierauthor=S.+Kahramanauthor=J.+Huauthor=V.+Dan%C4%8D%C3%ADkauthor=S.+M.+Burnsauthor=T.+J.+Gilbertauthor=D.+E.+Olsonauthor=P.+A.+Clemonsauthor=R.+N.+Kulkarniauthor=B.+K.+Wagner&title=Inhibition+of+DYRK1A+stimulated+human+%CE%B2-cell+proliferation&doi=10.2337%2Fdb15-1127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2337%2Fdb15-1127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-1127%26sid%3Dliteratum%253Aachs%26aulast%3DDirice%26aufirst%3DE.%26aulast%3DWalpita%26aufirst%3DD.%26aulast%3DVetere%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DB.%2BC.%26aulast%3DKahraman%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDan%25C4%258D%25C3%25ADk%26aufirst%3DV.%26aulast%3DBurns%26aufirst%3DS.%2BM.%26aulast%3DGilbert%26aufirst%3DT.%2BJ.%26aulast%3DOlson%26aufirst%3DD.%2BE.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DKulkarni%26aufirst%3DR.%2BN.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26atitle%3DInhibition%2520of%2520DYRK1A%2520stimulated%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1660%26epage%3D1671%26doi%3D10.2337%2Fdb15-1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belgardt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammert, E.</span></span> <span> </span><span class="NLM_article-title">DYRK1A: A promising drug target for islet transplant-based diabetes therapeutics</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1496</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.2337/dbi16-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.2337%2Fdbi16-0013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1496-1498&author=B.+F.+Belgardtauthor=E.+Lammert&title=DYRK1A%3A+A+promising+drug+target+for+islet+transplant-based+diabetes+therapeutics&doi=10.2337%2Fdbi16-0013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2337%2Fdbi16-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdbi16-0013%26sid%3Dliteratum%253Aachs%26aulast%3DBelgardt%26aufirst%3DB.%2BF.%26aulast%3DLammert%26aufirst%3DE.%26atitle%3DDYRK1A%253A%2520A%2520promising%2520drug%2520target%2520for%2520islet%2520transplant-based%2520diabetes%2520therapeutics%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1496%26epage%3D1498%26doi%3D10.2337%2Fdbi16-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiraboschi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey-Bloom, J.</span></span> <span> </span><span class="NLM_article-title">The importance of neuritic plaques and tangles to the development and evolution of AD</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1984</span>– <span class="NLM_lpage">1989</span>, <span class="refDoi"> DOI: 10.1212/01.WNL.0000129697.01779.0A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1212%2F01.WNL.0000129697.01779.0A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=15184601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A280%3ADC%252BD2c3osVCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2004&pages=1984-1989&author=P.+Tiraboschiauthor=L.+A.+Hansenauthor=L.+J.+Thalauthor=J.+Corey-Bloom&title=The+importance+of+neuritic+plaques+and+tangles+to+the+development+and+evolution+of+AD&doi=10.1212%2F01.WNL.0000129697.01779.0A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of neuritic plaques and tangles to the development and evolution of AD</span></div><div class="casAuthors">Tiraboschi P; Hansen L A; Thal L J; Corey-Bloom J</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1984-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine the relation of neuritic plaques (NPs) and neurofibrillary tangles (NFTs) to the development and evolution of Alzheimer disease (AD).  METHODS:  An autopsy series of 102 patients with dementia and pathologically confirmed AD and 29 normal control subjects (NCs) was studied.  AD cases were stratified according to their last Mini-Mental State Examination (MMSE) before death as mild, moderate, severe, or very severe.  NPs and NFTs were enumerated in the midfrontal (MF), inferior parietal (IP), superior temporal (ST), hippocampal (Hip), or entorhinal cortices using thioflavin-S preparations.  RESULTS:  Most (87%) of the NCs had allocortical NFTs, whereas only a minority (37%) displayed neocortical NPs, and even fewer (19%) showed Hip NPs.  In contrast, none of the NCs exhibited neocortical NFTs, except one case with a single ST tangle.  However, neocortical NFTs were not detected in even 10% of the patients with AD and, in particular, were absent in nearly 50% of those with mild disease at death.  Thus, their sensitivity as a marker of AD was lower than that of NPs, which, conversely, were found in all patients with AD.  Comparing NCs and patients with mild AD, significant differences were found for numbers of NPs only.  Across the AD groups, in contrast, although NP and NFT density increased with dementia severity, significant differences consistently emerged for NFTs alone.  CONCLUSIONS:  Deterioration in Alzheimer disease appears to be driven by neuritic plaques and neurofibrillary tangles at different stages of the disease.  The significant increase in neuritic plaques, but not neurofibrillary tangles, in patients with even mild Alzheimer disease at death compared with normal control subjects suggests that only neuritic plaques are associated with the earliest symptoms of Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtbOFsmd0HcJVVjGoY74BafW6udTcc2eacSm5qBS3_hbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3osVCmsA%253D%253D&md5=9cb1dea591db3220956389aa8cfd73db</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1212%2F01.WNL.0000129697.01779.0A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.WNL.0000129697.01779.0A%26sid%3Dliteratum%253Aachs%26aulast%3DTiraboschi%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DL.%2BA.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26aulast%3DCorey-Bloom%26aufirst%3DJ.%26atitle%3DThe%2520importance%2520of%2520neuritic%2520plaques%2520and%2520tangles%2520to%2520the%2520development%2520and%2520evolution%2520of%2520AD%26jtitle%3DNeurology%26date%3D2004%26volume%3D62%26spage%3D1984%26epage%3D1989%26doi%3D10.1212%2F01.WNL.0000129697.01779.0A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gotz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennanen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eersel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schild, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ittner, L. M.</span></span> <span> </span><span class="NLM_article-title">Animal models reveal role for tau phosphorylation in human disease</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1802</i></span>,  <span class="NLM_fpage">860</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2009.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bbadis.2009.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=19751831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1802&publication_year=2010&pages=860-871&author=J.+Gotzauthor=A.+Gladbachauthor=L.+Pennanenauthor=J.+van+Eerselauthor=A.+Schildauthor=D.+Davidauthor=L.+M.+Ittner&title=Animal+models+reveal+role+for+tau+phosphorylation+in+human+disease&doi=10.1016%2Fj.bbadis.2009.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models reveal role for tau phosphorylation in human disease</span></div><div class="casAuthors">Gotz, Jurgen; Gladbach, Amadeus; Pennanen, Luis; van Eersel, Janet; Schild, Andreas; David, Della; Ittner, Lars M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1802</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">860-871</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Many proteins that are implicated in human disease are post-translationally modified.  This includes the microtubule-assocd. protein tau that is deposited in a hyperphosphorylated form in brains of Alzheimer's disease patients.  The focus of this review article is on the physiol. and pathol. phosphorylation of tau; the relevance of aberrant phosphorylation for disease; the role of kinases and phosphatases in this process; its modeling in transgenic mice, flies, and worms; and implications of phosphorylation for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCmQpme0Wu1LVg90H21EOLACvtfcHk0lg4zFZBy6WLVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsrzI&md5=fd569479d7942ffb8f9f3eadce1e4b78</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2009.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2009.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DGotz%26aufirst%3DJ.%26aulast%3DGladbach%26aufirst%3DA.%26aulast%3DPennanen%26aufirst%3DL.%26aulast%3Dvan%2BEersel%26aufirst%3DJ.%26aulast%3DSchild%26aufirst%3DA.%26aulast%3DDavid%26aufirst%3DD.%26aulast%3DIttner%26aufirst%3DL.%2BM.%26atitle%3DAnimal%2520models%2520reveal%2520role%2520for%2520tau%2520phosphorylation%2520in%2520human%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2010%26volume%3D1802%26spage%3D860%26epage%3D871%26doi%3D10.1016%2Fj.bbadis.2009.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuripa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akatsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funakoshi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishitomi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uema, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span> <span> </span><span class="NLM_article-title">The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between β-amyloid production and tau phosphorylation in Alzheimer disease</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddl437</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1093%2Fhmg%2Fddl437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17135279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=15-23&author=R.+Kimuraauthor=K.+Kaminoauthor=M.+Yamamotoauthor=A.+Nuripaauthor=T.+Kidaauthor=H.+Kazuiauthor=R.+Hashimotoauthor=T.+Tanakaauthor=T.+Kudoauthor=H.+Yamagataauthor=Y.+Tabaraauthor=T.+Mikiauthor=H.+Akatsuauthor=K.+Kosakaauthor=E.+Funakoshiauthor=K.+Nishitomiauthor=G.+Sakaguchiauthor=A.+Katoauthor=H.+Hattoriauthor=T.+Uemaauthor=M.+Takeda&title=The+DYRK1A+gene%2C+encoded+in+chromosome+21+Down+syndrome+critical+region%2C+bridges+between+%CE%B2-amyloid+production+and+tau+phosphorylation+in+Alzheimer+disease&doi=10.1093%2Fhmg%2Fddl437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between β-amyloid production and tau phosphorylation in Alzheimer disease</span></div><div class="casAuthors">Kimura, Ryo; Kamino, Kouzin; Yamamoto, Mitsuko; Nuripa, Aidaralieva; Kida, Tomoyuki; Kazui, Hiroaki; Hashimoto, Ryota; Tanaka, Toshihisa; Kudo, Takashi; Yamagata, Hidehisa; Tabara, Yasuharu; Miki, Tetsuro; Akatsu, Hiroyasu; Kosaka, Kenji; Funakoshi, Eishi; Nishitomi, Kouhei; Sakaguchi, Gaku; Kato, Akira; Hattori, Hideyuki; Uema, Takeshi; Takeda, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-23</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We scanned throughout chromosome 21 to assess genetic assocns. with late-onset Alzheimer disease (AD) using 374 Japanese patients and 375 population-based controls, because trisomy 21 is known to be assocd. with early deposition of β-amyloid (Aβ) in the brain.  Among 417 markers spanning 33 Mb, 22 markers showed assocns. with either the allele or the genotype frequency (P < 0.05).  Logistic regression anal. with age, sex and apolipoprotein E (APOE)-ε4 dose supported genetic risk of 17 markers, of which eight markers were linked to the SAMSN1, PRSS7, NCAM2, RUNX1, DYRK1A and KCNJ6 genes.  In logistic regression, the DYRK1A (dual-specificity tyrosine-regulated kinase 1A) gene, located in the Down syndrome crit. region, showed the highest significance [OR = 2.99 (95% CI: 1.72-5.19), P = 0.001], whereas the RUNX1 gene showed a high odds ratio [OR = 23.3 (95% CI: 2.76-196.5), P = 0.038].  DYRK1A mRNA level in the hippocampus was significantly elevated in patients with AD when compared with pathol. controls (P < 0.01).  DYRK1A mRNA level was upregulated along with an increase in the Aβ-level in the brain of transgenic mice, overproducing Aβ at 9 mo of age.  In neuroblastoma cells, Aβ induced an increase in the DYRK1A transcript, which also led to tau phosphorylation at Thr212 under the overexpression of tau.  Therefore, the upregulation of DYRK1A transcription results from Aβ loading, further leading to tau phosphorylation.  These result indicates that DYRK1A could be a key mol. bridging between β-amyloid prodn. and tau phosphorylation in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpETsvyVeafabVg90H21EOLACvtfcHk0lg4zFZBy6WLVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVWksA%253D%253D&md5=5aa7f15a92ce6328d33cb5cb179b2be2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddl437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddl437%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DR.%26aulast%3DKamino%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DNuripa%26aufirst%3DA.%26aulast%3DKida%26aufirst%3DT.%26aulast%3DKazui%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKudo%26aufirst%3DT.%26aulast%3DYamagata%26aufirst%3DH.%26aulast%3DTabara%26aufirst%3DY.%26aulast%3DMiki%26aufirst%3DT.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DKosaka%26aufirst%3DK.%26aulast%3DFunakoshi%26aufirst%3DE.%26aulast%3DNishitomi%26aufirst%3DK.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DHattori%26aufirst%3DH.%26aulast%3DUema%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DM.%26atitle%3DThe%2520DYRK1A%2520gene%252C%2520encoded%2520in%2520chromosome%252021%2520Down%2520syndrome%2520critical%2520region%252C%2520bridges%2520between%2520%25CE%25B2-amyloid%2520production%2520and%2520tau%2520phosphorylation%2520in%2520Alzheimer%2520disease%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2007%26volume%3D16%26spage%3D15%26epage%3D23%26doi%3D10.1093%2Fhmg%2Fddl437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryoo, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radnaabazar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span> <span> </span><span class="NLM_article-title">Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s disease</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2007.05075.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1471-4159.2007.05075.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=18005339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2008&pages=1333-1344&author=S.+R.+Ryooauthor=H.+J.+Choauthor=H.+W.+Leeauthor=H.+K.+Jeongauthor=C.+Radnaabazarauthor=Y.+S.+Kimauthor=M.+J.+Kimauthor=M.+Y.+Sonauthor=H.+Seoauthor=S.+H.+Chungauthor=W.+J.+Song&title=Dual-specificity+tyrosine%28Y%29-phosphorylation+regulated+kinase+1A-mediated+phosphorylation+of+amyloid+precursor+protein%3A+evidence+for+a+functional+link+between+Down+syndrome+and+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2007.05075.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease</span></div><div class="casAuthors">Ryoo, Soo-Ryoon; Cho, Hyun-Jeong; Lee, Hye-Won; Jeong, Hey Kyeong; Radnaabazar, Chinzorig; Kim, Yeun-Soo; Kim, Min-Jeong; Son, Mi-Young; Seo, Hyemyung; Chung, Sul-Hee; Song, Woo-Joo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1333-1344</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Most individuals with Down Syndrome (DS) show an early-onset of Alzheimer's disease (AD), which potentially results from the presence of an extra copy of a segment of chromosome 21.  Located on chromosome 21 are the genes that encode β-amyloid (Aβ) precursor protein (APP), a key protein involved in the pathogenesis of AD, and dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A (DYRK1A), a proline-directed protein kinase that plays a crit. role in neurodevelopment.  Here, the authors describe a potential mechanism for the regulation of AD pathol. in DS brains by DYRK1A-mediated phosphorylation of APP.  The authors show that APP is phosphorylated at Thr668 by DYRK1A in vitro and in mammalian cells.  The amts. of phospho-APP and Aβ are increased in the brains of transgenic mice that over-express the human DYRK1A protein.  Furthermore, we show that the amts. of phospho-APP as well as those of APP and DYRK1A are elevated in human DS brains.  Taken together, these results reveal a potential regulatory link between APP and DYRK1A in DS brains, and suggest that the overexpression of DYRK1A in DS may play a role in accelerating AD pathogenesis through phosphorylation of APP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5GqsDKfbC6bVg90H21EOLACvtfcHk0ljiCe7eJ-9B-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCntLc%253D&md5=ab7a959cf5a06be742d89f1afb4f635d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.05075.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.05075.x%26sid%3Dliteratum%253Aachs%26aulast%3DRyoo%26aufirst%3DS.%2BR.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DJeong%26aufirst%3DH.%2BK.%26aulast%3DRadnaabazar%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DSon%26aufirst%3DM.%2BY.%26aulast%3DSeo%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DS.%2BH.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26atitle%3DDual-specificity%2520tyrosine%2528Y%2529-phosphorylation%2520regulated%2520kinase%25201A-mediated%2520phosphorylation%2520of%2520amyloid%2520precursor%2520protein%253A%2520evidence%2520for%2520a%2520functional%2520link%2520between%2520Down%2520syndrome%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D104%26spage%3D1333%26epage%3D1344%26doi%3D10.1111%2Fj.1471-4159.2007.05075.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span> <span> </span><span class="NLM_article-title">Regulation of global gene expression and cell proliferation by APP</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22460</span>, <span class="refDoi"> DOI: 10.1038/srep22460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fsrep22460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26936520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1ehuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22460&author=Y.+Wuauthor=S.+Zhangauthor=Q.+Xuauthor=H.+Zouauthor=W.+Zhouauthor=F.+Caiauthor=T.+Liauthor=W.+Song&title=Regulation+of+global+gene+expression+and+cell+proliferation+by+APP&doi=10.1038%2Fsrep22460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of global gene expression and cell proliferation by APP</span></div><div class="casAuthors">Wu, Yili; Zhang, Si; Xu, Qin; Zou, Haiyan; Zhou, Weihui; Cai, Fang; Li, Tingyu; Song, Weihong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22460</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Down syndrome (DS), caused by trisomy of chromosome 21, is one of the most common genetic disorders.  Patients with DS display growth retardation and inevitably develop characteristic Alzheimer's disease (AD) neuropathol., including neurofibrillary tangles and neuritic plaques.  The expression of amyloid precursor protein (APP) is increased in both DS and AD patients.  To reveal the function of APP and elucidate the pathogenic role of increased APP expression in DS and AD, we performed gene expression profiling using microarray method in human cells overexpressing APP.  A set of genes are significantly altered, which are involved in cell cycle, cell proliferation and p53 signaling.  We found that overexpression of APP inhibits cell proliferation.  Furthermore, we confirmed that the downregulation of two validated genes, PSMA5 and PSMB7, inhibits cell proliferation, suggesting that the downregulation of PSMA5 and PSMB7 is involved in APP-induced cell proliferation impairment.  Taken together, this study suggests that APP regulates global gene expression and increased APP expression inhibits cell proliferation.  Our study provides a novel insight that APP overexpression may contribute to the growth impairment in DS patients and promote AD pathogenesis by inhibiting cell proliferation including neural stem cell proliferation and neurogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppfw8KFjhgAbVg90H21EOLACvtfcHk0ljiCe7eJ-9B-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1ehuro%253D&md5=7d067033a11b2fe039f132f09b61a462</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1038%2Fsrep22460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22460%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DW.%26atitle%3DRegulation%2520of%2520global%2520gene%2520expression%2520and%2520cell%2520proliferation%2520by%2520APP%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22460%26doi%3D10.1038%2Fsrep22460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gearhart, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oster-Granite, M. L.</span></span> <span> </span><span class="NLM_article-title">Expression of the amyloid precursor protein gene in mouse oocytes and embryos</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">1779</span>– <span class="NLM_lpage">1782</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.5.1779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1073%2Fpnas.88.5.1779" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=1779-1782&author=S.+Fisherauthor=J.+D.+Gearhartauthor=M.+L.+Oster-Granite&title=Expression+of+the+amyloid+precursor+protein+gene+in+mouse+oocytes+and+embryos&doi=10.1073%2Fpnas.88.5.1779"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.5.1779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.5.1779%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DGearhart%26aufirst%3DJ.%2BD.%26aulast%3DOster-Granite%26aufirst%3DM.%2BL.%26atitle%3DExpression%2520of%2520the%2520amyloid%2520precursor%2520protein%2520gene%2520in%2520mouse%2520oocytes%2520and%2520embryos%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26spage%3D1779%26epage%3D1782%26doi%3D10.1073%2Fpnas.88.5.1779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meechoovet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gately, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shcherbakova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span> <span> </span><span class="NLM_article-title">β-Carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer’s disease-related sites</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e19264</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0019264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1371%2Fjournal.pone.0019264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21573099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e19264&author=D.+Frostauthor=B.+Meechoovetauthor=T.+Wangauthor=S.+Gatelyauthor=M.+Giorgettiauthor=I.+Shcherbakovaauthor=T.+Dunckley&title=%CE%B2-Carboline+compounds%2C+including+harmine%2C+inhibit+DYRK1A+and+tau+phosphorylation+at+multiple+Alzheimer%E2%80%99s+disease-related+sites&doi=10.1371%2Fjournal.pone.0019264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites</span></div><div class="casAuthors">Frost, Danielle; Meechoovet, Bessie; Wang, Tong; Gately, Stephen; Giorgetti, Marco; Shcherbakova, Irina; Dunckley, Travis</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e19264</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Harmine, a β-carboline alkaloid, is a high affinity inhibitor of the dual specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) protein.  The DYRK1A gene is located within the Down Syndrome Crit. Region (DSCR) on chromosome 21.  We and others have implicated DYRK1A in the phosphorylation of tau protein on multiple sites assocd. with tau pathol. in Down Syndrome and in Alzheimer's disease (AD).  Pharmacol. inhibition of this kinase may provide an opportunity to intervene therapeutically to alter the onset or progression of tau pathol. in AD.  Here we test the ability of harmine, and numerous addnl. β-carboline compds., to inhibit the DYRK1A dependent phosphorylation of tau protein on serine 396, serine 262/serine 356 (12E8 epitope), and threonine 231 in cell culture assays and in vitro phosphorylation assays.  Results demonstrate that the β-carboline compds. (1) potently reduce the expression of all three phosphorylated forms of tau protein, and (2) inhibit the DYRK1A catalyzed direct phosphorylation of tau protein on serine 396.  By assaying several β-carboline compds., we define certain chem. groups that modulate the affinity of this class of compds. for inhibition of tau phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIyW3w-np5NrVg90H21EOLACvtfcHk0lhQiqhGPbaFKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D&md5=586705088397bfee8f58955b94bcc1db</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019264%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DD.%26aulast%3DMeechoovet%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGately%26aufirst%3DS.%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DDunckley%26aufirst%3DT.%26atitle%3D%25CE%25B2-Carboline%2520compounds%252C%2520including%2520harmine%252C%2520inhibit%2520DYRK1A%2520and%2520tau%2520phosphorylation%2520at%2520multiple%2520Alzheimer%25E2%2580%2599s%2520disease-related%2520sites%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De19264%26doi%3D10.1371%2Fjournal.pone.0019264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rachidi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, C.</span></span> <span> </span><span class="NLM_article-title">Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways</span>. <i>Eur. J. Paediatr. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1016/j.ejpn.2007.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejpn.2007.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17933568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A280%3ADC%252BD1c3mvF2lsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=168-182&author=M.+Rachidiauthor=C.+Lopes&title=Mental+retardation+and+associated+neurological+dysfunctions+in+Down+syndrome%3A+a+consequence+of+dysregulation+in+critical+chromosome+21+genes+and+associated+molecular+pathways&doi=10.1016%2Fj.ejpn.2007.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways</span></div><div class="casAuthors">Rachidi Mohammed; Lopes Carmela</div><div class="citationInfo"><span class="NLM_cas:title">European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">168-82</span>
        ISSN:<span class="NLM_cas:issn">1090-3798</span>.
    </div><div class="casAbstract">Down syndrome (DS), affecting 1/700 live births, is the major genetic cause of mental retardation (MR), a cognitive disorder with hard impact on public health.  DS brain is characterized by a reduced cerebellar volume and number of granular cells, defective cortical lamination and reduced cortical neurons, malformed dendritic trees and spines, and abnormal synapses.  These neurological alterations, also found in trisomic mouse models, result from gene-dosage effects of Human Chromosome 21 (HC21) on the expression of critical developmental genes.  HC21 sequencing, mouse ortholog gene identification and DS mouse model generation lead to determine HC21 gene functions and the effects of protein-dosage alterations in neurodevelopmental and metabolic pathways in DS individuals.  Trisomic brain transcriptome of DS patients and trisomic mouse models identified some molecular changes determined by gene-overdosage and associated dysregulation of some disomic gene expression in DS brains.  These transcriptional variations cause developmental alterations in neural patterning and signal transduction pathways that may lead to defective neuronal circuits responsible for the pathogenesis of MR in DS.  Recently, the first altered molecular pathway responsible of some DS phenotypes, including neurological and cognitive disorders has been identified.  In this pathway, two critical HC21 genes (DYRK1A and DSCR1) act synergistically to control the phosphorylation levels of NFATc and NFATc-regulated gene expression.  Interestingly, the NFATc mice show neurological dysfunctions similar to those seen in DS patients and trisomic mouse models.  Treatment of DS mouse model Ts65Dn with GABA(A) antagonists allowed post-drug rescue of cognitive defects, indicating a hopeful direction in clinical therapies for MR in children with DS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTC_YleMWvr1rt7lRqEFUJVfW6udTcc2ebTmRuSi4QyPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3mvF2lsQ%253D%253D&md5=8103c577a5e480eaa427bb98cabe4c53</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpn.2007.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpn.2007.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DRachidi%26aufirst%3DM.%26aulast%3DLopes%26aufirst%3DC.%26atitle%3DMental%2520retardation%2520and%2520associated%2520neurological%2520dysfunctions%2520in%2520Down%2520syndrome%253A%2520a%2520consequence%2520of%2520dysregulation%2520in%2520critical%2520chromosome%252021%2520genes%2520and%2520associated%2520molecular%2520pathways%26jtitle%3DEur.%2520J.%2520Paediatr.%2520Neurol.%26date%3D2008%26volume%3D12%26spage%3D168%26epage%3D182%26doi%3D10.1016%2Fj.ejpn.2007.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternberg, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasten-Sportes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keuren, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glover, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurnit, D. M.</span></span> <span> </span><span class="NLM_article-title">Isolation of human and murine homologues of the <i>Drosophila</i> minibrain gene: human homologue maps to 21q22.2 in the Down syndrome “critical region</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1006/geno.1996.0636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1006%2Fgeno.1996.0636" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=331-339&author=W.+J.+Songauthor=L.+R.+Sternbergauthor=C.+Kasten-Sportesauthor=M.+L.+Keurenauthor=S.+H.+Chungauthor=A.+C.+Slackauthor=D.+E.+Millerauthor=T.+W.+Gloverauthor=P.+W.+Chiangauthor=L.+Louauthor=D.+M.+Kurnit&title=Isolation+of+human+and+murine+homologues+of+the+Drosophila+minibrain+gene%3A+human+homologue+maps+to+21q22.2+in+the+Down+syndrome+%E2%80%9Ccritical+region&doi=10.1006%2Fgeno.1996.0636"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1996.0636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1996.0636%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DW.%2BJ.%26aulast%3DSternberg%26aufirst%3DL.%2BR.%26aulast%3DKasten-Sportes%26aufirst%3DC.%26aulast%3DKeuren%26aufirst%3DM.%2BL.%26aulast%3DChung%26aufirst%3DS.%2BH.%26aulast%3DSlack%26aufirst%3DA.%2BC.%26aulast%3DMiller%26aufirst%3DD.%2BE.%26aulast%3DGlover%26aufirst%3DT.%2BW.%26aulast%3DChiang%26aufirst%3DP.%2BW.%26aulast%3DLou%26aufirst%3DL.%26aulast%3DKurnit%26aufirst%3DD.%2BM.%26atitle%3DIsolation%2520of%2520human%2520and%2520murine%2520homologues%2520of%2520the%2520Drosophila%2520minibrain%2520gene%253A%2520human%2520homologue%2520maps%2520to%252021q22.2%2520in%2520the%2520Down%2520syndrome%2520%25E2%2580%259Ccritical%2520region%26jtitle%3DGenomics%26date%3D1996%26volume%3D38%26spage%3D331%26epage%3D339%26doi%3D10.1006%2Fgeno.1996.0636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toiber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azkona, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Ari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torán, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soreq, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierssen, M.</span></span> <span> </span><span class="NLM_article-title">Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2010.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.nbd.2010.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=20600907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=348-359&author=D.+Toiberauthor=G.+Azkonaauthor=S.+Ben-Ariauthor=N.+Tor%C3%A1nauthor=H.+Soreqauthor=M.+Dierssen&title=Engineering+DYRK1A+overdosage+yields+Down+syndrome-characteristic+cortical+splicing+aberrations&doi=10.1016%2Fj.nbd.2010.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations</span></div><div class="casAuthors">Toiber, Debra; Azkona, Garikoitz; Ben-Ari, Shani; Toran, Nuria; Soreq, Hermona; Dierssen, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">348-359</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Down syndrome (DS) assocs. with impaired brain functions, but the underlying mechanism(s) are yet unclear.  The "gene dosage" hypothesis predicts that in DS, overexpression of a single gene can impair multiple brain functions through a signal amplification effect due to impaired regulatory mechanism(s).  Here, we report findings attributing to impairments in the splicing process such a regulatory role.  We have used DS fetal brain samples in search for initial evidence and employed engineered mice with MMU16 partial trisomy (Ts65Dn) or direct excess of the splicing-assocd. nuclear kinase Dyrk1A, overdosed in DS for further analyses.  We present specific albeit modest changes in the DS brain's splicing machinery with subsequently amplified effects in target transcripts; and we demonstrate that engineered excess of Dyrk1A can largely recapitulate these changes.  Specifically, in both the fetal DS brains and the Dyrk1A overdose models, we found ample modestly modified splicing-assocd. transcripts which apparently induced secondary enhancement in exon inclusion of key synaptic transcripts.  Thus, DS-reduced levels of the dominant-neg. TRKBT1 transcript, but not other TRKB mRNA transcripts, were accompanied by corresponding decreases in BDNF.  In addn., the DS brains and Dyrk1A overdosage models showed selective changes in the transcripts compn. of neuroligin mRNAs as well as redns. in the "synaptic" acetylcholinesterase variant AChE-S mRNA and corresponding increases in the stress-inducible AChE-R mRNA variant, yielding key synaptic proteins with unusual features.  In cotransfected cells, Dyrk1A overdosage caused parallel changes in the splicing pattern of an AChE mini-gene, suggesting that Dyrk1A overdosage is both essential and sufficient to induce the obsd. change in the compn. of AChE mRNA variants.  Furthermore, the Dyrk1A overdosage animal models showed pronounced changes in the structure of neuronal nuclear speckles, where splicing events take place and in SR proteins phosphorylation known to be required for the splicing process.  Together, our findings demonstrate DS-like brain splicing machinery malfunctioning in Dyrk1A overexpressing mice.  Since individual splicing choices may alter cell fate detn., axon guidance, and synaptogenesis, these findings suggest the retrieval of balanced splicing as a goal for DS therapeutic manipulations early in DS development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLpyIlkfn_WrVg90H21EOLACvtfcHk0lgrwawVnqEMnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7rO&md5=185113212f1323f82c2fad8425a88651</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2010.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2010.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DToiber%26aufirst%3DD.%26aulast%3DAzkona%26aufirst%3DG.%26aulast%3DBen-Ari%26aufirst%3DS.%26aulast%3DTor%25C3%25A1n%26aufirst%3DN.%26aulast%3DSoreq%26aufirst%3DH.%26aulast%3DDierssen%26aufirst%3DM.%26atitle%3DEngineering%2520DYRK1A%2520overdosage%2520yields%2520Down%2520syndrome-characteristic%2520cortical%2520splicing%2520aberrations%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D40%26spage%3D348%26epage%3D359%26doi%3D10.1016%2Fj.nbd.2010.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aranda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laguna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de La Luna, S.</span></span> <span> </span><span class="NLM_article-title">Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">5899</span>– <span class="NLM_lpage">5911</span>, <span class="refDoi"> DOI: 10.1128/MCB.00394-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1128%2FMCB.00394-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=18678649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2gt73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=5899-5911&author=S.+Arandaauthor=M.+Alvarezauthor=S.+Turroauthor=A.+Lagunaauthor=S.+de+La+Luna&title=Sprouty2-mediated+inhibition+of+fibroblast+growth+factor+signaling+is+modulated+by+the+protein+kinase+DYRK1A&doi=10.1128%2FMCB.00394-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A</span></div><div class="casAuthors">Aranda, Sergi; Alvarez, Monica; Turro, Silvia; Laguna, Ariadna; de la Luna, Susana</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5899-5911</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Raf-MEK-extracellular signal-regulated kinase (Erk) signaling initiated by growth factor-engaged receptor tyrosine kinases (RTKs) is modulated by an intricate network of pos. and neg. feedback loops which det. the specificity and spatiotemporal characteristics of the intracellular signal.  Well-known antagonists of RTK signaling are the Sprouty proteins.  The activity of Sprouty proteins is modulated by phosphorylation.  However, little is known about the kinases responsible for these posttranslational modifications.  We identify DYRK1A as one of the protein kinases of Sprouty2.  We show that DYRK1A interacts with and regulates the phosphorylation status of Sprouty2.  Moreover, we identify Thr75 on Sprouty2 as a DYRK1A phosphorylation site in vitro and in vivo.  This site is functional, since its mutation enhanced the repressive function of Sprouty2 on fibroblast growth factor (FGF)-induced Erk signaling.  Further supporting the idea of a functional interaction, DYRK1A and Sprouty2 are present in protein complexes in mouse brain, where their expression overlaps in several structures.  Moreover, both proteins copurify with the synaptic plasma membrane fraction of a crude synaptosomal prepn. and colocalize in growth cones, pointing to a role in nerve terminals.  Our results suggest, therefore, that DYRK1A pos. regulates FGF-mitogen-activated protein kinase signaling by phosphorylation-dependent impairment of the inhibitory activity of Sprouty2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof664Ahh528LVg90H21EOLACvtfcHk0lgrwawVnqEMnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2gt73F&md5=735de015391f4b58c2f73ebf493823cc</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FMCB.00394-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00394-08%26sid%3Dliteratum%253Aachs%26aulast%3DAranda%26aufirst%3DS.%26aulast%3DAlvarez%26aufirst%3DM.%26aulast%3DTurro%26aufirst%3DS.%26aulast%3DLaguna%26aufirst%3DA.%26aulast%3Dde%2BLa%2BLuna%26aufirst%3DS.%26atitle%3DSprouty2-mediated%2520inhibition%2520of%2520fibroblast%2520growth%2520factor%2520signaling%2520is%2520modulated%2520by%2520the%2520protein%2520kinase%2520DYRK1A%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D5899%26epage%3D5911%26doi%3D10.1128%2FMCB.00394-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misteli, T.</span></span> <span> </span><span class="NLM_article-title">Small molecule modulators of pre-mRNA splicing in cancer therapy</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2015.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.molmed.2015.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26700537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGitr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=28-37&author=M.+Saltonauthor=T.+Misteli&title=Small+molecule+modulators+of+pre-mRNA+splicing+in+cancer+therapy&doi=10.1016%2Fj.molmed.2015.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy</span></div><div class="casAuthors">Salton, Maayan; Misteli, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-37</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pre-mRNA splicing is a fundamental process in mammalian gene expression and alternative RNA splicing plays a considerable role in generating protein diversity.  RNA splicing events are also key to the pathol. of numerous diseases, particularly cancers.  Some tumors are molecularly addicted to specific RNA splicing isoforms making interference with pre-mRNA processing a viable therapeutic strategy.  Several RNA splicing modulators have recently been characterized, some showing promise in preclin. studies.  While the targets of most splicing modulators are constitutive RNA processing components, possibly leading to undesirable side effects, selectivity for individual splicing events has been obsd.  Given the high prevalence of splicing defects in cancer, small mol. modulators of RNA processing represent a potentially promising novel therapeutic strategy in cancer treatment.  Here, we review their reported effects, mechanisms, and limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeM5XnpAvEVLVg90H21EOLACvtfcHk0lgJgnLMMnkJig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGitr%252FK&md5=b1c76eb9e583e3e1da2e2c5918a020d7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2015.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2015.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DSalton%26aufirst%3DM.%26aulast%3DMisteli%26aufirst%3DT.%26atitle%3DSmall%2520molecule%2520modulators%2520of%2520pre-mRNA%2520splicing%2520in%2520cancer%2520therapy%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D28%26epage%3D37%26doi%3D10.1016%2Fj.molmed.2015.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soppa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florencio Ortiz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasqualon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">The Down syndrome-related protein kinase DYRK1A phosphorylates p27<sup>Kip1</sup> and cyclin D1 and induces cell cycle exit and neuronal differentiation</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2084</span>– <span class="NLM_lpage">2100</span>, <span class="refDoi"> DOI: 10.4161/cc.29104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.4161%2Fcc.29104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=2084-2100&author=U.+Soppaauthor=J.+Schumacherauthor=V.+Florencio+Ortizauthor=T.+Pasqualonauthor=F.+J.+Tejedorauthor=W.+Becker&title=The+Down+syndrome-related+protein+kinase+DYRK1A+phosphorylates+p27Kip1+and+cyclin+D1+and+induces+cell+cycle+exit+and+neuronal+differentiation&doi=10.4161%2Fcc.29104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.4161%2Fcc.29104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.29104%26sid%3Dliteratum%253Aachs%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DSchumacher%26aufirst%3DJ.%26aulast%3DFlorencio%2BOrtiz%26aufirst%3DV.%26aulast%3DPasqualon%26aufirst%3DT.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DThe%2520Down%2520syndrome-related%2520protein%2520kinase%2520DYRK1A%2520phosphorylates%2520p27Kip1%2520and%2520cyclin%2520D1%2520and%2520induces%2520cell%2520cycle%2520exit%2520and%2520neuronal%2520differentiation%26jtitle%3DCell%2520Cycle%26date%3D2014%26volume%3D13%26spage%3D2084%26epage%3D2100%26doi%3D10.4161%2Fcc.29104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. R.</span></span> <span> </span><span class="NLM_article-title">DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">6268</span>– <span class="NLM_lpage">6280</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2008.06751.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1742-4658.2008.06751.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2008&pages=6268-6280&author=A.+Seifertauthor=L.+A.+Allanauthor=P.+R.+Clarke&title=DYRK1A+phosphorylates+caspase+9+at+an+inhibitory+site+and+is+potently+inhibited+in+human+cells+by+harmine&doi=10.1111%2Fj.1742-4658.2008.06751.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2008.06751.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2008.06751.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeifert%26aufirst%3DA.%26aulast%3DAllan%26aufirst%3DL.%2BA.%26aulast%3DClarke%26aufirst%3DP.%2BR.%26atitle%3DDYRK1A%2520phosphorylates%2520caspase%25209%2520at%2520an%2520inhibitory%2520site%2520and%2520is%2520potently%2520inhibited%2520in%2520human%2520cells%2520by%2520harmine%26jtitle%3DFEBS%2520J.%26date%3D2008%26volume%3D275%26spage%3D6268%26epage%3D6280%26doi%3D10.1111%2Fj.1742-4658.2008.06751.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Perez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsenfeld, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivendran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocaña, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1038/nm.3820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fnm.3820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25751815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=383-388&author=P.+Wangauthor=J.+C.+Alvarez-Perezauthor=D.+P.+Felsenfeldauthor=H.+Liuauthor=S.+Sivendranauthor=A.+Benderauthor=A.+Kumarauthor=R.+Sanchezauthor=D.+K.+Scottauthor=A.+Garcia-Oca%C3%B1aauthor=A.+F.+Stewart&title=A+high-throughput+chemical+screen+reveals+that+harmine-mediated+inhibition+of+DYRK1A+increases+human+pancreatic+beta+cell+replication&doi=10.1038%2Fnm.3820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span></div><div class="casAuthors">Wang, Peng; Alvarez-Perez, Juan-Carlos; Felsenfeld, Dan P.; Liu, Hongtao; Sivendran, Sharmila; Bender, Aaron; Kumar, Anil; Sanchez, Roberto; Scott, Donald K.; Garcia-Ocana, Adolfo; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-388</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Types 1 and 2 diabetes affect some 380 million people worldwide.  Both ultimately result from a deficiency of functional pancreatic insulin-producing beta cells.  Beta cells proliferate in humans during a brief temporal window beginning around the time of birth, with a peak percentage (∼2%) engaged in the cell cycle in the first year of life.  In embryonic life and after early childhood, beta cell replication is barely detectable.  Whereas beta cell expansion seems an obvious therapeutic approach to beta cell deficiency, adult human beta cells have proven recalcitrant to such efforts.  Hence, there remains an urgent need for antidiabetic therapeutic agents that can induce regeneration and expansion of adult human beta cells in vivo or ex vivo.  Here, using a high-throughput small-mol. screen (HTS), we find that analogs of the small mol. harmine function as a new class of human beta cell mitogenic compds.  We also define dual-specificity tyrosine-regulated kinase-1a (DYRK1A) as the likely target of harmine and the nuclear factors of activated T cells (NFAT) family of transcription factors as likely mediators of human beta cell proliferation and differentiation.  Using three different mouse and human islet in vivo-based models, we show that harmine is able to induce beta cell proliferation, increase islet mass and improve glycemic control.  These observations suggest that harmine analogs may have unique therapeutic promise for human diabetes therapy.  Enhancing the potency and beta cell specificity of these compds. are important future challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp11xY4tql3VbVg90H21EOLACvtfcHk0liyr5XzhvIUGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D&md5=32a02c393defd14b8922ac9efff63389</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnm.3820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3820%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DAlvarez-Perez%26aufirst%3DJ.%2BC.%26aulast%3DFelsenfeld%26aufirst%3DD.%2BP.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSivendran%26aufirst%3DS.%26aulast%3DBender%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DD.%2BK.%26aulast%3DGarcia-Oca%25C3%25B1a%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DA%2520high-throughput%2520chemical%2520screen%2520reveals%2520that%2520harmine-mediated%2520inhibition%2520of%2520DYRK1A%2520increases%2520human%2520pancreatic%2520beta%2520cell%2520replication%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D383%26epage%3D388%26doi%3D10.1038%2Fnm.3820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kentrup, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heukelbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilmes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schurmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppertz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kainulainen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span> <span> </span><span class="NLM_article-title">Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residue between subdomains VII and VIII</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">3488</span>– <span class="NLM_lpage">3495</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.7.3488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1074%2Fjbc.271.7.3488" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=3488-3495&author=H.+Kentrupauthor=W.+Beckerauthor=J.+Heukelbachauthor=A.+Wilmesauthor=A.+Schurmannauthor=C.+Huppertzauthor=H.+Kainulainenauthor=H.+G.+Joost&title=Dyrk%2C+a+dual+specificity+protein+kinase+with+unique+structural+features+whose+activity+is+dependent+on+tyrosine+residue+between+subdomains+VII+and+VIII&doi=10.1074%2Fjbc.271.7.3488"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.7.3488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.7.3488%26sid%3Dliteratum%253Aachs%26aulast%3DKentrup%26aufirst%3DH.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DHeukelbach%26aufirst%3DJ.%26aulast%3DWilmes%26aufirst%3DA.%26aulast%3DSchurmann%26aufirst%3DA.%26aulast%3DHuppertz%26aufirst%3DC.%26aulast%3DKainulainen%26aufirst%3DH.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26atitle%3DDyrk%252C%2520a%2520dual%2520specificity%2520protein%2520kinase%2520with%2520unique%2520structural%2520features%2520whose%2520activity%2520is%2520dependent%2520on%2520tyrosine%2520residue%2520between%2520subdomains%2520VII%2520and%2520VIII%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D3488%26epage%3D3495%26doi%3D10.1074%2Fjbc.271.7.3488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roos, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savitsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettenbach, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eswaran, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span> <span> </span><span class="NLM_article-title">Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">986</span>– <span class="NLM_lpage">996</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.str.2013.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=23665168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=986-996&author=M.+Soundararajanauthor=A.+K.+Roosauthor=P.+Savitskyauthor=P.+Filippakopoulosauthor=A.+N.+Kettenbachauthor=J.+V.+Olsenauthor=S.+A.+Gerberauthor=J.+Eswaranauthor=S.+Knappauthor=J.+M.+Elkins&title=Structures+of+Down+syndrome+kinases%2C+DYRKs%2C+reveal+mechanisms+of+kinase+activation+and+substrate+recognition&doi=10.1016%2Fj.str.2013.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition</span></div><div class="casAuthors">Soundararajan, Meera; Roos, Annette K.; Savitsky, Pavel; Filippakopoulos, Panagis; Kettenbach, Arminja N.; Olsen, Jesper V.; Gerber, Scott A.; Eswaran, Jeyanthy; Knapp, Stefan; Elkins, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">986-996</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine-(Y)-phosphorylation-regulated kinases (DYRKs) play key roles in brain development, regulation of splicing, and apoptosis, and are potential drug targets for neurodegenerative diseases and cancer.  We present crystal structures of one representative member of each DYRK subfamily: DYRK1A with an ATP-mimetic inhibitor and consensus peptide, and DYRK2 including NAPA and DH (DYRK homol.) box regions.  The current activation model suggests that DYRKs are Ser/Thr kinases that only autophosphorylate the second tyrosine of the activation loop YxY motif during protein translation.  The structures explain the roles of this tyrosine and of the DH box in DYRK activation and provide a structural model for DYRK substrate recognition.  Phosphorylation of a library of naturally occurring peptides identified substrate motifs that lack proline in the P+1 position, suggesting that DYRK1A is not a strictly proline-directed kinase.  Our data also show that DYRK1A wild-type and Y321F mutant retain tyrosine autophosphorylation activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDShaymgKcfLVg90H21EOLACvtfcHk0ljLCF5jdL7Ikw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D&md5=f101707a987083c7d3d637b39332db35</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DRoos%26aufirst%3DA.%2BK.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKettenbach%26aufirst%3DA.%2BN.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DEswaran%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26atitle%3DStructures%2520of%2520Down%2520syndrome%2520kinases%252C%2520DYRKs%252C%2520reveal%2520mechanisms%2520of%2520kinase%2520activation%2520and%2520substrate%2520recognition%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D986%26epage%3D996%26doi%3D10.1016%2Fj.str.2013.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adayev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen-Hwang, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolton, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span> <span> </span><span class="NLM_article-title">Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity <i>in vitro</i></span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7614</span>– <span class="NLM_lpage">7624</span>, <span class="refDoi"> DOI: 10.1021/bi700251n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi700251n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=7614-7624&author=T.+Adayevauthor=M.+C.+Chen-Hwangauthor=N.+Murakamiauthor=E.+Leeauthor=D.+C.+Boltonauthor=Y.+W.+Hwang&title=Dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A+does+not+require+tyrosine+phosphorylation+for+activity+in+vitro&doi=10.1021%2Fbi700251n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fbi700251n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700251n%26sid%3Dliteratum%253Aachs%26aulast%3DAdayev%26aufirst%3DT.%26aulast%3DChen-Hwang%26aufirst%3DM.%2BC.%26aulast%3DMurakami%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DBolton%26aufirst%3DD.%2BC.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DDual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2520does%2520not%2520require%2520tyrosine%2520phosphorylation%2520for%2520activity%2520in%2520vitro%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D7614%26epage%3D7624%26doi%3D10.1021%2Fbi700251n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Himpel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Specificity determinants of substrate recognition by the protein kinase DYRK1A</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">2431</span>– <span class="NLM_lpage">2438</span>, <span class="refDoi"> DOI: 10.1074/jbc.275.4.2431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1074%2Fjbc.275.4.2431" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=2431-2438&author=S.+Himpelauthor=W.+Teggeauthor=R.+Frankauthor=S.+Lederauthor=H.+G.+Joostauthor=W.+Becker&title=Specificity+determinants+of+substrate+recognition+by+the+protein+kinase+DYRK1A&doi=10.1074%2Fjbc.275.4.2431"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.4.2431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.4.2431%26sid%3Dliteratum%253Aachs%26aulast%3DHimpel%26aufirst%3DS.%26aulast%3DTegge%26aufirst%3DW.%26aulast%3DFrank%26aufirst%3DR.%26aulast%3DLeder%26aufirst%3DS.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DSpecificity%2520determinants%2520of%2520substrate%2520recognition%2520by%2520the%2520protein%2520kinase%2520DYRK1A%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D2431%26epage%3D2438%26doi%3D10.1074%2Fjbc.275.4.2431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiechmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czajkowska, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Unusual function of the activation loop in the protein kinase DYRK1A</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(03)00148-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2FS0006-291X%2803%2900148-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=403-408&author=S.+Wiechmannauthor=H.+Czajkowskaauthor=K.+de+Graafauthor=J.+Grotzingerauthor=H.+G.+Joostauthor=W.+Becker&title=Unusual+function+of+the+activation+loop+in+the+protein+kinase+DYRK1A&doi=10.1016%2FS0006-291X%2803%2900148-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2900148-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252900148-7%26sid%3Dliteratum%253Aachs%26aulast%3DWiechmann%26aufirst%3DS.%26aulast%3DCzajkowska%26aufirst%3DH.%26aulast%3Dde%2BGraaf%26aufirst%3DK.%26aulast%3DGrotzinger%26aufirst%3DJ.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DUnusual%2520function%2520of%2520the%2520activation%2520loop%2520in%2520the%2520protein%2520kinase%2520DYRK1A%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D302%26spage%3D403%26epage%3D408%26doi%3D10.1016%2FS0006-291X%2803%2900148-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hérault, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">Dual-specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1183</span>– <span class="NLM_lpage">1199</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1360285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1080%2F13543776.2017.1360285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=28766366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ojs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1183-1199&author=T.+L.+Nguyenauthor=C.+Fruitauthor=Y.+H%C3%A9raultauthor=L.+Meijerauthor=T.+Besson&title=Dual-specificity+tyrosine+phosphorylation+regulated+kinase+1A+%28DYRK1A%29+inhibitors%3A+a+survey+of+recent+patent+literature&doi=10.1080%2F13543776.2017.1360285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature</span></div><div class="casAuthors">Nguyen, Thu Lan; Fruit, Corinne; Herault, Yann; Meijer, Laurent; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1183-1199</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a eukaryotic serine-threonine protein kinase belonging to the CMGC group.  DYRK1A hyperactivity appears to contribute to the development of a no. of human malignancies and to cognitive deficits obsd. in Down syndrome and Alzheimer's disease.  As a result, the DYRK1A kinase represents an attractive target for the synthesis and optimization of pharmacol. inhibitors of potential therapeutic interest.  Like most tyrosine kinase inhibitors developed up to the market, DYRK1A inhibitors are essentially acting by competing with ATP for binding at the catalytic site of the kinase.  This paper reviews patent activity assocd. with the discovery of synthetic novel heterocyclic mols. inhibiting the catalytic activity of DYRK1A.  Despite the important role of DYRK1A in biol. processes and the growing interest in the design of new therapeutic drugs, there are only few patented synthetic DYRK1A inhibitors and most of them were and are still developed by academic research groups, sometimes with industrial partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotMS30KxawIbVg90H21EOLACvtfcHk0lik2lNaG-MmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ojs7jO&md5=3cdf56f9f96f917133b4625dd5d4d09c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1360285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1360285%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DFruit%26aufirst%3DC.%26aulast%3DH%25C3%25A9rault%26aufirst%3DY.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DDual-specificity%2520tyrosine%2520phosphorylation%2520regulated%2520kinase%25201A%2520%2528DYRK1A%2529%2520inhibitors%253A%2520a%2520survey%2520of%2520recent%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D1183%26epage%3D1199%26doi%3D10.1080%2F13543776.2017.1360285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, C.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer’s?</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1021/cn300094k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300094k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=857-872&author=B.+Smithauthor=F.+Meddaauthor=V.+Gokhaleauthor=T.+Dunckleyauthor=C.+Hulme&title=Recent+advances+in+the+design%2C+synthesis%2C+and+biological+evaluation+of+selective+DYRK1A+inhibitors%3A+a+new+avenue+for+a+disease+modifying+treatment+of+Alzheimer%E2%80%99s%3F&doi=10.1021%2Fcn300094k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer's?</span></div><div class="casAuthors">Smith, Breland; Medda, Federico; Gokhale, Vijay; Dunckley, Travis; Hulme, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">857-872</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  With 24.3 million people affected in 2005 and an estd. rise to 42.3 million in 2020, dementia is currently a leading unmet medical need and costly burden on public health.  Seventy percent of these cases have been attributed to Alzheimer's disease (AD), a neurodegenerative pathol. whose most evident symptom is a progressive decline in cognitive functions.  Dual specificity tyrosine phosphorylation regulated kinase-1A (DYRK1A) is important in neuronal development and plays a variety of functional roles within the adult central nervous system.  The DYRK1A gene is located within the Down syndrome crit. region (DSCR) on human chromosome 21 and current research suggests that overexpression of DYRK1A may be a significant factor leading to cognitive deficits in people with Alzheimer's disease (AD) and Down syndrome (DS).  Currently, treatment options for cognitive deficiencies assocd. with Down syndrome, as well as Alzheimer's disease, are extremely limited and represent a major unmet therapeutic need.  Small mol. inhibition of DYRK1A activity in the brain may provide an avenue for pharmaceutical intervention of mental impairment assocd. with AD and other neurodegenerative diseases.  We herein review the current state of the art in the development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqSAw8CXNiP7Vg90H21EOLACvtfcHk0lik2lNaG-MmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K&md5=2009c25bc00389971cd71f64ead2da4a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fcn300094k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300094k%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DDunckley%26aufirst%3DT.%26aulast%3DHulme%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520selective%2520DYRK1A%2520inhibitors%253A%2520a%2520new%2520avenue%2520for%2520a%2520disease%2520modifying%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D857%26epage%3D872%26doi%3D10.1021%2Fcn300094k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span> <span> </span><span class="NLM_article-title">Activation, regulation and inhibition of DYRK1A</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07956.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1742-4658.2010.07956.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=246-256&author=W.+Beckerauthor=W.+Sippl&title=Activation%2C+regulation+and+inhibition+of+DYRK1A&doi=10.1111%2Fj.1742-4658.2010.07956.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07956.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07956.x%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DActivation%252C%2520regulation%2520and%2520inhibition%2520of%2520DYRK1A%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D246%26epage%3D256%26doi%3D10.1111%2Fj.1742-4658.2010.07956.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adayev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.-W.</span></span> <span> </span><span class="NLM_article-title">An ELISA DYRK1A non-radioactive assay suitable for the characterization of inhibitors</span>. <i>F1000Research</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">42</span>, <span class="refDoi"> DOI: 10.12688/f1000research.10582.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.12688%2Ff1000research.10582.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=28163906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlGrt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=42&author=Y.+Liuauthor=T.+Adayevauthor=Y.-W.+Hwang&title=An+ELISA+DYRK1A+non-radioactive+assay+suitable+for+the+characterization+of+inhibitors&doi=10.12688%2Ff1000research.10582.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">An ELISA DYRK1A non-radioactive assay suitable for the characterization of inhibitors [version 1; referees: 2 approved]</span></div><div class="casAuthors">Liu, Yong; Adayev, Tatyana; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">F1000Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42/1-42/12</span>CODEN:
                <span class="NLM_cas:coden">FRESJL</span>;
        ISSN:<span class="NLM_cas:issn">2046-1402</span>.
    
            (<span class="NLM_cas:orgname">F1000 Research Ltd.</span>)
        </div><div class="casAbstract">The DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) gene encodes a proline-directed Ser/Thr kinase.  Elevated expression and/or altered distribution of the kinase have been implicated in the neurol. impairments assocd. with Down syndrome (DS) and Alzheimer's disease (AD).  Consequently, DYRK1A inhibition has been of significant interest as a potential strategy for therapeutic intervention of DS and AD.  Many classes of novel inhibitors have been described in the past decade.  Although non-radioactive methods for analyzing DYRK1A inhibition have been developed, methods employing radioactive tracers are still commonly used for quant. characterization of DYRK1A inhibitors.  Here, we present a non-radioactive ELISA assay based on the detection of DYRK1A-phosphorylated dynamin 1a fragment using a phosphorylation site-specific antibody.  The assay was verified by the use of two well-characterized DYRK1A inhibitors, epigallocatechin gallate (EGCG) and harmine.  The IC s for EGCG and harmine detd. by the ELISA method were found to be comparable to those previously measured by radioactive tracing methods.  Furthermore, we detd. the mode of inhibition for EGCG and harmine by a modification of the ELISA assay.  This assay confirms the mode of inhibition of EGCG (non-ATP-competitive) and harmine (ATP-competitive), as previously detd.  We conclude that the ELISA platform demonstrated here is a viable alternative to the traditional radioactive tracer assays for analyzing DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSKO0R1KokF7Vg90H21EOLACvtfcHk0lik2lNaG-MmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlGrt7fP&md5=019b81d5c3d19f5afb045d8dbc7e3c7b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.10582.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.10582.2%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAdayev%26aufirst%3DT.%26aulast%3DHwang%26aufirst%3DY.-W.%26atitle%3DAn%2520ELISA%2520DYRK1A%2520non-radioactive%2520assay%2520suitable%2520for%2520the%2520characterization%2520of%2520inhibitors%26jtitle%3DF1000Research%26date%3D2017%26volume%3D6%26spage%3D42%26doi%3D10.12688%2Ff1000research.10582.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onogi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">86</span>, <span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+Down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eaIHzzNovHmO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520Down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adayev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen-Hwang, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span> <span> </span><span class="NLM_article-title">Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">12011</span>– <span class="NLM_lpage">12019</span>, <span class="refDoi"> DOI: 10.1021/bi060632j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi060632j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=12011-12019&author=T.+Adayevauthor=M.+C.+Chen-Hwangauthor=N.+Murakamiauthor=J.+Wegielauthor=Y.+W.+Hwang&title=Kinetic+properties+of+a+MNB%2FDYRK1A+mutant+suitable+for+the+elucidation+of+biochemical+pathways&doi=10.1021%2Fbi060632j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fbi060632j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060632j%26sid%3Dliteratum%253Aachs%26aulast%3DAdayev%26aufirst%3DT.%26aulast%3DChen-Hwang%26aufirst%3DM.%2BC.%26aulast%3DMurakami%26aufirst%3DN.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DKinetic%2520properties%2520of%2520a%2520MNB%252FDYRK1A%2520mutant%2520suitable%2520for%2520the%2520elucidation%2520of%2520biochemical%2520pathways%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D12011%26epage%3D12019%26doi%3D10.1021%2Fbi060632j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1042/bj20021535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update&doi=10.1042%2Fbj20021535"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204%26doi%3D10.1042%2Fbj20021535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamoral-Theys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pottier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufrasne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neve, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornienko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingrassia, L.</span></span> <span> </span><span class="NLM_article-title">Natural polyphenols that display anticancer properties through inhibition of kinase activity</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">812</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.2174/092986710790712183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.2174%2F092986710790712183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=20156174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFOhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=812-825&author=D.+Lamoral-Theysauthor=L.+Pottierauthor=F.+Dufrasneauthor=J.+Neveauthor=J.+Duboisauthor=A.+Kornienkoauthor=R.+Kissauthor=L.+Ingrassia&title=Natural+polyphenols+that+display+anticancer+properties+through+inhibition+of+kinase+activity&doi=10.2174%2F092986710790712183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Natural polyphenols that display anticancer properties through inhibition of kinase activity</span></div><div class="casAuthors">Lamoral-Theys, D.; Pottier, L.; Dufrasne, F.; Neve, J.; Dubois, J.; Kornienko, A.; Kiss, R.; Ingrassia, L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">812-825</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over eleven hundred publications reporting anticancer activities of polyphenols have appeared in the peer-reviewed literature.  In addn., a search of the PubMed database using "polyphenols - cancer - review" as keywords produced over 320 hits for review articles (July 2009).  Targeting specific protein kinases to combat cancer represents a major focus of oncol. research within the so-called targeted therapy approach.  An exhaustive search of the PubMed database (July 2009) using "polyphenols - cancer - kinases" as keywords resulted in more than 130 hits, half of them having been published within the past five years.  Furthermore, the PubMed database contains 25 reviews on the subject of anti-kinase activity of some specific polyphenols, including mainly curcumin and the green tea polyphenol (-)-epigallocatechin 3-gallate (EGCG).  However, no attempt has been made yet to review this area of research in a comprehensive, general manner.  The current review therefore aims to highlight those anticancer polyphenols that target specific kinases in various types of cancer.  The present review also provides an in-depth anal. of polyphenol structure-activity relationships in relation to their anticancer activities and specific kinase targeting.  Lastly, a no. of polyphenols are identified as potential antitumor agents that could be used to combat biol. aggressive cancers, including metastasizing cancers, through the targeting of specific kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9MlNLk928FrVg90H21EOLACvtfcHk0ljMrCYCQDsNvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFOhsr8%253D&md5=0054313c7fe542d4862b6c505318a228</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.2174%2F092986710790712183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710790712183%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DPottier%26aufirst%3DL.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DNeve%26aufirst%3DJ.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DIngrassia%26aufirst%3DL.%26atitle%3DNatural%2520polyphenols%2520that%2520display%2520anticancer%2520properties%2520through%2520inhibition%2520of%2520kinase%2520activity%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D812%26epage%3D825%26doi%3D10.2174%2F092986710790712183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guedj, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebrie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivals, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizot, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span> <span> </span><span class="NLM_article-title">Green tea polyphenols rescue of brain deficits induced by overexpression of DYRK1A</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e4606</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0004606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1371%2Fjournal.pone.0004606" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e4606&author=F.+Guedjauthor=C.+Sebrieauthor=I.+Rivalsauthor=A.+Ledruauthor=E.+Palyauthor=J.+C.+Bizotauthor=D.+Smithauthor=E.+Rubinauthor=B.+Gilletauthor=M.+Arbonesauthor=J.+M.+Delabar&title=Green+tea+polyphenols+rescue+of+brain+deficits+induced+by+overexpression+of+DYRK1A&doi=10.1371%2Fjournal.pone.0004606"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004606%26sid%3Dliteratum%253Aachs%26aulast%3DGuedj%26aufirst%3DF.%26aulast%3DSebrie%26aufirst%3DC.%26aulast%3DRivals%26aufirst%3DI.%26aulast%3DLedru%26aufirst%3DA.%26aulast%3DPaly%26aufirst%3DE.%26aulast%3DBizot%26aufirst%3DJ.%2BC.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DRubin%26aufirst%3DE.%26aulast%3DGillet%26aufirst%3DB.%26aulast%3DArbones%26aufirst%3DM.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26atitle%3DGreen%2520tea%2520polyphenols%2520rescue%2520of%2520brain%2520deficits%2520induced%2520by%2520overexpression%2520of%2520DYRK1A%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De4606%26doi%3D10.1371%2Fjournal.pone.0004606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sueoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawangkan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suganuma, M.</span></span> <span> </span><span class="NLM_article-title">Cancer prevention with green tea and its principal constituent, EGCG: from early investigations to current focus on human cancer stem cells</span>. <i>Mol. Cells</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.14348/molcells.2018.2227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.14348%2Fmolcells.2018.2227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=29429153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFarurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=73-82&author=H.+Fujikiauthor=T.+Watanabeauthor=E.+Sueokaauthor=A.+Rawangkanauthor=M.+Suganuma&title=Cancer+prevention+with+green+tea+and+its+principal+constituent%2C+EGCG%3A+from+early+investigations+to+current+focus+on+human+cancer+stem+cells&doi=10.14348%2Fmolcells.2018.2227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53aR"><div class="casContent"><span class="casTitleNuber">53a</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer prevention with green tea and its principal constituent, EGCG: from early investigations to current focus on human cancer stem cells</span></div><div class="casAuthors">Fujiki, Hirota; Watanabe, Tatsuro; Sueoka, Eisaburo; Rawangkan, Anchalee; Suganuma, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Molecules and Cells</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-82</span>CODEN:
                <span class="NLM_cas:coden">MOCEEK</span>;
        ISSN:<span class="NLM_cas:issn">1016-8478</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Molecular and Cellular Biology</span>)
        </div><div class="casAbstract">Cancer preventive activities of green tea and its main constituent, (-)-epigallocatechin gallate (EGCG) have been extensively studied by scientists all over the world.  Since 1983, we have studied the cancer chemopreventive effects of EGCG as well as green tea ext. and underlying mol. mechanisms.  The first part of this review summarizes groundbreaking topics with EGCG and green tea ext.: (1) Delayed cancer onset as revealed by a 10-yr prospective cohort study, (2) Prevention of colorectal adenoma recurrence by a double-blind randomized clin. phase II trial, (3) Inhibition of metastasis of B16 melanoma cells to the lungs of mice, (4) Increase in the av. value of Young's moduli, i.e., cell stiffness, for human lung cancer cell lines and inhibition of cell motility and (5) Synergistic enhancement of anticancer activity against human cancer cell lines with the combination of EGCG and anticancer compds.  In the second part, we became interested in cancer stem cells (CSCs). (1) Cancer stem cells in mouse skin carcinogenesis by way of introduction, after which we discuss two subjects from our review on human CSCs reported by other investigators gathered from a search of PubMed, (2) Expression of stemness markers of human CSCs compared with their parental cells, and (3) EGCG decreases or increases the expression of mRNA and protein in human CSCs.  On this point, EGCG inhibited self-renewal and expression of pluripotency-maintaining transcription factors in human CSCs.  Human CSCs are thus a target for cancer prevention and treatment with EGCG and green tea catechins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHqgM9r05vt7Vg90H21EOLACvtfcHk0lgwabQOzxxIEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFarurjN&md5=6ee60a289e7e8b4b4cdfc07f86690841</span></div><a href="/servlet/linkout?suffix=cit53a&amp;dbid=16384&amp;doi=10.14348%2Fmolcells.2018.2227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14348%252Fmolcells.2018.2227%26sid%3Dliteratum%253Aachs%26aulast%3DFujiki%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DSueoka%26aufirst%3DE.%26aulast%3DRawangkan%26aufirst%3DA.%26aulast%3DSuganuma%26aufirst%3DM.%26atitle%3DCancer%2520prevention%2520with%2520green%2520tea%2520and%2520its%2520principal%2520constituent%252C%2520EGCG%253A%2520from%2520early%2520investigations%2520to%2520current%2520focus%2520on%2520human%2520cancer%2520stem%2520cells%26jtitle%3DMol.%2520Cells%26date%3D2018%26volume%3D41%26spage%3D73%26epage%3D82%26doi%3D10.14348%2Fmolcells.2018.2227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit53b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rady, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rady, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhtar, H.</span></span> <span> </span><span class="NLM_article-title">Cancer preventive and therapeutic effects of EGCG, the major polyphenol in green tea</span>. <i>Egypt. J. Basic Appl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.ejbas.2017.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejbas.2017.12.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=1-23&author=I.+Radyauthor=H.+Mohamedauthor=M.+Radyauthor=I.+A.+Siddiquiauthor=H.+Mukhtar&title=Cancer+preventive+and+therapeutic+effects+of+EGCG%2C+the+major+polyphenol+in+green+tea&doi=10.1016%2Fj.ejbas.2017.12.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejbas.2017.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejbas.2017.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DRady%26aufirst%3DI.%26aulast%3DMohamed%26aufirst%3DH.%26aulast%3DRady%26aufirst%3DM.%26aulast%3DSiddiqui%26aufirst%3DI.%2BA.%26aulast%3DMukhtar%26aufirst%3DH.%26atitle%3DCancer%2520preventive%2520and%2520therapeutic%2520effects%2520of%2520EGCG%252C%2520the%2520major%2520polyphenol%2520in%2520green%2520tea%26jtitle%3DEgypt.%2520J.%2520Basic%2520Appl.%2520Sci.%26date%3D2018%26volume%3D5%26spage%3D1%26epage%3D23%26doi%3D10.1016%2Fj.ejbas.2017.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. S.</span></span> <span> </span><span class="NLM_article-title">Biotransformation of green tea polyphenols and the biological activities of those metabolites</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">819</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.1021/mp700075m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp700075m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1altr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=819-825&author=J.+D.+Lambertauthor=S.+Sangauthor=C.+S.+Yang&title=Biotransformation+of+green+tea+polyphenols+and+the+biological+activities+of+those+metabolites&doi=10.1021%2Fmp700075m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation of Green Tea Polyphenols and the Biological Activities of Those Metabolites</span></div><div class="casAuthors">Lambert, Joshua D.; Sang, Shengmin; Yang, Chung S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">819-825</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Green tea (Camellia sinensis, Theaceae) and its major polyphenol constituents, the catechins, have been reported to have many health benefits including the prevention of cancer and heart disease.  Many mechanisms of action have been proposed based on in vitro models; however, the importance of most of these mechanisms remains to be detd. in vivo.  The bioavailability and biotransformation of tea catechins play a key role in detg. the importance of various mechanisms in vivo.  Likewise, the biol. activity and bioavailability of tea catechin metabolites, an understudied area, are important in understanding the potential beneficial effects of tea.  In this article, we review the data available on the biotransformation of the tea catechins and the limited data set available on the biol. activities of the catechin metabolites.  Careful interpretation of available data, carefully designed animal expts., and integration of bioavailability and biol. activity data are needed if the disease preventive activity of tea is to be understood.  We hope this article will spark research efforts on some of the important questions regarding tea polyphenol bioavailability, biotransformation, and the biol. activities of tea catechin metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVvvkPngliqLVg90H21EOLACvtfcHk0lgwabQOzxxIEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1altr%252FK&md5=7437af46e569f47fcfe1cfede71ede2a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fmp700075m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp700075m%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DJ.%2BD.%26aulast%3DSang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BS.%26atitle%3DBiotransformation%2520of%2520green%2520tea%2520polyphenols%2520and%2520the%2520biological%2520activities%2520of%2520those%2520metabolites%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2007%26volume%3D4%26spage%3D819%26epage%3D825%26doi%3D10.1021%2Fmp700075m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodlett, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, R. J.</span></span> <span> </span><span class="NLM_article-title">Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits</span>. <i>Mol. Genet. Genomic Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">451</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1002/mgg3.334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1002%2Fmgg3.334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=28944229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOntL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=451-465&author=M.+Stringerauthor=C.+R.+Goodlettauthor=R.+J.+Roper&title=Targeting+trisomic+treatments%3A+optimizing+Dyrk1a+inhibition+to+improve+Down+syndrome+deficits&doi=10.1002%2Fmgg3.334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits</span></div><div class="casAuthors">Stringer, Megan; Goodlett, Charles R.; Roper, Randall J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics & Genomic Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">451-465</span>CODEN:
                <span class="NLM_cas:coden">MGGMC6</span>;
        ISSN:<span class="NLM_cas:issn">2324-9269</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Overexpression of Dual-specificity tyrosine-phosphorylated regulated kinase 1A (DYRK1A), located on human chromosome 21, may alter mol. processes linked to developmental deficits in Down syndrome (DS).  Trisomic DYRK1A is a rational therapeutic target, and although redns. in Dyrk1a genetic dosage have shown improvements in trisomic mouse models, attempts to reduce Dyrk1a activity by pharmacol. mechanisms and correct these DS-assocd. phenotypes have been largely unsuccessful.  Epigallocatechin-3-gallate (EGCG) inhibits DYRK1A activity in vitro and this action has been postulated to account for improvement of some DS-assocd. phenotypes that have been reported in preclin. studies and clin. trials.  However, the beneficial effects of EGCG are inconsistent and there is no direct evidence that any obsd. improvement actually occurs through Dyrk1a inhibition.  Inconclusive outcomes likely reflect a lack of knowledge about the tissue-specific patterns of spatial and temporal overexpression and elevated activity of Dyrk1a that may contribute to emerging DS traits during development.  Emerging evidence indicates that Dyrk1a expression varies over the life span in DS mouse models, yet preclin. therapeutic treatments targeting Dyrk1a have largely not considered these developmental changes.  Therapies intended to improve DS phenotypes through normalizing trisomic Dyrk1a need to optimize the timing and dose of treatment to match the spatiotemporal patterning of excessive Dyrk1a activity in relevant tissues.  This will require more precise identification of developmental periods of vulnerability to enduring adverse effects of elevated Dyrk1a, representing the concurrence of increased Dyrk1a expression together with hypothesized tissue-specific-sensitive periods when Dyrk1a regulates cellular processes that shape the long-term functional properties of the tissue.  Future efforts targeting inhibition of trisomic Dyrk1a should identify these putative spatiotemporally specific developmental sensitive periods and det. whether normalizing Dyrk1a activity then can lead to improved outcomes in DS phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7hKbmonKy97Vg90H21EOLACvtfcHk0ljeFfPdqPxBkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOntL%252FN&md5=5a99b154e1a12b6f8af4d73e391bb966</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fmgg3.334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmgg3.334%26sid%3Dliteratum%253Aachs%26aulast%3DStringer%26aufirst%3DM.%26aulast%3DGoodlett%26aufirst%3DC.%2BR.%26aulast%3DRoper%26aufirst%3DR.%2BJ.%26atitle%3DTargeting%2520trisomic%2520treatments%253A%2520optimizing%2520Dyrk1a%2520inhibition%2520to%2520improve%2520Down%2520syndrome%2520deficits%26jtitle%3DMol.%2520Genet.%2520Genomic%2520Med.%26date%3D2017%26volume%3D5%26spage%3D451%26epage%3D465%26doi%3D10.1002%2Fmgg3.334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeysekera, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaCombe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stancombe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dria, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodlett, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, R. J.</span></span> <span> </span><span class="NLM_article-title">Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes</span>. <i>Physiol. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/j.physbeh.2017.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.physbeh.2017.05.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2017&pages=230-241&author=M.+Stringerauthor=I.+Abeysekeraauthor=J.+Thomasauthor=J.+LaCombeauthor=K.+Stancombeauthor=R.+J.+Stewartauthor=K.+J.+Driaauthor=J.+M.+Wallaceauthor=C.+R.+Goodlettauthor=R.+J.+Roper&title=Epigallocatechin-3-gallate+%28EGCG%29+consumption+in+the+Ts65Dn+model+of+Down+syndrome+fails+to+improve+behavioral+deficits+and+is+detrimental+to+skeletal+phenotypes&doi=10.1016%2Fj.physbeh.2017.05.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.physbeh.2017.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.physbeh.2017.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DStringer%26aufirst%3DM.%26aulast%3DAbeysekera%26aufirst%3DI.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DLaCombe%26aufirst%3DJ.%26aulast%3DStancombe%26aufirst%3DK.%26aulast%3DStewart%26aufirst%3DR.%2BJ.%26aulast%3DDria%26aufirst%3DK.%2BJ.%26aulast%3DWallace%26aufirst%3DJ.%2BM.%26aulast%3DGoodlett%26aufirst%3DC.%2BR.%26aulast%3DRoper%26aufirst%3DR.%2BJ.%26atitle%3DEpigallocatechin-3-gallate%2520%2528EGCG%2529%2520consumption%2520in%2520the%2520Ts65Dn%2520model%2520of%2520Down%2520syndrome%2520fails%2520to%2520improve%2520behavioral%2520deficits%2520and%2520is%2520detrimental%2520to%2520skeletal%2520phenotypes%26jtitle%3DPhysiol.%2520Behav.%26date%3D2017%26volume%3D177%26spage%3D230%26epage%3D241%26doi%3D10.1016%2Fj.physbeh.2017.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abeysekera, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dria, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, R. J.</span></span> <span> </span><span class="NLM_article-title">Differential effects of epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/mnfr.201500781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1002%2Fmnfr.201500781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26748562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28Xitlyruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=717-726&author=I.+Abeysekeraauthor=J.+Thomasauthor=T.+M.+Georgiadisauthor=A.+G.+Bermanauthor=M.+A.+Hammondauthor=K.+J.+Driaauthor=J.+M.+Wallaceauthor=R.+J.+Roper&title=Differential+effects+of+epigallocatechin-3-gallate+containing+supplements+on+correcting+skeletal+defects+in+a+Down+syndrome+mouse+model&doi=10.1002%2Fmnfr.201500781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model</span></div><div class="casAuthors">Abeysekera, Irushi; Thomas, Jared; Georgiadis, Taxiarchis M.; Berman, Alycia G.; Hammond, Max A.; Dria, Karl J.; Wallace, Joseph M.; Roper, Randall J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Nutrition & Food Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">717-726</span>CODEN:
                <span class="NLM_cas:coden">MNFRCV</span>;
        ISSN:<span class="NLM_cas:issn">1613-4125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Scope : Down syndrome (DS), caused by trisomy of human chromosome 21 (Hsa21), is characterized by a spectrum of phenotypes including skeletal abnormalities.  The Ts65Dn DS mouse model exhibits similar skeletal phenotypes as humans with DS.  DYRK1A, a kinase encoded on Hsa21, has been linked to deficiencies in bone homeostasis in DS mice and individuals with DS.  Treatment with Epigallocatechin-3-gallate (EGCG), a known inhibitor of Dyrk1a, improves some skeletal abnormalities assocd. with DS in mice.  EGCG supplements are widely available but the effectiveness of different EGCG-contg. supplements has not been well studied.  Methods and results : Six com. available supplements contg. EGCG were analyzed, and two of these supplements were compared with pure EGCG for their impact on skeletal deficits in a DS mouse model.  The results demonstrate differential effects of com. supplements on correcting skeletal abnormalities in Ts65Dn mice.  Different EGCG-contg. supplements display differences in degrdn., polyphenol content, and effects on trisomic bone.  Conclusion : This work suggests that the dose of EGCG and compn. of EGCG-contg. supplements may be important in correcting skeletal deficits assocd. with DS.  Careful analyses of these parameters may lead to a better understanding of how to improve skeletal and other deficits that impair individuals with DS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU4omzUCj_cLVg90H21EOLACvtfcHk0ljeFfPdqPxBkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xitlyruro%253D&md5=9b05b7d1ffc4a90a815e002ae1569e5d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.201500781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.201500781%26sid%3Dliteratum%253Aachs%26aulast%3DAbeysekera%26aufirst%3DI.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DGeorgiadis%26aufirst%3DT.%2BM.%26aulast%3DBerman%26aufirst%3DA.%2BG.%26aulast%3DHammond%26aufirst%3DM.%2BA.%26aulast%3DDria%26aufirst%3DK.%2BJ.%26aulast%3DWallace%26aufirst%3DJ.%2BM.%26aulast%3DRoper%26aufirst%3DR.%2BJ.%26atitle%3DDifferential%2520effects%2520of%2520epigallocatechin-3-gallate%2520containing%2520supplements%2520on%2520correcting%2520skeletal%2520defects%2520in%2520a%2520Down%2520syndrome%2520mouse%2520model%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2016%26volume%3D60%26spage%3D717%26epage%3D726%26doi%3D10.1002%2Fmnfr.201500781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span> <span> </span><span class="NLM_article-title">Chemical con artists foil drug discovery</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1038/513481a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2F513481a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25254460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=481-483&author=J.+Baellauthor=M.+A.+Walters&title=Chemical+con+artists+foil+drug+discovery&doi=10.1038%2F513481a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58aR"><div class="casContent"><span class="casTitleNuber">58a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry: Chemical con artists foil drug discovery</span></div><div class="casAuthors">Baell, Jonathan; Walters, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">7519</span>),
    <span class="NLM_cas:pages">481-483</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Naivety about promiscuous, assay-duping mols. is polluting the literature and wasting resources, warn Jonathan Baell and Michael A. Walters.  Academic drug discoverers must be more vigilant.  Mols. that show the strongest activity in screening might not be the best starting points for drugs.  PAINS hits should almost always be ignored.  Even trained medicinal chemists have to be careful until they become experienced in screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFYQ0B4VVoLVg90H21EOLACvtfcHk0ljbNZW8HZLWFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsL7M&md5=f5788d81d006460c688e4b78e6200503</span></div><a href="/servlet/linkout?suffix=cit58a&amp;dbid=16384&amp;doi=10.1038%2F513481a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F513481a%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26atitle%3DChemical%2520con%2520artists%2520foil%2520drug%2520discovery%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D481%26epage%3D483%26doi%3D10.1038%2F513481a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit58b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58bR"><div class="casContent"><span class="casTitleNuber">58b</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0ljbNZW8HZLWFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit58b&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wataha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, S.</span></span> <span> </span><span class="NLM_article-title">Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>308</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1124/jpet.103.058891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1124%2Fjpet.103.058891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=14569057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsFentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2004&pages=317-323&author=T.+Yamamotoauthor=J.+Lewisauthor=J.+Watahaauthor=D.+Dickinsonauthor=B.+Singhauthor=W.+B.+Bollagauthor=E.+Uetaauthor=T.+Osakiauthor=M.+Atharauthor=G.+Schusterauthor=S.+Hsu&title=Roles+of+catalase+and+hydrogen+peroxide+in+green+tea+polyphenol-induced+chemopreventive+effects&doi=10.1124%2Fjpet.103.058891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59aR"><div class="casContent"><span class="casTitleNuber">59a</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects</span></div><div class="casAuthors">Yamamoto, Tetsuya; Lewis, Jill; Wataha, John; Dickinson, Douglas; Singh, Baldev; Bollag, Wendy B.; Ueta, Eisaku; Osaki, Tokio; Athar, Mohammad; Schuster, George; Hsu, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">317-323</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) possesses promising anticancer potential.  Although in vivo studies unveiled the metabolic routes and pharmacokinetics of EGCG and showed no adverse effects, in vitro studies at high concns. demonstrated oxidative stress.  EGCG causes differential oxidative environments in tumor vs. normal epithelial cells, but the roles that EGCG, hydrogen peroxide (H2O2), and intracellular catalase play in the epithelial system are largely unknown.  The current study employed enzyme activity assays, reactive oxygen species quantification, and immunoblotting to investigate whether, EGCG-induced differential effects correlate with levels of key antioxidant enzymes and H2O2.  It was found that normal human keratinocytes with high catalase activity are least susceptible to H2O2, whereas H2O2 caused significant cytotoxicity in oral carcinoma cell lines.  However, the EGCG-induced differential effects could not be duplicated by H2O2 alone.  The addn. of exogenous catalase failed to completely prevent the EGCG-induced cytotoxicity and rescue the EGCG-induced growth arrest in the tumor cells.  The antioxidant N-acetyl-L-cysteine rescued the tumor cells from H2O2-induced damage only, but not from EGCG-induced mitochondrial damage.  Finally, alterations in catalase or superoxide dismutase activities were not obsd. upon EGCG exposure.  In conclusion, although endogenous catalase may play a role in response to H2O2-induced cytotoxicity, the EGCG-induced cytotoxic effects on tumor cells mainly result from sources other than H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs-PXEbs2cibVg90H21EOLACvtfcHk0liKn15uRy-y7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsFentA%253D%253D&md5=cb1d379ec5dfedb267ac4f76f012524e</span></div><a href="/servlet/linkout?suffix=cit59a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.058891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.058891%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DWataha%26aufirst%3DJ.%26aulast%3DDickinson%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DBollag%26aufirst%3DW.%2BB.%26aulast%3DUeta%26aufirst%3DE.%26aulast%3DOsaki%26aufirst%3DT.%26aulast%3DAthar%26aufirst%3DM.%26aulast%3DSchuster%26aufirst%3DG.%26aulast%3DHsu%26aufirst%3DS.%26atitle%3DRoles%2520of%2520catalase%2520and%2520hydrogen%2520peroxide%2520in%2520green%2520tea%2520polyphenol-induced%2520chemopreventive%2520effects%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D308%26spage%3D317%26epage%3D323%26doi%3D10.1124%2Fjpet.103.058891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit59b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Naasani, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh-hashi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh-hara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruo, T.</span></span> <span> </span><span class="NLM_article-title">Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=824-830&author=I.+Naasaniauthor=F.+Oh-hashiauthor=T.+Oh-haraauthor=W.+Y.+Fengauthor=J.+Johnstonauthor=K.+Chanauthor=T.+Tsuruo&title=Blocking+telomerase+by+dietary+polyphenols+is+a+major+mechanism+for+limiting+the+growth+of+human+cancer+cells+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaasani%26aufirst%3DI.%26aulast%3DOh-hashi%26aufirst%3DF.%26aulast%3DOh-hara%26aufirst%3DT.%26aulast%3DFeng%26aufirst%3DW.%2BY.%26aulast%3DJohnston%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DTsuruo%26aufirst%3DT.%26atitle%3DBlocking%2520telomerase%2520by%2520dietary%2520polyphenols%2520is%2520a%2520major%2520mechanism%2520for%2520limiting%2520the%2520growth%2520of%2520human%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D824%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Feeling nature’s PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS)</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=616-628&author=J.+B.+Baell&title=Feeling+nature%E2%80%99s+PAINS%3A+natural+products%2C+natural+product+drugs%2C+and+pan+assay+interference+compounds+%28PAINS%29&doi=10.1021%2Facs.jnatprod.5b00947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60aR"><div class="casContent"><span class="casTitleNuber">60a</span><div class="casTitle"><span class="NLM_cas:atitle">Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-628</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We have previously reported on classes of compds. that can interfere with bioassays via a no. of different mechanisms and termed such compds. Pan Assay INterference compds., or PAINS.  These compds. were defined on the basis of high-throughput data derived from vendor-supplied synthetics.  The question therefore arises whether the concept of PAINS is relevant to compds. of natural origin.  Here, it is shown that this is indeed the case, but that the context of the biol. readout is an important factor that must be brought into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFy3lN9vzSbVg90H21EOLACvtfcHk0liKn15uRy-y7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D&md5=199b040b1f6f3d636521879acae0114d</span></div><a href="/servlet/linkout?suffix=cit60a&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00947%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DFeeling%2520nature%25E2%2580%2599s%2520PAINS%253A%2520natural%2520products%252C%2520natural%2520product%2520drugs%252C%2520and%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D616%26epage%3D628%26doi%3D10.1021%2Facs.jnatprod.5b00947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit60b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Subramony, J. A.</span></span> <span> </span><span class="NLM_article-title">Apomorphine in dopaminergic therapy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1021/mp060012c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp060012c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFShsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=380-385&author=J.+A.+Subramony&title=Apomorphine+in+dopaminergic+therapy&doi=10.1021%2Fmp060012c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60bR"><div class="casContent"><span class="casTitleNuber">60b</span><div class="casTitle"><span class="NLM_cas:atitle">Apomorphine in Dopaminergic Therapy</span></div><div class="casAuthors">Subramony, J. Anand</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">380-385</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Apomorphine is a potent mol. for the treatment of Parkinson's disease (PD).  It can be obtained in both the R and S forms, and it is the former that is the therapeutically active form.  Due to its structural similarity with 3,4-dihydroxyphenethylamine, dopamine, apomorphine can function as an agonist in the treatment of PD as it can stimulate both the D1 and D2 receptors of the striatum.  The clin. efficacy of apomorphine is similar to that of 3,4-dihydroxyphenylalanine, levodopa (L-dopa), the cornerstone drug in dopaminergic therapy.  (R)-Apomorphine is efficacious for one of the most challenging aspects in the management of PD, namely, managing the unpredictable "on-off" period as a rescue medication after oral administration of a therapeutic drug such as L-dopa.  The effectiveness is due to its rapid control of the wearing-off period of the orally administered medicine.  This short review will trace the progress of apomorphine use starting with its initial discovery and the first indications for which it was used, discovery of its "cure" for PD, and the studies that led to demonstrating its therapeutic efficacy.  The key structural features of apomorphine responsible for its activity are illustrated along with major issues of chem. stability.  From a drug delivery point of view, the current form of administration of apomorphine and some of the potential alternate methods of delivery are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopmXWNc0iSHbVg90H21EOLACvtfcHk0liKn15uRy-y7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFShsbY%253D&md5=f17c44ba82d572eaaf1f134fb545c1a1</span></div><a href="/servlet/linkout?suffix=cit60b&amp;dbid=16384&amp;doi=10.1021%2Fmp060012c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp060012c%26sid%3Dliteratum%253Aachs%26aulast%3DSubramony%26aufirst%3DJ.%2BA.%26atitle%3DApomorphine%2520in%2520dopaminergic%2520therapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2006%26volume%3D3%26spage%3D380%26epage%3D385%26doi%3D10.1021%2Fmp060012c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ingolfsson, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobart, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Periole, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yilmaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maretzky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmings, H. C.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrink, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, O. S.</span></span> <span> </span><span class="NLM_article-title">Phytochemicals perturb membranes and promiscuously alter protein function</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1788</span>– <span class="NLM_lpage">1798</span>, <span class="refDoi"> DOI: 10.1021/cb500086e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500086e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptlyqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1788-1798&author=H.+I.+Ingolfssonauthor=P.+Thakurauthor=K.+F.+Heroldauthor=E.+A.+Hobartauthor=N.+B.+Ramseyauthor=X.+Perioleauthor=D.+H.+de+Jongauthor=M.+Zwamaauthor=D.+Yilmazauthor=K.+Hallauthor=T.+Maretzkyauthor=H.+C.+Hemmingsauthor=C.+Blobelauthor=S.+J.+Marrinkauthor=A.+Kocerauthor=J.+T.+Sackauthor=O.+S.+Andersen&title=Phytochemicals+perturb+membranes+and+promiscuously+alter+protein+function&doi=10.1021%2Fcb500086e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Phytochemicals Perturb Membranes and Promiscuously Alter Protein Function</span></div><div class="casAuthors">Ingolfsson, Helgi I.; Thakur, Pratima; Herold, Karl F.; Hobart, E. Ashley; Ramsey, Nicole B.; Periole, Xavier; de Jong, Djurre H.; Zwama, Martijn; Yilmaz, Duygu; Hall, Katherine; Maretzky, Thorsten; Hemmings, Hugh C.; Blobel, Carl; Marrink, Siewert J.; Kocer, Armagan; Sack, Jon T.; Andersen, Olaf S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1788-1798</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A wide variety of phytochems. are consumed for their perceived health benefits.  Many of these phytochems. have been found to alter numerous cell functions, but the mechanisms underlying their biol. activity tend to be poorly understood.  Phenolic phytochems. are particularly promiscuous modifiers of membrane protein function, suggesting that some of their actions may be due to a common, membrane bilayer-mediated mechanism.  To test whether bilayer perturbation may underlie this diversity of actions, we examd. five bioactive phenols reported to have medicinal value: capsaicin from chili peppers, curcumin from turmeric, EGCG from green tea, genistein from soybeans, and resveratrol from grapes.  We find that each of these widely consumed phytochems. alters lipid bilayer properties and the function of diverse membrane proteins.  Mol. dynamics simulations show that these phytochems. modify bilayer properties by localizing to the bilayer/soln. interface.  Bilayer-modifying propensity was verified using a gramicidin-based assay, and indiscriminate modulation of membrane protein function was demonstrated using four proteins: membrane-anchored metalloproteases, mechanosensitive ion channels, and voltage-dependent potassium and sodium channels.  Each protein exhibited similar responses to multiple phytochems., consistent with a common, bilayer-mediated mechanism.  Our results suggest that many effects of amphiphilic phytochems. are due to cell membrane perturbations, rather than specific protein binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL0NNb8_Q6qrVg90H21EOLACvtfcHk0lj6mj3pyDYMwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptlyqt7s%253D&md5=b61876239e926b652adea2e130627bc3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fcb500086e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500086e%26sid%3Dliteratum%253Aachs%26aulast%3DIngolfsson%26aufirst%3DH.%2BI.%26aulast%3DThakur%26aufirst%3DP.%26aulast%3DHerold%26aufirst%3DK.%2BF.%26aulast%3DHobart%26aufirst%3DE.%2BA.%26aulast%3DRamsey%26aufirst%3DN.%2BB.%26aulast%3DPeriole%26aufirst%3DX.%26aulast%3Dde%2BJong%26aufirst%3DD.%2BH.%26aulast%3DZwama%26aufirst%3DM.%26aulast%3DYilmaz%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DK.%26aulast%3DMaretzky%26aufirst%3DT.%26aulast%3DHemmings%26aufirst%3DH.%2BC.%26aulast%3DBlobel%26aufirst%3DC.%26aulast%3DMarrink%26aufirst%3DS.%2BJ.%26aulast%3DKocer%26aufirst%3DA.%26aulast%3DSack%26aufirst%3DJ.%2BT.%26aulast%3DAndersen%26aufirst%3DO.%2BS.%26atitle%3DPhytochemicals%2520perturb%2520membranes%2520and%2520promiscuously%2520alter%2520protein%2520function%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1788%26epage%3D1798%26doi%3D10.1021%2Fcb500086e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mclauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevernic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+Mclauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lj6mj3pyDYMwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMclauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adayev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span> <span> </span><span class="NLM_article-title">Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>507</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2010.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.abb.2010.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21185805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit12jsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2011&pages=212-218&author=T.+Adayevauthor=J.+Wegielauthor=Y.+W.+Hwang&title=Harmine+is+an+ATP-competitive+inhibitor+for+dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A+%28Dyrk1A%29&doi=10.1016%2Fj.abb.2010.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)</span></div><div class="casAuthors">Adayev, Tatyana; Wegiel, Jerzy; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-218</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Harmine is a β-carboline alkaloid.  The compd. is a potent inhibitor of dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A), a kinase implicated in Down syndrome.  In this study, we show that harmine functions as an ATP-competitive inhibitor against Dyrk1A.  Our conclusion is supported by kinetic anal. of harmine inhibition as well as by the characterization of a Dyrk1A mutation conferring significant resistance to harmine.  The mutation, V306A, is located next to the highly conserved D307 residue in kinases known to coordinate the phosphate groups of ATP through a Mg2+ ion.  The V306A mutation offers harmine resistance by differentially altering Dyrk1A affinity for harmine and ATP.  The V306A mutation causes no apparent alteration to Dyrk1A activity except for the redn. in ATP affinity.  This deficiency could be fully compensated by supplying ATP with a concn. in the physiol. range.  Our results reveal that harmine inhibits Dyrk1A activity by interacting with residues in the ATP-binding pocket and displacing ATP.  Our results also suggest that harmine will be a good lead compd. for further designing of selective ATP-competitive Dyrk1A inhibitors through exploration of the ATP-binding pocket of Dyrk1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-plj_OO0trVg90H21EOLACvtfcHk0lj6mj3pyDYMwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit12jsbo%253D&md5=bd3cd9608d332bc43b5b04f56059b62e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2010.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2010.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DAdayev%26aufirst%3DT.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DHarmine%2520is%2520an%2520ATP-competitive%2520inhibitor%2520for%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2520%2528Dyrk1A%2529%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2011%26volume%3D507%26spage%3D212%26epage%3D218%26doi%3D10.1016%2Fj.abb.2010.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Göckler, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jofre, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soppa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">6324</span>– <span class="NLM_lpage">6337</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1742-4658.2009.07346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=19796173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+G%C3%B6cklerauthor=G.+Jofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+DYRK1A+and+interferes+with+neurite+formation&doi=10.1111%2Fj.1742-4658.2009.07346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span></div><div class="casAuthors">Gockler Nora; Jofre Guillermo; Papadopoulos Chrisovalantis; Soppa Ulf; Tejedor Francisco J; Becker Walter</div><div class="citationInfo"><span class="NLM_cas:title">The FEBS journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6324-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">DYRK1A is a dual-specificity protein kinase that autophosphorylates a conserved tyrosine residue in the activation loop but phosphorylates exogenous substrates only at serine or threonine residues.  Tyrosine autophosphorylation of DYRKs is a one-off event that takes place during translation and induces the activation of the kinase.  Here we characterize the beta-carboline alkaloid harmine as a potent and specific inhibitor of DYRK1A both in vitro and in cultured cells.  Comparative in vitro assays of four kinases of the DYRK family showed that harmine inhibited substrate phosphorylation by DYRK1A more potently than it inhibited substrate phosphorylation by the closely related kinase DYRK1B [half maximal inhibitory concentrations (IC(50)) of 33 nm versus 166 nm, respectively] and by the more distant members of the family, DYRK2 and DYRK4 (1.9 microm and 80 microm, respectively).  Much higher concentrations of harmine were required to suppress tyrosine autophosphorylation of the translational intermediate of DYRK1A in a bacterial in vitro translation system (IC(50) = 1.9 microm).  Importantly, harmine inhibited the phosphorylation of a specific substrate by DYRK1A in cultured cells with a potency similar to that observed in vitro (IC(50) = 48 nm), without negative effects on the viability of the cells.  Overexpression of the DYRK1A gene on chromosome 21 has been implicated in the altered neuronal development observed in Down syndrome.  Here, we show that harmine interferes with neuritogenesis in cultured hippocampal neurons.  In summary, our data show that harmine inhibits DYRK1A substrate phosphorylation more potently than it inhibits tyrosine autophosphorylation, and provide evidence for a role of DYRK1A in the regulation of neurite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYQnyD9o3hqhe4jJGKT5N0fW6udTcc2eZzlrVvNTGTwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D&md5=f59bc35eb74546f6351a4705f2d5fda7</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07346.x%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ckler%26aufirst%3DN.%26aulast%3DJofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520DYRK1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337%26doi%3D10.1111%2Fj.1742-4658.2009.07346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span> <span> </span><span class="NLM_article-title">Anticancer activities of harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2017.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.phymed.2017.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=28478808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFygsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=10-18&author=C.+Liauthor=Y.+Wangauthor=C.+Wangauthor=X.+Yiauthor=M.+Liauthor=X.+He&title=Anticancer+activities+of+harmine+by+inducing+a+pro-death+autophagy+and+apoptosis+in+human+gastric+cancer+cells&doi=10.1016%2Fj.phymed.2017.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65aR"><div class="casContent"><span class="casTitleNuber">65a</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer activities of harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells</span></div><div class="casAuthors">Li, Chuan; Wang, Yihai; Wang, Chunhua; Yi, Xiaomin; Li, Mingya; He, Xiangjiu</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10-18</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Harmine, a β-carboline alkaloid from Peganum harmala, has multiple anti-tumor activities, esp. for its folk therapy for digestive system neoplasm.  However, the underlying mechanism of harmine on gastric cancer remains unclear.  To illuminate the potential anti-tumor activity and mechanism of harmine against gastric cancer cells.  The anti-proliferative activity of harmine in vitro was evaluated by MTT assay.  The autophagic activity induced by harmine was assessed using GFP-LC3 transfection.  FITC/PI double staining was applied for the apoptosis inspection.  The mitochondrial membrane potential was detected by JC-1 fluorescence probe.  The potential mechanisms for proteins level in autophagy and apoptosis were analyzed by Western blot.  Harmine exhibited potent effects on both autophagy and apoptosis.  Treatment with harmine could enhance dots of GFP-LC3 in cells.  Meanwhile, the process had connection with Beclin-1, LC3-II, and p62 by the inhibition of Akt/mTOR/p70S6K signaling.  However, high concn. of harmine led to apoptosis characterized by the propidium/Annexin V-pos. cell pollution, cell shrunk and the collapse of mitochondrial membrane potential.  The regulation of Bcl-2, Bax and the gathering of cleaved-PARP, cleaved-caspase 3 and cleaved-caspase 9 contributed to the induction of apoptosis.  In addn., 10 μM LY294002 (a specific inhibitor of PI3K/Akt) combination with 40 μM harmine significantly increased the cytotoxicity to the gastric cancer cells and up-regulated both the apoptosis-related protein (cleaved-PARP, cleaved-caspase-3) and autophagy-related protein (Beclin-1, LC3-II, and p62).  Adding the inhibitor of autophagy, 3-MA or BafA1, increased the viability of harmine-exposured gastric cancer cells, which confirmed the role of autophagy played in the gastric cancer cell death induced by harmine.  Harmine might be a potent inducer of apoptosis and autophagy, which offered evidences to therapy of harmine in gastric carcinoma in the folk medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb4bB5rtowvLVg90H21EOLACvtfcHk0liY_sAsFMA0lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFygsrk%253D&md5=566aade0aa66a553312a2af413dc2ea1</span></div><a href="/servlet/linkout?suffix=cit65a&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2017.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2017.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DX.%26atitle%3DAnticancer%2520activities%2520of%2520harmine%2520by%2520inducing%2520a%2520pro-death%2520autophagy%2520and%2520apoptosis%2520in%2520human%2520gastric%2520cancer%2520cells%26jtitle%3DPhytomedicine%26date%3D2017%26volume%3D28%26spage%3D10%26epage%3D18%26doi%3D10.1016%2Fj.phymed.2017.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit65b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Malinge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliss-Moreau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirsammer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diebold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chlon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurbuxani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispino, J. D.</span></span> <span> </span><span class="NLM_article-title">Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">948</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1172/JCI60455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1172%2FJCI60455" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=948-962&author=S.+Malingeauthor=M.+Bliss-Moreauauthor=G.+Kirsammerauthor=L.+Dieboldauthor=T.+Chlonauthor=S.+Gurbuxaniauthor=J.+D.+Crispino&title=Increased+dosage+of+the+chromosome+21+ortholog+Dyrk1a+promotes+megakaryoblastic+leukemia+in+a+murine+model+of+Down+syndrome&doi=10.1172%2FJCI60455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65b&amp;dbid=16384&amp;doi=10.1172%2FJCI60455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI60455%26sid%3Dliteratum%253Aachs%26aulast%3DMalinge%26aufirst%3DS.%26aulast%3DBliss-Moreau%26aufirst%3DM.%26aulast%3DKirsammer%26aufirst%3DG.%26aulast%3DDiebold%26aufirst%3DL.%26aulast%3DChlon%26aufirst%3DT.%26aulast%3DGurbuxani%26aufirst%3DS.%26aulast%3DCrispino%26aufirst%3DJ.%2BD.%26atitle%3DIncreased%2520dosage%2520of%2520the%2520chromosome%252021%2520ortholog%2520Dyrk1a%2520promotes%2520megakaryoblastic%2520leukemia%2520in%2520a%2520murine%2520model%2520of%2520Down%2520syndrome%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26spage%3D948%26epage%3D962%26doi%3D10.1172%2FJCI60455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit65c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pozo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahonero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricoy, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Lain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepulveda, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Gomez, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A destabilizes EGFR and reduces EGFR dependent glioblastoma growth</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">2475</span>– <span class="NLM_lpage">2487</span>, <span class="refDoi"> DOI: 10.1172/JCI63623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1172%2FJCI63623" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=2475-2487&author=N.+Pozoauthor=C.+Zahoneroauthor=P.+Fernandezauthor=J.+M.+Linaresauthor=A.+Ayusoauthor=M.+Hagiwaraauthor=A.+Perezauthor=J.+R.+Ricoyauthor=A.+Hernandez-Lainauthor=J.+M.+Sepulvedaauthor=P.+Sanchez-Gomez&title=Inhibition+of+DYRK1A+destabilizes+EGFR+and+reduces+EGFR+dependent+glioblastoma+growth&doi=10.1172%2FJCI63623"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65c&amp;dbid=16384&amp;doi=10.1172%2FJCI63623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI63623%26sid%3Dliteratum%253Aachs%26aulast%3DPozo%26aufirst%3DN.%26aulast%3DZahonero%26aufirst%3DC.%26aulast%3DFernandez%26aufirst%3DP.%26aulast%3DLinares%26aufirst%3DJ.%2BM.%26aulast%3DAyuso%26aufirst%3DA.%26aulast%3DHagiwara%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DA.%26aulast%3DRicoy%26aufirst%3DJ.%2BR.%26aulast%3DHernandez-Lain%26aufirst%3DA.%26aulast%3DSepulveda%26aufirst%3DJ.%2BM.%26aulast%3DSanchez-Gomez%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520DYRK1A%2520destabilizes%2520EGFR%2520and%2520reduces%2520EGFR%2520dependent%2520glioblastoma%2520growth%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D2475%26epage%3D2487%26doi%3D10.1172%2FJCI63623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zaker, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oody, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arjmand, A.</span></span> <span> </span><span class="NLM_article-title">A Study on the antitumoral and differentiation effects of peganum harmala derivatives in combination with ATRA on leukemic cells</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">849</span>, <span class="refDoi"> DOI: 10.1007/BF02978835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1007%2FBF02978835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17703736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFensbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=844-849&author=F.+Zakerauthor=A.+Oodyauthor=A.+Arjmand&title=A+Study+on+the+antitumoral+and+differentiation+effects+of+peganum+harmala+derivatives+in+combination+with+ATRA+on+leukemic+cells&doi=10.1007%2FBF02978835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66aR"><div class="casContent"><span class="casTitleNuber">66a</span><div class="casTitle"><span class="NLM_cas:atitle">A study on the antitumoral and differentiation effects of Peganum harmala derivatives in combination with ATRA on leukaemic cells</span></div><div class="casAuthors">Zaker, Farhad; Oody, Arezo; Arjmand, Alireza</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">844-849</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Plant derived agents may exert a new approach to the treatment of leukemia.  The present study was an evaluation of proliferation, cytotoxicity and differentiation of harmine and harmaline on HL60 cells, alone or in combination with ATRA and G-CSF.  Counting of cells, viability, MTT assay, morphol., NBT redn. and flow cytometry anal. were performed using CD11b and CD 14 monoclonal antibodies.  The data showed that harmine and harmaline reduced proliferation in dose and time dependent manner.  Optimal antiproliferative concn. of these agents was chosen.  However, both agents in higher doses were cytotoxic.  Combination of ATRA, G-CSF and each agent alone, particularly harmaline in optimal dose, resulted in partially additive decrease in cell proliferation.  Cells treated with both harmaline and ATRA demonstrated some morphol. changes and NBT positivity, but the extent of changes obsd. following treatment with harmaline was less than ATRA.  Flow cytometric anal. showed that ATRA induced a neutrophilic differentiation, while harmaline led to a predominantly monocytic differentiation.  Combination of harmine and harmaline with ATRA and G-CSF did not change the extent of differentiation, and the cells differentiated into the neutrophilic lineage.  This shows that the direction of differentiation is dominantly detd. by ATRA.  These preliminary data implies a new approach in treatment of leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg1ZM-rdb87rVg90H21EOLACvtfcHk0liIATuBzPM8aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFensbo%253D&md5=411ec4a220294ca62931e59dcec54f80</span></div><a href="/servlet/linkout?suffix=cit66a&amp;dbid=16384&amp;doi=10.1007%2FBF02978835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02978835%26sid%3Dliteratum%253Aachs%26aulast%3DZaker%26aufirst%3DF.%26aulast%3DOody%26aufirst%3DA.%26aulast%3DArjmand%26aufirst%3DA.%26atitle%3DA%2520Study%2520on%2520the%2520antitumoral%2520and%2520differentiation%2520effects%2520of%2520peganum%2520harmala%2520derivatives%2520in%2520combination%2520with%2520ATRA%2520on%2520leukemic%2520cells%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2007%26volume%3D30%26spage%3D844%26epage%3D849%26doi%3D10.1007%2FBF02978835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit66b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span> <span> </span><span class="NLM_article-title">Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2013.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.phymed.2013.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=24176842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslehsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=348-355&author=H.+Zhangauthor=K.+Sunauthor=J.+Dingauthor=H.+Xuauthor=L.+Zhuauthor=K.+Zhangauthor=X.+Liauthor=W.+Sun&title=Harmine+induces+apoptosis+and+inhibits+tumor+cell+proliferation%2C+migration+and+invasion+through+down-regulation+of+cyclooxygenase-2+expression+in+gastric+cancer&doi=10.1016%2Fj.phymed.2013.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66bR"><div class="casContent"><span class="casTitleNuber">66b</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer</span></div><div class="casAuthors">Zhang, Hao; Sun, Kun; Ding, Jing; Xu, Huae; Zhu, Lingjun; Zhang, Kai; Li, Xiaolin; Sun, Weihao</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">348-355</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Cyclooxygenase-2 (COX-2) plays an important role in the carcinogenesis and progression of gastric cancer.  Harmine is reported as a promising drug candidate for cancer therapy; however, effects and action mechanism of harmine on the human gastric cancer cells remain unclear.  This study evaluated the anti-tumor effects of harmine on human gastric cancer both in vitro and in vivo.  The cell proliferation was detd. using MTT colorimetric assay.  Apoptosis was measured by DAPI staining and flow cytometry anal.  The wound healing and transwell invasion assays were performed to evaluate the effects of harmine on the migration and invasion of gastric cancer cells.  The expression of COX-2, proliferating cell nuclear antigen (PCNA), Bcl-2, Bax and matrix metalloproteinase-2 (MMP-2) was detected by Western blot anal.  Our results showed that harmine significantly inhibited cellular proliferation, migration, invasion and induced apoptosis in vitro, as well as inhibited tumor growth in vivo.  In addn., harmine significantly inhibited the expression of COX-2, PCNA, Bcl-2 and MMP-2 as well as increased Bax expression in gastric cancer cells.  These results collectively indicate that harmine induces apoptosis and inhibits proliferation, migration and invasion of human gastric cancer cells, which may be mediated by down-regulation of COX-2 expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5qPnBMAG2k7Vg90H21EOLACvtfcHk0liIATuBzPM8aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslehsrzF&md5=0c0e8e2014f751c9b602bd7eb5b2b216</span></div><a href="/servlet/linkout?suffix=cit66b&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2013.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2013.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DK.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DW.%26atitle%3DHarmine%2520induces%2520apoptosis%2520and%2520inhibits%2520tumor%2520cell%2520proliferation%252C%2520migration%2520and%2520invasion%2520through%2520down-regulation%2520of%2520cyclooxygenase-2%2520expression%2520in%2520gastric%2520cancer%26jtitle%3DPhytomedicine%26date%3D2014%26volume%3D21%26spage%3D348%26epage%3D355%26doi%3D10.1016%2Fj.phymed.2013.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Waki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damoiseaux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilpitz, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontonoz, P.</span></span> <span> </span><span class="NLM_article-title">The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ expression</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2007.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.cmet.2007.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17488638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=357-370&author=H.+Wakiauthor=K.+W.+Parkauthor=N.+Mitroauthor=L.+Peiauthor=R.+Damoiseauxauthor=D.+C.+Wilpitzauthor=K.+Reueauthor=E.+Saezauthor=P.+Tontonoz&title=The+small+molecule+harmine+is+an+antidiabetic+cell-type-specific+regulator+of+PPAR%CE%B3+expression&doi=10.1016%2Fj.cmet.2007.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67aR"><div class="casContent"><span class="casTitleNuber">67a</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ expression</span></div><div class="casAuthors">Waki, Hironori; Park, Kye Won; Mitro, Nico; Pei, Liming; Damoiseaux, Robert; Wilpitz, Damien C.; Reue, Karen; Saez, Enrique; Tontonoz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-370</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PPARγ is the master regulator of adipogenesis and the mol. target of the thiazolidinedione antidiabetic drugs.  By screening for compds. that promote adipogenesis, we identified a small mol. that targets the PPARγ pathway by a distinct mechanism.  This mol., harmine, is not a ligand for the receptor; rather, it acts as a cell-type-specific regulator of PPARγ expression.  Administration of harmine to diabetic mice mimics the effects of PPARγ ligands on adipocyte gene expression and insulin sensitivity.  Unlike thiazolidinediones, however, harmine does not cause significant wt. gain or hepatic lipid accumulation.  Mol. studies indicate that harmine controls PPARγ expression through inhibition of the Wnt signaling pathway.  This work validates phenotypic screening of adipocytes as a promising strategy for the identification of bioactive small mols. and suggests that regulators of PPARγ expression may represent a complementary approach to PPARγ ligands in the treatment of insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Im5tRGS5LbVg90H21EOLACvtfcHk0liIATuBzPM8aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqu7s%253D&md5=a2b9ff7b3eb65a8eef51d848d185b386</span></div><a href="/servlet/linkout?suffix=cit67a&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DWaki%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DK.%2BW.%26aulast%3DMitro%26aufirst%3DN.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DDamoiseaux%26aufirst%3DR.%26aulast%3DWilpitz%26aufirst%3DD.%2BC.%26aulast%3DReue%26aufirst%3DK.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DTontonoz%26aufirst%3DP.%26atitle%3DThe%2520small%2520molecule%2520harmine%2520is%2520an%2520antidiabetic%2520cell-type-specific%2520regulator%2520of%2520PPAR%25CE%25B3%2520expression%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D5%26spage%3D357%26epage%3D370%26doi%3D10.1016%2Fj.cmet.2007.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit67b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villanueva, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monticelli, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDougald, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldrath, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontonoz, P.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-gamma expression and adipocyte differentiation</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2038</span>– <span class="NLM_lpage">2048</span>, <span class="refDoi"> DOI: 10.1210/me.2007-0454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1210%2Fme.2007-0454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=18562627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2itL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=2038-2048&author=K.+W.+Parkauthor=H.+Wakiauthor=C.+J.+Villanuevaauthor=L.+A.+Monticelliauthor=C.+Hongauthor=S.+Kangauthor=O.+A.+MacDougaldauthor=A.+W.+Goldrathauthor=P.+Tontonoz&title=Inhibitor+of+DNA+binding+2+is+a+small+molecule-inducible+modulator+of+peroxisome+proliferator-activated+receptor-gamma+expression+and+adipocyte+differentiation&doi=10.1210%2Fme.2007-0454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67bR"><div class="casContent"><span class="casTitleNuber">67b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-γ expression and adipocyte differentiation</span></div><div class="casAuthors">Park, Kye Won; Waki, Hironori; Villanueva, Claudio J.; Monticelli, Laurel A.; Hong, Cynthia; Kang, Sona; MacDougald, Ormond A.; Goldrath, Ananda W.; Tontonoz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2038-2048</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The authors previously identified the small mol. harmine as a regulator of peroxisome proliferator activated-receptor γ (PPARγ) and adipocyte differentiation.  In an effort to identify signaling pathways mediating harmine's effects, the authors performed transcriptional profiling of 3T3-F442A preadipocytes.  Inhibitor of DNA biding 2 (Id2) was identified as a gene rapidly induced by harmine but not by PPARγ agonists.  Id2 is also induced in 3T3-L1 preadipocytes treated with dexamethasone, 3-isobutyl-1-methylxanthine, and insulin, suggesting that Id2 regulation is a common feature of the adipogenic program.  Stable overexpression of Id2 in preadipocytes promotes expression of PPARγ and enhances morphol. differentiation and lipid accumulation.  Conversely, small interfering RNA-mediated knockdown of Id2 antagonizes adipocyte differentiation.  Mice lacking Id2 expression display reduced adiposity, and embryonic fibroblasts derived from these mice exhibit reduced PPARγ expression and a diminished capacity for adipocyte differentiation.  Finally, Id2 expression is elevated in adipose tissues of obese mice and humans.  These results outline a role for Id2 in the modulation of PPARγ expression and adipogenesis and underscore the utility of adipogenic small mols. as tools to dissect adipocyte biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYPeLsKlo07LVg90H21EOLACvtfcHk0liyTk6gjn3TQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2itL%252FM&md5=cd3985530abf57aab9b6fa80805449f4</span></div><a href="/servlet/linkout?suffix=cit67b&amp;dbid=16384&amp;doi=10.1210%2Fme.2007-0454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2007-0454%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%2BW.%26aulast%3DWaki%26aufirst%3DH.%26aulast%3DVillanueva%26aufirst%3DC.%2BJ.%26aulast%3DMonticelli%26aufirst%3DL.%2BA.%26aulast%3DHong%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DMacDougald%26aufirst%3DO.%2BA.%26aulast%3DGoldrath%26aufirst%3DA.%2BW.%26aulast%3DTontonoz%26aufirst%3DP.%26atitle%3DInhibitor%2520of%2520DNA%2520binding%25202%2520is%2520a%2520small%2520molecule-inducible%2520modulator%2520of%2520peroxisome%2520proliferator-activated%2520receptor-gamma%2520expression%2520and%2520adipocyte%2520differentiation%26jtitle%3DMol.%2520Endocrinol.%26date%3D2008%26volume%3D22%26spage%3D2038%26epage%3D2048%26doi%3D10.1210%2Fme.2007-0454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablin, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase A by β-carboline derivatives</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1006/abbi.1996.9771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1006%2Fabbi.1996.9771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=8990278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADyaK2sXktlGitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1997&pages=137-142&author=H.+Kimauthor=S.+O.+Sablinauthor=R.+R.+Ramsay&title=Inhibition+of+monoamine+oxidase+A+by+%CE%B2-carboline+derivatives&doi=10.1006%2Fabbi.1996.9771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68aR"><div class="casContent"><span class="casTitleNuber">68a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase A by β-carboline derivatives</span></div><div class="casAuthors">Kim, Hoon; Sablin, Sergey O.; Ramsay, Rona R.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-142</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">β-Carbolines are endogenous inhibitors of monoamine oxidase (MAO).  The interaction of nine β-carboline derivs. and four 3,4-dihydro forms with purified MAO A was investigated.  All the compds. tested were reversible competitive inhibitors selective for MAO A, in agreement with previous studies on membrane prepns.  The oxidn. of kynuramine by MAO A in the presence of the more effective inhibitors showed a lag period before reaching the steady state.  In general, the 1-Me and 7-methoxy substituents increased the potency.  Harmine, 2-methylharminium, 2,9-dimethylharminium, and harmaline were the most effective inhibitors of the purified MAO A, with low Ki values of 5,69, 15, and 48 nM, resp.  The inhibitors interacted with the covalently bound flavin to induce distinct spectral changes, the magnitude of which correlated with the efficacy of the inhibition.  The more effective inhibitors could be in situ inhibitors of MAO A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkrxSogWwJzrVg90H21EOLACvtfcHk0ljnKOsNkAi8yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlGitg%253D%253D&md5=04c6fecf6acc0097ab0ee54d0b6fb1e6</span></div><a href="/servlet/linkout?suffix=cit68a&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1996.9771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1996.9771%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DSablin%26aufirst%3DS.%2BO.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520A%2520by%2520%25CE%25B2-carboline%2520derivatives%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1997%26volume%3D337%26spage%3D137%26epage%3D142%26doi%3D10.1006%2Fabbi.1996.9771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit68b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Samoylenko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekwani, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, I.</span></span> <span> </span><span class="NLM_article-title"><i>Banisteriopsis caapi</i>, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson’s disease</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2009.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.jep.2009.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=19879939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot12msg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2010&pages=357-367&author=V.+Samoylenkoauthor=M.+Rahmanauthor=B.+L.+Tekwaniauthor=L.+M.+Tripathiauthor=Y.+H.+Wangauthor=S.+I.+Khanauthor=I.+A.+Khanauthor=L.+S.+Millerauthor=V.+C.+Joshiauthor=I.+Muhammad&title=Banisteriopsis+caapi%2C+a+unique+combination+of+MAO+inhibitory+and+antioxidative+constituents+for+the+activities+relevant+to+neurodegenerative+disorders+and+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.jep.2009.10.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68bR"><div class="casContent"><span class="casTitleNuber">68b</span><div class="casTitle"><span class="NLM_cas:atitle">Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease</span></div><div class="casAuthors">Samoylenko, Volodymyr; Rahman, Md. Mostafizur; Tekwani, Babu L.; Tripathi, Lalit M.; Wang, Yan-Hong; Khan, Shabana I.; Khan, Ikhlas A.; Miller, Loren S.; Joshi, Vaishali C.; Muhammad, Ilias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Aim of the study: Parkinson's disease is a neurol. disorder mostly effecting the elder population of the world.  Currently there is no definitive treatment or cure for this disease.  Therefore, in this study the compn. and constituents of the aq. ext. of Banisteriopsis caapi for monoamine oxidases (MAO) inhibitory and antioxidant activities were assessed, which are relevant to the prevention of neurol. disorders, including Parkinsonism.  Materials and methods: The aq. ext. of Banisteriopsis caapi stems was standardized and then fractionated using reversed-phase (RP) chromatog.  Pure compds. were isolated either by reversed-phase (RP) chromatog. or centrifugal preparative TLC, using a Chromatotron.  Structure elucidation was carried out by 1D and 2D NMR, Mass, IR and CD spectroscopy and chem. derivatization.  Chem. profiling of the ext. was carried out with RP-HPLC.  The inhibitory activity of MAO-A, MAO-B, acetylcholinesterase, butyrylcholinesterase and catechol-O-Me transferase enzymes, as well as antioxidant and cytotoxic activities of both Banisteriopsis caapi ext. and isolated compds. was evaluated.  Results: An examn. of the aq. exts. of Banisteriopsis caapi cultivar Da Vine yielded two new alkaloidal glycosides, named banistenoside A (1) and banistenoside B (2), contg. "azepino[1,2-a]tetrahydro-β-carboline" unique carbon framework.  One addnl. new natural tetrahydronorharmine (4), four known β-carbolines harmol (3), tetrahydroharmine (5), harmaline (6) and harmine (7), two known proanthocyanidines (-)-epicatechin (8) and (-)-procyanidin B2 (9), and a new disaccharide β--fructofuranosyl-(2 → 5)-fructopyranose (14) together with known saccharose (15) and β--glucose (16) were also isolated.  In addn., the acetates of 1, 2, 8, 9, 14 and 15 (compds. 10-13, 17, 18) were also prepd.  Harmaline (6) and harmine (7) showed potent in vitro inhibitory activity against recombinant human brain monoamine oxidase (MAO)-A and -B enzymes (IC50 2.5 and 2.0 nM, and 25 and 20 μM, resp.), and (-)-epicatechin (8) and (-)-procyanidin B2 (9) showed potent antioxidant and moderate MAO-B inhibitory activities (IC50 < 0.13 and 0.57 μg/mL, and 65 and 35 μM).  HPLC anal. revealed that most of the dominant chem. and bioactive markers (1, 2, 5, 7-9) were present in high concns. in dried bark of large branch.  Anal. of regular/com. Banisteriopsis caapi dried stems showed a similar qual. HPLC pattern, but relatively low content of dominant markers 1, 2, 7, and 9, which led to decreased MAO inhibitory and antioxidant potency.  Conclusion: Collectively, these results give addnl. basis to the existing claim of Banisteriopsis caapi stem ext. for the treatment of Parkinsonism, including other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaBgCrkOfxxrVg90H21EOLACvtfcHk0ljnKOsNkAi8yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot12msg%253D%253D&md5=85cf0e8497c021bb6fb3107d6e72670a</span></div><a href="/servlet/linkout?suffix=cit68b&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2009.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2009.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DSamoylenko%26aufirst%3DV.%26aulast%3DRahman%26aufirst%3DM.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DTripathi%26aufirst%3DL.%2BM.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26aulast%3DMiller%26aufirst%3DL.%2BS.%26aulast%3DJoshi%26aufirst%3DV.%2BC.%26aulast%3DMuhammad%26aufirst%3DI.%26atitle%3DBanisteriopsis%2520caapi%252C%2520a%2520unique%2520combination%2520of%2520MAO%2520inhibitory%2520and%2520antioxidative%2520constituents%2520for%2520the%2520activities%2520relevant%2520to%2520neurodegenerative%2520disorders%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2010%26volume%3D127%26spage%3D357%26epage%3D367%26doi%3D10.1016%2Fj.jep.2009.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit68c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Reniers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masereel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmc.2010.11.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21183355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=134-144&author=J.+Reniersauthor=S.+Robertauthor=R.+Frederickauthor=B.+Masereelauthor=S.+Vincentauthor=J.+Wouters&title=Synthesis+and+evaluation+of+%CE%B2-carboline+derivatives+as+potential+monoamine+oxidase+inhibitors&doi=10.1016%2Fj.bmc.2010.11.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68cR"><div class="casContent"><span class="casTitleNuber">68c</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span></div><div class="casAuthors">Reniers, J.; Robert, S.; Frederick, R.; Masereel, B.; Vincent, S.; Wouters, J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-144</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies have shown that harmine is a reversible inhibitor of human monoamine oxidase A (MAO-A).  Moreover, the crystal structure of human MAO-A in complex with harmine has been recently solved.  This crystal structure shows that close to the methoxy group of the harmine moiety, a lipophilic pocket is left vacant within the binding site of human MAO-A.  Our objective was to optimize the β-carboline series against human MAO-A in order to explore this pocket.  Therefore, a series of β-carboline derivs. has been synthesized.  The compds. were evaluated for their human monoamine oxidase A and B inhibitory potency and their Ki values were estd.  The results show that O-alkylated compds. with lipophilic groups like cyclohexyl, Ph and aliph. chains increase the inhibition of MAO-A compared to harmine.  Compd. 3e (I), with the trifluorobutyloxy group, was the most active of this series, with a Ki against MAO-A of 3.6 nM.  Mol. docking studies show that the trifluorobutyloxy chain occupies the hydrophobic pocket vacant with harmine.  The O-alkylated compds. are less active on MAO-B than on MAO-A.  However, several compds. show a better inhibition on MAO-B compared to harmine.  Compd. 3f, with the cyclohexylmethoxy chain, displayed the best inhibitory activity against MAO-B with a Ki value of 221.6 nM.  This cyclohexyl bearing analog is also a potent MAO-A inhibitor with a Ki value of 4.3 nM.  Mol. docking studies show that the cyclohexyl chain also occupies a hydrophobic pocket but in different ways in MAO-A or MAO-B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz8NiKL6ru47Vg90H21EOLACvtfcHk0lhgJLUPW2rKIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D&md5=8e6a16abe22ac5353add1a3eab31d4fb</span></div><a href="/servlet/linkout?suffix=cit68c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DReniers%26aufirst%3DJ.%26aulast%3DRobert%26aufirst%3DS.%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DS.%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%25CE%25B2-carboline%2520derivatives%2520as%2520potential%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D134%26epage%3D144%26doi%3D10.1016%2Fj.bmc.2010.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, D. J.</span></span> <span> </span><span class="NLM_article-title">Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2004.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.pharmthera.2004.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=15163593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVCitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2004&pages=111-129&author=D.+J.+McKenna&title=Clinical+investigations+of+the+therapeutic+potential+of+ayahuasca%3A+rationale+and+regulatory+challenges&doi=10.1016%2Fj.pharmthera.2004.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69aR"><div class="casContent"><span class="casTitleNuber">69a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges</span></div><div class="casAuthors">McKenna, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-129</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Ayahuasca is a hallucinogenic beverage that is prominent in the ethnomedicine and shamanism of indigenous Amazonian tribes.  Its unique pharmacol. depends on the oral activity of the hallucinogen, N,N-dimethyltryptamine (DMT), which results from inhibition of monoamine oxidase (MAO) by β-carboline alkaloids.  MAO is the enzyme that normally degrades DMT in the liver and gut.  Ayahuasca has long been integrated into mestizo folk medicine in the northwest Amazon.  In Brazil, it is used as a sacrament by several syncretic churches.  Some of these organizations have incorporated in the United States.  The recreational and religious use of ayahuasca in the United States, as well as "ayahuasca tourism" in the Amazon, is increasing.  The current legal status of ayahuasca or its source plants in the United States is unclear, although DMT is a Schedule I controlled substance.  One ayahuasca church has received favorable rulings in 2 federal courts in response to its petition to the Department of Justice for the right to use ayahuasca under the Religious Freedom Restoration Act.  A biomedical study of one of the churches, the Un~iao do Vegetal (UDV), indicated that ayahuasca may have therapeutic applications for the treatment of alcoholism, substance abuse, and possibly other disorders.  Clin. studies conducted in Spain have demonstrated that ayahuasca can be used safely in normal healthy adults, but have done little to clarify its potential therapeutic uses.  Because of ayahuasca's ill-defined legal status and variable botanical and chem. compn., clin. investigations in the United States, ideally under an approved Investigational New Drug (IND) protocol, are complicated by both regulatory and methodol. issues.  This article provides an overview of ayahuasca and discusses some of the challenges that must be overcome before it can be clin. investigated in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCoBn82YvdZ7Vg90H21EOLACvtfcHk0lhgJLUPW2rKIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVCitbk%253D&md5=f44206dc223bee9a44b26b12f7f56a7c</span></div><a href="/servlet/linkout?suffix=cit69a&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DMcKenna%26aufirst%3DD.%2BJ.%26atitle%3DClinical%2520investigations%2520of%2520the%2520therapeutic%2520potential%2520of%2520ayahuasca%253A%2520rationale%2520and%2520regulatory%2520challenges%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D102%26spage%3D111%26epage%3D129%26doi%3D10.1016%2Fj.pharmthera.2004.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit69b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastos, M. de L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedes
de Pinho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, M.</span></span> <span> </span><span class="NLM_article-title">The hallucinogenic world of tryptamines: an updated review</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">1151</span>– <span class="NLM_lpage">1173</span>, <span class="refDoi"> DOI: 10.1007/s00204-015-1513-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1007%2Fs00204-015-1513-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25877327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXms1Grt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=1151-1173&author=A.+M.+Araujoauthor=F.+Carvalhoauthor=M.+de+L.+Bastosauthor=P.+Guedes%0Ade+Pinhoauthor=M.+Carvalho&title=The+hallucinogenic+world+of+tryptamines%3A+an+updated+review&doi=10.1007%2Fs00204-015-1513-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69bR"><div class="casContent"><span class="casTitleNuber">69b</span><div class="casTitle"><span class="NLM_cas:atitle">The hallucinogenic world of tryptamines: an updated review</span></div><div class="casAuthors">Araujo, Ana Margarida; Carvalho, Felix; Bastos, Maria de Lourdes; Guedes de Pinho, Paula; Carvalho, Marcia</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1151-1173</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In the area of psychotropic drugs, tryptamines are known to be a broad class of classical or serotonergic hallucinogens.  These drugs are capable of producing profound changes in sensory perception, mood and thought in humans and act primarily as agonists of the 5-HT2A receptor.  Well-known tryptamines such as psilocybin contained in Aztec sacred mushrooms and N,N-dimethyltryptamine (DMT), present in South American psychoactive beverage ayahuasca, have been restrictedly used since ancient times in sociocultural and ritual contexts.  However, with the discovery of hallucinogenic properties of lysergic acid diethylamide (LSD) in mid-1900s, tryptamines began to be used recreationally among young people.  More recently, new synthetically produced tryptamine hallucinogens, such as alpha-methyltryptamine (AMT), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), emerged in the recreational drug market, which have been claimed as the next-generation designer drugs to replace LSD ('legal' alternatives to LSD).  Tryptamine derivs. are widely accessible over the Internet through companies selling them as 'research chems.', but can also be sold in 'headshops' and street dealers.  Reports of intoxication and deaths related to the use of new tryptamines have been described over the last years, raising international concern over tryptamines.  However, the lack of literature pertaining to pharmacol. and toxicol. properties of new tryptamine hallucinogens hampers the assessment of their actual potential harm to general public health.  This review provides a comprehensive update on tryptamine hallucinogens, concerning their historical background, prevalence, patterns of use and legal status, chem., toxicokinetics, toxicodynamics and their physiol. and toxicol. effects on animals and humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSfClZKsa4RrVg90H21EOLACvtfcHk0lhscEqie4nTsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXms1Grt7s%253D&md5=719ab1ac55f187d434d769efeaccfef9</span></div><a href="/servlet/linkout?suffix=cit69b&amp;dbid=16384&amp;doi=10.1007%2Fs00204-015-1513-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-015-1513-x%26sid%3Dliteratum%253Aachs%26aulast%3DAraujo%26aufirst%3DA.%2BM.%26aulast%3DCarvalho%26aufirst%3DF.%26aulast%3DBastos%26aufirst%3DM.%2Bde%2BL.%26aulast%3DGuedes%2Bde%2BPinho%26aufirst%3DP.%26aulast%3DCarvalho%26aufirst%3DM.%26atitle%3DThe%2520hallucinogenic%2520world%2520of%2520tryptamines%253A%2520an%2520updated%2520review%26jtitle%3DArch.%2520Toxicol.%26date%3D2015%26volume%3D89%26spage%3D1151%26epage%3D1173%26doi%3D10.1007%2Fs00204-015-1513-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balint, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzalegui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbridge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotschy, A. S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and synthesis of harmine derivatives with different selectivity profiles in kinase versus monoamine oxidase inhibition</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1002%2Fcmdc.201600539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=28264138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1Wisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=932-939&author=B.+Balintauthor=C.+Weberauthor=F.+Cruzaleguiauthor=M.+Burbridgeauthor=A.+S.+Kotschy&title=Structure-based+design+and+synthesis+of+harmine+derivatives+with+different+selectivity+profiles+in+kinase+versus+monoamine+oxidase+inhibition&doi=10.1002%2Fcmdc.201600539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Synthesis of Harmine Derivatives with Different Selectivity Profiles in Kinase versus Monoamine Oxidase Inhibition</span></div><div class="casAuthors">Balint, Balazs; Weber, Csaba; Cruzalegui, Francisco; Burbridge, Mike; Kotschy, Andras</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">932-939</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is an emerging biol. target with implications in diverse therapeutic areas such as neurol. disorders (Down syndrome, in particular), metab., and oncol.  Harmine, a natural product that selectively inhibits DYRK1A amongst kinases, could serve as a tool compd. to better understand the biol. processes that arise from DYRK1A inhibition.  On the other hand, harmine is also a potent inhibitor of monoamine oxidase A (MAO-A).  Using structure-based design, we synthesized a collection of harmine analogs with tunable selectivity toward these two enzymes.  Modifications at the 7-position typically decreased affinity for DYRK1A, whereas substitution at the 9-position had a similar effect on MAO-A inhibition but DYRK1A inhibition was maintained.  The resulting collection of compds. can help to understand the biol. role of DYRK1A and also to assess the interference in the biol. effect originating in MAO-A inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsY4lpVOJVlbVg90H21EOLACvtfcHk0lhscEqie4nTsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1Wisro%253D&md5=f713602f24c608cbe5c97d965ea3727d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600539%26sid%3Dliteratum%253Aachs%26aulast%3DBalint%26aufirst%3DB.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DCruzalegui%26aufirst%3DF.%26aulast%3DBurbridge%26aufirst%3DM.%26aulast%3DKotschy%26aufirst%3DA.%2BS.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520harmine%2520derivatives%2520with%2520different%2520selectivity%2520profiles%2520in%2520kinase%2520versus%2520monoamine%2520oxidase%2520inhibition%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D932%26epage%3D939%26doi%3D10.1002%2Fcmdc.201600539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarragiotto, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span> <span> </span><span class="NLM_article-title">Computational and experimental evaluation of the structure/activity relationship of β-carbolines as DYRK1A inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4854</span>– <span class="NLM_lpage">4860</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2014.08.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4854-4860&author=B.+Drungauthor=C.+Scholzauthor=V.+Barbosaauthor=A.+Nazariauthor=M.+H.+Sarragiottoauthor=B.+Schmidt&title=Computational+and+experimental+evaluation+of+the+structure%2Factivity+relationship+of+%CE%B2-carbolines+as+DYRK1A+inhibitors&doi=10.1016%2Fj.bmcl.2014.08.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.054%26sid%3Dliteratum%253Aachs%26aulast%3DDrung%26aufirst%3DB.%26aulast%3DScholz%26aufirst%3DC.%26aulast%3DBarbosa%26aufirst%3DV.%26aulast%3DNazari%26aufirst%3DA.%26aulast%3DSarragiotto%26aufirst%3DM.%2BH.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DComputational%2520and%2520experimental%2520evaluation%2520of%2520the%2520structure%252Factivity%2520relationship%2520of%2520%25CE%25B2-carbolines%2520as%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4854%26epage%3D4860%26doi%3D10.1016%2Fj.bmcl.2014.08.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruben, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurzlbauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Selectivity profiling and biological activity of novel β-carbolines as potent and selective DYRK1 kinase inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0132453</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0132453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1371%2Fjournal.pone.0132453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26192590" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0132453&author=K.+Rubenauthor=A.+Wurzlbauerauthor=A.+Walteauthor=W.+Sipplauthor=F.+Bracherauthor=W.+Becker&title=Selectivity+profiling+and+biological+activity+of+novel+%CE%B2-carbolines+as+potent+and+selective+DYRK1+kinase+inhibitors&doi=10.1371%2Fjournal.pone.0132453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132453%26sid%3Dliteratum%253Aachs%26aulast%3DRuben%26aufirst%3DK.%26aulast%3DWurzlbauer%26aufirst%3DA.%26aulast%3DWalte%26aufirst%3DA.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DSelectivity%2520profiling%2520and%2520biological%2520activity%2520of%2520novel%2520%25CE%25B2-carbolines%2520as%2520potent%2520and%2520selective%2520DYRK1%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0132453%26doi%3D10.1371%2Fjournal.pone.0132453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruben, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birner-Gruenberger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preisinger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamberg-Lemper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Mechanism of dual specificity kinase activity of DYRK1A</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">4495</span>– <span class="NLM_lpage">4511</span>, <span class="refDoi"> DOI: 10.1111/febs.12411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Ffebs.12411" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=4495-4511&author=A.+Walteauthor=K.+Rubenauthor=R.+Birner-Gruenbergerauthor=C.+Preisingerauthor=S.+Bamberg-Lemperauthor=N.+Hilzauthor=F.+Bracherauthor=W.+Becker&title=Mechanism+of+dual+specificity+kinase+activity+of+DYRK1A&doi=10.1111%2Ffebs.12411"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12411%26sid%3Dliteratum%253Aachs%26aulast%3DWalte%26aufirst%3DA.%26aulast%3DRuben%26aufirst%3DK.%26aulast%3DBirner-Gruenberger%26aufirst%3DR.%26aulast%3DPreisinger%26aufirst%3DC.%26aulast%3DBamberg-Lemper%26aufirst%3DS.%26aulast%3DHilz%26aufirst%3DN.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DMechanism%2520of%2520dual%2520specificity%2520kinase%2520activity%2520of%2520DYRK1A%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D4495%26epage%3D4511%26doi%3D10.1111%2Ffebs.12411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beniddir, M.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Borgne, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iorga, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litaudon, M.</span></span> <span> </span><span class="NLM_article-title">Acridone alkaloids from <i>Glycosmis chlorosperma</i> as DYRK1A inhibitors</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1117</span>– <span class="NLM_lpage">1122</span>, <span class="refDoi"> DOI: 10.1021/np400856h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400856h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=1117-1122&author=M.%0AA.+Beniddirauthor=E.+Le+Borgneauthor=B.+I.+Iorgaauthor=N.+Loa%C3%ABcauthor=O.+Lozachauthor=L.+Meijerauthor=K.+Awangauthor=M.+Litaudon&title=Acridone+alkaloids+from+Glycosmis+chlorosperma+as+DYRK1A+inhibitors&doi=10.1021%2Fnp400856h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fnp400856h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400856h%26sid%3Dliteratum%253Aachs%26aulast%3DBeniddir%26aufirst%3DM.%2BA.%26aulast%3DLe%2BBorgne%26aufirst%3DE.%26aulast%3DIorga%26aufirst%3DB.%2BI.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAwang%26aufirst%3DK.%26aulast%3DLitaudon%26aufirst%3DM.%26atitle%3DAcridone%2520alkaloids%2520from%2520Glycosmis%2520chlorosperma%2520as%2520DYRK1A%2520inhibitors%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2014%26volume%3D77%26spage%3D1117%26epage%3D1122%26doi%3D10.1021%2Fnp400856h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemling, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offen, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Brosse, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarau, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westley, J. W.</span></span> <span> </span><span class="NLM_article-title">New leukotriene B4 receptor antagonist: leucettamine A and related imidazole alkaloids from the marine sponge <i>Leucetta microraphis</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1021/np50091a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50091a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1993&pages=116-121&author=G.+W.+Chanauthor=S.+Mongauthor=M.+E.+Hemlingauthor=A.+J.+Freyerauthor=P.+M.+Offenauthor=C.+W.+De+Brosseauthor=H.+M.+Sarauauthor=J.+W.+Westley&title=New+leukotriene+B4+receptor+antagonist%3A+leucettamine+A+and+related+imidazole+alkaloids+from+the+marine+sponge+Leucetta+microraphis&doi=10.1021%2Fnp50091a016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75a&amp;dbid=16384&amp;doi=10.1021%2Fnp50091a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50091a016%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%2BW.%26aulast%3DMong%26aufirst%3DS.%26aulast%3DHemling%26aufirst%3DM.%2BE.%26aulast%3DFreyer%26aufirst%3DA.%2BJ.%26aulast%3DOffen%26aufirst%3DP.%2BM.%26aulast%3DDe%2BBrosse%26aufirst%3DC.%2BW.%26aulast%3DSarau%26aufirst%3DH.%2BM.%26aulast%3DWestley%26aufirst%3DJ.%2BW.%26atitle%3DNew%2520leukotriene%2520B4%2520receptor%2520antagonist%253A%2520leucettamine%2520A%2520and%2520related%2520imidazole%2520alkaloids%2520from%2520the%2520marine%2520sponge%2520Leucetta%2520microraphis%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1993%26volume%3D56%26spage%3D116%26epage%3D121%26doi%3D10.1021%2Fnp50091a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit75b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwashima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iguchi, K.</span></span> <span> </span><span class="NLM_article-title">A new bioactive triene aldehyde from the marine sponge <i>Leucetta microraphis</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">258</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1021/np9903503</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np9903503" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2000&pages=258-260&author=K.+Watanabeauthor=Y.+Tsudaauthor=M.+Iwashimaauthor=K.+Iguchi&title=A+new+bioactive+triene+aldehyde+from+the+marine+sponge+Leucetta+microraphis&doi=10.1021%2Fnp9903503"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75b&amp;dbid=16384&amp;doi=10.1021%2Fnp9903503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp9903503%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DY.%26aulast%3DIwashima%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DK.%26atitle%3DA%2520new%2520bioactive%2520triene%2520aldehyde%2520from%2520the%2520marine%2520sponge%2520Leucetta%2520microraphis%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2000%26volume%3D63%26spage%3D258%26epage%3D260%26doi%3D10.1021%2Fnp9903503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attanasio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villiers, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alencar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roué, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguet-Kondracki, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proksch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limanton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiheneuf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klautau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Marine-derived 2-aminoimidazolone alkaloids. Leucettamine B-related polyandrocarpamines inhibit mammalian and protozoan DYRK & CLK kinases</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">316</span>, <span class="refDoi"> DOI: 10.3390/md15100316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.3390%2Fmd15100316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVKnt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=316&author=N.+Loa%C3%ABcauthor=E.+Attanasioauthor=B.+Villiersauthor=E.+Durieuauthor=T.+Tahtouhauthor=M.+Camauthor=R.+A.+Davisauthor=A.+Alencarauthor=M.+Rou%C3%A9author=M.-L.+Bourguet-Kondrackiauthor=P.+Prokschauthor=E.+Limantonauthor=S.+Guiheneufauthor=F.+Carreauxauthor=J.-P.+Bazureauauthor=M.+Klautauauthor=L.+Meijer&title=Marine-derived+2-aminoimidazolone+alkaloids.+Leucettamine+B-related+polyandrocarpamines+inhibit+mammalian+and+protozoan+DYRK+%26+CLK+kinases&doi=10.3390%2Fmd15100316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Marine-derived 2-aminoimidazolone alkaloids. leucettamine B-related polyandrocarpamines inhibit mammalian and protozoan DYRK & CLK kinases</span></div><div class="casAuthors">Loaec, Nadege; Attanasio, Eletta; Villiers, Benoit; Durieu, Emilie; Tahtouh, Tania; Cam, Morgane; Davis, Rohan A.; Alencar, Aline; Roue, Melanie; Bourguet-Kondracki, Marie-Lise; Proksch, Peter; Limanton, Emmanuelle; Guiheneuf, Olene; Carreaux, Francois; Bazureau, Jean-Pierre; Klautau, Michelle; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">316/1-316/15</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A large diversity of 2-aminoimidazolone alkaloids is produced by various marine invertebrates, esp. by the marine Calcareous sponges Leucetta and Clathrina.  The phylogeny of these sponges and the wide scope of 2-aminoimidazolone alkaloids they produce are reviewed in this article.  The origin (invertebrate cells, assocd. microorganisms, or filtered plankton), physiol. functions, and natural mol. targets of these alkaloids are largely unknown.  Following the identification of leucettamine B as an inhibitor of selected protein kinases, we synthesized a family of analogs, collectively named leucettines, as potent inhibitors of DYRKs (dual-specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) and potential pharmacol. leads for the treatment of several diseases, including Alzheimer's disease and Down syndrome.  We assembled a small library of marine sponge- and ascidian-derived 2-aminoimidazolone alkaloids, along with several synthetic analogs, and tested them on a panel of mammalian and protozoan kinases.  Polyandrocarpamines A and B were found to be potent and selective inhibitors of DYRKs and CLKs.  They inhibited cyclin D1 phosphorylation on a DYRK1A phosphosite in cultured cells. 2-Aminoimidazolones thus represent a promising chem. scaffold for the design of potential therapeutic drug candidates acting as specific inhibitors of disease-relevant kinases, and possibly other disease-relevant targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVUruCIbF4drVg90H21EOLACvtfcHk0lje3N1col0sSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVKnt77J&md5=c3132730ae4c301918038bf0e4a13433</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.3390%2Fmd15100316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd15100316%26sid%3Dliteratum%253Aachs%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DAttanasio%26aufirst%3DE.%26aulast%3DVilliers%26aufirst%3DB.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DCam%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DR.%2BA.%26aulast%3DAlencar%26aufirst%3DA.%26aulast%3DRou%25C3%25A9%26aufirst%3DM.%26aulast%3DBourguet-Kondracki%26aufirst%3DM.-L.%26aulast%3DProksch%26aufirst%3DP.%26aulast%3DLimanton%26aufirst%3DE.%26aulast%3DGuiheneuf%26aufirst%3DS.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26aulast%3DKlautau%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DMarine-derived%25202-aminoimidazolone%2520alkaloids.%2520Leucettamine%2520B-related%2520polyandrocarpamines%2520inhibit%2520mammalian%2520and%2520protozoan%2520DYRK%2520%2526%2520CLK%2520kinases%26jtitle%3DMar.%2520Drugs%26date%3D2017%26volume%3D15%26spage%3D316%26doi%3D10.3390%2Fmd15100316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhommel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberholzer, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Selectivity, co-crystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9312</span>– <span class="NLM_lpage">9330</span>, <span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+co-crystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520co-crystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Naert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferré, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmstrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Givalois, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25–35 peptide administration in mice</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2170</span>– <span class="NLM_lpage">2182</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2015.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.euroneuro.2015.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26381812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2170-2182&author=G.+Naertauthor=V.+Ferr%C3%A9author=J.+Meunierauthor=E.+Kellerauthor=S.+Malmstromauthor=L.+Givaloisauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=T.+Maurice&title=Leucettine+L41%2C+a+DYRK1A-preferential+DYRKs%2FCLKs+inhibitor%2C+prevents+memory+impairments+and+neurotoxicity+induced+by+oligomeric+A%CE%B225%E2%80%9335+peptide+administration+in+mice&doi=10.1016%2Fj.euroneuro.2015.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78aR"><div class="casContent"><span class="casTitleNuber">78a</span><div class="casTitle"><span class="NLM_cas:atitle">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice</span></div><div class="casAuthors">Naert, Gaelle; Ferre, Valentine; Meunier, Johann; Keller, Emeline; Malmstrom, Susanna; Givalois, Laurent; Carreaux, Francois; Bazureau, Jean-Pierre; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2170-2182</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) are implicated in the onset and progression of Down syndrome (DS) and Alzheimer's disease (AD).  DYRK1A has emerged as a possible link between amyloid-β (Aβ) and Tau, the major pathol. proteins in AD.  We here assessed the neuroprotective potential of a novel inhibitor of DYRKs/CLKs.  The Leucettine L41, acting preferentially on DYRK1A, was tested in Aβ25-35-treated mice, a nontransgenic model of AD-like toxicity.  We co-injected intracerebroventricularly oligomeric Aβ25-35 peptide and L41 in Swiss male mice.  After 7 days, they were submitted to behavioral tests addressing spatial and non-spatial, short- and long-term memories.  The oxidative stress, apoptotic markers, kinases involved in Tau phosphorylation, and synaptic integrity were analyzed by Western blot and ELISA in the hippocampus.  L41, tested at 0.4, 1.2, 4 μg, prevented the Aβ25-35-induced memory deficits in the Y-maze, passive avoidance and water-maze tests, with the most active dose being 4 μg.  The inhibitor prevented the Aβ25-35-induced oxidative stress, as revealed by measures of lipid peroxidn. levels and reactive oxygen species accumulation, and abolished Aβ25-35-induced expression of pro-apoptotic markers.  L41 prevented the Aβ25-35-induced decrease of AKT activation and increase of glycogen synthase kinase-3β (GSK-3β) activation, resulting in a decrease of Tau phosphorylation.  Finally, L41 restored Aβ25-35-reduced levels of synaptic markers.  The novel DYRK1A-preferential inhibitor L41 therefore prevented Aβ25-35-induced memory impairments and neurotoxicity in the mouse hippocampus.  These in vivo data highlighted particularly DYRK1A as a major kinase involved in Aβ pathol. and suggested therapeutic developments for DYRK1A inhibitors in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSRN-4HYiJs7Vg90H21EOLACvtfcHk0lhI2Z-L7n9IEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D&md5=0ddd499193f1ef57d02b46a39f225abb</span></div><a href="/servlet/linkout?suffix=cit78a&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2015.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2015.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DNaert%26aufirst%3DG.%26aulast%3DFerr%25C3%25A9%26aufirst%3DV.%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DE.%26aulast%3DMalmstrom%26aufirst%3DS.%26aulast%3DGivalois%26aufirst%3DL.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DLeucettine%2520L41%252C%2520a%2520DYRK1A-preferential%2520DYRKs%252FCLKs%2520inhibitor%252C%2520prevents%2520memory%2520impairments%2520and%2520neurotoxicity%2520induced%2520by%2520oligomeric%2520A%25CE%25B225%25E2%2580%259335%2520peptide%2520administration%2520in%2520mice%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2015%26volume%3D25%26spage%3D2170%26epage%3D2182%26doi%3D10.1016%2Fj.euroneuro.2015.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit78b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Debdab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babault, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baratte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenreich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span> <span> </span><span class="NLM_article-title">Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4172</span>– <span class="NLM_lpage">4186</span>, <span class="refDoi"> DOI: 10.1021/jm200274d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200274d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4172-4186&author=M.+Debdabauthor=F.+Carreauxauthor=S.+Renaultauthor=M.+Soundararajanauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=O.+Lozachauthor=L.+Babaultauthor=T.+Tahtouhauthor=B.+Baratteauthor=Y.+Ogawaauthor=M.+Hagiwaraauthor=A.+Eisenreichauthor=U.+Rauchauthor=S.+Knappauthor=L.+Meijerauthor=J.+P.+Bazureau&title=Leucettines%2C+a+class+of+potent+inhibitors+of+cdc2-like+kinases+and+dual+specificity%2C+tyrosine+phosphorylation+regulated+kinases+derived+from+the+marine+sponge+leucettamine+B%3A+modulation+of+alternative+pre-RNA+splicing&doi=10.1021%2Fjm200274d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78b&amp;dbid=16384&amp;doi=10.1021%2Fjm200274d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200274d%26sid%3Dliteratum%253Aachs%26aulast%3DDebdab%26aufirst%3DM.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DRenault%26aufirst%3DS.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBabault%26aufirst%3DL.%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DHagiwara%26aufirst%3DM.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26atitle%3DLeucettines%252C%2520a%2520class%2520of%2520potent%2520inhibitors%2520of%2520cdc2-like%2520kinases%2520and%2520dual%2520specificity%252C%2520tyrosine%2520phosphorylation%2520regulated%2520kinases%2520derived%2520from%2520the%2520marine%2520sponge%2520leucettamine%2520B%253A%2520modulation%2520of%2520alternative%2520pre-RNA%2520splicing%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4172%26epage%3D4186%26doi%3D10.1021%2Fjm200274d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foll-Josselin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limanton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span> <span> </span><span class="NLM_article-title">Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">737</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.01.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2013.01.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=728-737&author=G.+Burgyauthor=T.+Tahtouhauthor=E.+Durieuauthor=B.+Foll-Josselinauthor=E.+Limantonauthor=L.+Meijerauthor=F.+Carreauxauthor=J.+P.+Bazureau&title=Chemical+synthesis+and+biological+validation+of+immobilized+protein+kinase+inhibitory+Leucettines&doi=10.1016%2Fj.ejmech.2013.01.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.01.035%26sid%3Dliteratum%253Aachs%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DFoll-Josselin%26aufirst%3DB.%26aulast%3DLimanton%26aufirst%3DE.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26atitle%3DChemical%2520synthesis%2520and%2520biological%2520validation%2520of%2520immobilized%2520protein%2520kinase%2520inhibitory%2520Leucettines%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D62%26spage%3D728%26epage%3D737%26doi%3D10.1016%2Fj.ejmech.2013.01.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterlin Masic, L. P.</span></span> <span> </span><span class="NLM_article-title">Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1517/17460441.2012.688743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1517%2F17460441.2012.688743" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=549-560&author=T.+Tomasicauthor=L.+P.+Peterlin+Masic&title=Rhodanine+as+a+scaffold+in+drug+discovery%3A+a+critical+review+of+its+biological+activities+and+mechanisms+of+target+modulation&doi=10.1517%2F17460441.2012.688743"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80a&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.688743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.688743%26sid%3Dliteratum%253Aachs%26aulast%3DTomasic%26aufirst%3DT.%26aulast%3DPeterlin%2BMasic%26aufirst%3DL.%2BP.%26atitle%3DRhodanine%2520as%2520a%2520scaffold%2520in%2520drug%2520discovery%253A%2520a%2520critical%2520review%2520of%2520its%2520biological%2520activities%2520and%2520mechanisms%2520of%2520target%2520modulation%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D549%26epage%3D560%26doi%3D10.1517%2F17460441.2012.688743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit80b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gilberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpfe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Activity profiles of analog series containing pan assay interference compounds</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">35638</span>– <span class="NLM_lpage">35647</span>, <span class="refDoi"> DOI: 10.1039/C7RA06736D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1039%2FC7RA06736D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFyhs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=35638-35647&author=E.+Gilbergauthor=D.+Stumpfeauthor=J.+Bajorath&title=Activity+profiles+of+analog+series+containing+pan+assay+interference+compounds&doi=10.1039%2FC7RA06736D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80bR"><div class="casContent"><span class="casTitleNuber">80b</span><div class="casTitle"><span class="NLM_cas:atitle">Activity profiles of analog series containing pan assay interference compounds</span></div><div class="casAuthors">Gilberg, Erik; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">57</span>),
    <span class="NLM_cas:pages">35638-35647</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Activity artifacts in assays present a major problem for biol. screening and medicinal chem.  Such artifacts are often caused by compds. that form aggregates or are reactive under assay conditions.  Many pan assay interference compds. (PAINS) have been proposed to cause false-pos. assay readouts.  PAINS are typically contained as substructures in larger mols.  They are used as computational filters to detect compds. with potential chem. liabilities.  Recent studies have shown that mols. contg. the same PAINS substructure often have greatly varying hit rates in screening assays.  Even the overall most frequently active PAINS substructures are found in compds. that are only rarely active or consistently inactive in many assays they are tested in.  These observations suggest that the structural context in which PAINS are presented may play an important role for eliciting false-pos. activities.  However, this assumption remains to be investigated.  Herein, we report the systematic identification of analog series of screening compds. that contain PAINS or exclusively consist of PAINS and the anal. of their activity profiles.  Comparison of analogs or different series of analogs contg. the same PAINS substructure provides structural context information.  For many PAINS, extensively tested series with distinct activity profiles were detected.  Furthermore, analogs within the same series often displayed significant differences in hit rates.  The analog series reported herein organize PAINS in different structural contexts.  Their activity profiles provide many opportunities for exptl. follow-up investigations to better understand PAINS characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4gvYh5SuHrLVg90H21EOLACvtfcHk0liXJzGTSIXqJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFyhs7zP&md5=88d15494e03827a9e0ca2a920a97a09a</span></div><a href="/servlet/linkout?suffix=cit80b&amp;dbid=16384&amp;doi=10.1039%2FC7RA06736D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA06736D%26sid%3Dliteratum%253Aachs%26aulast%3DGilberg%26aufirst%3DE.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DActivity%2520profiles%2520of%2520analog%2520series%2520containing%2520pan%2520assay%2520interference%2520compounds%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D35638%26epage%3D35647%26doi%3D10.1039%2FC7RA06736D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joffe, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puricelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seldes, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, J. A.</span></span> <span> </span><span class="NLM_article-title">Indole alkaloids from the tunicate <i>Aplidum meridianum</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1130</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1021/np970493u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np970493u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1998&pages=1130-1132&author=L.+H.+Francoauthor=E.+B.+Joffeauthor=L.+Puricelliauthor=M.+Tatianauthor=A.+M.+Seldesauthor=J.+A.+Palermo&title=Indole+alkaloids+from+the+tunicate+Aplidum+meridianum&doi=10.1021%2Fnp970493u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=10.1021%2Fnp970493u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp970493u%26sid%3Dliteratum%253Aachs%26aulast%3DFranco%26aufirst%3DL.%2BH.%26aulast%3DJoffe%26aufirst%3DE.%2BB.%26aulast%3DPuricelli%26aufirst%3DL.%26aulast%3DTatian%26aufirst%3DM.%26aulast%3DSeldes%26aufirst%3DA.%2BM.%26aulast%3DPalermo%26aufirst%3DJ.%2BA.%26atitle%3DIndole%2520alkaloids%2520from%2520the%2520tunicate%2520Aplidum%2520meridianum%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1998%26volume%3D61%26spage%3D1130%26epage%3D1132%26doi%3D10.1021%2Fnp970493u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit81b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Seldes, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez Brasco, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez Franco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, J. A.</span></span> <span> </span><span class="NLM_article-title">Identification of two meridianins from the crude extract of the tunicate <i>Aplidium meridianum</i> by tandem mass spectrometry</span>. <i>Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1080/14786410601133517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1080%2F14786410601133517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17497427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFSitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=555-563&author=A.+M.+Seldesauthor=M.+F.+Rodriguez+Brascoauthor=L.+Hernandez+Francoauthor=J.+A.+Palermo&title=Identification+of+two+meridianins+from+the+crude+extract+of+the+tunicate+Aplidium+meridianum+by+tandem+mass+spectrometry&doi=10.1080%2F14786410601133517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81bR"><div class="casContent"><span class="casTitleNuber">81b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of two meridianins from the crude extract of the tunicate Aplidium meridianum by tandem mass spectrometry</span></div><div class="casAuthors">Seldes, A. M.; Brasco, M. F. Rodriguez; Franco, L. Hernandez; Palermo, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">555-563</span>CODEN:
                <span class="NLM_cas:coden">NPRAAT</span>;
        ISSN:<span class="NLM_cas:issn">1478-6419</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">As part of the development of an anal. technique for the detection of meridianins and related compds. in biol. fluids, a crude ext. of the tunicate Aplidium meridianum was analyzed using neutral loss tandem mass spectrometry.  The 41 u neutral loss-EI(+) mass spectrum showed mol. ions corresponding to two previously undetected alkaloids.  We report the isolation and structure elucidation of the alkaloids, meridianins F and G.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmCqhJsIWLdrVg90H21EOLACvtfcHk0liXJzGTSIXqJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFSitbk%253D&md5=6ca7a7595bde47385c0437fdbea4c2a4</span></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=10.1080%2F14786410601133517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14786410601133517%26sid%3Dliteratum%253Aachs%26aulast%3DSeldes%26aufirst%3DA.%2BM.%26aulast%3DRodriguez%2BBrasco%26aufirst%3DM.%2BF.%26aulast%3DHernandez%2BFranco%26aufirst%3DL.%26aulast%3DPalermo%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520two%2520meridianins%2520from%2520the%2520crude%2520extract%2520of%2520the%2520tunicate%2520Aplidium%2520meridianum%2520by%2520tandem%2520mass%2520spectrometry%26jtitle%3DNat.%2520Prod.%2520Res.%26date%3D2007%26volume%3D21%26spage%3D555%26epage%3D563%26doi%3D10.1080%2F14786410601133517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gompel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leost, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Kier
Joffe, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puricelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernancez Franco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Meridianins, a new family of protein kinase inhibitors isolated from the ascidian <i>Aplidium meridianum</i></span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1703</span>– <span class="NLM_lpage">1707</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.01.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2004.01.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1703-1707&author=M.+Gompelauthor=M.+Leostauthor=E.+B.+De+Kier%0AJoffeauthor=L.+Puricelliauthor=L.+Hernancez+Francoauthor=J.+Palermoauthor=L.+Meijer&title=Meridianins%2C+a+new+family+of+protein+kinase+inhibitors+isolated+from+the+ascidian+Aplidium+meridianum&doi=10.1016%2Fj.bmcl.2004.01.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.01.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.01.050%26sid%3Dliteratum%253Aachs%26aulast%3DGompel%26aufirst%3DM.%26aulast%3DLeost%26aufirst%3DM.%26aulast%3DDe%2BKier%2BJoffe%26aufirst%3DE.%2BB.%26aulast%3DPuricelli%26aufirst%3DL.%26aulast%3DHernancez%2BFranco%26aufirst%3DL.%26aulast%3DPalermo%26aufirst%3DJ.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DMeridianins%252C%2520a%2520new%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520isolated%2520from%2520the%2520ascidian%2520Aplidium%2520meridianum%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1703%26epage%3D1707%26doi%3D10.1016%2Fj.bmcl.2004.01.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit82b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Radwan, M. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Sherbiny, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antitumor activity of indolylpyrimidines: marine natural product meridianin D analogues</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1206</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmc.2006.11.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=1206-1211&author=M.+A.+A.+Radwanauthor=M.+El-Sherbiny&title=Synthesis+and+antitumor+activity+of+indolylpyrimidines%3A+marine+natural+product+meridianin+D+analogues&doi=10.1016%2Fj.bmc.2006.11.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DRadwan%26aufirst%3DM.%2BA.%2BA.%26aulast%3DEl-Sherbiny%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520antitumor%2520activity%2520of%2520indolylpyrimidines%253A%2520marine%2520natural%2520product%2520meridianin%2520D%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D1206%26epage%3D1211%26doi%3D10.1016%2Fj.bmc.2006.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giraud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debiton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nauton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thery, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anizon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, protein kinase inhibitory potencies, and <i>in vitro</i> antiproliferative activities of meridianin derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4474</span>– <span class="NLM_lpage">4489</span>, <span class="refDoi"> DOI: 10.1021/jm200464w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200464w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4474-4489&author=F.+Giraudauthor=G.+Alvesauthor=E.+Debitonauthor=L.+Nautonauthor=V.+Theryauthor=E.+Durieuauthor=Y.+Ferandinauthor=O.+Lozachauthor=L.+Meijerauthor=F.+Anizonauthor=E.+Pereiraauthor=P.+Moreau&title=Synthesis%2C+protein+kinase+inhibitory+potencies%2C+and+in+vitro+antiproliferative+activities+of+meridianin+derivatives&doi=10.1021%2Fjm200464w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Protein Kinase Inhibitory Potencies, and in Vitro Antiproliferative Activities of Meridianin Derivatives</span></div><div class="casAuthors">Giraud, Francis; Alves, Georges; Debiton, Eric; Nauton, Lionel; Thery, Vincent; Durieu, Emilie; Ferandin, Yoan; Lozach, Olivier; Meijer, Laurent; Anizon, Fabrice; Pereira, Elisabeth; Moreau, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4474-4489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of new meridianin derivs., e.g., I (X = H, Y = 7-Br; X = I, Y = 6-Br, 7-Br) (II), is described.  The indolic ring system was substituted at the C-4 to C-7 positions either by a bromine atom or by nitro or amino groups.  Addnl., an iodine atom or various aryl groups were introduced at the C-5 position of the 2-aminopyrimidine ring.  These compds., as well as some of their synthetic intermediates, were tested for their kinase inhibitory potencies and for their in vitro antiproliferative activities.  We found that this series of compds. is particularly interesting in the development of new inhibitors of DYRK1A and CLK1 kinases.  The most effective compds. toward these two kinase families are the 6- and 7-bromo derivs. II that showed more than 45-fold selectivity toward DYRK1A/CLK1 kinases over the other kinases tested.  Meridianin derivs. could thus be developed toward potent and selective inhibitors of key RNA splicing regulators and potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBjkvRn0gdELVg90H21EOLACvtfcHk0lgjlsnDTevpsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D&md5=7689b7e5afd91dd2dc1b1b1c3aec6a5d</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm200464w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200464w%26sid%3Dliteratum%253Aachs%26aulast%3DGiraud%26aufirst%3DF.%26aulast%3DAlves%26aufirst%3DG.%26aulast%3DDebiton%26aufirst%3DE.%26aulast%3DNauton%26aufirst%3DL.%26aulast%3DThery%26aufirst%3DV.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DPereira%26aufirst%3DE.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520protein%2520kinase%2520inhibitory%2520potencies%252C%2520and%2520in%2520vitro%2520antiproliferative%2520activities%2520of%2520meridianin%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4474%26epage%3D4489%26doi%3D10.1021%2Fjm200464w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perry, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettouati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litaudon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blunt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, M. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hope, H.</span></span> <span> </span><span class="NLM_article-title">Alkaloids from the antarctic sponge <i>Kirkpatrickia varialosa</i>. Part 1: variolin B, a new antitumour and antiviral compound</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3987</span>– <span class="NLM_lpage">3992</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)89673-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2FS0040-4020%2801%2989673-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=3987-3992&author=N.+B.+Perryauthor=L.+Ettouatiauthor=M.+Litaudonauthor=J.+W.+Bluntauthor=M.+H.+G.+Munroauthor=S.+Parkinauthor=H.+Hope&title=Alkaloids+from+the+antarctic+sponge+Kirkpatrickia+varialosa.+Part+1%3A+variolin+B%2C+a+new+antitumour+and+antiviral+compound&doi=10.1016%2FS0040-4020%2801%2989673-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2989673-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252989673-3%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DN.%2BB.%26aulast%3DEttouati%26aufirst%3DL.%26aulast%3DLitaudon%26aufirst%3DM.%26aulast%3DBlunt%26aufirst%3DJ.%2BW.%26aulast%3DMunro%26aufirst%3DM.%2BH.%2BG.%26aulast%3DParkin%26aufirst%3DS.%26aulast%3DHope%26aufirst%3DH.%26atitle%3DAlkaloids%2520from%2520the%2520antarctic%2520sponge%2520Kirkpatrickia%2520varialosa.%2520Part%25201%253A%2520variolin%2520B%252C%2520a%2520new%2520antitumour%2520and%2520antiviral%2520compound%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D3987%26epage%3D3992%26doi%3D10.1016%2FS0040-4020%2801%2989673-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Simone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erba, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vikhanskaya, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Francesco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuevas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez Sousa-Faro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Incalci, M.</span></span> <span> </span><span class="NLM_article-title">Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2366</span>– <span class="NLM_lpage">2377</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2005.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejca.2005.05.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=2366-2377&author=M.+Simoneauthor=E.+Erbaauthor=G.+Damiaauthor=F.+Vikhanskayaauthor=A.+M.+Di+Francescoauthor=R.+Riccardiauthor=C.+Baillyauthor=C.+Cuevasauthor=J.+M.+Fernandez+Sousa-Faroauthor=M.+D%E2%80%99Incalci&title=Variolin+B+and+its+derivate+deoxy-variolin+B%3A+new+marine+natural+compounds+with+cyclin-dependent+kinase+inhibitor+activity&doi=10.1016%2Fj.ejca.2005.05.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2005.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2005.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DSimone%26aufirst%3DM.%26aulast%3DErba%26aufirst%3DE.%26aulast%3DDamia%26aufirst%3DG.%26aulast%3DVikhanskaya%26aufirst%3DF.%26aulast%3DDi%2BFrancesco%26aufirst%3DA.%2BM.%26aulast%3DRiccardi%26aufirst%3DR.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DCuevas%26aufirst%3DC.%26aulast%3DFernandez%2BSousa-Faro%26aufirst%3DJ.%2BM.%26aulast%3DD%25E2%2580%2599Incalci%26aufirst%3DM.%26atitle%3DVariolin%2520B%2520and%2520its%2520derivate%2520deoxy-variolin%2520B%253A%2520new%2520marine%2520natural%2520compounds%2520with%2520cyclin-dependent%2520kinase%2520inhibitor%2520activity%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2005%26volume%3D41%26spage%3D2366%26epage%3D2377%26doi%3D10.1016%2Fj.ejca.2005.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit85b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Echalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettayeb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin complex</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1021/jm700940h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm700940h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=737-751&author=A.+Echalierauthor=K.+Bettayebauthor=Y.+Ferandinauthor=O.+Lozachauthor=M.+Clementauthor=A.+Valetteauthor=F.+Ligerauthor=B.+Marquetauthor=J.+C.+Morrisauthor=J.+A.+Endicottauthor=B.+Josephauthor=L.+Meijer&title=Meriolins+%283-%28pyrimidin-4-yl%29-7-azaindoles%29%3A+synthesis%2C+kinase+inhibitory+activity%2C+cellular+effects%2C+and+structure+of+a+CDK2%2Fcyclin+A%2Fmeriolin+complex&doi=10.1021%2Fjm700940h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85bR"><div class="casContent"><span class="casTitleNuber">85b</span><div class="casTitle"><span class="NLM_cas:atitle">Meriolins (3-(Pyrimidin-4-yl)-7-azaindoles): Synthesis, Kinase Inhibitory Activity, Cellular Effects, and Structure of a CDK2/Cyclin A/Meriolin Complex</span></div><div class="casAuthors">Echalier, Aude; Bettayeb, Karima; Ferandin, Yoan; Lozach, Olivier; Clelment, Monique; Valette, Annie; Liger, Francois; Marquet, Bernard; Morris, Jonathan C.; Endicott, Jane A.; Joseph, Benoit; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">737-751</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis and biol. characterization of 3-(pyrimidin-4-yl)-7-azaindoles (meriolins), a chem. hybrid between the natural products meridianins and variolins, derived from marine organisms.  Meriolins display potent inhibitory activities toward cyclin-dependent kinases (CDKs) and, to a lesser extent, other kinases (GSK-3, DYRK1A).  The crystal structures of I (meriolin 5) and variolin B in complex with CDK2/cyclin A reveal that the two inhibitors are oriented in very different ways inside the ATP-binding pocket of the kinase.  A structure-activity relationship provides further insight into the mol. mechanism of action of this family of kinase inhibitors.  Meriolins are also potent antiproliferative and proapoptotic agents in cells cultured either as monolayers or in spheroids.  Proapoptotic efficacy of meriolins correlates best with their CDK2 and CDK9 inhibitory activity.  Meriolins thus constitute a promising class of pharmacol. agents to be further evaluated against the numerous human diseases that imply abnormal regulation of CDKs including cancers, neurodegenerative disorders, and polycystic kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJgno3A1_7LVg90H21EOLACvtfcHk0lgjlsnDTevpsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msL8%253D&md5=1bfb3d02c6894c04237eee27bbccaa5b</span></div><a href="/servlet/linkout?suffix=cit85b&amp;dbid=16384&amp;doi=10.1021%2Fjm700940h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700940h%26sid%3Dliteratum%253Aachs%26aulast%3DEchalier%26aufirst%3DA.%26aulast%3DBettayeb%26aufirst%3DK.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DClement%26aufirst%3DM.%26aulast%3DValette%26aufirst%3DA.%26aulast%3DLiger%26aufirst%3DF.%26aulast%3DMarquet%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DMeriolins%2520%25283-%2528pyrimidin-4-yl%2529-7-azaindoles%2529%253A%2520synthesis%252C%2520kinase%2520inhibitory%2520activity%252C%2520cellular%2520effects%252C%2520and%2520structure%2520of%2520a%2520CDK2%252Fcyclin%2520A%252Fmeriolin%2520complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D737%26epage%3D751%26doi%3D10.1021%2Fjm700940h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span> <span> </span><span class="NLM_article-title">Variolins and related alkaloids</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3080</span>– <span class="NLM_lpage">3098</span>, <span class="refDoi"> DOI: 10.1021/cr900032s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900032s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1ensL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=3080-3098&author=S.+R.+Walkerauthor=E.+J.+Carterauthor=B.+C.+Huffauthor=J.+C.+Morris&title=Variolins+and+related+alkaloids&doi=10.1021%2Fcr900032s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Variolins and Related Alkaloids</span></div><div class="casAuthors">Walker, Scott R.; Carter, Erin J.; Huff, Belinda C.; Morris, Jonathan C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3080-3098</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review was presented that summarized the isolation, structure detn., synthetic studies and biol. activities of the variolins, meridianins, and meriolins.  The identification and development of new cyclin-dependent kinase (CDK) inhibitors is an important area of research, particularly in the area of cancer chemotherapeutics.  The isolation of variolin B and the meridianins has resulted in a new scaffold being identified.  However, access to these compds. from their natural source, particularly in the case of variolin B, is very difficult, and as such, total synthesis was required to restore access.  This has allowed for more thorough biol. testing and allowed insights into the mode of action of these compds.  It is difficult to say whether variolin B or its deoxy analog will make it to clin. trials because there are issues with their soly. in water and their pharmacokinetic behavior.  However, work on these natural products has led to the discovery that the meriolins, synthetic hybrids that contain common structural features from each family, possess biol. activities that surpass those of either class of natural products.  Work by Meijer and co-workers suggests that the meriolins constitute a potent kinase inhibitory scaffold, and as such, these compds. may in turn inform the development of the next generation of cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHctKcp2TF0bVg90H21EOLACvtfcHk0ljSY3hgIexlwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1ensL8%253D&md5=7e617c38d72081988898dae97a40c3d8</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fcr900032s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900032s%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DS.%2BR.%26aulast%3DCarter%26aufirst%3DE.%2BJ.%26aulast%3DHuff%26aufirst%3DB.%2BC.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26atitle%3DVariolins%2520and%2520related%2520alkaloids%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D3080%26epage%3D3098%26doi%3D10.1021%2Fcr900032s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharate, S. B.</span></span> <span> </span><span class="NLM_article-title">Meridianin derivatives as potent Dyrk1A inhibitors and neuroprotective agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2948</span>– <span class="NLM_lpage">2952</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2015.05.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2948-2952&author=R.+R.+Yadavauthor=S.+Sharmaauthor=P.+Joshiauthor=A.+Waniauthor=R.+A.+Vishwakarmaauthor=A.+Kumarauthor=S.+B.+Bharate&title=Meridianin+derivatives+as+potent+Dyrk1A+inhibitors+and+neuroprotective+agents&doi=10.1016%2Fj.bmcl.2015.05.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DR.%2BR.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DWani%26aufirst%3DA.%26aulast%3DVishwakarma%26aufirst%3DR.%2BA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DBharate%26aufirst%3DS.%2BB.%26atitle%3DMeridianin%2520derivatives%2520as%2520potent%2520Dyrk1A%2520inhibitors%2520and%2520neuroprotective%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2948%26epage%3D2952%26doi%3D10.1016%2Fj.bmcl.2015.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brana, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda-Lucena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J. A.</span></span> <span> </span><span class="NLM_article-title">Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_fpage">4118</span>– <span class="NLM_lpage">4120</span>, <span class="refDoi"> DOI: 10.1039/b905068j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1039%2Fb905068j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=19568652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvV2gu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=4118-4120&author=C.+Sanchezauthor=A.+P.+Salasauthor=A.+F.+Branaauthor=M.+Palominoauthor=A.+Pineda-Lucenaauthor=R.+J.+Carbajoauthor=C.+Mendezauthor=F.+Morisauthor=J.+A.+Salas&title=Generation+of+potent+and+selective+kinase+inhibitors+by+combinatorial+biosynthesis+of+glycosylated+indolocarbazoles&doi=10.1039%2Fb905068j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles</span></div><div class="casAuthors">Sanchez, Cesar; Salas, Aaroa P.; Brana, Alfredo F.; Palomino, Martina; Pineda-Lucena, Antonio; Carbajo, Rodrigo J.; Mendez, Carmen; Moris, Francisco; Salas, Jose A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">4118-4120</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report the generation of novel glycosylated indolocarbazoles by combinatorial biosynthesis, and the identification of two novel potent and selective compds. inhibitors of JAK2 and Ikkb kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB8EFvS1PgfrVg90H21EOLACvtfcHk0ljSY3hgIexlwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvV2gu7o%253D&md5=a79d52d492546915300b2b0d67230ffb</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1039%2Fb905068j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb905068j%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DA.%2BP.%26aulast%3DBrana%26aufirst%3DA.%2BF.%26aulast%3DPalomino%26aufirst%3DM.%26aulast%3DPineda-Lucena%26aufirst%3DA.%26aulast%3DCarbajo%26aufirst%3DR.%2BJ.%26aulast%3DMendez%26aufirst%3DC.%26aulast%3DMoris%26aufirst%3DF.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DGeneration%2520of%2520potent%2520and%2520selective%2520kinase%2520inhibitors%2520by%2520combinatorial%2520biosynthesis%2520of%2520glycosylated%2520indolocarbazoles%26jtitle%3DChem.%2520Commun.%26date%3D2009%26spage%3D4118%26epage%3D4120%26doi%3D10.1039%2Fb905068j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rothweiler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandsdal, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. S.</span></span> <span> </span><span class="NLM_article-title">Probing the ATP-binding pocket of protein kinase DYRK1A with benzothiazole fragment molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9814</span>– <span class="NLM_lpage">9824</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01086</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01086" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9814-9824&author=U.+Rothweilerauthor=W.+Stensenauthor=B.+O.+Brandsdalauthor=J.+Isakssonauthor=F.+A.+Leesonauthor=R.+A.+Enghauthor=J.+S.+Svendsen&title=Probing+the+ATP-binding+pocket+of+protein+kinase+DYRK1A+with+benzothiazole+fragment+molecules&doi=10.1021%2Facs.jmedchem.6b01086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the ATP-Binding Pocket of Protein Kinase DYRK1A with Benzothiazole Fragment Molecules</span></div><div class="casAuthors">Rothweiler, Ulli; Stensen, Wenche; Brandsdal, Bjoern Olav; Isaksson, Johan; Leeson, Frederick Alan; Engh, Richard Alan; Svendsen, John S. Mjoeen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9814-9824</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRK1A has emerged as a potential target for therapies of Alzheimer's disease using small mols.  Based on the observation of selective DYRK1A inhibition by firefly D-luciferin, we have explored static and dynamic structural properties of fragment sized variants of the benzothiazole scaffold with respect to DYRK1A using X-ray crystallog. and NMR techniques.  The compds. have excellent ligand efficiencies and show a remarkable diversity of binding modes in dynamic equil.  Binding geometries are detd. in part by interactions often considered "weak", including "orthogonal multipolar" types represented by e.g. F-CO, sulfur-aromat, and halogen-aromat interactions, together with hydrogen bonds that are modulated by variation of electron withdrawing groups.  These studies show how the benzothiazole scaffold is highly promising for the development of therapeutic DYRK1A inhibitors.  In addn., the subtleties of the binding interactions, including dynamics, show how full structural studies are required to fully interpret the essential phys. determinants of binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYSQe1_5bEjLVg90H21EOLACvtfcHk0ljSY3hgIexlwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7P&md5=edb850b232f53b3e161a5023915972e6</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01086%26sid%3Dliteratum%253Aachs%26aulast%3DRothweiler%26aufirst%3DU.%26aulast%3DStensen%26aufirst%3DW.%26aulast%3DBrandsdal%26aufirst%3DB.%2BO.%26aulast%3DIsaksson%26aufirst%3DJ.%26aulast%3DLeeson%26aufirst%3DF.%2BA.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26aulast%3DSvendsen%26aufirst%3DJ.%2BS.%26atitle%3DProbing%2520the%2520ATP-binding%2520pocket%2520of%2520protein%2520kinase%2520DYRK1A%2520with%2520benzothiazole%2520fragment%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9814%26epage%3D9824%26doi%3D10.1021%2Facs.jmedchem.6b01086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Masaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4434</span>– <span class="NLM_lpage">4441</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmc.2015.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26145823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=4434-4441&author=S.+Masakiauthor=I.+Kiiauthor=Y.+Sumidaauthor=T.+Kato-Sumidaauthor=Y.+Ogawaauthor=N.+Itoauthor=M.+Nakamuraauthor=R.+Sonamotoauthor=N.+Kataokaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Design+and+synthesis+of+a+potent+inhibitor+of+class+1+DYRK+kinases+as+a+suppressor+of+adipogenesis&doi=10.1016%2Fj.bmc.2015.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90aR"><div class="casContent"><span class="casTitleNuber">90a</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis</span></div><div class="casAuthors">Masaki, So; Kii, Isao; Sumida, Yuto; Kato-Sumida, Tomoe; Ogawa, Yasushi; Ito, Nobutoshi; Nakamura, Mitsuhiro; Sonamoto, Rie; Kataoka, Naoyuki; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4434-4441</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dysregulation of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) has been demonstrated in several pathol. conditions, including Alzheimer's disease and cancer progression.  It has been recently reported that a gain of function-mutation in the human DYRK1B gene exacerbates metabolic syndrome by enhancing obesity.  In the previous study, we developed an inhibitor of DYRK family kinases (INDY) and demonstrated that INDY suppresses the pathol. phenotypes induced by overexpression of DYRK1A or DYRK1B in cellular and animal models.  In this study, we designed and synthesized a novel inhibitor of DYRK family kinases based on the crystal structure of the DYRK1A/INDY complex by replacing the phenol group of INDY with dibenzofuran to produce a deriv., named BINDY.  This compd. exhibited potent and selective inhibitory activity toward DYRK family kinases in an in vitro assay.  Furthermore, treatment of 3T3-L1 pre-adipocytes with BINDY hampered adipogenesis by suppressing gene expression of the crit. transcription factors PPARγ and C/EBPα.  This study indicates the possibility of BINDY as a potential drug for metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRt6yDW_MVw7Vg90H21EOLACvtfcHk0ljPMod57JmnSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fF&md5=7429d22909732d8ea03f373158969dfb</span></div><a href="/servlet/linkout?suffix=cit90a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DMasaki%26aufirst%3DS.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DKataoka%26aufirst%3DN.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520potent%2520inhibitor%2520of%2520class%25201%2520DYRK%2520kinases%2520as%2520a%2520suppressor%2520of%2520adipogenesis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D4434%26epage%3D4441%26doi%3D10.1016%2Fj.bmc.2015.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit90b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span>; <span class="NLM_string-name">Kobayashi, A.</span></span> <span> </span><span class="NLM_article-title">Compound Pertaining to Neuropoiesis and Drug Composition</span>. <span class="NLM_patent">WO 2015083750</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Hagiwara&author=A.+Kobayashi&title=Compound+Pertaining+to+Neuropoiesis+and+Drug+Composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DCompound%2520Pertaining%2520to%2520Neuropoiesis%2520and%2520Drug%2520Composition%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the kinase DYRK1A by targeting its folding process</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11391</span>, <span class="refDoi"> DOI: 10.1038/ncomms11391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fncomms11391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27102360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11391&author=I.+Kiiauthor=Y.+Sumidaauthor=T.+Gotoauthor=R.+Sonamotoauthor=Y.+Okunoauthor=S.+Yoshidaauthor=T.+Kato-Sumidaauthor=Y.+Koikeauthor=M.+Abeauthor=Y.+Nonakaauthor=T.+Ikuraauthor=N.+Itoauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Selective+inhibition+of+the+kinase+DYRK1A+by+targeting+its+folding+process&doi=10.1038%2Fncomms11391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the kinase DYRK1A by targeting its folding process</span></div><div class="casAuthors">Kii, Isao; Sumida, Yuto; Goto, Toshiyasu; Sonamoto, Rie; Okuno, Yukiko; Yoshida, Suguru; Kato-Sumida, Tomoe; Koike, Yuka; Abe, Minako; Nonaka, Yosuke; Ikura, Teikichi; Ito, Nobutoshi; Shibuya, Hiroshi; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11391</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophosphorylation of amino-acid residues is part of the folding process of various protein kinases.  Conventional chem. screening of mature kinases has missed inhibitors that selectively interfere with the folding process.  Here we report a cell-based assay that evaluates inhibition of a kinase at a transitional state during the folding process and identify a folding intermediate-selective inhibitor of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), which we refer to as FINDY.  FINDY suppresses intramol. autophosphorylation of Ser97 in DYRK1A in cultured cells, leading to its degrdn., but does not inhibit substrate phosphorylation catalyzed by the mature kinase.  FINDY also suppresses Ser97 autophosphorylation of recombinant DYRK1A, suggesting direct inhibition, and shows high selectivity for DYRK1A over other DYRK family members.  In addn., FINDY rescues DYRK1A-induced developmental malformations in Xenopus laevis embryos.  Our study demonstrates that transitional folding intermediates of protein kinases can be targeted by small mols., and paves the way for developing novel types of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2gsAsp-YjLVg90H21EOLACvtfcHk0lj8W-sp2mhi-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D&md5=5d64de412dd168a415a3da052d3afedc</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1038%2Fncomms11391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11391%26sid%3Dliteratum%253Aachs%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520kinase%2520DYRK1A%2520by%2520targeting%2520its%2520folding%2520process%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11391%26doi%3D10.1038%2Fncomms11391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Identification of a DYRK1A inhibitor that induces degradation of the target kinase using co-chaperone CDC37 fused with luciferase nanoKAZ</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">12728</span>, <span class="refDoi"> DOI: 10.1038/srep12728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fsrep12728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26234946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKiur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=12728&author=R.+Sonamotoauthor=I.+Kiiauthor=Y.+Koikeauthor=Y.+Sumidaauthor=T.+Kato-Sumidaauthor=Y.+Okunoauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Identification+of+a+DYRK1A+inhibitor+that+induces+degradation+of+the+target+kinase+using+co-chaperone+CDC37+fused+with+luciferase+nanoKAZ&doi=10.1038%2Fsrep12728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a DYRK1A inhibitor that induces degradation of the target kinase using co-chaperone CDC37 fused with luciferase nanoKAZ</span></div><div class="casAuthors">Sonamoto, Rie; Kii, Isao; Koike, Yuka; Sumida, Yuto; Kato-Sumida, Tomoe; Okuno, Yukiko; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12728</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The protein kinase family includes attractive targets for drug development.  Methods for screening of kinase inhibitors remain largely limited to in vitro catalytic assays.  It has been shown that ATP-competitive inhibitors antagonize interaction between the target kinase and kinase-specific co-chaperone CDC37 in living cells.  Here we show a cell-based method to screen kinase inhibitors using fusion protein of CDC37 with a mutated catalytic 19-kDa component of Oplophorus luciferase, nanoKAZ (CDC37-nanoKAZ).  A dual-specificity kinase DYRK1A, an importance of which has been highlighted in Alzheimer's disease, was targeted in this study.  We established 293T cells stably expressing CDC37-nanoKAZ, and analyzed interaction between CDC37-nanoKAZ and DYRK1A.  We revealed that DYRK1A interacted with CDC37-nanoKAZ.  Importantly, point mutations that affect autophosphorylation strengthened the interaction, thus improving signal/noise ratio of the interaction relative to non-specific binding of CDC37-nanoKAZ.  This high signal/noise ratio enabled screening of chem. library that resulted in identification of a potent inhibitor of DYRK1A, named CaNDY.  CaNDY induced selective degrdn. of DYRK1A, and inhibited catalytic activity of recombinant DYRK1A with IC50 value of 7.9 nM by competing with ATP.  This method based on a mutant target kinase and a bioluminescence-eliciting co-chaperone CDC37 could be applicable to evaluation and development of inhibitors targeting other kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQSIZOeUORKbVg90H21EOLACvtfcHk0lj8W-sp2mhi-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKiur%252FI&md5=de399d0f2c6e925396db0405c8eb0476</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fsrep12728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep12728%26sid%3Dliteratum%253Aachs%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520DYRK1A%2520inhibitor%2520that%2520induces%2520degradation%2520of%2520the%2520target%2520kinase%2520using%2520co-chaperone%2520CDC37%2520fused%2520with%2520luciferase%2520nanoKAZ%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D12728%26doi%3D10.1038%2Fsrep12728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huth, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black-Schaefer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorwin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladror, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severin, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartley, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span> <span> </span><span class="NLM_article-title">Toxicological evaluation of thiol-reactive compounds identified using a la assay to detect reactive molecules by nuclear magnetic resonance</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1752</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1021/tx700319t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700319t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSkurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1752-1759&author=J.+R.+Huthauthor=D.+Songauthor=R.+R.+Mendozaauthor=C.+L.+Black-Schaeferauthor=J.+C.+Mackauthor=S.+A.+Dorwinauthor=U.+S.+Ladrorauthor=J.+M.+Severinauthor=K.+A.+Walterauthor=D.+M.+Bartleyauthor=P.+J.+Hajduk&title=Toxicological+evaluation+of+thiol-reactive+compounds+identified+using+a+la+assay+to+detect+reactive+molecules+by+nuclear+magnetic+resonance&doi=10.1021%2Ftx700319t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicological Evaluation of Thiol-Reactive Compounds Identified Using a La Assay To Detect Reactive Molecules by Nuclear Magnetic Resonance</span></div><div class="casAuthors">Huth, Jeffrey R.; Song, Danying; Mendoza, Renaldo R.; Black-Schaefer, Candice L.; Mack, Jamey C.; Dorwin, Sarah A.; Ladror, Uri S.; Severin, Jean M.; Walter, Karl A.; Bartley, Diane M.; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1752-1759</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have recently reported on the development of a La assay to detect reactive mols. by NMR (ALARM NMR) to detect reactive false pos. hits from high-throughput screening, in which we obsd. a surprisingly large no. of compds. that can oxidize or form covalent adducts with protein thiols groups.  In the vast majority of these cases, the covalent interactions are largely nonspecific (e.g., affect many protein targets) and therefore unsuitable for drug development.  However, certain thiol-reactive species do appear to inhibit the target of interest in a specific manner.  The question then arises as to the potential toxicol. risks of developing a drug that can react with protein thiol groups.  Here, we report on the evaluation of a large set of ALARM-reactive and -nonreactive compds. against a panel of addnl. proteins (aldehyde dehydrogenase, superoxide dismutase, and three cytochrome P 450 enzymes).  It was obsd. that ALARM-reactive compds. have significantly increased risks of interacting with one or more of these enzymes in vitro.  Thus, ALARM NMR seems to be a sensitive tool to rapidly identify compds. with an enhanced risk of producing side effects in humans, including alc. intolerance, the formation of reactive oxygen species, and drug-drug interactions.  In conjunction with other toxicol. assays, ALARM NMR should be a valuable tool for prioritizing compds. for lead optimization and animal testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqli4LigspmibVg90H21EOLACvtfcHk0liX-71HbAcmAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSkurjP&md5=a70fc352f67e637753a3e5d410875a89</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Ftx700319t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700319t%26sid%3Dliteratum%253Aachs%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DMendoza%26aufirst%3DR.%2BR.%26aulast%3DBlack-Schaefer%26aufirst%3DC.%2BL.%26aulast%3DMack%26aufirst%3DJ.%2BC.%26aulast%3DDorwin%26aufirst%3DS.%2BA.%26aulast%3DLadror%26aufirst%3DU.%2BS.%26aulast%3DSeverin%26aufirst%3DJ.%2BM.%26aulast%3DWalter%26aufirst%3DK.%2BA.%26aulast%3DBartley%26aufirst%3DD.%2BM.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DToxicological%2520evaluation%2520of%2520thiol-reactive%2520compounds%2520identified%2520using%2520a%2520la%2520assay%2520to%2520detect%2520reactive%2520molecules%2520by%2520nuclear%2520magnetic%2520resonance%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1752%26epage%3D1759%26doi%3D10.1021%2Ftx700319t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenreich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szklarczyk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2010.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.chembiol.2010.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21276940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=67-76&author=O.+Fedorovauthor=K.+Huberauthor=A.+Eisenreichauthor=P.+Filippakopoulosauthor=O.+Kingauthor=A.+N.+Bullockauthor=D.+Szklarczykauthor=L.+J.+Jensenauthor=D.+Fabbroauthor=J.+Trappeauthor=U.+Rauchauthor=F.+Bracherauthor=S.+Knapp&title=Specific+CLK+inhibitors+from+a+novel+chemotype+for+regulation+of+alternative+splicing&doi=10.1016%2Fj.chembiol.2010.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing</span></div><div class="casAuthors">Fedorov, Oleg; Huber, Kilian; Eisenreich, Andreas; Filippakopoulos, Panagis; King, Oliver; Bullock, Alex N.; Szklarczyk, Damian; Jensen, Lars J.; Fabbro, Doriano; Trappe, Jorg; Rauch, Ursula; Bracher, Franz; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-76</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">There is a growing recognition of the importance of protein kinases in the control of alternative splicing.  To define the underlying regulatory mechanisms, highly selective inhibitors are needed.  Here, we report the discovery and characterization of the dichloroindolyl enaminonitrile KH-CB19, a potent and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4).  Cocrystal structures of KH-CB19 with CLK1 and CLK3 revealed a non-ATP mimetic binding mode, conformational changes in helix αC and the phosphate binding loop and halogen bonding to the kinase hinge region.  KH-CB19 effectively suppressed phosphorylation of SR (serine/arginine) proteins in cells, consistent with its expected mechanism of action.  Chem. inhibition of CLK1/CLK4 generated a unique pattern of splicing factor dephosphorylation and had at low nM concn. a profound effect on splicing of the two tissue factor isoforms flTF (full-length TF) and asHTF (alternatively spliced human TF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqnKjNEjPBHbVg90H21EOLACvtfcHk0liX-71HbAcmAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D&md5=b2b17a9934f15f2d0d9a76a8d3179e95</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKing%26aufirst%3DO.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DSzklarczyk%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DL.%2BJ.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DSpecific%2520CLK%2520inhibitors%2520from%2520a%2520novel%2520chemotype%2520for%2520regulation%2520of%2520alternative%2520splicing%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D67%26epage%3D76%26doi%3D10.1016%2Fj.chembiol.2010.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, C.</span>; <span class="NLM_string-name">Labriere, C.</span>; <span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Kinase Inhibitors</span>. <span class="NLM_patent">WO 2014115071</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Guillou&author=C.+Labriere&author=L.+Meijer&title=Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuillou%26aufirst%3DC.%26atitle%3DKinase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labriere, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blairvacq, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, C.</span></span> <span> </span><span class="NLM_article-title">Further investigation of paprotrain: towards the conception of selective and multi-targeted CNS kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.08.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2016.08.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=920-934&author=C.+Labriereauthor=O.+Lozachauthor=M.+Blairvacqauthor=L.+Meijerauthor=C.+Guillou&title=Further+investigation+of+paprotrain%3A+towards+the+conception+of+selective+and+multi-targeted+CNS+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2016.08.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.08.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.08.069%26sid%3Dliteratum%253Aachs%26aulast%3DLabriere%26aufirst%3DC.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBlairvacq%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DGuillou%26aufirst%3DC.%26atitle%3DFurther%2520investigation%2520of%2520paprotrain%253A%2520towards%2520the%2520conception%2520of%2520selective%2520and%2520multi-targeted%2520CNS%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D920%26epage%3D934%26doi%3D10.1016%2Fj.ejmech.2016.08.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myrianthopoulos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kritsanida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriaud-Kolar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magiatis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaltsounis, A.-L.</span></span> <span> </span><span class="NLM_article-title">Novel inverse binding mode of indirubin derivatives yields improved selectivity for DYRK kinases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1021/ml300207a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300207a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=22-26&author=V.+Myrianthopoulosauthor=M.+Kritsanidaauthor=N.+Gaboriaud-Kolarauthor=P.+Magiatisauthor=Y.+Ferandinauthor=E.+Durieuauthor=O.+Lozachauthor=D.+Cappelauthor=M.+Soundararajanauthor=P.+Filippakopoulosauthor=W.+Shermanauthor=S.+Knappauthor=L.+Meijerauthor=E.+Mikrosauthor=A.-L.+Skaltsounis&title=Novel+inverse+binding+mode+of+indirubin+derivatives+yields+improved+selectivity+for+DYRK+kinases&doi=10.1021%2Fml300207a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases</span></div><div class="casAuthors">Myrianthopoulos, Vassilios; Kritsanida, Marina; Gaboriaud-Kolar, Nicolas; Magiatis, Prokopios; Ferandin, Yoan; Durieu, Emilie; Lozach, Olivier; Cappel, Daniel; Soundararajan, Meera; Filippakopoulos, Panagis; Sherman, Woody; Knapp, Stefan; Meijer, Laurent; Mikros, Emmanuel; Skaltsounis, Alexios-Leandros</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-26</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRK kinases are involved in alternative pre-mRNA splicing as well as in neuropathol. states such as Alzheimer's disease and Down syndrome.  In this study, we present the design, synthesis, and biol. evaluation of indirubins as DYRK inhibitors with enhanced selectivity.  Modifications of the bis-indole included polar or acidic functionalities at positions 5' and 6' and a bromine or a trifluoromethyl group at position 7, affording analogs that possess high activity and pronounced specificity.  Compd. 6i (I) carrying a 5'-carboxylate moiety demonstrated the best inhibitory profile.  A novel inverse binding mode, which forms the basis for the improved selectivity, was suggested by mol. modeling and confirmed by detg. the crystal structure of DYRK2 in complex with 6i.  Structure-activity relationships were further established, including a thermodn. anal. of binding site water mols., offering a structural explanation for the selective DYRK inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbTKuspwpHLrVg90H21EOLACvtfcHk0lgtKyrj5TP-dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrjJ&md5=4c98785d2d8264a1a46fa93cbb611e35</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fml300207a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300207a%26sid%3Dliteratum%253Aachs%26aulast%3DMyrianthopoulos%26aufirst%3DV.%26aulast%3DKritsanida%26aufirst%3DM.%26aulast%3DGaboriaud-Kolar%26aufirst%3DN.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DCappel%26aufirst%3DD.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DMikros%26aufirst%3DE.%26aulast%3DSkaltsounis%26aufirst%3DA.-L.%26atitle%3DNovel%2520inverse%2520binding%2520mode%2520of%2520indirubin%2520derivatives%2520yields%2520improved%2520selectivity%2520for%2520DYRK%2520kinases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D22%26epage%3D26%26doi%3D10.1021%2Fml300207a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Kinase inhibitors: not just for kinases anymore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1483</span>, <span class="refDoi"> DOI: 10.1021/jm020427b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020427b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1478-1483&author=S.+L.+McGovernauthor=B.+K.+Shoichet&title=Kinase+inhibitors%3A+not+just+for+kinases+anymore&doi=10.1021%2Fjm020427b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Inhibitors: Not Just for Kinases Anymore</span></div><div class="casAuthors">McGovern, Susan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1478-1483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinase inhibitors are widely employed as biol. reagents and as leads for drug design.  Their use is often complicated by their lack of specificity.  Although binding conserved ATP sites accounts for some of their nonspecificity, some compds. inhibit proteins not known to bind ATP.  It has been found that promiscuous hits from high-throughput screening may act as aggregates.  To explore whether this mechanism might explain the action of widely used nonspecific kinase inhibitors, 15 such compds. were studied.  Eight of these, rottlerin, quercetin, K-252c, bisindolylmaleimide I, bisindolylmaleimide IX, U0126, indirubin, and indigo, inhibited three diverse non-kinase enzymes.  Inhibition was time-dependent and sensitive to enzyme concn.; by light scattering, the compds. formed particles of 100-1000 nm diam.  These observations suggest that these eight kinase inhibitors, at least at micromolar concns., are promiscuous and act as aggregates.  Results obtained from the use of these compds. at micromolar or higher concns. against individual enzymes should be interpreted cautiously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-JSJ7FPf7e7Vg90H21EOLACvtfcHk0lgtKyrj5TP-dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D&md5=1d7e4e99a27be5ab279744aff92de26d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm020427b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020427b%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DKinase%2520inhibitors%253A%2520not%2520just%2520for%2520kinases%2520anymore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1478%26epage%3D1483%26doi%3D10.1021%2Fjm020427b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neagoie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedrenne, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merour, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldeyrou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansiaux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of chromeno[3,4-b]indoles as <i>Lamellarin</i> D analogues: a novel DYRK1A inhibitor class</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.01.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2012.01.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=22305342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFOrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2012&pages=379-396&author=C.+Neagoieauthor=E.+Vedrenneauthor=F.+Buronauthor=J.+Y.+Merourauthor=S.+Roscaauthor=S.+Bourgauthor=O.+Lozachauthor=L.+Meijerauthor=B.+Baldeyrouauthor=A.+Lansiauxauthor=S.+Routier&title=Synthesis+of+chromeno%5B3%2C4-b%5Dindoles+as+Lamellarin+D+analogues%3A+a+novel+DYRK1A+inhibitor+class&doi=10.1016%2Fj.ejmech.2012.01.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues : A novel DYRK1A inhibitor class</span></div><div class="casAuthors">Neagoie, Cleopatra; Vedrenne, Emeline; Buron, Frederic; Merour, Jean-Yves; Rosca, Sorin; Bourg, Stephane; Lozach, Olivier; Meijer, Laurent; Baldeyrou, Brigitte; Lansiaux, Amelie; Routier, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">379-396</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A library of substituted chromeno[3,4-b]indoles was developed as Lamellarin isosteres.  Synthesis was achieved from indoles after a four-step pathway sequence involving C-3 iodination, a Suzuki cross-coupling reaction, and a one pot deprotection/lactonization step.  Twenty final compds. were tested in order to det. their activity against topoisomerase I and kinases, the two major biol. activities of Lamellarins.  One newly synthesized deriv. exhibited a strong topoisomerase activity comparable to ref. compds. such as campthotecin and Lamellarin with only a weak kinase inhibition.  Two other lead compds. were identified as new nanomolar DYRK1A inhibitors and several other drugs affected the kinases in the sub-micromolar range.  These results will enable us to use the chromeno[3,4-b]indole as a pharmacophore to develop potent treatments for neurol. or oncol. disorders in which DYRK1A is fully involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopoVhDdU5tMbVg90H21EOLACvtfcHk0lgtKyrj5TP-dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFOrsLs%253D&md5=7d371529cde68f5fc4680c317a0d0a85</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DNeagoie%26aufirst%3DC.%26aulast%3DVedrenne%26aufirst%3DE.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DMerour%26aufirst%3DJ.%2BY.%26aulast%3DRosca%26aufirst%3DS.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBaldeyrou%26aufirst%3DB.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520chromeno%255B3%252C4-b%255Dindoles%2520as%2520Lamellarin%2520D%2520analogues%253A%2520a%2520novel%2520DYRK1A%2520inhibitor%2520class%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D49%26spage%3D379%26epage%3D396%26doi%3D10.1016%2Fj.ejmech.2012.01.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kassis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzeszcz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bénéteau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Guével, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillouzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewiński, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colliandre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(phenyl) pyridine or pyrazine V-shaped molecules as kinase inhibitors and cytotoxic agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5416</span>– <span class="NLM_lpage">5434</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.08.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2011.08.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21944287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=5416-5434&author=P.+Kassisauthor=J.+Brzeszczauthor=V.+B%C3%A9n%C3%A9teauauthor=O.+Lozachauthor=L.+Meijerauthor=R.+Le+Gu%C3%A9velauthor=C.+Guillouzoauthor=K.+Lewi%C5%84skiauthor=S.+Bourgauthor=L.+Colliandreauthor=S.+Routierauthor=J.+Y.+M%C3%A9rour&title=Synthesis+and+biological+evaluation+of+new+3-%286-hydroxyindol-2-yl%29-5-%28phenyl%29+pyridine+or+pyrazine+V-shaped+molecules+as+kinase+inhibitors+and+cytotoxic+agents&doi=10.1016%2Fj.ejmech.2011.08.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(Phenyl) pyridine or pyrazine V-Shaped molecules as kinase inhibitors and cytotoxic agents</span></div><div class="casAuthors">Kassis, Pamela; Brzeszcz, Joanna; Beneteau, Valerie; Lozach, Olivier; Meijer, Laurent; Le Guevel, Remi; Guillouzo, Christiane; Lewinski, Krzysztof; Bourg, Stephane; Colliandre, Lionel; Routier, Sylvain; Merour, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5416-5434</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Herein is reported the synthesis and biol. evaluation of new 3-[(2-indolyl)]-5-phenyl-3,5-pyridine, 3-[(2-indolyl)]-5-phenyl-2,4-pyridine and 3-[(2-indolyl)]-5-phenyl-2,6-pyrazine derivs. designed as potential CDK inhibitors.  Indoles and phenyls were used to generate several substitutions of the pyridine and pyrazine rings.  The syntheses included Stille or Suzuki type reactions, which were carried out on the 3,5-dibromopyridine, 2,4-dichloropyridine and 2,6-dichloro-1-4-pyrazine moieties.  Cell effects of the V-shaped family were in the micromolar range.  Kinase assays were conducted and showed that compd. I inhibited CDK5 with an inhibitory concn. of 160 nM with a moderate selectivity over GSK3 compared to the ref. compd. II which exhibited a slightly lower activity on CDK5 (1.5 μM).  Compd. I was also found to be the most potent compd. in the series and was identified as a new lead for DYRK1A inhibitor discovery (IC50 = 60 nM).  Docking studies were carried out in order to investigate the inhibition of DYRK1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw8p7-Tg5B6LVg90H21EOLACvtfcHk0ljFmEdQ5_3e-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbbJ&md5=1b960c962e74420cf3ddad26ffeeec94</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.08.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.08.048%26sid%3Dliteratum%253Aachs%26aulast%3DKassis%26aufirst%3DP.%26aulast%3DBrzeszcz%26aufirst%3DJ.%26aulast%3DB%25C3%25A9n%25C3%25A9teau%26aufirst%3DV.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DLe%2BGu%25C3%25A9vel%26aufirst%3DR.%26aulast%3DGuillouzo%26aufirst%3DC.%26aulast%3DLewi%25C5%2584ski%26aufirst%3DK.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DColliandre%26aufirst%3DL.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.%2BY.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%25203-%25286-hydroxyindol-2-yl%2529-5-%2528phenyl%2529%2520pyridine%2520or%2520pyrazine%2520V-shaped%2520molecules%2520as%2520kinase%2520inhibitors%2520and%2520cytotoxic%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D5416%26epage%3D5434%26doi%3D10.1016%2Fj.ejmech.2011.08.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakano-Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">10268</span>– <span class="NLM_lpage">10273</span>, <span class="refDoi"> DOI: 10.1073/pnas.1704143114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1073%2Fpnas.1704143114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=10268-10273&author=A.+Nakano-Kobayashiauthor=T.+Awayaauthor=I.+Kiiauthor=Y.+Sumidaauthor=Y.+Okunoauthor=S.+Yoshidaauthor=T.+Sumidaauthor=T.+Inoueauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Prenatal+neurogenesis+induction+therapy+normalizes+brain+structure+and+function+in+Down+syndrome+mice&doi=10.1073%2Fpnas.1704143114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1704143114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1704143114%26sid%3Dliteratum%253Aachs%26aulast%3DNakano-Kobayashi%26aufirst%3DA.%26aulast%3DAwaya%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DSumida%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DPrenatal%2520neurogenesis%2520induction%2520therapy%2520normalizes%2520brain%2520structure%2520and%2520function%2520in%2520Down%2520syndrome%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D10268%26epage%3D10273%26doi%3D10.1073%2Fpnas.1704143114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazimierczuk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orzeszko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">The selectivity of inhibitors of protein kinase CK2: an update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>415</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1042/BJ20080309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1042%2FBJ20080309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2008&pages=353-365&author=M.+A.+Paganoauthor=J.+Bainauthor=Z.+Kazimierczukauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=G.+Di+Mairaauthor=M.+Elliottauthor=A.+Orzeszkoauthor=G.+Cozzaauthor=F.+Meggioauthor=L.+A.+Pinna&title=The+selectivity+of+inhibitors+of+protein+kinase+CK2%3A+an+update&doi=10.1042%2FBJ20080309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102a&amp;dbid=16384&amp;doi=10.1042%2FBJ20080309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20080309%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DThe%2520selectivity%2520of%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D415%26spage%3D353%26epage%3D365%26doi%3D10.1042%2FBJ20080309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit102b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brzozka, K.</span>; <span class="NLM_string-name">Czardybon, W.</span>; <span class="NLM_string-name">Sabiniarz, A.</span>; <span class="NLM_string-name">Millik, M.</span>; <span class="NLM_string-name">Windak, R.</span>; <span class="NLM_string-name">Zarebski, A.</span>; <span class="NLM_string-name">Beuzen, N.</span></span> <span> </span><span class="NLM_article-title">A Compound, a Process for its Preparation, a Pharmaceutical Composition, Use of Compound, a Method for Modulating, or Regulating Serine/Threonine Kinases and a Serine/ Threonine Kinases Modulating Agent</span>. <span class="NLM_patent">WO 2011058139</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.+Brzozka&author=W.+Czardybon&author=A.+Sabiniarz&author=M.+Millik&author=R.+Windak&author=A.+Zarebski&author=N.+Beuzen&title=A+Compound%2C+a+Process+for+its+Preparation%2C+a+Pharmaceutical+Composition%2C+Use+of+Compound%2C+a+Method+for+Modulating%2C+or+Regulating+Serine%2FThreonine+Kinases+and+a+Serine%2F+Threonine+Kinases+Modulating+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrzozka%26aufirst%3DK.%26atitle%3DA%2520Compound%252C%2520a%2520Process%2520for%2520its%2520Preparation%252C%2520a%2520Pharmaceutical%2520Composition%252C%2520Use%2520of%2520Compound%252C%2520a%2520Method%2520for%2520Modulating%252C%2520or%2520Regulating%2520Serine%252FThreonine%2520Kinases%2520and%2520a%2520Serine%252F%2520Threonine%2520Kinases%2520Modulating%2520Agent%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit102c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Czardybon, W.</span>; <span class="NLM_string-name">Brzózka, K.</span>; <span class="NLM_string-name">Galezowski, M.</span>; <span class="NLM_string-name">Windak, R.</span>; <span class="NLM_string-name">Milik, M.</span>; <span class="NLM_string-name">Zawadzka, M.</span>; <span class="NLM_string-name">Guzik, P.</span>; <span class="NLM_string-name">Wincza, E.</span>; <span class="NLM_string-name">Prokop, M.</span>; <span class="NLM_string-name">Wiklik, K.</span>; <span class="NLM_string-name">Sabiniarz, A.</span>; <span class="NLM_string-name">Cholody, W. M.</span>; <span class="NLM_string-name">Horvath, R.</span>; <span class="NLM_string-name">Rzymski, T.</span></span> <span> </span><span class="NLM_article-title">Novel Benzimidazole Derivatives as Kinase Inhibitors</span>. <span class="NLM_patent">WO 2014096388</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=W.+Czardybon&author=K.+Brz%C3%B3zka&author=M.+Galezowski&author=R.+Windak&author=M.+Milik&author=M.+Zawadzka&author=P.+Guzik&author=E.+Wincza&author=M.+Prokop&author=K.+Wiklik&author=A.+Sabiniarz&author=W.+M.+Cholody&author=R.+Horvath&author=T.+Rzymski&title=Novel+Benzimidazole+Derivatives+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCzardybon%26aufirst%3DW.%26atitle%3DNovel%2520Benzimidazole%2520Derivatives%2520as%2520Kinase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, C.</span>; <span class="NLM_string-name">Dunckley, T.</span>; <span class="NLM_string-name">Shaw, Y.
J.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Inhibitors of DYRK1A and Uses Thereof</span>. <span class="NLM_patent">WO 2017040993</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Hulme&author=T.+Dunckley&author=Y.%0AJ.+Shaw&title=Small+Molecule+Inhibitors+of+DYRK1A+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHulme%26aufirst%3DC.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520DYRK1A%2520and%2520Uses%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balint, B.</span>; <span class="NLM_string-name">Kotschy, A.</span>; <span class="NLM_string-name">Sipos, M.</span>; <span class="NLM_string-name">Weber, C.</span>; <span class="NLM_string-name">Foloppe, N.</span>; <span class="NLM_string-name">Walmsley, D.</span>; <span class="NLM_string-name">Burbridge, M. F.</span>; <span class="NLM_string-name">Cruzalegui, F. H.</span></span> <span> </span><span class="NLM_article-title">New Imidazo[4,5-<i>b</i>]pyridine Derivatives as Dual Dyrk1/clk1 Inhibitors</span>. <span class="NLM_patent">WO 2017055530A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=B.+Balint&author=A.+Kotschy&author=M.+Sipos&author=C.+Weber&author=N.+Foloppe&author=D.+Walmsley&author=M.+F.+Burbridge&author=F.+H.+Cruzalegui&title=New+Imidazo%5B4%2C5-b%5Dpyridine+Derivatives+as+Dual+Dyrk1%2Fclk1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBalint%26aufirst%3DB.%26atitle%3DNew%2520Imidazo%255B4%252C5-b%255Dpyridine%2520Derivatives%2520as%2520Dual%2520Dyrk1%252Fclk1%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gourdain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dairou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denhez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues-Lima, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cariou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. H.</span></span> <span> </span><span class="NLM_article-title">Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9569</span>– <span class="NLM_lpage">9585</span>, <span class="refDoi"> DOI: 10.1021/jm401049v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401049v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9569-9585&author=S.+Gourdainauthor=J.+Dairouauthor=C.+Denhezauthor=L.+C.+Buiauthor=F.+Rodrigues-Limaauthor=N.+Janelauthor=J.+M.+Delabarauthor=K.+Cariouauthor=R.+H.+Dodd&title=Development+of+DANDYs%2C+new+3%2C5-diaryl-7-azaindoles+demonstrating+potent+DYRK1A+kinase+inhibitory+activity&doi=10.1021%2Fjm401049v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Development of DANDYs, New 3,5-Diaryl-7-azaindoles Demonstrating Potent DYRK1A Kinase Inhibitory Activity</span></div><div class="casAuthors">Gourdain, Stephanie; Dairou, Julien; Denhez, Clement; Bui, Linh Chi; Rodrigues-Lima, Fernando; Janel, Nathalie; Delabar, Jean M.; Cariou, Kevin; Dodd, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9569-9585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3,5-diaryl-1H-pyrrolo[2,3-b]pyridines was synthesized and evaluated for inhibition of DYRK1A kinase in vitro.  Derivs. having hydroxy groups on the aryl moieties demonstrated high inhibitory potencies with Kis in the low nanomolar range.  Their methoxy analogs were up to 100 times less active.  Docking studies at the ATP binding site suggested that these compds. bind tightly to this site via a network of multiple H-bonds with the peptide backbone.  None of the active compds. was cytotoxic to KB cells at 10-6 M.  Kinase profiling revealed that compd. I showed 2-fold selectivity for DYRK1A with respect to DYRK2 and DYRK3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1vxODs_tGD7Vg90H21EOLACvtfcHk0liIVXI9PdD8zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K&md5=27dcc77a1c0d413cf0ab5c999cf9a195</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm401049v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401049v%26sid%3Dliteratum%253Aachs%26aulast%3DGourdain%26aufirst%3DS.%26aulast%3DDairou%26aufirst%3DJ.%26aulast%3DDenhez%26aufirst%3DC.%26aulast%3DBui%26aufirst%3DL.%2BC.%26aulast%3DRodrigues-Lima%26aufirst%3DF.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3DCariou%26aufirst%3DK.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DDevelopment%2520of%2520DANDYs%252C%2520new%25203%252C5-diaryl-7-azaindoles%2520demonstrating%2520potent%2520DYRK1A%2520kinase%2520inhibitory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9569%26epage%3D9585%26doi%3D10.1021%2Fjm401049v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourdain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albac, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dairou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz-Afonso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues-Lima, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Caer, J-P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touboul, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delatour, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cariou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. H.</span></span> <span> </span><span class="NLM_article-title">DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2859</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-20984-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fs41598-018-20984-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=29434250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A280%3ADC%252BC1MrgslSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=2859&author=F.+Neumannauthor=S.+Gourdainauthor=C.+Albacauthor=A.+D.+Dekkerauthor=L.+C.+Buiauthor=J.+Dairouauthor=I.+Schmitz-Afonsoauthor=N.+Hueauthor=F.+Rodrigues-Limaauthor=J.+M.+Delabarauthor=M.-C.+Potierauthor=J-P.+L.+Le+Caerauthor=D.+Touboulauthor=B.+Delatourauthor=K.+Cariouauthor=R.+H.+Dodd&title=DYRK1A+inhibition+and+cognitive+rescue+in+a+Down+syndrome+mouse+model+are+induced+by+new+fluoro-DANDY+derivatives&doi=10.1038%2Fs41598-018-20984-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives</span></div><div class="casAuthors">Neumann Fernanda; Gourdain Stephanie; Schmitz-Afonso Isabelle; Hue Nathalie; Le Caer Jean-Pierre; Touboul David; Cariou Kevin; Dodd Robert H; Albac Christelle; Dekker Alain D; Delabar Jean M; Potier Marie-Claude; Delatour Benoit; Dekker Alain D; Bui Linh Chi; Rodrigues-Lima Fernando; Dairou Julien</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2859</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inhibition of DYRK1A kinase, produced by chromosome 21 and consequently overproduced in trisomy 21 subjects, has been suggested as a therapeutic approach to treating the cognitive deficiencies observed in Down syndrome (DS).  We now report the synthesis and potent DYRK1A inhibitory activities of fluoro derivatives of 3,5-di(polyhydroxyaryl)-7-azaindoles (F-DANDYs).  One of these compounds (3-(4-fluorophenyl)-5-(3,4-dihydroxyphenyl)-1H-pyrrolo[2,3-b]pyridine, 5a) was selected for in vivo studies of cognitive rescuing effects in a standard mouse model of DS (Ts65Dn line).  Using the Morris water maze task, Ts65Dn mice treated i.p. with 20 mg/kg of 5a performed significantly better than Ts65Dn mice treated with placebo, confirming the promnesiant effect of 5a in the trisomic mice.  Overall, these results demonstrate for the first time that selective and competitive inhibition of DYRK1A kinase by the F-DANDY derivative 5a may provide a viable treatment strategy for combating the memory and learning deficiencies encountered in DS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9xn_VdnX4CeR_TJajKxJDfW6udTcc2eZm-q_0aLUHh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MrgslSlsA%253D%253D&md5=2bfeabab1bcd8f8f661e8304a7bde167</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-20984-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-20984-z%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DF.%26aulast%3DGourdain%26aufirst%3DS.%26aulast%3DAlbac%26aufirst%3DC.%26aulast%3DDekker%26aufirst%3DA.%2BD.%26aulast%3DBui%26aufirst%3DL.%2BC.%26aulast%3DDairou%26aufirst%3DJ.%26aulast%3DSchmitz-Afonso%26aufirst%3DI.%26aulast%3DHue%26aufirst%3DN.%26aulast%3DRodrigues-Lima%26aufirst%3DF.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3DPotier%26aufirst%3DM.-C.%26aulast%3DLe%2BCaer%26aufirst%3DJ-P.%2BL.%26aulast%3DTouboul%26aufirst%3DD.%26aulast%3DDelatour%26aufirst%3DB.%26aulast%3DCariou%26aufirst%3DK.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DDYRK1A%2520inhibition%2520and%2520cognitive%2520rescue%2520in%2520a%2520Down%2520syndrome%2520mouse%2520model%2520are%2520induced%2520by%2520new%2520fluoro-DANDY%2520derivatives%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D2859%26doi%3D10.1038%2Fs41598-018-20984-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phoa, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbassi, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reekie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Font, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">Structural optimization and pharmacological evaluation of inhibitors targeting dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) and CDC-like kinases (CLK) in glioblastoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2052</span>– <span class="NLM_lpage">2070</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01840</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01840" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFSrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2052-2070&author=Q.+Zhouauthor=A.+F.+Phoaauthor=R.+H.+Abbassiauthor=M.+Hoqueauthor=T.+A.+Reekieauthor=J.+S.+Fontauthor=R.+M.+Ryanauthor=B.+W.+Stringerauthor=B.+W.+Dayauthor=T.+G.+Johnsauthor=L.+Munozauthor=M.+Kassiou&title=Structural+optimization+and+pharmacological+evaluation+of+inhibitors+targeting+dual-specificity+tyrosine+phosphorylation-regulated+kinases+%28DYRK%29+and+CDC-like+kinases+%28CLK%29+in+glioblastoma&doi=10.1021%2Facs.jmedchem.6b01840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma</span></div><div class="casAuthors">Zhou, Qingqing; Phoa, Athena F.; Abbassi, Ramzi H.; Hoque, Monira; Reekie, Tristan A.; Font, Josep S.; Ryan, Renae M.; Stringer, Brett W.; Day, Bryan W.; Johns, Terrance G.; Munoz, Lenka; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2052-2070</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The DYRK family contains kinases that are up-regulated in malignancy and control several cancer hallmarks.  To assess the anticancer potential of inhibitors targeting DYRK kinases, we developed a series of novel DYRK inhibitors based on the 7-azaindole scaffold.  All compds. were tested for their ability to inhibit DYRK1A, DYRK1B, DYRK2, and the structurally related CLK1.  The library was screened for anticancer efficacy in established and stem cell-like glioblastoma cell lines.  The most potent inhibitors (IC50 ≤ 50 nM) significantly decreased viability, clonogenic survival, migration, and invasion of glioblastoma cells.  Target engagement was confirmed with genetic knockdown and the cellular thermal shift assay.  We demonstrate that DYRK1A's thermal stability in cells is increased upon compd. treatment, confirming binding in cells.  In summary, we present synthesis, structure-activity relationship, and efficacy in glioblastoma-relevant models for a library of novel 7-azaindoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpju5xkVf0S5bVg90H21EOLACvtfcHk0lhoBry70xMD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFSrtLc%253D&md5=953769f2edcb1e524ee73a84788f6e83</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01840%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DPhoa%26aufirst%3DA.%2BF.%26aulast%3DAbbassi%26aufirst%3DR.%2BH.%26aulast%3DHoque%26aufirst%3DM.%26aulast%3DReekie%26aufirst%3DT.%2BA.%26aulast%3DFont%26aufirst%3DJ.%2BS.%26aulast%3DRyan%26aufirst%3DR.%2BM.%26aulast%3DStringer%26aufirst%3DB.%2BW.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DJohns%26aufirst%3DT.%2BG.%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DStructural%2520optimization%2520and%2520pharmacological%2520evaluation%2520of%2520inhibitors%2520targeting%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinases%2520%2528DYRK%2529%2520and%2520CDC-like%2520kinases%2520%2528CLK%2529%2520in%2520glioblastoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2052%26epage%3D2070%26doi%3D10.1021%2Facs.jmedchem.6b01840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goff, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltgalvis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsella, T. M.</span></span> <span> </span><span class="NLM_article-title">Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2617</span>– <span class="NLM_lpage">2621</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2017.03.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2617-2621&author=S.+J.+Shawauthor=D.+A.+Goffauthor=N.+Linauthor=R.+Singhauthor=W.+Liauthor=J.+McLaughlinauthor=K.+A.+Baltgalvisauthor=D.+G.+Payanauthor=T.+M.+Kinsella&title=Developing+DYRK+inhibitors+derived+from+the+meridianins+as+a+means+of+increasing+levels+of+NFAT+in+the+nucleus&doi=10.1016%2Fj.bmcl.2017.03.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.037%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DS.%2BJ.%26aulast%3DGoff%26aufirst%3DD.%2BA.%26aulast%3DLin%26aufirst%3DN.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMcLaughlin%26aufirst%3DJ.%26aulast%3DBaltgalvis%26aufirst%3DK.%2BA.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DKinsella%26aufirst%3DT.%2BM.%26atitle%3DDeveloping%2520DYRK%2520inhibitors%2520derived%2520from%2520the%2520meridianins%2520as%2520a%2520means%2520of%2520increasing%2520levels%2520of%2520NFAT%2520in%2520the%2520nucleus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2617%26epage%3D2621%26doi%3D10.1016%2Fj.bmcl.2017.03.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arris, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardcastle, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewsbury, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesguiche, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitfield, H. J.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1038/nsb842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fnsb842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=745-749&author=T.+G.+Daviesauthor=J.+Bentleyauthor=C.+E.+Arrisauthor=F.+T.+Boyleauthor=N.+J.+Curtinauthor=J.+A.+Endicottauthor=A.+E.+Gibsonauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=I.+R.+Hardcastleauthor=P.+Jewsburyauthor=L.+N.+Johnsonauthor=V.+Mesguicheauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=J.+A.+Tuckerauthor=L.+Wangauthor=H.+J.+Whitfield&title=Structure-based+design+of+a+potent+purine-based+cyclin-dependent+kinase+inhibitor&doi=10.1038%2Fnsb842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fnsb842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb842%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWhitfield%26aufirst%3DH.%2BJ.%26atitle%3DStructure-based%2520design%2520of%2520a%2520potent%2520purine-based%2520cyclin-dependent%2520kinase%2520inhibitor%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D745%26epage%3D749%26doi%3D10.1038%2Fnsb842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scales, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goold, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon-Weeks, P. R.</span></span> <span> </span><span class="NLM_article-title">Nonprimed and DYRK1A-primed GSK3β-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">2424</span>– <span class="NLM_lpage">2435</span>, <span class="refDoi"> DOI: 10.1242/jcs.040162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1242%2Fjcs.040162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=19549690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFGmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=2424-2435&author=T.+M.+Scalesauthor=S.+Linauthor=M.+Krausauthor=R.+G.+Gooldauthor=P.+R.+Gordon-Weeks&title=Nonprimed+and+DYRK1A-primed+GSK3%CE%B2-phosphorylation+sites+on+MAP1B+regulate+microtubule+dynamics+in+growing+axons&doi=10.1242%2Fjcs.040162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Nonprimed and DYRK1A-primed GSK3β-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons</span></div><div class="casAuthors">Scales, Timothy M. E.; Lin, Shen; Kraus, Michaela; Goold, Robert G.; Gordon-Weeks, Phillip R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2424-2435</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">MAP1B is a developmentally regulated microtubule-assocd. phosphoprotein that regulates microtubule dynamics in growing axons and growth cones.  We used mass spectrometry to map 28 phosphorylation sites on MAP1B, and selected for further study a putative primed GSK3β site and compared it with two nonprimed GSK3β sites that we had previously characterized.  We raised a panel of phosphospecific antibodies to these sites on MAP1B and used it to assess the distribution of phosphorylated MAP1B in the developing nervous system.  This showed that the nonprimed sites are restricted to growing axons, whereas the primed sites are also expressed in the neuronal cell body.  To identify kinases phosphorylating MAP1B, we added kinase inhibitors to cultured embryonic cortical neurons and monitored MAP1B phosphorylation with our panel of phosphospecific antibodies.  These expts. identified dual-specificity tyrosine-phosphorylation-regulated kinase (DYRK1A) as the kinase that primes sites of GSK3β phosphorylation in MAP1B, and we confirmed this by knocking down DYRK1A in cultured embryonic cortical neurons by using shRNA.  DYRK1A knockdown compromised neuritogenesis and was assocd. with alterations in microtubule stability.  These expts. demonstrate that MAP1B has DYRK1A-primed and nonprimed GSK3β sites that are involved in the regulation of microtubule stability in growing axons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKRvNhhYBbLVg90H21EOLACvtfcHk0lgu1RJ3Kgmpkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFGmu7w%253D&md5=916cf24a8826a66240a64c96c90b76bf</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1242%2Fjcs.040162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.040162%26sid%3Dliteratum%253Aachs%26aulast%3DScales%26aufirst%3DT.%2BM.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DGoold%26aufirst%3DR.%2BG.%26aulast%3DGordon-Weeks%26aufirst%3DP.%2BR.%26atitle%3DNonprimed%2520and%2520DYRK1A-primed%2520GSK3%25CE%25B2-phosphorylation%2520sites%2520on%2520MAP1B%2520regulate%2520microtubule%2520dynamics%2520in%2520growing%2520axons%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2009%26volume%3D122%26spage%3D2424%26epage%3D2435%26doi%3D10.1242%2Fjcs.040162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bettayeb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sallam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popowycz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2713</span>– <span class="NLM_lpage">2724</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1158%2F1535-7163.MCT-08-0080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=18790752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSms7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2713-2724&author=K.+Bettayebauthor=H.+Sallamauthor=Y.+Ferandinauthor=F.+Popowyczauthor=G.+Fournetauthor=M.+Hassanauthor=A.+Echalierauthor=P.+Bernardauthor=J.+Endicottauthor=B.+Josephauthor=L.+Meijer&title=N-%26-N%2C+a+new+class+of+cell+death-inducing+kinase+inhibitors+derived+from+the+purine+roscovitine&doi=10.1158%2F1535-7163.MCT-08-0080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine</span></div><div class="casAuthors">Bettayeb, Karima; Sallam, Hatem; Ferandin, Yoan; Popowycz, Florence; Fournet, Guy; Hassan, Moustapha; Echalier, Aude; Bernard, Philippe; Endicott, Jane; Joseph, Benoit; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2713-2724</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) and their regulators show frequent abnormalities in tumors.  Ten low mol. wt. pharmacol. inhibitors of CDKs are currently in clin. trials against various cancers, including the 2,6,9-trisubstituted purine (R)-roscovitine (CYC202/Seliciclib).  We here report the characterization of N-&-N1, a bioisoster of roscovitine displaying improved antitumoral properties.  N-&-N1 shows exquisite selectivity for CDKs, with 2- to 3-fold enhanced potency compared with (R)-roscovitine.  Inhibition of retinoblastoma protein phosphorylation and RNA polymerase II Ser2 phosphorylation in neuroblastoma SH-SY5Y cells exposed to N-&-N1 indicates that N-&-N1 is able to inhibit CDKs in a cellular context.  N-&-N1 also down-regulates the expression of RNA polymerase.  Cocrystal structures of N-&-N1 and (R)-roscovitine in complex with CDK2/cyclin A reveal that both inhibitors adopt similar binding modes.  A competitive assay shows that, compared with (R)-roscovitine, N-&-N1 has reduced affinity for Erk2 and pyridoxal kinase.  N-&-N1 triggers cell death in a panel of diverse cell lines.  Cell death is accompanied by events characteristic of apoptosis: cytochrome c release, activation of effector caspases, and poly(ADP-ribose) polymerase cleavage.  Induction of p53 and p21CIP1 and down-regulation of the Mcl-1 antiapoptotic factor were also obsd.  Studies in mice show that N-&-N1 has pharmacokinetics properties similar to those of (R)-roscovitine.  Altogether, these results show that analogs of (R)-roscovitine can be designed with improved antitumor potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAdPDD672MabVg90H21EOLACvtfcHk0lgu1RJ3Kgmpkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSms7nL&md5=a2d1cc3e59c608be45064a2ace6f0426</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0080%26sid%3Dliteratum%253Aachs%26aulast%3DBettayeb%26aufirst%3DK.%26aulast%3DSallam%26aufirst%3DH.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DPopowycz%26aufirst%3DF.%26aulast%3DFournet%26aufirst%3DG.%26aulast%3DHassan%26aufirst%3DM.%26aulast%3DEchalier%26aufirst%3DA.%26aulast%3DBernard%26aufirst%3DP.%26aulast%3DEndicott%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DN-%2526-N%252C%2520a%2520new%2520class%2520of%2520cell%2520death-inducing%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520purine%2520roscovitine%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2713%26epage%3D2724%26doi%3D10.1158%2F1535-7163.MCT-08-0080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bettayeb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oumata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galons, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5797</span>– <span class="NLM_lpage">5807</span>, <span class="refDoi"> DOI: 10.1038/onc.2008.191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fonc.2008.191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=18574471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFyqtrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5797-5807&author=K.+Bettayebauthor=N.+Oumataauthor=A.+Echalierauthor=Y.+Ferandinauthor=J.+A.+Endicottauthor=H.+Galonsauthor=L.+Meijer&title=CR8%2C+a+potent+and+selective%2C+roscovitine-derived+inhibitor+of+cyclin-dependent+kinases&doi=10.1038%2Fonc.2008.191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases</span></div><div class="casAuthors">Bettayeb, K.; Oumata, N.; Echalier, A.; Ferandin, Y.; Endicott, J. A.; Galons, H.; Meijer, L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">5797-5807</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Among the ten pharmacol. inhibitors of cyclin-dependent kinases (CDKs) currently in clin. trials, the purine roscovitine (CYC202, Seliciclib) is undergoing phase 2 trials against non-small-cell lung and nasopharyngeal cancers.  An extensive medicinal chem. study, designed to generate more potent analogs of roscovitine, led to the identification of an optimal substitution at the N6 position (compd. CR8).  An extensive selectivity study (108 kinases) highlights the exquisite selectivity of CR8 for CDK1/2/3/5/7/9.  CR8 was 2- to 4-fold more potent than (R)-roscovitine at inhibiting these kinases.  Cocrystal structures of (R)-CR8 and (R)-roscovitine with pCDK2/cyclin A showed that both inhibitors adopt essentially identical positions.  The cellular effects of CR8 and (R)-roscovitine were investigated in human neuroblastoma SH-SY5Y cells.  CR8 inhibited the phosphorylation of CDK1 and 9 substrates, with a 25-50 times higher potency compared to (R)-roscovitine.  CR8 was consistently more potent than (R)-roscovitine at inducing apoptotic cell death parameters: 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium redn. (40-fold), lactate dehydrogenase release (35-fold), caspases activation (68-fold) and poly-(ADP-ribose)polymerase cleavage (50-fold).  This improved cell death-inducing activity of CR8 over (R)-roscovitine was obsd. in 25 different cell lines.  Altogether these results show that second-generation analogs of (R)-roscovitine can be designed with improved antitumor potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvXAJQBwEMJbVg90H21EOLACvtfcHk0lgu1RJ3Kgmpkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFyqtrfI&md5=31e226f8a2f23caf88e6c9422138d2d7</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fonc.2008.191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2008.191%26sid%3Dliteratum%253Aachs%26aulast%3DBettayeb%26aufirst%3DK.%26aulast%3DOumata%26aufirst%3DN.%26aulast%3DEchalier%26aufirst%3DA.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DCR8%252C%2520a%2520potent%2520and%2520selective%252C%2520roscovitine-derived%2520inhibitor%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5797%26epage%3D5807%26doi%3D10.1038%2Fonc.2008.191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span>; <span class="NLM_string-name">Bettayeb, K.</span>; <span class="NLM_string-name">Galons, H.</span>; <span class="NLM_string-name">Demange, L.</span>; <span class="NLM_string-name">Oumata, N.</span></span> <span> </span><span class="NLM_article-title">Perharidines as CDK Inhibitors</span>. <span class="NLM_patent">WO 2009034475A2</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=L.+Meijer&author=K.+Bettayeb&author=H.+Galons&author=L.+Demange&author=N.+Oumata&title=Perharidines+as+CDK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DPerharidines%2520as%2520CDK%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diharce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Désiré, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">An unusual binding model of the methyl 9-anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) confers high selectivity for dual-specificity tyrosine phosphorylation-regulated kinases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10315</span>– <span class="NLM_lpage">10321</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01083</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01083" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10315-10321&author=A.+Chaikuadauthor=J.+Diharceauthor=M.+Schr%C3%B6derauthor=A.+Foucourtauthor=B.+Leblondauthor=A.+S.+Casagrandeauthor=L.+D%C3%A9sir%C3%A9author=P.+Bonnetauthor=S.+Knappauthor=T.+Besson&title=An+unusual+binding+model+of+the+methyl+9-anilinothiazolo%5B5%2C4-f%5D+quinazoline-2-carbimidates+%28EHT+1610+and+EHT+5372%29+confers+high+selectivity+for+dual-specificity+tyrosine+phosphorylation-regulated+kinases&doi=10.1021%2Facs.jmedchem.6b01083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114aR"><div class="casContent"><span class="casTitleNuber">114a</span><div class="casTitle"><span class="NLM_cas:atitle">An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases</span></div><div class="casAuthors">Chaikuad, Apirat; Diharce, Julien; Schroder, Martin; Foucourt, Alicia; Leblond, Bertrand; Casagrande, Anne-Sophie; Desire, Laurent; Bonnet, Pascal; Knapp, Stefan; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10315-10321</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Me 9-anilinothiazolo[5,4-f]quinazoline-2-carbimidates 1 (EHT 5372) and 2 (EHT 1610) are strong inhibitors of DYRK's family kinases.  The crystal structures of the complex revealed a non-canonical binding mode of compd. 1 and 2 in DYRK2 explaining the remarkable selectivity and potency of these inhibitors.  The structural data and comparison presented here provide therefore a template for further improvement of this inhibitor class and for the development of novel inhibitors selectively targeting DYRK kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp91_JqCRXGqLVg90H21EOLACvtfcHk0liWc4tAJ3cZdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM&md5=856551b47ad21c90c55563b064001358</span></div><a href="/servlet/linkout?suffix=cit114a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01083%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DDiharce%26aufirst%3DJ.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DM.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DCasagrande%26aufirst%3DA.%2BS.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DAn%2520unusual%2520binding%2520model%2520of%2520the%2520methyl%25209-anilinothiazolo%255B5%252C4-f%255D%2520quinazoline-2-carbimidates%2520%2528EHT%25201610%2520and%2520EHT%25205372%2529%2520confers%2520high%2520selectivity%2520for%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10315%26epage%3D10321%26doi%3D10.1021%2Facs.jmedchem.6b01083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit114b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rosse, G.</span></span> <span> </span><span class="NLM_article-title">Tricyclic pyrimidines as inhibitors of DYRK1A/DYRK1B as potential treatment for Down’s syndrome or Alzheimer’s disease</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1021/ml400137s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400137s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=502-503&author=G.+Rosse&title=Tricyclic+pyrimidines+as+inhibitors+of+DYRK1A%2FDYRK1B+as+potential+treatment+for+Down%E2%80%99s+syndrome+or+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fml400137s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114b&amp;dbid=16384&amp;doi=10.1021%2Fml400137s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400137s%26sid%3Dliteratum%253Aachs%26aulast%3DRosse%26aufirst%3DG.%26atitle%3DTricyclic%2520pyrimidines%2520as%2520inhibitors%2520of%2520DYRK1A%252FDYRK1B%2520as%2520potential%2520treatment%2520for%2520Down%25E2%2580%2599s%2520syndrome%2520or%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D502%26epage%3D503%26doi%3D10.1021%2Fml400137s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit114c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span>; <span class="NLM_string-name">Casagrande, A.-S.</span>; <span class="NLM_string-name">Desire, L.</span>; <span class="NLM_string-name">Foucourt, A.</span>; <span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">DYRK1 Inhibitors and Uses Thereof</span>. <span class="NLM_patent">US 9446044B2</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=B.+Leblond&author=A.-S.+Casagrande&author=L.+Desire&author=A.+Foucourt&author=T.+Besson&title=DYRK1+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLeblond%26aufirst%3DB.%26atitle%3DDYRK1%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutadeur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyamine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalonde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taverne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pando, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desire, L.</span></span> <span> </span><span class="NLM_article-title">A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer’s disease: effect on Tau and amyloid pathologies <i>in vitro</i></span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1111/jnc.13018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fjnc.13018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25556849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2015&pages=440-451&author=S.+Coutadeurauthor=H.+Benyamineauthor=L.+Delalondeauthor=C.+de+Oliveiraauthor=B.+Leblondauthor=A.+Foucourtauthor=T.+Bessonauthor=A.+S.+Casagrandeauthor=T.+Taverneauthor=A.+Girardauthor=M.+P.+Pandoauthor=L.+Desire&title=A+novel+DYRK1A+%28dual+specificity+tyrosine+phosphorylation-regulated+kinase+1A%29+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+effect+on+Tau+and+amyloid+pathologies+in+vitro&doi=10.1111%2Fjnc.13018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro</span></div><div class="casAuthors">Coutadeur, Severine; Benyamine, Helene; Delalonde, Laurence; de Oliveira, Catherine; Leblond, Bertrand; Foucourt, Alicia; Besson, Thierry; Casagrande, Anne-Sophie; Taverne, Thierry; Girard, Angelique; Pando, Matthew P.; Desire, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-451</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene is located within the Down Syndrome (DS) crit. region on chromosome 21 and is implicated in the generation of Tau and amyloid pathologies that are assocd. with the early onset Alzheimer's Disease (AD) obsd. in DS.  DYRK1A is also found assocd. with neurofibrillary tangles in sporadic AD and phosphorylates key AD players (Tau, amyloid precursor, protein, etc).  Thus, DYRK1A may be an important therapeutic target to modify the course of Tau and amyloid beta (Aβ) pathologies.  Here, we describe EHT 5372 (Me 9-(2,4-dichlorophenylamino) thiazolo[5,4-f]quinazoline-2-carbimidate), a novel, highly potent (IC50 = 0.22 nM) DYRK1A inhibitor with a high degree of selectivity over 339 kinases.  Models in which inhibition of DYRK1A by siRNA reduced and DYRK1A over-expression induced Tau phosphorylation or Aβ prodn. were used.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation at multiple AD-relevant sites in biochem. and cellular assays.  EHT 5372 also normalizes both Aβ-induced Tau phosphorylation and DYRK1A-stimulated Aβ prodn.  DYRK1A is thus as a key element of Aβ-mediated Tau hyperphosphorylation, which links Tau and amyloid pathologies.  EHT 5372 and other compds. in its class warrant in vivo investigation as a novel, high-potential therapy for AD and other Tau opathies.  Inhibition of the dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is a new high-potential therapeutic approach for Alzheimer disease.  Here we describe EHT 5372, a novel potent and selective DYRK1A inhibitor.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation, Aβ prodn. and Aβ effects on phospho-Tau, including Tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVswt1MX4I7Vg90H21EOLACvtfcHk0liWc4tAJ3cZdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D&md5=5953fc5e56b7ea3c86ea414bd3de7863</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13018%26sid%3Dliteratum%253Aachs%26aulast%3DCoutadeur%26aufirst%3DS.%26aulast%3DBenyamine%26aufirst%3DH.%26aulast%3DDelalonde%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.%2BS.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DPando%26aufirst%3DM.%2BP.%26aulast%3DDesire%26aufirst%3DL.%26atitle%3DA%2520novel%2520DYRK1A%2520%2528dual%2520specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520effect%2520on%2520Tau%2520and%2520amyloid%2520pathologies%2520in%2520vitro%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D133%26spage%3D440%26epage%3D451%26doi%3D10.1111%2Fjnc.13018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hédou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of thiazolo[5,4-f]quinazolin-9(8H)-ones as multi-target directed ligands of Ser/Thr kinases</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">578</span>, <span class="refDoi"> DOI: 10.3390/molecules21050578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.3390%2Fmolecules21050578" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=578&author=D.+H%C3%A9douauthor=J.+Godeauauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=C.+Fruitauthor=T.+Besson&title=Synthesis+of+thiazolo%5B5%2C4-f%5Dquinazolin-9%288H%29-ones+as+multi-target+directed+ligands+of+Ser%2FThr+kinases&doi=10.3390%2Fmolecules21050578"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21050578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21050578%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DGodeau%26aufirst%3DJ.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DFruit%26aufirst%3DC.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520thiazolo%255B5%252C4-f%255Dquinazolin-9%25288H%2529-ones%2520as%2520multi-target%2520directed%2520ligands%2520of%2520Ser%252FThr%2520kinases%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D578%26doi%3D10.3390%2Fmolecules21050578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeunynck, M.</span></span> <span> </span><span class="NLM_article-title">Catalyst-free synthesis of quinazolin-4-ones from (hetero)aryl-guanidines: application to the synthesis of pyrazolo[4,3-f]quinazolin-9-ones, a new family of DYRK1A inhibitors</span>. <i>Mol. Diversity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1007/s11030-012-9397-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1007%2Fs11030-012-9397-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=659-667&author=J.+Debrayauthor=S.+Bonteauthor=O.+Lozachauthor=L.+Meijerauthor=M.+Demeunynck&title=Catalyst-free+synthesis+of+quinazolin-4-ones+from+%28hetero%29aryl-guanidines%3A+application+to+the+synthesis+of+pyrazolo%5B4%2C3-f%5Dquinazolin-9-ones%2C+a+new+family+of+DYRK1A+inhibitors&doi=10.1007%2Fs11030-012-9397-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1007%2Fs11030-012-9397-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11030-012-9397-7%26sid%3Dliteratum%253Aachs%26aulast%3DDebray%26aufirst%3DJ.%26aulast%3DBonte%26aufirst%3DS.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DDemeunynck%26aufirst%3DM.%26atitle%3DCatalyst-free%2520synthesis%2520of%2520quinazolin-4-ones%2520from%2520%2528hetero%2529aryl-guanidines%253A%2520application%2520to%2520the%2520synthesis%2520of%2520pyrazolo%255B4%252C3-f%255Dquinazolin-9-ones%252C%2520a%2520new%2520family%2520of%2520DYRK1A%2520inhibitors%26jtitle%3DMol.%2520Diversity%26date%3D2012%26volume%3D16%26spage%3D659%26epage%3D667%26doi%3D10.1007%2Fs11030-012-9397-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drygin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streiner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliesath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaebe, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span> <span> </span><span class="NLM_article-title">CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">10288</span>– <span class="NLM_lpage">10298</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1158%2F0008-5472.CAN-10-1893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21159648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10288-10298&author=A.+Siddiqui-Jainauthor=D.+Dryginauthor=N.+Streinerauthor=P.+Chuaauthor=F.+Pierreauthor=S.+E.+O%E2%80%99Brienauthor=J.+Bliesathauthor=M.+Omoriauthor=N.+Huserauthor=C.+Hoauthor=C.+Proffittauthor=M.+K.+Schwaebeauthor=D.+M.+Ryckmanauthor=W.+G.+Riceauthor=K.+Anderes&title=CX-4945%2C+an+orally+bioavailable+selective+inhibitor+of+protein+kinase+CK2%2C+inhibits+prosurvival+and+angiogenic+signaling+and+exhibits+antitumor+efficacy&doi=10.1158%2F0008-5472.CAN-10-1893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118aR"><div class="casContent"><span class="casTitleNuber">118a</span><div class="casTitle"><span class="NLM_cas:atitle">CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy</span></div><div class="casAuthors">Siddiqui-Jain, Adam; Drygin, Denis; Streiner, Nicole; Chua, Peter; Pierre, Fabrice; O'Brien, Sean E.; Bliesath, Josh; Omori, Mayuko; Huser, Nanni; Ho, Caroline; Proffitt, Chris; Schwaebe, Michael K.; Ryckman, David M.; Rice, William G.; Anderes, Kenna</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10288-10298</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Malignant transformation and maintenance of the malignant phenotype depends on oncogenic and non-oncogenic proteins that are essential to mediate oncogene signaling and to support the altered physiol. demands induced by transformation.  Protein kinase CK2 supports key prosurvival signaling pathways and represents a prototypical non-oncogene.  In this study, we describe CX-4945, a potent and selective orally bioavailable small mol. inhibitor of CK2.  The antiproliferative activity of CX-4945 against cancer cells correlated with expression levels of the CK2α catalytic subunit.  Attenuation of PI3K/Akt signaling by CX-4945 was evidenced by dephosphorylation of Akt on the CK2-specific S129 site and the canonical S473 and T308 regulatory sites.  CX-4945 caused cell-cycle arrest and selectively induced apoptosis in cancer cells relative to normal cells.  In models of angiogenesis, CX-4945 inhibited human umbilical vein endothelial cell migration, tube formation, and blocked CK2-dependent hypoxia-induced factor 1 alpha (HIF-1α) transcription in cancer cells.  When administered orally in murine xenograft models, CX-4945 was well tolerated and demonstrated robust antitumor activity with concomitant redns. of the mechanism-based biomarker phospho-p21 (T145).  The obsd. antiproliferative and anti-angiogenic responses to CX-4945 in tumor cells and endothelial cells collectively illustrate that this compd. exerts its antitumor effects through inhibition of CK2-dependent signaling in multiple pathways.  Finally, CX-4945 is the first orally bioavailable small mol. inhibitor of CK2 to advance into human clin. trials, thereby paving the way for an entirely new class of targeted treatment for cancer.  Cancer Res; 70(24); 10288-98.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8s0Sa3hOwtbVg90H21EOLACvtfcHk0lj9CC91RQOkkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7fK&md5=bfcfe06730e099719e752574a6636dfb</span></div><a href="/servlet/linkout?suffix=cit118a&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1893%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DChua%26aufirst%3DP.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DOmori%26aufirst%3DM.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DSchwaebe%26aufirst%3DM.%2BK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DAnderes%26aufirst%3DK.%26atitle%3DCX-4945%252C%2520an%2520orally%2520bioavailable%2520selective%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%252C%2520inhibits%2520prosurvival%2520and%2520angiogenic%2520signaling%2520and%2520exhibits%2520antitumor%2520efficacy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D10288%26epage%3D10298%26doi%3D10.1158%2F0008-5472.CAN-10-1893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit118b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel function of CX-4945 as a splicing regulator</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e94978</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0094978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1371%2Fjournal.pone.0094978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=24743259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e94978&author=H.+Kimauthor=K.+Choiauthor=H.+Kangauthor=S.+Y.+Leeauthor=S.+W.+Chiauthor=M.+S.+Leeauthor=J.+Songauthor=D.+Imauthor=Y.+Choiauthor=S.+Cho&title=Identification+of+a+novel+function+of+CX-4945+as+a+splicing+regulator&doi=10.1371%2Fjournal.pone.0094978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118bR"><div class="casContent"><span class="casTitleNuber">118b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel function of CX-4945 as a splicing regulator</span></div><div class="casAuthors">Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Lee, So-Young; Chi, Seung-wook; Lee, Min-sung; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e94978/1-e94978/8, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Alternative splicing is a nearly ubiquitous versatile process that controls gene expression and creates numerous protein isoforms with different functions from a single gene.  The significance of alternative splicing has been confirmed by the increasing no. of human diseases that are caused by misregulation of splicing events.  Very few compds., however, have been reported to act as inhibitors of alternative splicing, and their potential clin. use needs to be evaluated.  Here, we report that CX-4945, a previously well-characterized inhibitor of casein kinase 2 (CK2) and a mol. currently in clin. trials (Phase II) for cancer treatment, regulates splicing in mammalian cells in a CK2-independent manner.  Transcriptome-wide anal. using exon array also showed a widespread alteration in alternative splicing of numerous genes.  We found that CX-4945 potently inhibits the Cdc2-like kinases (Clks) in vitro and in turn, leads to suppression of the phosphorylation of serine/arginine-rich (SR) proteins in mammalian cells.  Surprisingly, the overall efficacy of CX-4945 on Clks (IC50 = 3-90 nM) was stronger than that of TG-003, the strongest inhibitor reported to date.  Of the Clks, Clk2 was most strongly inhibited by CX-4945 in an ATP-competitive manner.  Our research revealed an unexpected activity of the drug candidate CX-4945 as a potent splicing modulator and also suggested a potential application for therapy of diseases caused by abnormal splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEmZdGtUZUe7Vg90H21EOLACvtfcHk0lg_s7UrBmzn1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL&md5=5edb2338401d950cddbcba7d35e57c04</span></div><a href="/servlet/linkout?suffix=cit118b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0094978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0094978%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DChi%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DD.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520novel%2520function%2520of%2520CX-4945%2520as%2520a%2520splicing%2520regulator%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De94978%26doi%3D10.1371%2Fjournal.pone.0094978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. C.</span>; <span class="NLM_string-name">Kim, H. K.</span>; <span class="NLM_string-name">Lee, K. S.</span>; <span class="NLM_string-name">Choi, K. M.</span>; <span class="NLM_string-name">Chi, S. W.</span>; <span class="NLM_string-name">Yu, K.</span>; <span class="NLM_string-name">Kim, A. K.</span>; <span class="NLM_string-name">Choi, M. R.</span>; <span class="NLM_string-name">Kang, H. J.</span>; <span class="NLM_string-name">Lee, J. S.</span>; <span class="NLM_string-name">Lee, M. S.</span></span> <span> </span><span class="NLM_article-title">Pharmaceutical Composition for Preventing and Treating Degenerative Brain Diseases, Containing CX-4945 as Active Ingredient</span>. <span class="NLM_patent">WO 2015199503</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+C.+Cho&author=H.+K.+Kim&author=K.+S.+Lee&author=K.+M.+Choi&author=S.+W.+Chi&author=K.+Yu&author=A.+K.+Kim&author=M.+R.+Choi&author=H.+J.+Kang&author=J.+S.+Lee&author=M.+S.+Lee&title=Pharmaceutical+Composition+for+Preventing+and+Treating+Degenerative+Brain+Diseases%2C+Containing+CX-4945+as+Active+Ingredient"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BC.%26atitle%3DPharmaceutical%2520Composition%2520for%2520Preventing%2520and%2520Treating%2520Degenerative%2520Brain%2520Diseases%252C%2520Containing%2520CX-4945%2520as%2520Active%2520Ingredient%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span> <span> </span><span class="NLM_article-title">A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition</span>. <i>Dis. Models &amp; Mech.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.1242/dmm.025668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1242%2Fdmm.025668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2hsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=839-848&author=H.+Kimauthor=K.+S.+Leeauthor=A.+K.+Kimauthor=M.+Choiauthor=K.+Choiauthor=M.+Kangauthor=S.+W.+Chiauthor=M.+S.+Leeauthor=J.+S.+Leeauthor=S.+Y.+Leeauthor=W.+J.+Songauthor=K.+Yuauthor=S.+Cho&title=A+chemical+with+proven+clinical+safety+rescues+Down-syndrome-related+phenotypes+in+through+DYRK1A+inhibition&doi=10.1242%2Fdmm.025668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical with proven clinical safety rescues Down-syndromerelated phenotypes in through DYRK1A inhibition</span></div><div class="casAuthors">Kim, Hyeongki; Lee, Kyu-Sun; Kim, Ae-Kyeong; Choi, Miri; Choi, Kwangman; Kang, Mingu; Chi, Seung-Wook; Lee, Min-Sung; Lee, Jeong-Soo; Lee, So-Young; Song, Woo-Joo; Yu, Kweon; Cho, Sungchan</div><div class="citationInfo"><span class="NLM_cas:title">Disease Models & Mechanisms</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">839-848</span>CODEN:
                <span class="NLM_cas:coden">DMMIAX</span>;
        ISSN:<span class="NLM_cas:issn">1754-8403</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">DYRK1A is important in neuronal development and function, and its excessive activity is considered a significant pathogenic factor in Down syndrome and Alzheimer's disease.  Thus, inhibition of DYRK1A has been suggested to be a new strategy to modify the disease.  Very few compds., however, have been reported to act as inhibitors, and their potential clin. uses require further evaluation.  Here,we newly identify CX-4945, the safety of which has been already proven in the clin. setting, as a potent inhibitor ofDYRK1A that acts in an ATP-competitive manner.  The inhibitory potency of CX-4945 on DYRK1A (IC50=6.8 nM) in vitro was higher than that of harmine, INDY or proINDY, which are well-known potent inhibitors of DYRK1A.  CX-4945 effectively reverses the aberrant phosphorylation of Tau, amyloid precursor protein (APP) and presenilin 1 (PS1) inmammalian cells.  To our surprise, feedingwith CX-4945 significantly restored the neurol. and phenotypic defects induced by the overexpression of minibrain, an ortholog of human DYRK1A, in the Drosophila model.  Moreover, oral administration of CX-4945 acutely suppressed Tau hyperphosphorylation in the hippocampus of DYRK1A-overexpressing mice.  Our research results demonstrate that CX-4945 is a potent DYRK1A inhibitor and also suggest that it has therapeutic potential for DYRK1A-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwgsUZXI8Gj7Vg90H21EOLACvtfcHk0lg_s7UrBmzn1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2hsLbN&md5=bfc074ed6a4162a09435959405fa0529</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1242%2Fdmm.025668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.025668%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DA.%2BK.%26aulast%3DChoi%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DChi%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DCho%26aufirst%3DS.%26atitle%3DA%2520chemical%2520with%2520proven%2520clinical%2520safety%2520rescues%2520Down-syndrome-related%2520phenotypes%2520in%2520through%2520DYRK1A%2520inhibition%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2016%26volume%3D9%26spage%3D839%26epage%3D848%26doi%3D10.1242%2Fdmm.025668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luk, K. T.</span></span> <span> </span><span class="NLM_article-title">1,6- and 1,8-Naphthyridines Useful as Dyrk1 Inhibitors</span>. <span class="NLM_patent">WO 2012098066</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+T.+Luk&title=1%2C6-+and+1%2C8-Naphthyridines+Useful+as+Dyrk1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLuk%26aufirst%3DK.%2BT.%26atitle%3D1%252C6-%2520and%25201%252C8-Naphthyridines%2520Useful%2520as%2520Dyrk1%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu Jhaisha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunick, C.</span></span> <span> </span><span class="NLM_article-title">10-Iodo-11<i>H</i>-indolo[3,2-<i>c</i>]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3143</span>, <span class="refDoi"> DOI: 10.1021/jm501994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3131-3143&author=H.+Falkeauthor=A.+Chaikuadauthor=A.+Beckerauthor=N.+Loa%C3%ABcauthor=O.+Lozachauthor=S.+Abu+Jhaishaauthor=W.+Beckerauthor=P.+G.+Jonesauthor=L.+Preuauthor=K.+Baumannauthor=S.+Knappauthor=L.+Meijerauthor=C.+Kunick&title=10-Iodo-11H-indolo%5B3%2C2-c%5Dquinoline-6-carboxylic+acids+are+selective+inhibitors+of+DYRK1A&doi=10.1021%2Fjm501994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A</span></div><div class="casAuthors">Falke, Hannes; Chaikuad, Apirat; Becker, Anja; Loaec, Nadege; Lozach, Olivier; Abu Jhaisha, Samira; Becker, Walter; Jones, Peter G.; Preu, Lutz; Baumann, Knut; Knapp, Stefan; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3131-3143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase DYRK1A has been suggested to act as one of the intracellular regulators contributing to neurol. alterations found in individuals with Down syndrome.  For an assessment of the role of DYRK1A, selective synthetic inhibitors are valuable pharmacol. tools.  However, the DYRK1A inhibitors described in the literature so far either are not sufficiently selective or have not been tested against closely related kinases from the DYRK and the CLK protein kinase families.  The aim of this study was the identification of DYRK1A inhibitors exhibiting selectivity vs. the structurally and functionally closely related DYRK and CLK isoforms.  Structure modification of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity relationships for kinase inhibition and enabled the design of 10-iodo-substituted derivs. as very potent DYRK1A inhibitors with considerable selectivity against CLKs.  X-ray structure detn. of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystd. with DYRK1A confirmed the predicted binding mode within the ATP binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4rHbgYJUsbVg90H21EOLACvtfcHk0lhqBRySXe_l2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D&md5=70efbb6ad590a1240764ccc78af019ec</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm501994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501994d%26sid%3Dliteratum%253Aachs%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DAbu%2BJhaisha%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3D10-Iodo-11H-indolo%255B3%252C2-c%255Dquinoline-6-carboxylic%2520acids%2520are%2520selective%2520inhibitors%2520of%2520DYRK1A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3131%26epage%3D3143%26doi%3D10.1021%2Fjm501994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunick, C.</span></span> <span> </span><span class="NLM_article-title">Indole-3-carbonitriles as DYRK1A inhibitors by fragment-based drug design</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">64</span>, <span class="refDoi"> DOI: 10.3390/molecules23020064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.3390%2Fmolecules23020064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1OhurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=64&author=R.+Meineauthor=W.+Beckerauthor=H.+Falkeauthor=L.+Preuauthor=N.+Loaecauthor=L.+Meijerauthor=C.+Kunick&title=Indole-3-carbonitriles+as+DYRK1A+inhibitors+by+fragment-based+drug+design&doi=10.3390%2Fmolecules23020064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Indole-3-carbonitriles as DYRK1A inhibitors by fragment-based drug design</span></div><div class="casAuthors">Meine, Rosanna; Becker, Walter; Falke, Hannes; Preu, Lutz; Loaeec, Nadege; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">64/1-64/23</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a potential drug target because of its role in the development of Down syndrome and Alzheimer's disease.  The selective DYRK1A inhibitor 10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acid (KuFal194), a large, flat and lipophilic mol., suffers from poor water soly., limiting its use as chem. probe in cellular assays and animal models.  Based on the structure of KuFal194, 7-chloro-1H-indole-3-carbonitrile was selected as fragment template for the development of smaller and less lipophilic DYRK1A inhibitors.  By modification of this fragment, a series of indole-3-carbonitriles was designed and evaluated as potential DYRK1A ligands by mol. docking studies.  Synthesis and in vitro assays on DYRK1A and related protein kinases identified novel double-digit nanomolar inhibitors with submicromolar activity in cell culture assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkYtRPnACcGLVg90H21EOLACvtfcHk0lhqBRySXe_l2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1OhurfK&md5=3c41761df0f75e3f8a98c1ee3c057ff9</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23020064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23020064%26sid%3Dliteratum%253Aachs%26aulast%3DMeine%26aufirst%3DR.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3DIndole-3-carbonitriles%2520as%2520DYRK1A%2520inhibitors%2520by%2520fragment-based%2520drug%2520design%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D64%26doi%3D10.3390%2Fmolecules23020064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shcherbakova, I.</span>; <span class="NLM_string-name">Nikolich, K.</span>; <span class="NLM_string-name">Nikolyukin, Y.</span></span> <span> </span><span class="NLM_article-title">Compositions and Methods for Inhibiting DYRK1A to Treat Central Nervous System Diseases and Disorders</span>. <span class="NLM_patent">WO 2011068990</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=I.+Shcherbakova&author=K.+Nikolich&author=Y.+Nikolyukin&title=Compositions+and+Methods+for+Inhibiting+DYRK1A+to+Treat+Central+Nervous+System+Diseases+and+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26atitle%3DCompositions%2520and%2520Methods%2520for%2520Inhibiting%2520DYRK1A%2520to%2520Treat%2520Central%2520Nervous%2520System%2520Diseases%2520and%2520Disorders%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dominique, R.</span>; <span class="NLM_string-name">Luk, K.
T.</span>; <span class="NLM_string-name">Qiao, Q.</span>; <span class="NLM_string-name">Rossman, P. L.</span></span> <span> </span><span class="NLM_article-title">Quinoline DYRK1 Inhibitors</span>. <span class="NLM_patent">WO 2012098070</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Dominique&author=K.%0AT.+Luk&author=Q.+Qiao&author=P.+L.+Rossman&title=Quinoline+DYRK1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDominique%26aufirst%3DR.%26atitle%3DQuinoline%2520DYRK1%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sliman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blairvacq, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmaële, D.</span></span> <span> </span><span class="NLM_article-title">Identication and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1kinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2801</span>– <span class="NLM_lpage">2805</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2010.03.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2801-2805&author=F.+Slimanauthor=M.+Blairvacqauthor=E.+Durieuauthor=L.+Meijerauthor=J.+Rodrigoauthor=D.+Desma%C3%ABle&title=Identication+and+structure-activity+relationship+of+8-hydroxy-quinoline-7-carboxylic+acid+derivatives+as+inhibitors+of+Pim-1kinase&doi=10.1016%2Fj.bmcl.2010.03.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.061%26sid%3Dliteratum%253Aachs%26aulast%3DSliman%26aufirst%3DF.%26aulast%3DBlairvacq%26aufirst%3DM.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DDesma%25C3%25ABle%26aufirst%3DD.%26atitle%3DIdentication%2520and%2520structure-activity%2520relationship%2520of%25208-hydroxy-quinoline-7-carboxylic%2520acid%2520derivatives%2520as%2520inhibitors%2520of%2520Pim-1kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2801%26epage%3D2805%26doi%3D10.1016%2Fj.bmcl.2010.03.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chon, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span> <span> </span><span class="NLM_article-title">Putative therapeutic agents for the learning and memory deficits of people with Down syndrome</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3772</span>– <span class="NLM_lpage">3776</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2006.04.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=16698266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVykurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3772-3776&author=N.+D.+Kimauthor=J.+Yoonauthor=J.+H.+Kimauthor=J.+T.+Leeauthor=Y.+S.+Chonauthor=M.+K.+Hwangauthor=I.+Haauthor=W.+J.+Song&title=Putative+therapeutic+agents+for+the+learning+and+memory+deficits+of+people+with+Down+syndrome&doi=10.1016%2Fj.bmcl.2006.04.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Putative therapeutic agents for the learning and memory deficits of people with Down syndrome</span></div><div class="casAuthors">Kim, Nam Doo; Yoon, Jeonghyeok; Kim, Jung Ho; Lee, Jung Tae; Chon, Yong Sog; Hwang, Mi-Kyung; Ha, Ilho; Song, Woo-Joo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3772-3776</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mental retardation is the most common and debilitating condition for individuals with Down syndrome (DS).  The hyper-activation of DYRK1A by overexpression causes significant learning and memory deficits in DS-model mice.  Thus far, no mechanism-based drug has been developed to address this.  After a combination of in silico and in vitro screenings, two DYRK1A inhibitors were isolated that are active in a cell-based assay.  Further optimization could lead to a novel drug discovery that could address DS learning and memory deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCFzbIFHKqJbVg90H21EOLACvtfcHk0lgI60HwiA3xBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVykurw%253D&md5=5a6a306f3de1c958ac3d4b7f06d24c82</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.042%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DYoon%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DChon%26aufirst%3DY.%2BS.%26aulast%3DHwang%26aufirst%3DM.%2BK.%26aulast%3DHa%26aufirst%3DI.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26atitle%3DPutative%2520therapeutic%2520agents%2520for%2520the%2520learning%2520and%2520memory%2520deficits%2520of%2520people%2520with%2520Down%2520syndrome%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3772%26epage%3D3776%26doi%3D10.1016%2Fj.bmcl.2006.04.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mott, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanega, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misteli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6700</span>– <span class="NLM_lpage">6705</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.09.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2009.09.121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6700-6705&author=B.+T.+Mottauthor=C.+Tanegaauthor=M.+Shenauthor=D.+J.+Maloneyauthor=P.+Shinnauthor=W.+Leisterauthor=J.+J.+Maruganauthor=J.+Ingleseauthor=C.+P.+Austinauthor=T.+Misteliauthor=D.+S.+Auldauthor=C.+J.+Thomas&title=Evaluation+of+substituted+6-arylquinazolin-4-amines+as+potent+and+selective+inhibitors+of+cdc2-like+kinases+%28Clk%29&doi=10.1016%2Fj.bmcl.2009.09.121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.121%26sid%3Dliteratum%253Aachs%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DShinn%26aufirst%3DP.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DEvaluation%2520of%2520substituted%25206-arylquinazolin-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520cdc2-like%2520kinases%2520%2528Clk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6700%26epage%3D6705%26doi%3D10.1016%2Fj.bmcl.2009.09.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span>; <span class="NLM_string-name">Mott, B. T.</span>; <span class="NLM_string-name">Tanega, C.</span>; <span class="NLM_string-name">Shen, M.</span>; <span class="NLM_string-name">Auld, D. S.</span>; <span class="NLM_string-name">Rosenthal, A. S.</span>; <span class="NLM_string-name">Maloney, D. J.</span></span> <span> </span><span class="NLM_article-title">Quinazolin-4-amine Derivatives; and Methods of Use</span>. <span class="NLM_patent">WO 2011041655A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+J.+Thomas&author=B.+T.+Mott&author=C.+Tanega&author=M.+Shen&author=D.+S.+Auld&author=A.+S.+Rosenthal&author=D.+J.+Maloney&title=Quinazolin-4-amine+Derivatives%3B+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DQuinazolin-4-amine%2520Derivatives%253B%2520and%2520Methods%2520of%2520Use%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit129b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanega, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mott, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougie, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misteli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (DYRK)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3152</span>– <span class="NLM_lpage">3158</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2011.02.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21450467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3152-3158&author=A.+S.+Rosenthalauthor=C.+Tanegaauthor=M.+Shenauthor=B.+T.+Mottauthor=J.+M.+Bougieauthor=D.+T.+Nguyenauthor=T.+Misteliauthor=D.+S.+Auldauthor=D.+J.+Maloneyauthor=C.+J.+Thomas&title=Potent+and+selective+small+molecule+inhibitors+of+specific+isoforms+of+Cdc2-like+kinases+%28Clk%29+and+dual+specificity+tyrosine-phosphorylation-regulated+kinases+%28DYRK%29&doi=10.1016%2Fj.bmcl.2011.02.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129bR"><div class="casContent"><span class="casTitleNuber">129b</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)</span></div><div class="casAuthors">Rosenthal, Andrew S.; Tanega, Cordelle; Shen, Min; Mott, Bryan T.; Bougie, James M.; Nguyen, Dac-Trung; Misteli, Tom; Auld, Douglas S.; Maloney, David J.; Thomas, Craig J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3152-3158</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Continued examn. of substituted 6-arylquinazolin-4-amines as Clk4 kinase inhibitors resulted in selective inhibitors of Clk1, Clk4, Dyrk1A, and Dyrk1B kinases.  Several of the most potent inhibitors were validated as being highly selective within a comprehensive kinome scan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-t6jcT2g9qrVg90H21EOLACvtfcHk0lgI60HwiA3xBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCls7o%253D&md5=37a7ffa16767005c19c559bbe9c3ae71</span></div><a href="/servlet/linkout?suffix=cit129b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.114%26sid%3Dliteratum%253Aachs%26aulast%3DRosenthal%26aufirst%3DA.%2BS.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DBougie%26aufirst%3DJ.%2BM.%26aulast%3DNguyen%26aufirst%3DD.%2BT.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520small%2520molecule%2520inhibitors%2520of%2520specific%2520isoforms%2520of%2520Cdc2-like%2520kinases%2520%2528Clk%2529%2520and%2520dual%2520specificity%2520tyrosine-phosphorylation-regulated%2520kinases%2520%2528DYRK%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3152%26epage%3D3158%26doi%3D10.1016%2Fj.bmcl.2011.02.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esvan, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeinyeh, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boibessot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nauton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thery, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anizon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2016.04.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=170-177&author=Y.+J.+Esvanauthor=W.+Zeinyehauthor=T.+Boibessotauthor=L.+Nautonauthor=V.+Theryauthor=S.+Knappauthor=A.+Chaikuadauthor=N.+Loaecauthor=L.+Meijerauthor=F.+Anizonauthor=F.+Giraudauthor=P.+Moreau&title=Discovery+of+pyrido%5B3%2C4-g%5Dquinazoline+derivatives+as+CMGC+family+protein+kinase+inhibitors%3A+Design%2C+synthesis%2C+inhibitory+potency+and+X-ray+co-crystal+structure&doi=10.1016%2Fj.ejmech.2016.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DEsvan%26aufirst%3DY.%2BJ.%26aulast%3DZeinyeh%26aufirst%3DW.%26aulast%3DBoibessot%26aufirst%3DT.%26aulast%3DNauton%26aufirst%3DL.%26aulast%3DThery%26aufirst%3DV.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DGiraud%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520pyrido%255B3%252C4-g%255Dquinazoline%2520derivatives%2520as%2520CMGC%2520family%2520protein%2520kinase%2520inhibitors%253A%2520Design%252C%2520synthesis%252C%2520inhibitory%2520potency%2520and%2520X-ray%2520co-crystal%2520structure%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D118%26spage%3D170%26epage%3D177%26doi%3D10.1016%2Fj.ejmech.2016.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span>; <span class="NLM_string-name">Guillaumet, G.</span>; <span class="NLM_string-name">Tikad, A.</span>; <span class="NLM_string-name">Dehbi, O.</span></span> <span> </span><span class="NLM_article-title">Pyrido[3,2-<i>d</i>]pyrimidine Derivatives, Processes for Preparing Same and Therapeutic Uses Thereof</span>. <span class="NLM_patent">WO 2011135259A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Routier&author=G.+Guillaumet&author=A.+Tikad&author=O.+Dehbi&title=Pyrido%5B3%2C2-d%5Dpyrimidine+Derivatives%2C+Processes+for+Preparing+Same+and+Therapeutic+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DPyrido%255B3%252C2-d%255Dpyrimidine%2520Derivatives%252C%2520Processes%2520for%2520Preparing%2520Same%2520and%2520Therapeutic%2520Uses%2520Thereof%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit131b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dehbi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aadil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akssira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillaumet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and optimization of an original V-shaped collection of 4–7-disubstituted Pyrido[3,2-d] pyrimidines as CDK5 and DYRK1A inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2014.04.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2014&pages=352-363&author=O.+Dehbiauthor=A.+Tikadauthor=S.+Bourgauthor=P.+Bonnetauthor=O.+Lozachauthor=L.+Meijerauthor=M.+Aadilauthor=M.+Akssiraauthor=G.+Guillaumetauthor=S.+Routier&title=Synthesis+and+optimization+of+an+original+V-shaped+collection+of+4%E2%80%937-disubstituted+Pyrido%5B3%2C2-d%5D+pyrimidines+as+CDK5+and+DYRK1A+inhibitors&doi=10.1016%2Fj.ejmech.2014.04.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.055%26sid%3Dliteratum%253Aachs%26aulast%3DDehbi%26aufirst%3DO.%26aulast%3DTikad%26aufirst%3DA.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAadil%26aufirst%3DM.%26aulast%3DAkssira%26aufirst%3DM.%26aulast%3DGuillaumet%26aufirst%3DG.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520optimization%2520of%2520an%2520original%2520V-shaped%2520collection%2520of%25204%25E2%2580%25937-disubstituted%2520Pyrido%255B3%252C2-d%255D%2520pyrimidines%2520as%2520CDK5%2520and%2520DYRK1A%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D80%26spage%3D352%26epage%3D363%26doi%3D10.1016%2Fj.ejmech.2014.04.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiumana, A.</span>; <span class="NLM_string-name">Foloppe, N.</span>; <span class="NLM_string-name">Ray, S.</span>; <span class="NLM_string-name">Walmsley, D.</span>; <span class="NLM_string-name">Kotschy, A.</span>; <span class="NLM_string-name">Burbridge, M. F.</span>; <span class="NLM_string-name">Cruzalegui, F. H.</span></span> <span> </span><span class="NLM_article-title">New Pyrrolo[2,3-<i>d</i>]pyrimidine Derivatives as Dual DYRK1/CLK1 Inhibitors</span>. <span class="NLM_patent">WO 2017055533</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+Fiumana&author=N.+Foloppe&author=S.+Ray&author=D.+Walmsley&author=A.+Kotschy&author=M.+F.+Burbridge&author=F.+H.+Cruzalegui&title=New+Pyrrolo%5B2%2C3-d%5Dpyrimidine+Derivatives+as+Dual+DYRK1%2FCLK1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFiumana%26aufirst%3DA.%26atitle%3DNew%2520Pyrrolo%255B2%252C3-d%255Dpyrimidine%2520Derivatives%2520as%2520Dual%2520DYRK1%252FCLK1%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span>; <span class="NLM_string-name">Luk, K.
T.</span>; <span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Pyrazolo Pyrimidines as Dyrk1a and Dyrk1b Inhibitors</span>. <span class="NLM_patent">WO 2012098068</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=W.+Liu&author=K.%0AT.+Luk&author=X.+Zhang&title=Pyrazolo+Pyrimidines+as+Dyrk1a+and+Dyrk1b+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DPyrazolo%2520Pyrimidines%2520as%2520Dyrk1a%2520and%2520Dyrk1b%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. W.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Luk, K. T.</span>; <span class="NLM_string-name">Rossman, P. L.</span>; <span class="NLM_string-name">Sun, H.</span>; <span class="NLM_string-name">Wovkulich, P. M.</span></span> <span> </span><span class="NLM_article-title">Pyrido Pyrimidines for Use as Dyrk1 Inhibitors</span>. <span class="NLM_patent">WO 2012098065A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Anderson&author=Y.+Chen&author=Z.+Chen&author=K.+T.+Luk&author=P.+L.+Rossman&author=H.+Sun&author=P.+M.+Wovkulich&title=Pyrido+Pyrimidines+for+Use+as+Dyrk1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%2BW.%26atitle%3DPyrido%2520Pyrimidines%2520for%2520Use%2520as%2520Dyrk1%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit134b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominique, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glenn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukacs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonskaia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Railkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilenchik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wovkulich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Pyrido[2,3-<i>d</i>]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6610</span>– <span class="NLM_lpage">6615</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2013.10.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6610-6615&author=K.+Andersonauthor=Y.+Chenauthor=Z.+Chenauthor=R.+Dominiqueauthor=K.+Glennauthor=Y.+Heauthor=C.+Jansonauthor=K.+C.+Lukauthor=C.+Lukacsauthor=A.+Polonskaiaauthor=Q.+Qiaoauthor=A.+Railkarauthor=P.+Rossmanauthor=H.+Sunauthor=Q.+Xiangauthor=M.+Vilenchikauthor=P.+Wovkulichauthor=X.+Zhang&title=Pyrido%5B2%2C3-d%5Dpyrimidines%3A+discovery+and+preliminary+SAR+of+a+novel+series+of+DYRK1B+and+DYRK1A+inhibitors&doi=10.1016%2Fj.bmcl.2013.10.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.055%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDominique%26aufirst%3DR.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DRossman%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidines%253A%2520discovery%2520and%2520preliminary%2520SAR%2520of%2520a%2520novel%2520series%2520of%2520DYRK1B%2520and%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6610%26epage%3D6615%26doi%3D10.1016%2Fj.bmcl.2013.10.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bendjeddou, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villiers, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spath, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galons, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oumata, N.</span></span> <span> </span><span class="NLM_article-title">Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">696</span>– <span class="NLM_lpage">709</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2016.09.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=696-709&author=L.+Z.+Bendjeddouauthor=N.+Loaecauthor=B.+Villiersauthor=E.+Prinaauthor=G.+F.+Spathauthor=H.+Galonsauthor=L.+Meijerauthor=N.+Oumata&title=Exploration+of+the+imidazo%5B1%2C2-b%5Dpyridazine+scaffold+as+a+protein+kinase+inhibitor&doi=10.1016%2Fj.ejmech.2016.09.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.064%26sid%3Dliteratum%253Aachs%26aulast%3DBendjeddou%26aufirst%3DL.%2BZ.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DVilliers%26aufirst%3DB.%26aulast%3DPrina%26aufirst%3DE.%26aulast%3DSpath%26aufirst%3DG.%2BF.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DOumata%26aufirst%3DN.%26atitle%3DExploration%2520of%2520the%2520imidazo%255B1%252C2-b%255Dpyridazine%2520scaffold%2520as%2520a%2520protein%2520kinase%2520inhibitor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D125%26spage%3D696%26epage%3D709%26doi%3D10.1016%2Fj.ejmech.2016.09.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bénéteau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabanne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Guevel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravache, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bénédetti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logé, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of new pyridazino[4,5-b]indol-4-ones and pyridazin-3 (2H)-one analogs as DYRK1A inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5037</span>– <span class="NLM_lpage">5040</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2014.09.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5037-5040&author=A.+Bruelauthor=R.+B%C3%A9n%C3%A9teauauthor=M.+Chabanneauthor=O.+Lozachauthor=R.+Le+Guevelauthor=M.+Ravacheauthor=H.+B%C3%A9n%C3%A9dettiauthor=L.+Meijerauthor=C.+Log%C3%A9author=J.+M.+Robert&title=Synthesis+of+new+pyridazino%5B4%2C5-b%5Dindol-4-ones+and+pyridazin-3+%282H%29-one+analogs+as+DYRK1A+inhibitors&doi=10.1016%2Fj.bmcl.2014.09.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DBruel%26aufirst%3DA.%26aulast%3DB%25C3%25A9n%25C3%25A9teau%26aufirst%3DR.%26aulast%3DChabanne%26aufirst%3DM.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DLe%2BGuevel%26aufirst%3DR.%26aulast%3DRavache%26aufirst%3DM.%26aulast%3DB%25C3%25A9n%25C3%25A9detti%26aufirst%3DH.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DLog%25C3%25A9%26aufirst%3DC.%26aulast%3DRobert%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%2520new%2520pyridazino%255B4%252C5-b%255Dindol-4-ones%2520and%2520pyridazin-3%2520%25282H%2529-one%2520analogs%2520as%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5037%26epage%3D5040%26doi%3D10.1016%2Fj.bmcl.2014.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzorana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1007/s00018-011-0758-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1007%2Fs00018-011-0758-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21720886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1GksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2012&pages=449-460&author=S.+Sarnoauthor=M.+Mazzoranaauthor=R.+Traynorauthor=M.+Ruzzeneauthor=G.+Cozzaauthor=M.+A.+Paganoauthor=F.+Meggioauthor=G.+Zagottoauthor=R.+Battistuttaauthor=L.+A.+Pinna&title=Structural+features+underlying+the+selectivity+of+the+kinase+inhibitors+NBC+and+dNBC%3A+role+of+a+nitro+group+that+discriminates+between+CK2+and+DYRK1A&doi=10.1007%2Fs00018-011-0758-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A</span></div><div class="casAuthors">Sarno, Stefania; Mazzorana, Marco; Traynor, Ryan; Ruzzene, Maria; Cozza, Giorgio; Pagano, Mario A.; Meggio, Flavio; Zagotto, Giuseppe; Battistutta, Roberto; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">449-460</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">8-Hydroxy-4-methyl-9-nitrobenzo(g)chromen-2-one (NBC) has been found to be a fairly potent ATP site-directed inhibitor of protein kinase CK2 (Ki = 0.22 μM).  Here, we show that NBC also inhibits PIM kinases, esp. PIM1 and PIM3, the latter as potently as CK2.  Upon removal of the nitro group, to give 8-hydroxy-4-methyl-benzo(g)chromen-2-one (here referred to as "denitro NBC", dNBC), the inhibitory power toward CK2 is almost entirely lost (IC50 > 30 μM) whereas that toward PIM1 and PIM3 is maintained; in addn., dNBC is a potent inhibitor of a no. of other kinases that are weakly inhibited or unaffected by NBC, with special ref. to DYRK1A whose IC50 values with NBC and dNBC are 15 and 0.60 μM, resp.  Therefore, the observation that NBC, unlike dNBC, is a potent inducer of apoptosis is consistent with the notion that this effect is mediated by inhibition of endogenous CK2.  The structural features underlying NBC selectivity have been revealed by inspecting its 3D structure in complex with the catalytic subunit of Z. mays CK2.  The crucial role of the nitro group is exerted both through a direct electrostatic interaction with the side chain of Lys68 and, indirectly, by enhancing the acidic dissocn. const. of the adjacent hydroxyl group which interacts with a conserved water mol. in the deepest part of the cavity.  By contrast, the very same nitro group is deleterious for the binding to the active site of DYRK1A, as disclosed by mol. docking.  This provides the rationale for preferential inhibition of DYRK1A by dNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPdF4WWERhM7Vg90H21EOLACvtfcHk0lgFxX28Id0jPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1GksQ%253D%253D&md5=1105a1fc71bd6db43e10b23e073c1b37</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1007%2Fs00018-011-0758-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-011-0758-7%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DTraynor%26aufirst%3DR.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DStructural%2520features%2520underlying%2520the%2520selectivity%2520of%2520the%2520kinase%2520inhibitors%2520NBC%2520and%2520dNBC%253A%2520role%2520of%2520a%2520nitro%2520group%2520that%2520discriminates%2520between%2520CK2%2520and%2520DYRK1A%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2012%26volume%3D69%26spage%3D449%26epage%3D460%26doi%3D10.1007%2Fs00018-011-0758-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Folmer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasius, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morceau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabudravu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dicato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaspars, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of TNFα-induced activation of nuclear factor κB by kava (<i>Piper methysticum</i>) derivatives</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1206</span>– <span class="NLM_lpage">1218</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2005.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bcp.2005.12.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1206-1218&author=F.+Folmerauthor=R.+Blasiusauthor=F.+Morceauauthor=J.+Tabudravuauthor=M.+Dicatoauthor=M.+Jasparsauthor=M.+Diederich&title=Inhibition+of+TNF%CE%B1-induced+activation+of+nuclear+factor+%CE%BAB+by+kava+%28Piper+methysticum%29+derivatives&doi=10.1016%2Fj.bcp.2005.12.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2005.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2005.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DFolmer%26aufirst%3DF.%26aulast%3DBlasius%26aufirst%3DR.%26aulast%3DMorceau%26aufirst%3DF.%26aulast%3DTabudravu%26aufirst%3DJ.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DJaspars%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520TNF%25CE%25B1-induced%2520activation%2520of%2520nuclear%2520factor%2520%25CE%25BAB%2520by%2520kava%2520%2528Piper%2520methysticum%2529%2520derivatives%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D71%26spage%3D1206%26epage%3D1218%26doi%3D10.1016%2Fj.bcp.2005.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, H.</span>; <span class="NLM_string-name">Toyang, N. J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Agents Containing Cannabis Flavonoid Derivatives Targeting Kinases, Sirtuins and Oncogenic Agents for the Treatment of Cancers</span>. <span class="NLM_patent">WO 2016178713A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+Lowe&author=N.+J.+Toyang&title=Therapeutic+Agents+Containing+Cannabis+Flavonoid+Derivatives+Targeting+Kinases%2C+Sirtuins+and+Oncogenic+Agents+for+the+Treatment+of+Cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DH.%26atitle%3DTherapeutic%2520Agents%2520Containing%2520Cannabis%2520Flavonoid%2520Derivatives%2520Targeting%2520Kinases%252C%2520Sirtuins%2520and%2520Oncogenic%2520Agents%2520for%2520the%2520Treatment%2520of%2520Cancers%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralinaghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">Hydroxybenzothiophene ketones are efficient pre-mRNA splicing modulators due to dual inhibition of Dyrk1A and Clk1/4</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">963</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1021/ml500059y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500059y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=963-967&author=C.+Schmittauthor=P.+Miralinaghiauthor=M.+Marianoauthor=R.+W.+Hartmannauthor=M.+Engel&title=Hydroxybenzothiophene+ketones+are+efficient+pre-mRNA+splicing+modulators+due+to+dual+inhibition+of+Dyrk1A+and+Clk1%2F4&doi=10.1021%2Fml500059y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fml500059y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500059y%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DMiralinaghi%26aufirst%3DP.%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DHydroxybenzothiophene%2520ketones%2520are%2520efficient%2520pre-mRNA%2520splicing%2520modulators%2520due%2520to%2520dual%2520inhibition%2520of%2520Dyrk1A%2520and%2520Clk1%252F4%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D963%26epage%3D967%26doi%3D10.1021%2Fml500059y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span> <span> </span><span class="NLM_article-title">Focus on PAINS: false friends in the quest for selective anti-protozoal lead structures from Nature?</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1039/C5MD00481K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1039%2FC5MD00481K" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=214-223&author=J.+Glaserauthor=U.+Holzgrabe&title=Focus+on+PAINS%3A+false+friends+in+the+quest+for+selective+anti-protozoal+lead+structures+from+Nature%3F&doi=10.1039%2FC5MD00481K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1039%2FC5MD00481K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00481K%26sid%3Dliteratum%253Aachs%26aulast%3DGlaser%26aufirst%3DJ.%26aulast%3DHolzgrabe%26aufirst%3DU.%26atitle%3DFocus%2520on%2520PAINS%253A%2520false%2520friends%2520in%2520the%2520quest%2520for%2520selective%2520anti-protozoal%2520lead%2520structures%2520from%2520Nature%253F%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26spage%3D214%26epage%3D223%26doi%3D10.1039%2FC5MD00481K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altafaj, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estivill, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">474</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1998.9967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1006%2Fbbrc.1998.9967" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1999&pages=474-479&author=S.+Lederauthor=Y.+Weberauthor=X.+Altafajauthor=X.+Estivillauthor=H.+G.+Joostauthor=W.+Becker&title=Cloning+and+characterization+of+DYRK1B%2C+a+novel+member+of+the+DYRK+family+of+protein+kinases&doi=10.1006%2Fbbrc.1998.9967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1998.9967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1998.9967%26sid%3Dliteratum%253Aachs%26aulast%3DLeder%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DY.%26aulast%3DAltafaj%26aufirst%3DX.%26aulast%3DEstivill%26aufirst%3DX.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DCloning%2520and%2520characterization%2520of%2520DYRK1B%252C%2520a%2520novel%2520member%2520of%2520the%2520DYRK%2520family%2520of%2520protein%2520kinases%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1999%26volume%3D254%26spage%3D474%26epage%3D479%26doi%3D10.1006%2Fbbrc.1998.9967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53a','cit53b'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58a','cit58b'],'ref59':['cit59a','cit59b'],'ref60':['cit60a','cit60b'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65a','cit65b','cit65c'],'ref66':['cit66a','cit66b'],'ref67':['cit67a','cit67b'],'ref68':['cit68a','cit68b','cit68c'],'ref69':['cit69a','cit69b'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75a','cit75b'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78a','cit78b'],'ref79':['cit79'],'ref80':['cit80a','cit80b'],'ref81':['cit81a','cit81b'],'ref82':['cit82a','cit82b'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85a','cit85b'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90a','cit90b'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102a','cit102b','cit102c'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114a','cit114b','cit114c'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118a','cit118b'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129a','cit129b'],'ref130':['cit130'],'ref131':['cit131a','cit131b'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134a','cit134b'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Csaba Weber, Melinda Sipos, Attila Paczal, Balazs Balint, Vilibald Kun, Nicolas Foloppe, Pawel Dokurno, Andrew J. Massey, David Lee Walmsley, Roderick E. Hubbard, James Murray, Karen Benwell, Thomas Edmonds, Didier Demarles, Alain Bruno, Mike Burbridge, Francisco Cruzalegui, <span class="NLM_string-name hlFld-ContribAuthor">Andras Kotschy</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6745-6764. <a href="https://doi.org/10.1021/acs.jmedchem.1c00023" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00023%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDiscovery%252Bof%252BPotent%252Band%252BSelective%252BDYRK1A%252BInhibitors%26aulast%3DWeber%26aufirst%3DCsaba%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D12052021%26volume%3D64%26issue%3D10%26spage%3D6745%26epage%3D6764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kunal Kumar, Chalada Suebsuwong, Peng Wang, Adolfo Garcia-Ocana, Andrew F. Stewart, <span class="NLM_string-name hlFld-ContribAuthor">Robert J. DeVita</span>. </span><span class="cited-content_cbyCitation_article-title">DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 2901-2922. <a href="https://doi.org/10.1021/acs.jmedchem.0c02050" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02050%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDYRK1A%252BInhibitors%252Bas%252BPotential%252BTherapeutics%252Bfor%252B%2525CE%2525B2-Cell%252BRegeneration%252Bfor%252BDiabetes%26aulast%3DKumar%26aufirst%3DKunal%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D25112020%26date%3D08032021%26volume%3D64%26issue%3D6%26spage%3D2901%26epage%3D2922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Scott H. Henderson, Fiona Sorrell, James Bennett, Marcus T. Hanley, Sean Robinson, Iva Hopkins Navratilova, Jonathan M. Elkins, <span class="NLM_string-name hlFld-ContribAuthor">Simon E. Ward</span>. </span><span class="cited-content_cbyCitation_article-title">Mining Public Domain Data to Develop Selective DYRK1A Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (8)
                                     , 1620-1626. <a href="https://doi.org/10.1021/acsmedchemlett.0c00279" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00279%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMining%252BPublic%252BDomain%252BData%252Bto%252BDevelop%252BSelective%252BDYRK1A%252BInhibitors%26aulast%3DHenderson%26aufirst%3DScott%2BH.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22052020%26date%3D30062020%26date%3D07072020%26date%3D30062020%26volume%3D11%26issue%3D8%26spage%3D1620%26epage%3D1626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yahu A. Liu, Qihui Jin, Yefen Zou, Qiang Ding, Shanshan Yan, Zhicheng Wang, Xueshi Hao, Bao Nguyen, Xiaoyue Zhang, Jianfeng Pan, Tingting Mo, Kate Jacobsen, Thanh Lam, Tom Y.-H. Wu, H. Michael Petrassi, Badry Bursulaya, Michael DiDonato, W. Perry Gordon, Bo Liu, Janine Baaten, Robert Hill, Vân Nguyen-Tran, Minhua Qiu, You-Qing Zhang, Anwesh Kamireddy, Sheryll Espinola, Lisa Deaton, Sukwon Ha, George Harb, Yong Jia, Jing Li, Weijun Shen, Andrew M. Schumacher, Karyn Colman, Richard Glynne, Shifeng Pan, Peter McNamara, Bryan Laffitte, Shelly Meeusen, Valentina Molteni, <span class="NLM_string-name hlFld-ContribAuthor">Jon Loren</span>. </span><span class="cited-content_cbyCitation_article-title">Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 2958-2973. <a href="https://doi.org/10.1021/acs.jmedchem.9b01624" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01624%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BDYRK1A%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BType%252B1%252BDiabetes%25253A%252BDiscovery%252Bof%252B6-Azaindole%252BDerivative%252BGNF2133%26aulast%3DLiu%26aufirst%3DYahu%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30092019%26date%3D20022020%26volume%3D63%26issue%3D6%26spage%3D2958%26epage%3D2973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya‐Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Can‐Can  Zheng</span>, <span class="hlFld-ContribAuthor ">Yun‐Na  Huang</span>, <span class="hlFld-ContribAuthor ">Ming‐Liang  He</span>, <span class="hlFld-ContribAuthor ">Wen Wen  Xu</span>, <span class="hlFld-ContribAuthor ">Bin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">MedComm</span><span> <strong>2021,</strong> <em>2 </em><a href="https://doi.org/10.1002/mco2.55" title="DOI URL">https://doi.org/10.1002/mco2.55</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mco2.55&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmco2.55%26sid%3Dliteratum%253Aachs%26jtitle%3DMedComm%26atitle%3DMolecular%252Bmechanisms%252Bof%252Bchemo%2525E2%252580%252590%252Band%252Bradiotherapy%252Bresistance%252Band%252Bthe%252Bpotential%252Bimplications%252Bfor%252Bcancer%252Btreatment%26aulast%3DLiu%26aufirst%3DYa%25E2%2580%2590Ping%26date%3D2021%26date%3D2021%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noor A.  Hussein</span>, <span class="hlFld-ContribAuthor ">Saloni  Malla</span>, <span class="hlFld-ContribAuthor ">Mariah A.  Pasternak</span>, <span class="hlFld-ContribAuthor ">David  Terrero</span>, <span class="hlFld-ContribAuthor ">Noah G.  Brown</span>, <span class="hlFld-ContribAuthor ">Charles R.  Ashby</span>, <span class="hlFld-ContribAuthor ">Yehuda G.  Assaraf</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Amit K.  Tiwari</span>. </span><span class="cited-content_cbyCitation_article-title">The role of endolysosomal trafficking in anticancer drug resistance. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2021,</strong> <em>151 </em>, 100769. <a href="https://doi.org/10.1016/j.drup.2021.100769" title="DOI URL">https://doi.org/10.1016/j.drup.2021.100769</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2021.100769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2021.100769%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DThe%252Brole%252Bof%252Bendolysosomal%252Btrafficking%252Bin%252Banticancer%252Bdrug%252Bresistance%26aulast%3DHussein%26aufirst%3DNoor%2BA.%26date%3D2021%26volume%3D151%26spage%3D100769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mattias F.  Lindberg</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 6047. <a href="https://doi.org/10.3390/ijms22116047" title="DOI URL">https://doi.org/10.3390/ijms22116047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22116047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22116047%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDual-Specificity%25252C%252BTyrosine%252BPhosphorylation-Regulated%252BKinases%252B%252528DYRKs%252529%252Band%252Bcdc2-Like%252BKinases%252B%252528CLKs%252529%252Bin%252BHuman%252BDisease%25252C%252Ban%252BOverview%26aulast%3DLindberg%26aufirst%3DMattias%2BF.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D6047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shulun  Chen</span>, <span class="hlFld-ContribAuthor ">Jing  Tan</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">The ups, downs and new trends of IDO1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104815. <a href="https://doi.org/10.1016/j.bioorg.2021.104815" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104815</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104815%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThe%252Bups%25252C%252Bdowns%252Band%252Bnew%252Btrends%252Bof%252BIDO1%252Binhibitors%26aulast%3DChen%26aufirst%3DShulun%26date%3D2021%26volume%3D110%26spage%3D104815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo L.G.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Adriano D.  Andricopulo</span>. </span><span class="cited-content_cbyCitation_article-title">Structure‐Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-54. <a href="https://doi.org/10.1002/0471266949.bmc141.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc141.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc141.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc141.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DStructure%2525E2%252580%252590Based%252BDrug%252BDesign%26aulast%3DFerreira%26aufirst%3DLeonardo%2BL.G.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D54%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dazhong  Xu</span>, <span class="hlFld-ContribAuthor ">Cen  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of the SIAH2-HIF-1 Axis by Protein Kinases and Its Implication in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fcell.2021.646687" title="DOI URL">https://doi.org/10.3389/fcell.2021.646687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2021.646687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2021.646687%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DRegulation%252Bof%252Bthe%252BSIAH2-HIF-1%252BAxis%252Bby%252BProtein%252BKinases%252Band%252BIts%252BImplication%252Bin%252BCancer%252BTherapy%26aulast%3DXu%26aufirst%3DDazhong%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul S.  Bhansali</span>, <span class="hlFld-ContribAuthor ">Malini  Rammohan</span>, <span class="hlFld-ContribAuthor ">Paul  Lee</span>, <span class="hlFld-ContribAuthor ">Anouchka P.  Laurent</span>, <span class="hlFld-ContribAuthor ">Qiang  Wen</span>, <span class="hlFld-ContribAuthor ">Praveen  Suraneni</span>, <span class="hlFld-ContribAuthor ">Bon Ham  Yip</span>, <span class="hlFld-ContribAuthor ">Yi-Chien  Tsai</span>, <span class="hlFld-ContribAuthor ">Silvia  Jenni</span>, <span class="hlFld-ContribAuthor ">Beat  Bornhauser</span>, <span class="hlFld-ContribAuthor ">Aurélie  Siret</span>, <span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">Alexandra  Pacheco-Benichou</span>, <span class="hlFld-ContribAuthor ">Ethan  Harris</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Thompson</span>, <span class="hlFld-ContribAuthor ">Young Ah  Goo</span>, <span class="hlFld-ContribAuthor ">Nobuko  Hijiya</span>, <span class="hlFld-ContribAuthor ">Maria  Vilenchik</span>, <span class="hlFld-ContribAuthor ">Shai  Izraeli</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Bourquin</span>, <span class="hlFld-ContribAuthor ">Sébastien  Malinge</span>, <span class="hlFld-ContribAuthor ">John D.  Crispino</span>. </span><span class="cited-content_cbyCitation_article-title">DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Investigation</span><span> <strong>2021,</strong> <em>131 </em>
                                    (1)
                                     <a href="https://doi.org/10.1172/JCI135937" title="DOI URL">https://doi.org/10.1172/JCI135937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/JCI135937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2FJCI135937%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Investigation%26atitle%3DDYRK1A%252Bregulates%252BB%252Bcell%252Bacute%252Blymphoblastic%252Bleukemia%252Bthrough%252Bphosphorylation%252Bof%252BFOXO1%252Band%252BSTAT3%26aulast%3DBhansali%26aufirst%3DRahul%2BS.%26date%3D2021%26date%3D2021%26volume%3D131%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Pacheco-Benichou</span>, <span class="hlFld-ContribAuthor ">Eugénie  Ivendengani</span>, <span class="hlFld-ContribAuthor ">Ioannis K.  Kostakis</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>, <span class="hlFld-ContribAuthor ">Corinne  Fruit</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed C–H Arylation of Fused-Pyrimidinone Derivatives Using Diaryliodonium Salts. </span><span class="cited-content_cbyCitation_journal-name">Catalysts</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 28. <a href="https://doi.org/10.3390/catal11010028" title="DOI URL">https://doi.org/10.3390/catal11010028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/catal11010028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcatal11010028%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysts%26atitle%3DCopper-Catalyzed%252BC%2525E2%252580%252593H%252BArylation%252Bof%252BFused-Pyrimidinone%252BDerivatives%252BUsing%252BDiaryliodonium%252BSalts%26aulast%3DPacheco-Benichou%26aufirst%3DAlexandra%26date%3D2021%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolaos  Kokkorakis</span>, <span class="hlFld-ContribAuthor ">Maria  Gaitanou</span>. </span><span class="cited-content_cbyCitation_article-title">Minibrain-related kinase/dual-specificity tyrosine-regulated kinase 1B implication in stem/cancer stem cells biology. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Stem Cells</span><span> <strong>2020,</strong> <em>12 </em>
                                    (12)
                                     , 1553-1575. <a href="https://doi.org/10.4252/wjsc.v12.i12.1553" title="DOI URL">https://doi.org/10.4252/wjsc.v12.i12.1553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4252/wjsc.v12.i12.1553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4252%2Fwjsc.v12.i12.1553%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Stem%2520Cells%26atitle%3DMinibrain-related%252Bkinase%25252Fdual-specificity%252Btyrosine-regulated%252Bkinase%252B1B%252Bimplication%252Bin%252Bstem%25252Fcancer%252Bstem%252Bcells%252Bbiology%26aulast%3DKokkorakis%26aufirst%3DNikolaos%26date%3D2020%26volume%3D12%26issue%3D12%26spage%3D1553%26epage%3D1575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajkumar  Veligeti</span>, <span class="hlFld-ContribAuthor ">Rajesh Bagepalli  Madhu</span>, <span class="hlFld-ContribAuthor ">Jayashree  Anireddy</span>, <span class="hlFld-ContribAuthor ">Visweswara Rao  Pasupuleti</span>, <span class="hlFld-ContribAuthor ">Vijaya Kumar Reddy  Avula</span>, <span class="hlFld-ContribAuthor ">Krishna S.  Ethiraj</span>, <span class="hlFld-ContribAuthor ">Srinivas  Uppalanchi</span>, <span class="hlFld-ContribAuthor ">Sivaprasad  Kasturi</span>, <span class="hlFld-ContribAuthor ">Yogeeswari  Perumal</span>, <span class="hlFld-ContribAuthor ">Hasitha Shilpa  Anantaraju</span>, <span class="hlFld-ContribAuthor ">Naveen  Polkam</span>, <span class="hlFld-ContribAuthor ">Mallilkarjuna Reddy  Guda</span>, <span class="hlFld-ContribAuthor ">Swetha  Vallela</span>, <span class="hlFld-ContribAuthor ">Grigory Vasilievich  Zyryanov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-77590-1" title="DOI URL">https://doi.org/10.1038/s41598-020-77590-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-77590-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-77590-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DSynthesis%252Bof%252Bnovel%252Bcytotoxic%252Btetracyclic%252Bacridone%252Bderivatives%252Band%252Bstudy%252Bof%252Btheir%252Bmolecular%252Bdocking%25252C%252BADMET%25252C%252BQSAR%25252C%252Bbioactivity%252Band%252Bprotein%252Bbinding%252Bproperties%26aulast%3DVeligeti%26aufirst%3DRajkumar%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Wurzlbauer</span>, <span class="hlFld-ContribAuthor ">Katharina  Rüben</span>, <span class="hlFld-ContribAuthor ">Ece  Gürdal</span>, <span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>, <span class="hlFld-ContribAuthor ">Walter  Becker</span>, <span class="hlFld-ContribAuthor ">Franz  Bracher</span>. </span><span class="cited-content_cbyCitation_article-title">How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition—The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (24)
                                     , 5962. <a href="https://doi.org/10.3390/molecules25245962" title="DOI URL">https://doi.org/10.3390/molecules25245962</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25245962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25245962%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DHow%252Bto%252BSeparate%252BKinase%252BInhibition%252Bfrom%252BUndesired%252BMonoamine%252BOxidase%252BA%252BInhibition%2525E2%252580%252594The%252BDevelopment%252Bof%252Bthe%252BDYRK1A%252BInhibitor%252BAnnH75%252Bfrom%252Bthe%252BAlkaloid%252BHarmine%26aulast%3DWurzlbauer%26aufirst%3DAnne%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D24%26spage%3D5962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hye Ree  Yoon</span>, <span class="hlFld-ContribAuthor ">Anand  Balupuri</span>, <span class="hlFld-ContribAuthor ">Kwang-Eun  Choi</span>, <span class="hlFld-ContribAuthor ">Nam Sook  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors of DYRK1A Identified by Computational and Experimental Approaches. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (18)
                                     , 6826. <a href="https://doi.org/10.3390/ijms21186826" title="DOI URL">https://doi.org/10.3390/ijms21186826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21186826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21186826%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSmall%252BMolecule%252BInhibitors%252Bof%252BDYRK1A%252BIdentified%252Bby%252BComputational%252Band%252BExperimental%252BApproaches%26aulast%3DYoon%26aufirst%3DHye%2BRee%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D18%26spage%3D6826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahu A.  Liu</span>, <span class="hlFld-ContribAuthor ">Qihui  Jin</span>, <span class="hlFld-ContribAuthor ">Qiang  Ding</span>, <span class="hlFld-ContribAuthor ">Xueshi  Hao</span>, <span class="hlFld-ContribAuthor ">Tingting  Mo</span>, <span class="hlFld-ContribAuthor ">Shanshan  Yan</span>, <span class="hlFld-ContribAuthor ">Yefen  Zou</span>, <span class="hlFld-ContribAuthor ">Zhihong  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaoyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenqi  Gao</span>, <span class="hlFld-ContribAuthor ">Tom Y.‐H.  Wu</span>, <span class="hlFld-ContribAuthor ">Chun  Li</span>, <span class="hlFld-ContribAuthor ">Badry  Bursalaya</span>, <span class="hlFld-ContribAuthor ">Michael  Di Donato</span>, <span class="hlFld-ContribAuthor ">You‐Qing  Zhang</span>, <span class="hlFld-ContribAuthor ">Lisa  Deaton</span>, <span class="hlFld-ContribAuthor ">Weijun  Shen</span>, <span class="hlFld-ContribAuthor ">Brandon  Taylor</span>, <span class="hlFld-ContribAuthor ">Anwesh  Kamireddy</span>, <span class="hlFld-ContribAuthor ">George  Harb</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Jia</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Schumacher</span>, <span class="hlFld-ContribAuthor ">Bryan  Laffitte</span>, <span class="hlFld-ContribAuthor ">Richard  Glynne</span>, <span class="hlFld-ContribAuthor ">Shifeng  Pan</span>, <span class="hlFld-ContribAuthor ">Peter  McNamara</span>, <span class="hlFld-ContribAuthor ">Valentina  Molteni</span>, <span class="hlFld-ContribAuthor ">Jon  Loren</span>. </span><span class="cited-content_cbyCitation_article-title">A Dual Inhibitor of DYRK1A and GSK3β for β‐Cell Proliferation: Aminopyrazine Derivative GNF4877. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (16)
                                     , 1562-1570. <a href="https://doi.org/10.1002/cmdc.202000183" title="DOI URL">https://doi.org/10.1002/cmdc.202000183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000183%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BDual%252BInhibitor%252Bof%252BDYRK1A%252Band%252BGSK3%2525CE%2525B2%252Bfor%252B%2525CE%2525B2%2525E2%252580%252590Cell%252BProliferation%25253A%252BAminopyrazine%252BDerivative%252BGNF4877%26aulast%3DLiu%26aufirst%3DYahu%2BA.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D16%26spage%3D1562%26epage%3D1570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacopo  Boni</span>, <span class="hlFld-ContribAuthor ">Carlota  Rubio-Perez</span>, <span class="hlFld-ContribAuthor ">Nuria  López-Bigas</span>, <span class="hlFld-ContribAuthor ">Cristina  Fillat</span>, <span class="hlFld-ContribAuthor ">Susana  de la Luna</span>. </span><span class="cited-content_cbyCitation_article-title">The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 2106. <a href="https://doi.org/10.3390/cancers12082106" title="DOI URL">https://doi.org/10.3390/cancers12082106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12082106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12082106%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BDYRK%252BFamily%252Bof%252BKinases%252Bin%252BCancer%25253A%252BMolecular%252BFunctions%252Band%252BTherapeutic%252BOpportunities%26aulast%3DBoni%26aufirst%3DJacopo%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D2106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yvonnick  Loidreau</span>, <span class="hlFld-ContribAuthor ">Carole  Dubouilh-Benard</span>, <span class="hlFld-ContribAuthor ">Marie-Renée  Nourrisson</span>, <span class="hlFld-ContribAuthor ">Nadège  Loaëc</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>, <span class="hlFld-ContribAuthor ">Pascal  Marchand</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Kinase Inhibition Properties of 9H-pyrimido[5,4-b]- and [4,5-b]indol-4-amine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (5)
                                     , 89. <a href="https://doi.org/10.3390/ph13050089" title="DOI URL">https://doi.org/10.3390/ph13050089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13050089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13050089%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DExploring%252BKinase%252BInhibition%252BProperties%252Bof%252B9H-pyrimido%25255B5%25252C4-b%25255D-%252Band%252B%25255B4%25252C5-b%25255Dindol-4-amine%252BDerivatives%26aulast%3DLoidreau%26aufirst%3DYvonnick%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D5%26spage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Allegretti</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Horton</span>, <span class="hlFld-ContribAuthor ">Yassan  Abdolazimi</span>, <span class="hlFld-ContribAuthor ">Hannah P.  Moeller</span>, <span class="hlFld-ContribAuthor ">Benjamin  Yeh</span>, <span class="hlFld-ContribAuthor ">Matthew  Caffet</span>, <span class="hlFld-ContribAuthor ">Guillermina  Michel</span>, <span class="hlFld-ContribAuthor ">Mark  Smith</span>, <span class="hlFld-ContribAuthor ">Justin P.  Annes</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of highly potent DYRK1A-dependent inducers of human β-Cell replication via Multi-Dimensional compound optimization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (1)
                                     , 115193. <a href="https://doi.org/10.1016/j.bmc.2019.115193" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115193%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DGeneration%252Bof%252Bhighly%252Bpotent%252BDYRK1A-dependent%252Binducers%252Bof%252Bhuman%252B%2525CE%2525B2-Cell%252Breplication%252Bvia%252BMulti-Dimensional%252Bcompound%252Boptimization%26aulast%3DAllegretti%26aufirst%3DPaul%2BA.%26date%3D2020%26volume%3D28%26issue%3D1%26spage%3D115193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Zhao</span>, <span class="hlFld-ContribAuthor ">Dun  Wang</span>, <span class="hlFld-ContribAuthor ">Zexuan  Gao</span>, <span class="hlFld-ContribAuthor ">Hongfeng  Kan</span>, <span class="hlFld-ContribAuthor ">Feng  Qiu</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Licocoumarone induces BxPC-3 pancreatic adenocarcinoma cell death by inhibiting DYRK1A. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2020,</strong> <em>316 </em>, 108913. <a href="https://doi.org/10.1016/j.cbi.2019.108913" title="DOI URL">https://doi.org/10.1016/j.cbi.2019.108913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2019.108913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2019.108913%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DLicocoumarone%252Binduces%252BBxPC-3%252Bpancreatic%252Badenocarcinoma%252Bcell%252Bdeath%252Bby%252Binhibiting%252BDYRK1A%26aulast%3DZhao%26aufirst%3DChao%26date%3D2020%26volume%3D316%26spage%3D108913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">Florence  Couly</span>, <span class="hlFld-ContribAuthor ">Rahul  Bhansali</span>, <span class="hlFld-ContribAuthor ">Malini  Rammohan</span>, <span class="hlFld-ContribAuthor ">Mattias F.  Lindberg</span>, <span class="hlFld-ContribAuthor ">John D.  Crispino</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (4)
                                     , 185. <a href="https://doi.org/10.3390/ph12040185" title="DOI URL">https://doi.org/10.3390/ph12040185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12040185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12040185%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DBiological%252BCharacterization%252Bof%252B8-Cyclopropyl-2-%252528pyridin-3-yl%252529thiazolo%25255B5%25252C4-f%25255Dquinazolin-9%2525288H%252529-one%25252C%252Ba%252BPromising%252BInhibitor%252Bof%252BDYRK1A%26aulast%3DFruit%26aufirst%3DCorinne%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D4%26spage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang‐ling  Li</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, <span class="hlFld-ContribAuthor ">Xiu  Hu</span>, <span class="hlFld-ContribAuthor ">Lin‐wen  Wu</span>, <span class="hlFld-ContribAuthor ">Dong‐mei  Zhou</span>, <span class="hlFld-ContribAuthor ">Ming‐jun  Rao</span>, <span class="hlFld-ContribAuthor ">Neng‐ming  Lin</span>, <span class="hlFld-ContribAuthor ">Chong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">DYRK1A inhibition suppresses STAT3/EGFR/Met signalling and sensitizes EGFR wild‐type NSCLC cells to AZD9291. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular and Molecular Medicine</span><span> <strong>2019,</strong> <em>23 </em>
                                    (11)
                                     , 7427-7437. <a href="https://doi.org/10.1111/jcmm.14609" title="DOI URL">https://doi.org/10.1111/jcmm.14609</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jcmm.14609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjcmm.14609%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520and%2520Molecular%2520Medicine%26atitle%3DDYRK1A%252Binhibition%252Bsuppresses%252BSTAT3%25252FEGFR%25252FMet%252Bsignalling%252Band%252Bsensitizes%252BEGFR%252Bwild%2525E2%252580%252590type%252BNSCLC%252Bcells%252Bto%252BAZD9291%26aulast%3DLi%26aufirst%3DYang%25E2%2580%2590ling%26date%3D2019%26date%3D2019%26volume%3D23%26issue%3D11%26spage%3D7427%26epage%3D7437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anaïs  Barré</span>, <span class="hlFld-ContribAuthor ">Rabah  Azzouz</span>, <span class="hlFld-ContribAuthor ">Vincent  Gembus</span>, <span class="hlFld-ContribAuthor ">Cyril  Papamicaël</span>, <span class="hlFld-ContribAuthor ">Vincent  Levacher</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Vitro Biological Activities of a Bio-Oxidizable Prodrug to Deliver Both ChEs and DYRK1A Inhibitors for AD Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (7)
                                     , 1264. <a href="https://doi.org/10.3390/molecules24071264" title="DOI URL">https://doi.org/10.3390/molecules24071264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24071264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24071264%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BVitro%252BBiological%252BActivities%252Bof%252Ba%252BBio-Oxidizable%252BProdrug%252Bto%252BDeliver%252BBoth%252BChEs%252Band%252BDYRK1A%252BInhibitors%252Bfor%252BAD%252BTherapy%26aulast%3DBarr%25C3%25A9%26aufirst%3DAna%25C3%25AFs%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D7%26spage%3D1264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helmi  Tazarki</span>, <span class="hlFld-ContribAuthor ">Wael  Zeinyeh</span>, <span class="hlFld-ContribAuthor ">Yannick J.  Esvan</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Deep  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Martin  Schröder</span>, <span class="hlFld-ContribAuthor ">Andreas C.  Joerger</span>, <span class="hlFld-ContribAuthor ">Jameleddine  Khiari</span>, <span class="hlFld-ContribAuthor ">Béatrice  Josselin</span>, <span class="hlFld-ContribAuthor ">Blandine  Baratte</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bach</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ruchaud</span>, <span class="hlFld-ContribAuthor ">Fabrice  Anizon</span>, <span class="hlFld-ContribAuthor ">Francis  Giraud</span>, <span class="hlFld-ContribAuthor ">Pascale  Moreau</span>. </span><span class="cited-content_cbyCitation_article-title">New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 304-317. <a href="https://doi.org/10.1016/j.ejmech.2019.01.052" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.052%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bpyrido%25255B3%25252C4-g%25255Dquinazoline%252Bderivatives%252Bas%252BCLK1%252Band%252BDYRK1A%252Binhibitors%25253A%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bbinding%252Bmode%252Banalysis%26aulast%3DTazarki%26aufirst%3DHelmi%26date%3D2019%26volume%3D166%26spage%3D304%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Llorach-Pares</span>, <span class="hlFld-ContribAuthor ">Alfons  Nonell-Canals</span>, <span class="hlFld-ContribAuthor ">Conxita  Avila</span>, <span class="hlFld-ContribAuthor ">Melchor  Sanchez-Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer’s Disease: A Computational Study. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2018,</strong> <em>16 </em>
                                    (10)
                                     , 386. <a href="https://doi.org/10.3390/md16100386" title="DOI URL">https://doi.org/10.3390/md16100386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md16100386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd16100386%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DKororamides%25252C%252BConvolutamines%25252C%252Band%252BIndole%252BDerivatives%252Bas%252BPossible%252BTau%252Band%252BDual-Specificity%252BKinase%252BInhibitors%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BA%252BComputational%252BStudy%26aulast%3DLlorach-Pares%26aufirst%3DLaura%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D10%26spage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florence  Couly</span>, <span class="hlFld-ContribAuthor ">Marine  Harari</span>, <span class="hlFld-ContribAuthor ">Carole  Dubouilh-Benard</span>, <span class="hlFld-ContribAuthor ">Laetitia  Bailly</span>, <span class="hlFld-ContribAuthor ">Emilie  Petit</span>, <span class="hlFld-ContribAuthor ">Julien  Diharce</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Kinase Inhibitors via Metal-Catalyzed C–H Arylation of 8-Alkyl-thiazolo[5,4-f]-quinazolin-9-ones Designed by Fragment-Growing Studies. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (9)
                                     , 2181. <a href="https://doi.org/10.3390/molecules23092181" title="DOI URL">https://doi.org/10.3390/molecules23092181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23092181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23092181%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDevelopment%252Bof%252BKinase%252BInhibitors%252Bvia%252BMetal-Catalyzed%252BC%2525E2%252580%252593H%252BArylation%252Bof%252B8-Alkyl-thiazolo%25255B5%25252C4-f%25255D-quinazolin-9-ones%252BDesigned%252Bby%252BFragment-Growing%252BStudies%26aulast%3DCouly%26aufirst%3DFlorence%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D9%26spage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of DYRK1A inhibitor <b>1</b> that has been co-crystallized with DYRK1A kinase.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of EGCG (<b>2</b>) as a DYRK1A inhibitor that contains bis-catechol PAINS motifs (shown in red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General structures of harmine (<b>3</b>) and its analogues (<b>4</b>–<b>8</b>) as potent DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Natural alkaloid <b>9</b> as a potent DYRK1A inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of leucettamine B (<b>10</b>) and leucettine L41 (<b>11</b>) as potent DYRK1A inhibitors, containing a Michael acceptor that is recognized as a PAINS motif.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Meridianins <b>12a</b>–<b>14b</b> and their structural analogue variolin B (<b>15</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structurally modified meridianins <b>16</b> and <b>17</b> and their aza-analogue meriolin (<b>18</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of the DYRK1A inhibitors <b>19</b> and <b>20</b> with an indolocarbazole ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative benzothiazole analogues as potent DYRK1A inhibitors, with recognized PAINS shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of selective DYRK1A inhibitors that contain recognizable rhodanine PAINS motifs (red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures of representative indole and carbazole derivatives as DYRK1A inhibitors, with PAINS shown in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Indazole derivatives <b>36</b> and <b>37</b> as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. General structures of benzimidazoles (<b>38</b>, <b>39</b>, and <b>41</b>) and imidazopyridine (<b>40</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Imidazo[4.5-<i>b</i>]pyridine analogue <b>42</b> as a dual DYRK1A/CLK1 kinase inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. DYRK1A inhibitors based on the 6- and 7- azaindole scaffold and a prominent PAINS motif (catechol, shown in red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Purine derivatives <b>48</b>–<b>53</b> as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Thiazolo[5,4-<i>f</i>]quinazoline derivatives as the most potent inhibitors of DYRK1A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Naphthyridine derivatives <b>61</b> and <b>62</b> as potent inhibitors of DYRK1A and DYRK1B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of β-carboline derivatives <b>63</b> and <b>64</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Examples of quinoline derivatives <b>65</b>–<b>68</b> as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Quinazoline derivatives <b>69</b>–<b>72</b> as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Representative pyrido[3,2-<i>d</i>]pyrimidine (<b>73</b>), pyrrolo[2,3-<i>d</i>]pyrimidine (<b>74</b>), and pyrazolo[3,4-<i>d</i>]pyrimidine (<b>75</b>) as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Pyrido[2,3-<i>d</i>]pyrimidine derivative <b>76</b> as a potent inhibitor of DYRK1A and DYRK1B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Pyridazine derivatives <b>77</b> and <b>78</b> as DYRK1A inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/medium/jm-2018-00185v_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Polyphenols <b>79</b>–<b>83</b> as DYRK1A inhibitors, with recognized PAINS motifs highlighted in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00185/20181119/images/large/jm-2018-00185v_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00185&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 142 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whyte, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudarsanam, S.</span></span> <span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span>,  <span class="NLM_fpage">1912</span>– <span class="NLM_lpage">1934</span>, <span class="refDoi"> DOI: 10.1126/science.1075762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome&doi=10.1126%2Fscience.1075762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0ljfCWYpZ2UOCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934%26doi%3D10.1126%2Fscience.1075762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanks, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1096/fasebj.9.8.7768349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1096%2Ffasebj.9.8.7768349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=7768349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1ajsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=576-596&author=S.+K.+Hanksauthor=T.+Hunter&title=Protein+kinases+6.+The+eukaryotic+protein+kinase+superfamily%3A+kinase+%28catalytic%29+domain+structure+and+classification&doi=10.1096%2Ffasebj.9.8.7768349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases. 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</span></div><div class="casAuthors">Hanks, Steven K.; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">576-96</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 48 refs.  The eukaryotic protein kinases make up a large superfamily of homologous proteins.  They are related by virtue of their kinase domains (also known as catalytic domains), which consist of ∼250-300 amino acid residues.  The kinase domains that define this group of enzymes contain 12 conserved subdomains that fold into a common catalytic core structure, as revealed by the 3-dimensional structures of several protein-serine kinases.  There are 2 main subdivisions within the superfamily: the protein-serine/threonine kinases and the protein-tyrosine kinases.  A classification scheme can be founded on a kinase domain phylogeny, which reveals families of enzymes that have related substrate specificities and modes of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxv30nsEyVU7Vg90H21EOLACvtfcHk0lgoCNImtck0Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1ajsbc%253D&md5=869a3926ba04f288947f80616bdcfb98</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.9.8.7768349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.9.8.7768349%26sid%3Dliteratum%253Aachs%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DProtein%2520kinases%25206.%2520The%2520eukaryotic%2520protein%2520kinase%2520superfamily%253A%2520kinase%2520%2528catalytic%2529%2520domain%2520structure%2520and%2520classification%26jtitle%3DFASEB%2520J.%26date%3D1995%26volume%3D9%26spage%3D576%26epage%3D596%26doi%3D10.1096%2Ffasebj.9.8.7768349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soppa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">DYRK protein kinases</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">R488</span>– <span class="NLM_lpage">R489</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2015.02.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.cub.2015.02.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26079075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1SgurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=R488-R489&author=U.+Soppaauthor=W.+Becker&title=DYRK+protein+kinases&doi=10.1016%2Fj.cub.2015.02.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK protein kinases</span></div><div class="casAuthors">Soppa, Ulf; Becker, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">R488-R489</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjVfjs-P7fGbVg90H21EOLACvtfcHk0lgoCNImtck0Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1SgurfM&md5=671c9aa42a244c7cdf1b640bde8829e6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2015.02.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2015.02.067%26sid%3Dliteratum%253Aachs%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DDYRK%2520protein%2520kinases%26jtitle%3DCurr.%2520Biol.%26date%3D2015%26volume%3D25%26spage%3DR488%26epage%3DR489%26doi%3D10.1016%2Fj.cub.2015.02.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aranda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laguna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de La Luna, S.</span></span> <span> </span><span class="NLM_article-title">DYRK family of protein kinases: evolutionary relationships, biochemical properties and functional roles</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1096/fj.10-165837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1096%2Ffj.10-165837" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=449-462&author=S.+Arandaauthor=A.+Lagunaauthor=S.+de+La+Luna&title=DYRK+family+of+protein+kinases%3A+evolutionary+relationships%2C+biochemical+properties+and+functional+roles&doi=10.1096%2Ffj.10-165837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1096%2Ffj.10-165837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.10-165837%26sid%3Dliteratum%253Aachs%26aulast%3DAranda%26aufirst%3DS.%26aulast%3DLaguna%26aufirst%3DA.%26aulast%3Dde%2BLa%2BLuna%26aufirst%3DS.%26atitle%3DDYRK%2520family%2520of%2520protein%2520kinases%253A%2520evolutionary%2520relationships%252C%2520biochemical%2520properties%2520and%2520functional%2520roles%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D449%26epage%3D462%26doi%3D10.1096%2Ffj.10-165837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span> <span> </span><span class="NLM_article-title">Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity</span>. <i>Prog. Nucleic Acid Res. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/S0079-6603(08)60503-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2FS0079-6603%2808%2960503-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1998&pages=1-17&author=W.+Beckerauthor=H.+G.+Joost&title=Structural+and+functional+characteristics+of+Dyrk%2C+a+novel+subfamily+of+protein+kinases+with+dual+specificity&doi=10.1016%2FS0079-6603%2808%2960503-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0079-6603%2808%2960503-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6603%252808%252960503-6%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26atitle%3DStructural%2520and%2520functional%2520characteristics%2520of%2520Dyrk%252C%2520a%2520novel%2520subfamily%2520of%2520protein%2520kinases%2520with%2520dual%2520specificity%26jtitle%3DProg.%2520Nucleic%2520Acid%2520Res.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D62%26spage%3D1%26epage%3D17%26doi%3D10.1016%2FS0079-6603%2808%2960503-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Himpel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panzer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eirmbter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czajkowska, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packman, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kentrup, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">505</span>, <span class="refDoi"> DOI: 10.1042/bj3590497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1042%2Fbj3590497" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2001&pages=497-505&author=S.+Himpelauthor=P.+Panzerauthor=K.+Eirmbterauthor=H.+Czajkowskaauthor=M.+Sayedauthor=L.+C.+Packmanauthor=T.+Blundellauthor=H.+Kentrupauthor=J.+Grotzingerauthor=H.+G.+Joostauthor=W.+Becker&title=Identification+of+the+autophosphorylation+sites+and+characterization+of+their+effects+in+the+protein+kinase+DYRK1A&doi=10.1042%2Fbj3590497"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2Fbj3590497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3590497%26sid%3Dliteratum%253Aachs%26aulast%3DHimpel%26aufirst%3DS.%26aulast%3DPanzer%26aufirst%3DP.%26aulast%3DEirmbter%26aufirst%3DK.%26aulast%3DCzajkowska%26aufirst%3DH.%26aulast%3DSayed%26aufirst%3DM.%26aulast%3DPackman%26aufirst%3DL.%2BC.%26aulast%3DBlundell%26aufirst%3DT.%26aulast%3DKentrup%26aufirst%3DH.%26aulast%3DGrotzinger%26aufirst%3DJ.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520the%2520autophosphorylation%2520sites%2520and%2520characterization%2520of%2520their%2520effects%2520in%2520the%2520protein%2520kinase%2520DYRK1A%26jtitle%3DBiochem.%2520J.%26date%3D2001%26volume%3D359%26spage%3D497%26epage%3D505%26doi%3D10.1042%2Fbj3590497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lochhead, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibbet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrice, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleghon, V.</span></span> <span> </span><span class="NLM_article-title">Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2005.03.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.cell.2005.03.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=15960979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1GksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2005&pages=925-936&author=P.+Lochheadauthor=G.+Sibbetauthor=N.+Morriceauthor=V.+Cleghon&title=Activation-loop+autophosphorylation+is+mediated+by+a+novel+transitional+intermediate+form+of+DYRKs&doi=10.1016%2Fj.cell.2005.03.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs</span></div><div class="casAuthors">Lochhead, Pamela A.; Sibbet, Gary; Morrice, Nick; Cleghon, Vaughn</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">925-936</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autophosphorylation of a crit. residue in the activation loop of several protein kinases is an essential maturation event required for full enzyme activity.  However, the mol. mechanism by which this happens is unknown.  We addressed this question for two dual-specificity tyrosine-phosphorylation-regulated protein kinases (DYRKs), as they autophosphorylate their activation loop on an essential tyrosine but phosphorylate their substrates on serine and threonine.  Here we demonstrate that autophosphorylation of the crit. activation-loop tyrosine is intramol. and mediated by the nascent kinase passing through a transitory intermediate form.  This DYRK intermediate differs in residue and substrate specificity, as well as sensitivity to small-mol. inhibitors, compared with its mature counterpart.  The intermediate's characteristics are lost upon completion of translation, making the crit. tyrosine autophosphorylation a one-off inceptive event.  This mechanism is likely to be shared with other kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtQ1sZC9Uhg7Vg90H21EOLACvtfcHk0lhFG30N8fnqnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1GksL8%253D&md5=ff5e78400ba9b038cef11b2a5c9b1801</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2005.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2005.03.034%26sid%3Dliteratum%253Aachs%26aulast%3DLochhead%26aufirst%3DP.%26aulast%3DSibbet%26aufirst%3DG.%26aulast%3DMorrice%26aufirst%3DN.%26aulast%3DCleghon%26aufirst%3DV.%26atitle%3DActivation-loop%2520autophosphorylation%2520is%2520mediated%2520by%2520a%2520novel%2520transitional%2520intermediate%2520form%2520of%2520DYRKs%26jtitle%3DCell%26date%3D2005%26volume%3D121%26spage%3D925%26epage%3D936%26doi%3D10.1016%2Fj.cell.2005.03.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guedj, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes Pereira, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barallobre, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souchet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebrie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herault, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span> <span> </span><span class="NLM_article-title">DYRK1A: A master regulatory protein controlling brain growth</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2012.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.nbd.2012.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=22293606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ontb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=190-203&author=F.+Guedjauthor=P.+Lopes+Pereiraauthor=S.+Najasauthor=M.+J.+Barallobreauthor=C.+Chabertauthor=B.+Souchetauthor=C.+Sebrieauthor=C.+Verneyauthor=Y.+Heraultauthor=M.+Arbonesauthor=J.+M.+Delabar&title=DYRK1A%3A+A+master+regulatory+protein+controlling+brain+growth&doi=10.1016%2Fj.nbd.2012.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A: A master regulatory protein controlling brain growth</span></div><div class="casAuthors">Guedj, Faycal; Pereira, Patricia Lopes; Najas, Sonia; Barallobre, Maria-Jose; Chabert, Caroline; Souchet, Benoit; Sebrie, Catherine; Verney, Catherine; Herault, Yann; Arbones, Mariona; Delabar, Jean M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-203</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Copy no. variation in a small region of chromosome 21 contg. DYRK1A produces morphol. and cognitive alterations in human.  In mouse models, haploinsufficiency results in microcephaly, and a human DYRK1A gain-of-function model (three alleles) exhibits increased brain vol.  To investigate these developmental aspects, we used a murine BAC clone contg. the entire gene to construct an overexpression model driven by endogenous regulatory sequences.  We compared this new model to two other mouse models with three copies of Dyrk1a, YACtgDyrk1a and Ts65Dn, as well as the loss-of-function model with one copy (Dyrk1a +/-).  Growth, viability, brain wt., and brain vol. depended strongly upon gene copy no.  Brain region-specific variations obsd. in gain-of-function models mirror their counterparts in the loss-of-function model.  Some variations, such as increased vol. of the superior colliculus and ventricles, were obsd. in both the BAC transgenic and Ts65Dn mice.  Using unbiased stereol. we found that, in the cortex, neuron d. is inversely related to Dyrk1a copy no. but, in thalamic nuclei, neuron d. is directly related to copy no.  In addn., six genes involved either in cell division (Ccnd1 and pAkt) or in neuronal machinery (Gap43, Map2, Syp, Snap25) were regulated by Dyrk1a throughout development, from birth to adult.  These results imply that Dyrk1a expression alters different cellular processes during brain development.  Dyrk1a, then, has two roles in the development process: shaping the brain and controlling the structure of neuronal components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopV3riBNwb3rVg90H21EOLACvtfcHk0ljOAk07XgpXrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ontb8%253D&md5=ebf45820a2d4fa915f03a4d35fb8dacd</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2012.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2012.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DGuedj%26aufirst%3DF.%26aulast%3DLopes%2BPereira%26aufirst%3DP.%26aulast%3DNajas%26aufirst%3DS.%26aulast%3DBarallobre%26aufirst%3DM.%2BJ.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DSouchet%26aufirst%3DB.%26aulast%3DSebrie%26aufirst%3DC.%26aulast%3DVerney%26aufirst%3DC.%26aulast%3DHerault%26aufirst%3DY.%26aulast%3DArbones%26aufirst%3DM.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26atitle%3DDYRK1A%253A%2520A%2520master%2520regulatory%2520protein%2520controlling%2520brain%2520growth%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2012%26volume%3D46%26spage%3D190%26epage%3D203%26doi%3D10.1016%2Fj.nbd.2012.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerle, B.</span></span> <span> </span><span class="NLM_article-title">MNB/DYRK1A as a multiple regulator of neuronal development</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07954.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1742-4658.2010.07954.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=223-235&author=F.+J.+Tejedorauthor=B.+Hammerle&title=MNB%2FDYRK1A+as+a+multiple+regulator+of+neuronal+development&doi=10.1111%2Fj.1742-4658.2010.07954.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07954.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07954.x%26sid%3Dliteratum%253Aachs%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DHammerle%26aufirst%3DB.%26atitle%3DMNB%252FDYRK1A%2520as%2520a%2520multiple%2520regulator%2520of%2520neuronal%2520development%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D223%26epage%3D235%26doi%3D10.1111%2Fj.1742-4658.2010.07954.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Fernandez, J.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valderrama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindreu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Luna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altafaj, X.</span></span> <span> </span><span class="NLM_article-title">DYRK1A-mediated phosphorylation of GluN2A at ser(1048) regulates the surface expression and channel activity of GluN1/GluN2A receptors</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">331</span>, <span class="refDoi"> DOI: 10.3389/fncel.2014.00331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.3389%2Ffncel.2014.00331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25368549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVynu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=331&author=C.+Grauauthor=K.+Aratoauthor=J.%0AM.+Fernandez-Fernandezauthor=A.+Valderramaauthor=C.+Sindreuauthor=C.+Fillatauthor=I.+Ferrerauthor=S.+de+la+Lunaauthor=X.+Altafaj&title=DYRK1A-mediated+phosphorylation+of+GluN2A+at+ser%281048%29+regulates+the+surface+expression+and+channel+activity+of+GluN1%2FGluN2A+receptors&doi=10.3389%2Ffncel.2014.00331"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A-mediated phosphorylation of GluN2A at Ser1048 regulates the surface expression and channel activity of GluN1/GluN2A receptors</span></div><div class="casAuthors">Grau, Cristina; Arato, Krisztina; Fernandez-Fernandez, Jose M.; Valderrama, Aitana; Sindreu, Carlos; Fillat, Cristina; Ferrer, Isidre; de la Luna, Susana; Altafaj, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">331/1-331/13</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate glutamate receptors (NMDARs) play a pivotal role in neural development and synaptic plasticity, as well as in neurol. disease.  Since NMDARs exert their function at the cell surface, their d. in the plasma membrane is finely tuned by a plethora of mols. that regulate their prodn., trafficking, docking and internalization in response to external stimuli.  In addn. to transcriptional regulation, the d. of NMDARs is also influenced by post-translational mechanisms like phosphorylation, a modification that also affects their biophys. properties.We previously described the increased surface expression of GluN1/GluN2A receptors in transgenic mice overexpressing the Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), suggesting that DYRK1A regulates NMDARs.  Here we have further investigated whether the d. and activity of NMDARs were modulated by DYRK1A phosphorylation.  Accordingly, we show that endogenous DYRK1A is recruited to GluN2A-contg. NMDARs in the adult mouse brain, and we identify a DYRK1A phosphorylation site at Ser1048 of GluN2A, within its intracellular C-terminal domain.  Mechanistically, the DYRK1A-dependent phosphorylation of GluN2A at Ser1048 hinders the internalization of GluN1/GluN2A, causing an increase of surface GluN1/GluN2A in heterologous systems, as well as in primary cortical neurons.  Furthermore, GluN2A phosphorylation at Ser1048 increases the c.d. and potentiates the gating of GluN1/GluN2A receptors.  We conclude that DYRK1A is a direct regulator of NMDA receptors and we propose a novel mechanism for the control of NMDAR activity in neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAkr-L6eNnULVg90H21EOLACvtfcHk0ljOAk07XgpXrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVynu7rE&md5=f3b39ef031a7d82dac155e5bf1ee5df0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2014.00331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2014.00331%26sid%3Dliteratum%253Aachs%26aulast%3DGrau%26aufirst%3DC.%26aulast%3DArato%26aufirst%3DK.%26aulast%3DFernandez-Fernandez%26aufirst%3DJ.%2BM.%26aulast%3DValderrama%26aufirst%3DA.%26aulast%3DSindreu%26aufirst%3DC.%26aulast%3DFillat%26aufirst%3DC.%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3Dde%2Bla%2BLuna%26aufirst%3DS.%26aulast%3DAltafaj%26aufirst%3DX.%26atitle%3DDYRK1A-mediated%2520phosphorylation%2520of%2520GluN2A%2520at%2520ser%25281048%2529%2520regulates%2520the%2520surface%2520expression%2520and%2520channel%2520activity%2520of%2520GluN1%252FGluN2A%2520receptors%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D331%26doi%3D10.3389%2Ffncel.2014.00331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbassi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, L.</span></span> <span> </span><span class="NLM_article-title">DYRK1A in neurodegeneration and cancer: molecular basis and clinical implications</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.pharmthera.2015.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25795597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2015&pages=87-98&author=R.+Abbassiauthor=T.+G.+Johnsauthor=M.+Kassiouauthor=L.+Munoz&title=DYRK1A+in+neurodegeneration+and+cancer%3A+molecular+basis+and+clinical+implications&doi=10.1016%2Fj.pharmthera.2015.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications</span></div><div class="casAuthors">Abbassi, Ramzi; Johns, Terrance G.; Kassiou, Michael; Munoz, Lenka</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Protein kinases are one of the most studied drug targets in current pharmacol. research, as evidenced by the vast no. of kinase-targeting agents enrolled in active clin. trials.  Dual-specificity Tyrosine phosphorylation-Regulated Kinase 1A (DYRK1A) has been much less studied compared to many other kinases.  DYRK1A primary function occurs during early development, where this protein regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells.  Although most extensively characterized for its role in brain development, DYRK1A is over-expressed in a variety of diseases including a no. of human malignancies, such as haematol. and brain cancers.  Here we review the accumulating mol. studies that support our understanding of how DYRK1A signalling could underlie these pathol. functions.  The relevance of DYRK1A in a no. of diseases is also substantiated with intensive drug discovery efforts to develop potent and selective inhibitors of DYRK1A.  Several classes of DYRK1A inhibitors have recently been disclosed and some mols. are promising leads to develop DYRK1A inhibitors as drugs for DYRK1A-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIdxPFd6Zn0LVg90H21EOLACvtfcHk0ljOAk07XgpXrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWgsr0%253D&md5=bbe08b211b477f0d4a279c34c6d36b42</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DAbbassi%26aufirst%3DR.%26aulast%3DJohns%26aufirst%3DT.%2BG.%26aulast%3DKassiou%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DL.%26atitle%3DDYRK1A%2520in%2520neurodegeneration%2520and%2520cancer%253A%2520molecular%2520basis%2520and%2520clinical%2520implications%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D151%26spage%3D87%26epage%3D98%26doi%3D10.1016%2Fj.pharmthera.2015.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span> <span> </span><span class="NLM_article-title">The role of DYRK1A in neurodegenerative diseases</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07955.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1742-4658.2010.07955.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21156028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=236-245&author=J.+Wegielauthor=C.+X.+Gongauthor=Y.+W.+Hwang&title=The+role+of+DYRK1A+in+neurodegenerative+diseases&doi=10.1111%2Fj.1742-4658.2010.07955.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of DYRK1A in neurodegenerative diseases</span></div><div class="casAuthors">Wegiel, Jerzy; Gong, Cheng-Xin; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-245</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Recent studies indicate that the dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene, which is located on chromosome 21q22.2 and is overexpressed in Down syndrome (DS), may play a significant role in developmental brain defects and in early onset neurodegeneration, neuronal loss and dementia in DS.  The identification of hundreds of genes deregulated by DYRK1A overexpression and numerous cytosolic, cytoskeletal and nuclear proteins, including transcription factors, phosphorylated by DYRK1A, indicates that DYRK1A overexpression is central for the deregulation of multiple pathways in the developing and aging DS brain, with structural and functional alterations including mental retardation and dementia.  DYRK1A overexpression in DS brains may contribute to early onset neurofibrillary degeneration directly through hyperphosphorylation of tau and indirectly through phosphorylation of alternative splicing factor, leading to an imbalance between 3R-tau and 4R-tau.  The several-fold increases in the no. of DYRK1A-pos. and 3R-tau-pos. neurofibrillary tangles in DS support this hypothesis.  Moreover, the enhanced phosphorylation of amyloid precursor protein by overexpressed DYRK1A facilitates amyloidogenic amyloid precursor protein cleavage elevating Aβ40 and 42 levels, and leading to brain β-amyloidosis.  Therefore, inhibiting DYRK1A activity in DS may serve to counteract the phenotypic effects of its overexpression and is a potential method of treatment of developmental defects and the prevention of age-assocd. neurodegeneration, including Alzheimer-type pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6EhMKZ0hzPbVg90H21EOLACvtfcHk0lguX_tHnZpKfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D&md5=ac857b61ce21452dac070f1c26a75d38</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07955.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07955.x%26sid%3Dliteratum%253Aachs%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DThe%2520role%2520of%2520DYRK1A%2520in%2520neurodegenerative%2520diseases%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D236%26epage%3D245%26doi%3D10.1111%2Fj.1742-4658.2010.07955.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hammerle, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elizalde, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galceran, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F. J.</span></span> <span> </span><span class="NLM_article-title">The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications</span>. <i>J. Neural Transm., Suppl.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1007/978-3-7091-6721-2_11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1007%2F978-3-7091-6721-2_11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2003&pages=129-137&author=B.+Hammerleauthor=C.+Elizaldeauthor=J.+Galceranauthor=W.+Beckerauthor=F.+J.+Tejedor&title=The+MNB%2FDYRK1A+protein+kinase%3A+neurobiological+functions+and+Down+syndrome+implications&doi=10.1007%2F978-3-7091-6721-2_11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-6721-2_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-6721-2_11%26sid%3Dliteratum%253Aachs%26aulast%3DHammerle%26aufirst%3DB.%26aulast%3DElizalde%26aufirst%3DC.%26aulast%3DGalceran%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520MNB%252FDYRK1A%2520protein%2520kinase%253A%2520neurobiological%2520functions%2520and%2520Down%2520syndrome%2520implications%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D2003%26volume%3D67%26spage%3D129%26epage%3D137%26doi%3D10.1007%2F978-3-7091-6721-2_11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altafaj, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierssen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baamonde, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martí, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimerà, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oset, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flórez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estivill, X.</span></span> <span> </span><span class="NLM_article-title">Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down’s syndrome</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1915</span>– <span class="NLM_lpage">1923</span>, <span class="refDoi"> DOI: 10.1093/hmg/10.18.1915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1093%2Fhmg%2F10.18.1915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=11555628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlSgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1915-1923&author=X.+Altafajauthor=M.+Dierssenauthor=C.+Baamondeauthor=E.+Mart%C3%ADauthor=J.+Visaauthor=J.+Guimer%C3%A0author=M.+Osetauthor=J.+R.+Gonz%C3%A1lezauthor=J.+Fl%C3%B3rezauthor=C.+Fillatauthor=X.+Estivill&title=Neurodevelopmental+delay%2C+motor+abnormalities+and+cognitive+deficits+in+transgenic+mice+overexpressing+Dyrk1A+%28minibrain%29%2C+a+murine+model+of+Down%E2%80%99s+syndrome&doi=10.1093%2Fhmg%2F10.18.1915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome</span></div><div class="casAuthors">Altafaj, Xavier; Dierssen, Mara; Baamonde, Carmela; Marti, Eulalia; Visa, Joana; Guimera, Jordi; Oset, Marta; Gonzalez, Juan Ramon; Florez, Jesus; Fillat, Cristina; Estivill, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1915-1923</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Down's syndrome (DS) is a major cause of mental retardation, hypotonia and delayed development.  Murine models of DS carrying large murine or human genomic fragments show motor alterations and memory deficits.  The specific genes responsible for these phenotypic alterations have not yet been defined.  DYRK1A, the human homolog of the Drosophila minibrain gene, maps to the DS crit. region of human chromosome 21 and is overexpressed in DS fetal brain.  DYRK1A encodes a serine-threonine kinase, probably involved in neuroblast proliferation.  Mutant Drosophila minibrain flies have a redn. in both optic lobes and central brain, showing learning deficits and hypoactivity.  We have generated transgenic mice (TgDyrk1A) overexpressing the full-length cDNA of Dyrk1A.  TgDyrk1A mice exhibit delayed craniocaudal maturation with functional consequences in neuromotor development.  TgDyrk1A mice also show altered motor skill acquisition and hyperactivity, which is maintained to adulthood.  In the Morris water maze, TgDyrk1A mice show a significant impairment in spatial learning and cognitive flexibility, indicative of hippocampal and prefrontal cortex dysfunction.  In the more complex repeated reversal learning paradigm, this defect turned out to be specifically related to ref. memory, whereas working memory was almost unimpaired.  These alterations are comparable with those found in the partial trisomy chromosome 16 murine models of DS and suggest a causative role of DYRK1A in mental retardation and in motor anomalies of DS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwXDiQutGJ07Vg90H21EOLACvtfcHk0lh7htFEuElfgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlSgsb0%253D&md5=f31c3a38ca72e9d5709a489f34732b6a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.18.1915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.18.1915%26sid%3Dliteratum%253Aachs%26aulast%3DAltafaj%26aufirst%3DX.%26aulast%3DDierssen%26aufirst%3DM.%26aulast%3DBaamonde%26aufirst%3DC.%26aulast%3DMart%25C3%25AD%26aufirst%3DE.%26aulast%3DVisa%26aufirst%3DJ.%26aulast%3DGuimer%25C3%25A0%26aufirst%3DJ.%26aulast%3DOset%26aufirst%3DM.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DJ.%2BR.%26aulast%3DFl%25C3%25B3rez%26aufirst%3DJ.%26aulast%3DFillat%26aufirst%3DC.%26aulast%3DEstivill%26aufirst%3DX.%26atitle%3DNeurodevelopmental%2520delay%252C%2520motor%2520abnormalities%2520and%2520cognitive%2520deficits%2520in%2520transgenic%2520mice%2520overexpressing%2520Dyrk1A%2520%2528minibrain%2529%252C%2520a%2520murine%2520model%2520of%2520Down%25E2%2580%2599s%2520syndrome%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1915%26epage%3D1923%26doi%3D10.1093%2Fhmg%2F10.18.1915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duchon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herault, Y.</span></span> <span> </span><span class="NLM_article-title">DYRK1A, a dosage-sensitive gene involved in neurodevelopment disorders, is a target for drug development in Down syndrome</span>. <i>Front. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">104</span>, <span class="refDoi"> DOI: 10.3389/fnbeh.2016.00104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.3389%2Ffnbeh.2016.00104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27375444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotVOjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=104&author=A.+Duchonauthor=Y.+Herault&title=DYRK1A%2C+a+dosage-sensitive+gene+involved+in+neurodevelopment+disorders%2C+is+a+target+for+drug+development+in+Down+syndrome&doi=10.3389%2Ffnbeh.2016.00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in down syndrome</span></div><div class="casAuthors">Duchon, Arnaud; Herault, Yann</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104/1-104/17</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Down syndrome (DS) is one of the leading causes of intellectual disability, and patients with DS face various health issues, including learning and memory deficits, congenital heart disease, Alzheimer's disease (AD), leukemia, and cancer, leading to huge medical and social costs.  Remarkable advances on DS research have been made in improving cognitive function in mouse models for future therapeutic approaches in patients.  Among the different approaches, DYRK1A inhibitors have emerged as promising therapeutics to reduce DS cognitive deficits.  DYRK1A is a dual-specificity kinase that is overexpressed in DS and plays a key role in neurogenesis, outgrowth of axons and dendrites, neuronal trafficking and aging.  Its pivotal role in the DS phenotype makes it a prime target for the development of therapeutics.  Recently, disruption of DYRK1A has been found in Autosomal Dominant Mental Retardation 7 (MRD7), resulting in severe mental deficiency.  Recent advances in the development of kinase inhibitors are expected, in the near future, to remove DS from the list of incurable diseases, providing certain conditions such as drug dosage and correct timing for the optimum long-term treatment.  In addn. the exact mol. and cellular mechanisms that are targeted by the inhibition of DYRK1A are still to be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7AgNJ5S7XmbVg90H21EOLACvtfcHk0lh7htFEuElfgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotVOjtrc%253D&md5=c343957f33c6d2dddac430de1904791d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2016.00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2016.00104%26sid%3Dliteratum%253Aachs%26aulast%3DDuchon%26aufirst%3DA.%26aulast%3DHerault%26aufirst%3DY.%26atitle%3DDYRK1A%252C%2520a%2520dosage-sensitive%2520gene%2520involved%2520in%2520neurodevelopment%2520disorders%252C%2520is%2520a%2520target%2520for%2520drug%2520development%2520in%2520Down%2520syndrome%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2016%26volume%3D10%26spage%3D104%26doi%3D10.3389%2Ffnbeh.2016.00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bronicki, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drunat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passemard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thevenon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riviere, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isidor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francannet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willems, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aylsworth, A. S.</span></span> <span> </span><span class="NLM_article-title">Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A</span>. <i>Eur. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1482</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1038/ejhg.2015.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fejhg.2015.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25920557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFyjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1482-1487&author=L.+M.+Bronickiauthor=C.+Redinauthor=S.+Drunatauthor=A.+Pitonauthor=M.+Lyonsauthor=S.+Passemardauthor=C.+Baumannauthor=L.+Faivreauthor=J.+Thevenonauthor=J.+B.+Riviereauthor=B.+Isidorauthor=G.+Ganauthor=C.+Francannetauthor=M.+Willemsauthor=M.+Gunelauthor=J.+R.+Jonesauthor=J.+G.+Gleesonauthor=J.+L.+Mandelauthor=R.+E.+Stevensonauthor=M.+J.+Friezauthor=A.+S.+Aylsworth&title=Ten+new+cases+further+delineate+the+syndromic+intellectual+disability+phenotype+caused+by+mutations+in+DYRK1A&doi=10.1038%2Fejhg.2015.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A</span></div><div class="casAuthors">Bronicki, Lucas M.; Redin, Claire; Drunat, Severine; Piton, Amelie; Lyons, Michael; Passemard, Sandrine; Baumann, Clarisse; Faivre, Laurence; Thevenon, Julien; Riviere, Jean-Baptiste; Isidor, Bertrand; Gan, Grace; Francannet, Christine; Willems, Marjolaine; Gunel, Murat; Jones, Julie R.; Gleeson, Joseph G.; Mandel, Jean-Louis; Stevenson, Roger E.; Friez, Michael J.; Aylsworth, Arthur S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1482-1487</span>CODEN:
                <span class="NLM_cas:coden">EJHGEU</span>;
        ISSN:<span class="NLM_cas:issn">1018-4813</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) gene, located on chromosome 21q22.13 within the Down syndrome crit. region, has been implicated in syndromic intellectual disability assocd. with Down syndrome and autism.  DYRK1A has a crit. role in brain growth and development primarily by regulating cell proliferation, neurogenesis, neuronal plasticity and survival.  Several patients have been reported with chromosome 21 aberrations such as partial monosomy, involving multiple genes including DYRK1A.  In addn., seven other individuals have been described with chromosomal rearrangements, intragenic deletions or truncating mutations that disrupt specifically DYRK1A.  Most of these patients have microcephaly and all have significant intellectual disability.  In the present study, we report 10 unrelated individuals with DYRK1A-assocd. intellectual disability (ID) who display a recurrent pattern of clin. manifestations including primary or acquired microcephaly, ID ranging from mild to severe, speech delay or absence, seizures, autism, motor delay, deep-set eyes, poor feeding and poor wt. gain.  We identified unique truncating and non-synonymous mutations (three nonsense, four frameshift and two missense) in DYRK1A in nine patients and a large chromosomal deletion that encompassed DYRK1A in one patient.  On the basis of increasing identification of mutations in DYRK1A, we suggest that this gene be considered potentially causative in patients presenting with ID, primary or acquired microcephaly, feeding problems and absent or delayed speech with or without seizures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6MOK9bTJTGbVg90H21EOLACvtfcHk0lgLdjCqSQSJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFyjsrg%253D&md5=ebf2ad7398ad34bdd2ab681d55613954</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fejhg.2015.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fejhg.2015.29%26sid%3Dliteratum%253Aachs%26aulast%3DBronicki%26aufirst%3DL.%2BM.%26aulast%3DRedin%26aufirst%3DC.%26aulast%3DDrunat%26aufirst%3DS.%26aulast%3DPiton%26aufirst%3DA.%26aulast%3DLyons%26aufirst%3DM.%26aulast%3DPassemard%26aufirst%3DS.%26aulast%3DBaumann%26aufirst%3DC.%26aulast%3DFaivre%26aufirst%3DL.%26aulast%3DThevenon%26aufirst%3DJ.%26aulast%3DRiviere%26aufirst%3DJ.%2BB.%26aulast%3DIsidor%26aufirst%3DB.%26aulast%3DGan%26aufirst%3DG.%26aulast%3DFrancannet%26aufirst%3DC.%26aulast%3DWillems%26aufirst%3DM.%26aulast%3DGunel%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DJ.%2BR.%26aulast%3DGleeson%26aufirst%3DJ.%2BG.%26aulast%3DMandel%26aufirst%3DJ.%2BL.%26aulast%3DStevenson%26aufirst%3DR.%2BE.%26aulast%3DFriez%26aufirst%3DM.%2BJ.%26aulast%3DAylsworth%26aufirst%3DA.%2BS.%26atitle%3DTen%2520new%2520cases%2520further%2520delineate%2520the%2520syndromic%2520intellectual%2520disability%2520phenotype%2520caused%2520by%2520mutations%2520in%2520DYRK1A%26jtitle%3DEur.%2520J.%2520Hum.%2520Genet.%26date%3D2015%26volume%3D23%26spage%3D1482%26epage%3D1487%26doi%3D10.1038%2Fejhg.2015.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Branca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfiore, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meechoovet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oddo, S.</span></span> <span> </span><span class="NLM_article-title">Dyrk1 inhibition improves Alzheimer’s disease-like pathology</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1146</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1111/acel.12648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Facel.12648" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=1146-1154&author=C.+Brancaauthor=D.+M.+Shawauthor=R.+Belfioreauthor=V.+Gokhaleauthor=A.+Y.+Shawauthor=C.+Foleyauthor=B.+Smithauthor=C.+Hulmeauthor=T.+Dunckleyauthor=B.+Meechoovetauthor=A.+Caccamoauthor=S.+Oddo&title=Dyrk1+inhibition+improves+Alzheimer%E2%80%99s+disease-like+pathology&doi=10.1111%2Facel.12648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Facel.12648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Facel.12648%26sid%3Dliteratum%253Aachs%26aulast%3DBranca%26aufirst%3DC.%26aulast%3DShaw%26aufirst%3DD.%2BM.%26aulast%3DBelfiore%26aufirst%3DR.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DShaw%26aufirst%3DA.%2BY.%26aulast%3DFoley%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DHulme%26aufirst%3DC.%26aulast%3DDunckley%26aufirst%3DT.%26aulast%3DMeechoovet%26aufirst%3DB.%26aulast%3DCaccamo%26aufirst%3DA.%26aulast%3DOddo%26aufirst%3DS.%26atitle%3DDyrk1%2520inhibition%2520improves%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%26jtitle%3DAging%2520Cell%26date%3D2017%26volume%3D16%26spage%3D1146%26epage%3D1154%26doi%3D10.1111%2Facel.12648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stotani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medda, F.</span></span> <span> </span><span class="NLM_article-title">DYRK1A inhibition as potential treatment for Alzheimer’s disease</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.4155%2Ffmc-2016-0013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27073990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=681-696&author=S.+Stotaniauthor=F.+Giordanettoauthor=F.+Medda&title=DYRK1A+inhibition+as+potential+treatment+for+Alzheimer%E2%80%99s+disease&doi=10.4155%2Ffmc-2016-0013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A inhibition as potential treatment for Alzheimer's disease</span></div><div class="casAuthors">Stotani, Silvia; Giordanetto, Fabrizio; Medda, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">681-696</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">In total, 47,500,000 people worldwide are affected by dementia and this no. is estd. to double by 2030 and triple within 2050 resulting in a huge burden on public health.  Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the most common cause of dementia, accounting for 60-70% of all the cases.  The cause of AD is still poorly understood but several brain abnormalities (e.g., loss of neuronal connections and neuronal death) have been identified in affected patients.  In addn. to the accumulation of β-amyloid plaques in the brain tissue, aberrant phosphorylation of tau proteins has proved to increase neuronal death.  DYRK1A phosphorylates tau on 11 different Ser/Thr residues, resulting in the formation of aggregates called 'neurofibrillary tangles' which, together with amyloid plaques, could be responsible for dementia, neuronal degeneration and cell death.  Small mol. inhibition of DYRK1A could thus represent an interesting approach toward the treatment of Alzheimer's and other neurodegenerative diseases.  Herein we review the current progress in the identification and development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIkkQdSVqce7Vg90H21EOLACvtfcHk0lgDkSCz6aVUjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFSqsrY%253D&md5=7f90e6dc11edc4d395371d7ad07460d7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0013%26sid%3Dliteratum%253Aachs%26aulast%3DStotani%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMedda%26aufirst%3DF.%26atitle%3DDYRK1A%2520inhibition%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D681%26epage%3D696%26doi%3D10.4155%2Ffmc-2016-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanjappa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puttamallesh, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaji, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahasrabuddhe, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, T. S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santosh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukumar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Califano, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangarajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidransky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A.</span></span> <span> </span><span class="NLM_article-title">A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">36132</span>, <span class="refDoi"> DOI: 10.1038/srep36132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fsrep36132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27796319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSitLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=36132&author=A.+Radhakrishnanauthor=V.+Nanjappaauthor=R.+Rajaauthor=G.+Satheauthor=V.+N.+Puttamalleshauthor=A.+P.+Jainauthor=S.+M.+Pintoauthor=S.+A.+Balajiauthor=S.+Chavanauthor=N.+A.+Sahasrabuddheauthor=P.+P.+Mathurauthor=M.+M.+Kumarauthor=T.+S.+K.+Prasadauthor=V.+Santoshauthor=G.+Sukumarauthor=J.+A.+Califanoauthor=A.+Rangarajanauthor=D.+Sidranskyauthor=A.+Pandeyauthor=H.+Gowdaauthor=A.+Chatterjee&title=A+dual+specificity+kinase%2C+DYRK1A%2C+as+a+potential+therapeutic+target+for+head+and+neck+squamous+cell+carcinoma&doi=10.1038%2Fsrep36132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma</span></div><div class="casAuthors">Radhakrishnan, Aneesha; Nanjappa, Vishalakshi; Raja, Remya; Sathe, Gajanan; Puttamallesh, Vinuth N.; Jain, Ankit P.; Pinto, Sneha M.; Balaji, Sai A.; Chavan, Sandip; Sahasrabuddhe, Nandini A.; Mathur, Premendu P.; Kumar, Mahesh M.; Prasad, T. S. Keshava; Santosh, Vani; Sukumar, Geethanjali; Califano, Joseph A.; Rangarajan, Annapoorni; Sidransky, David; Pandey, Akhilesh; Gowda, Harsha; Chatterjee, Aditi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36132</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite advances in clin. management, 5-yr survival rate in patients with late-stage head and neck squamous cell carcinoma (HNSCC) has not improved significantly over the past decade.  Targeted therapies have emerged as one of the most promising approaches to treat several malignancies.  Though tyrosine phosphorylation accounts for a minority of total phosphorylation, it is crit. for activation of signaling pathways and plays a significant role in driving cancers.  To identify activated tyrosine kinase signaling pathways in HNSCC, we compared the phosphotyrosine profiles of a panel of HNSCC cell lines to a normal oral keratinocyte cell line.  Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A) was one of the kinases hyperphosphorylated at Tyr-321 in all HNSCC cell lines.  Inhibition of DYRK1A resulted in an increased apoptosis and decrease in invasion and colony formation ability of HNSCC cell lines.  Further, administration of the small mol. inhibitor against DYRK1A in mice bearing HNSCC xenograft tumors induced regression of tumor growth.  Immunohistochem. labeling of DYRK1A in primary tumor tissues using tissue microarrays revealed strong to moderate staining of DYRK1A in 97.5% (39/40) of HNSCC tissues analyzed.  Taken together our results suggest that DYRK1A could be a novel therapeutic target in HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFYbEnXY2yF7Vg90H21EOLACvtfcHk0liPvud5yt4phA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSitLrM&md5=e62722030bd916a48be15e20230d32ff</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsrep36132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep36132%26sid%3Dliteratum%253Aachs%26aulast%3DRadhakrishnan%26aufirst%3DA.%26aulast%3DNanjappa%26aufirst%3DV.%26aulast%3DRaja%26aufirst%3DR.%26aulast%3DSathe%26aufirst%3DG.%26aulast%3DPuttamallesh%26aufirst%3DV.%2BN.%26aulast%3DJain%26aufirst%3DA.%2BP.%26aulast%3DPinto%26aufirst%3DS.%2BM.%26aulast%3DBalaji%26aufirst%3DS.%2BA.%26aulast%3DChavan%26aufirst%3DS.%26aulast%3DSahasrabuddhe%26aufirst%3DN.%2BA.%26aulast%3DMathur%26aufirst%3DP.%2BP.%26aulast%3DKumar%26aufirst%3DM.%2BM.%26aulast%3DPrasad%26aufirst%3DT.%2BS.%2BK.%26aulast%3DSantosh%26aufirst%3DV.%26aulast%3DSukumar%26aufirst%3DG.%26aulast%3DCalifano%26aufirst%3DJ.%2BA.%26aulast%3DRangarajan%26aufirst%3DA.%26aulast%3DSidransky%26aufirst%3DD.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DGowda%26aufirst%3DH.%26aulast%3DChatterjee%26aufirst%3DA.%26atitle%3DA%2520dual%2520specificity%2520kinase%252C%2520DYRK1A%252C%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D36132%26doi%3D10.1038%2Fsrep36132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Martinez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahonero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Gomez, P.</span></span> <span> </span><span class="NLM_article-title">DYRK: the double-edge kinase as a protagonist in cell growth and tumorigenesis</span>. <i>Mol. Cell. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e970048</span>, <span class="refDoi"> DOI: 10.4161/23723548.2014.970048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.4161%2F23723548.2014.970048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27308401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=e970048&author=P.+Fernandez-Martinezauthor=C.+Zahoneroauthor=P.+Sanchez-Gomez&title=DYRK%3A+the+double-edge+kinase+as+a+protagonist+in+cell+growth+and+tumorigenesis&doi=10.4161%2F23723548.2014.970048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis</span></div><div class="casAuthors">Fernandez-Martinez, P.; Zahonero, C.; Sanchez-Gomez, P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e970048/1-e970048/11</span>CODEN:
                <span class="NLM_cas:coden">MCOOCO</span>;
        ISSN:<span class="NLM_cas:issn">2372-3556</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">DYRK1A (dual-specificity tyrosine-regulated kinase 1A) is a kinase with multiple implications for embryonic development, esp. in the nervous system where it regulates the balance between proliferation and differentiation of neural progenitors.  The DYRK1A gene is located in the Down syndrome crit. region and may play a significant role in the developmental brain defects, early neurodegeneration, and cancer susceptibility of individuals with this syndrome.  DYRK1A is also expressed in adults, where it might participate in the regulation of cell cycle, survival, and tumorigenesis, thus representing a potential therapeutic target for certain types of cancer.  However, the final readout of DYRK1A overexpression or inhibition depends strongly on the cellular context, as it has both tumor suppressor and oncogenic activities.  Here, we will discuss the functions and substrates of DYRK1A assocd. with the control of cell growth and tumorigenesis with a focus on the potential use of DYRK1A inhibitors in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OUDGl-nB87Vg90H21EOLACvtfcHk0liPvud5yt4phA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWqtr0%253D&md5=27153f30af11f2572ba271ee09dd9939</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4161%2F23723548.2014.970048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F23723548.2014.970048%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Martinez%26aufirst%3DP.%26aulast%3DZahonero%26aufirst%3DC.%26aulast%3DSanchez-Gomez%26aufirst%3DP.%26atitle%3DDYRK%253A%2520the%2520double-edge%2520kinase%2520as%2520a%2520protagonist%2520in%2520cell%2520growth%2520and%2520tumorigenesis%26jtitle%3DMol.%2520Cell.%2520Oncol.%26date%3D2015%26volume%3D2%26spage%3De970048%26doi%3D10.4161%2F23723548.2014.970048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ionescu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufrasne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelbcke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoral-Theys, D.</span></span> <span> </span><span class="NLM_article-title">DYRK1A kinase inhibitors with emphasis on cancer</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1315</span>– <span class="NLM_lpage">1329</span>, <span class="refDoi"> DOI: 10.2174/13895575112091315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.2174%2F13895575112091315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=23016545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1315-1329&author=A.+Ionescuauthor=F.+Dufrasneauthor=M.+Gelbckeauthor=I.+Jabinauthor=R.+Kissauthor=D.+Lamoral-Theys&title=DYRK1A+kinase+inhibitors+with+emphasis+on+cancer&doi=10.2174%2F13895575112091315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A kinase inhibitors with emphasis on cancer</span></div><div class="casAuthors">Ionescu, A.; Dufrasne, F.; Gelbcke, M.; Jabin, I.; Kiss, R.; Lamoral-Theys, D.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1315-1329</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Various types of cancers (including gliomas, melanomas, and esophageal, pancreas and non-small-cell lung cancers) display intrinsic resistance to pro-apoptotic stimuli, such as conventional chemotherapy and radiotherapy, and/or the activation of a multidrug resistance phenotype, which are major barriers to effective treatment and lead to poor patient prognosis.  The DYRK1A kinase is directly implicated in the resistance of cancer cells to pro-apoptotic stimuli and drives several pathways that enhance proliferation, migration, and the redn. of cell death, leading to very aggressive biol. behavior in cancer cell populations.  The DYRK1A kinase is also implicated in neurol. diseases and in neoangiogenic processes.  Thus, the DYRK1A kinase is of great interest for both cancer and neuroscience research.  During the last decade, numerous compds. that inhibit DYRK1A have been synthesized.  The present review discusses the available mols. known to interfere with DYRK1A activity and the implications of DYRK1A in cancer and other diseases and serves as a rational anal. for researchers who aim to improve the anti-DYRK1A activity of currently available compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxH4Qznig8rVg90H21EOLACvtfcHk0lgTcybt9eXstg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12hu7jI&md5=9acac0cacdc9fbfd558d6199ff4e3a96</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F13895575112091315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13895575112091315%26sid%3Dliteratum%253Aachs%26aulast%3DIonescu%26aufirst%3DA.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DGelbcke%26aufirst%3DM.%26aulast%3DJabin%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DLamoral-Theys%26aufirst%3DD.%26atitle%3DDYRK1A%2520kinase%2520inhibitors%2520with%2520emphasis%2520on%2520cancer%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D1315%26epage%3D1329%26doi%3D10.2174%2F13895575112091315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen-Tran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeusen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamireddy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swafford, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursalaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiDonato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deaton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarez-Pinzon, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hering, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin Seidel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laffitte, B.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A and GSK3β induces human β-cell proliferation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8372</span>, <span class="refDoi"> DOI: 10.1038/ncomms9372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fncomms9372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26496802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslegu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8372&author=W.+Shenauthor=B.+Taylorauthor=Q.+Jinauthor=V.+Nguyen-Tranauthor=S.+Meeusenauthor=Y.+Q.+Zhangauthor=A.+Kamireddyauthor=A.+Swaffordauthor=A.+F.+Powersauthor=J.+Walkerauthor=J.+Lambauthor=B.+Bursalayaauthor=M.+DiDonatoauthor=G.+Harbauthor=M.+Qiuauthor=C.+M.+Filippiauthor=L.+Deatonauthor=C.+N.+Turkauthor=W.+L.+Suarez-Pinzonauthor=Y.+Liuauthor=X.+Haoauthor=T.+Moauthor=S.+Yanauthor=J.+Liauthor=A.+E.+Hermanauthor=B.+J.+Heringauthor=T.+Wuauthor=H.+Martin+Seidelauthor=P.+McNamaraauthor=R.+Glynneauthor=B.+Laffitte&title=Inhibition+of+DYRK1A+and+GSK3%CE%B2+induces+human+%CE%B2-cell+proliferation&doi=10.1038%2Fncomms9372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DYRK1A and GSK3B induces human β-cell proliferation</span></div><div class="casAuthors">Shen, Weijun; Taylor, Brandon; Jin, Qihui; Nguyen-Tran, Van; Meeusen, Shelly; Zhang, You-Qing; Kamireddy, Anwesh; Swafford, Austin; Powers, Andrew F.; Walker, John; Lamb, John; Bursalaya, Badry; DiDonato, Michael; Harb, George; Qiu, Minhua; Filippi, Christophe M.; Deaton, Lisa; Turk, Carolina N.; Suarez-Pinzon, Wilma L.; Liu, Yahu; Hao, Xueshi; Mo, Tingting; Yan, Shanshan; Li, Jing; Herman, Ann E.; Hering, Bernhard J.; Wu, Tom; Seidel, H. Martin; McNamara, Peter; Glynne, Richard; Laffitte, Bryan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8372</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Insufficient pancreatic β-cell mass or function results in diabetes mellitus.  While significant progress has been made in regulating insulin secretion from β-cells in diabetic patients, no pharmacol. agents have been described that increase β-cell replication in humans.  Here we report aminopyrazine compds. that stimulate robust β-cell proliferation in adult primary islets, most likely as a result of combined inhibition of DYRK1A and GSK3B.  Aminopyrazine-treated human islets retain functionality in vitro and after transplantation into diabetic mice.  Oral dosing of these compds. in diabetic mice induces β-cell proliferation, increases β-cell mass and insulin content, and improves glycemic control.  Biochem., genetic and cell biol. data point to Dyrk1a as the key mol. target.  This study supports the feasibility of treating diabetes with an oral therapy to restore β-cell mass, and highlights a tractable pathway for future drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVHzP-VkH5nrVg90H21EOLACvtfcHk0lgTcybt9eXstg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslegu7%252FK&md5=5ef960af3bfd2795b9fdce52876e5d59</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fncomms9372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9372%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTaylor%26aufirst%3DB.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DNguyen-Tran%26aufirst%3DV.%26aulast%3DMeeusen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%2BQ.%26aulast%3DKamireddy%26aufirst%3DA.%26aulast%3DSwafford%26aufirst%3DA.%26aulast%3DPowers%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DJ.%26aulast%3DLamb%26aufirst%3DJ.%26aulast%3DBursalaya%26aufirst%3DB.%26aulast%3DDiDonato%26aufirst%3DM.%26aulast%3DHarb%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DM.%26aulast%3DFilippi%26aufirst%3DC.%2BM.%26aulast%3DDeaton%26aufirst%3DL.%26aulast%3DTurk%26aufirst%3DC.%2BN.%26aulast%3DSuarez-Pinzon%26aufirst%3DW.%2BL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DMo%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHerman%26aufirst%3DA.%2BE.%26aulast%3DHering%26aufirst%3DB.%2BJ.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DMartin%2BSeidel%26aufirst%3DH.%26aulast%3DMcNamara%26aufirst%3DP.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DLaffitte%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520DYRK1A%2520and%2520GSK3%25CE%25B2%2520induces%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8372%26doi%3D10.1038%2Fncomms9372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirice, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dančík, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A stimulated human β-cell proliferation</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1660</span>– <span class="NLM_lpage">1671</span>, <span class="refDoi"> DOI: 10.2337/db15-1127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.2337%2Fdb15-1127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1660-1671&author=E.+Diriceauthor=D.+Walpitaauthor=A.+Vetereauthor=B.+C.+Meierauthor=S.+Kahramanauthor=J.+Huauthor=V.+Dan%C4%8D%C3%ADkauthor=S.+M.+Burnsauthor=T.+J.+Gilbertauthor=D.+E.+Olsonauthor=P.+A.+Clemonsauthor=R.+N.+Kulkarniauthor=B.+K.+Wagner&title=Inhibition+of+DYRK1A+stimulated+human+%CE%B2-cell+proliferation&doi=10.2337%2Fdb15-1127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2337%2Fdb15-1127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb15-1127%26sid%3Dliteratum%253Aachs%26aulast%3DDirice%26aufirst%3DE.%26aulast%3DWalpita%26aufirst%3DD.%26aulast%3DVetere%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DB.%2BC.%26aulast%3DKahraman%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDan%25C4%258D%25C3%25ADk%26aufirst%3DV.%26aulast%3DBurns%26aufirst%3DS.%2BM.%26aulast%3DGilbert%26aufirst%3DT.%2BJ.%26aulast%3DOlson%26aufirst%3DD.%2BE.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DKulkarni%26aufirst%3DR.%2BN.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26atitle%3DInhibition%2520of%2520DYRK1A%2520stimulated%2520human%2520%25CE%25B2-cell%2520proliferation%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1660%26epage%3D1671%26doi%3D10.2337%2Fdb15-1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belgardt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammert, E.</span></span> <span> </span><span class="NLM_article-title">DYRK1A: A promising drug target for islet transplant-based diabetes therapeutics</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1496</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.2337/dbi16-0013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.2337%2Fdbi16-0013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2016&pages=1496-1498&author=B.+F.+Belgardtauthor=E.+Lammert&title=DYRK1A%3A+A+promising+drug+target+for+islet+transplant-based+diabetes+therapeutics&doi=10.2337%2Fdbi16-0013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2337%2Fdbi16-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdbi16-0013%26sid%3Dliteratum%253Aachs%26aulast%3DBelgardt%26aufirst%3DB.%2BF.%26aulast%3DLammert%26aufirst%3DE.%26atitle%3DDYRK1A%253A%2520A%2520promising%2520drug%2520target%2520for%2520islet%2520transplant-based%2520diabetes%2520therapeutics%26jtitle%3DDiabetes%26date%3D2016%26volume%3D65%26spage%3D1496%26epage%3D1498%26doi%3D10.2337%2Fdbi16-0013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiraboschi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey-Bloom, J.</span></span> <span> </span><span class="NLM_article-title">The importance of neuritic plaques and tangles to the development and evolution of AD</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1984</span>– <span class="NLM_lpage">1989</span>, <span class="refDoi"> DOI: 10.1212/01.WNL.0000129697.01779.0A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1212%2F01.WNL.0000129697.01779.0A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=15184601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A280%3ADC%252BD2c3osVCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2004&pages=1984-1989&author=P.+Tiraboschiauthor=L.+A.+Hansenauthor=L.+J.+Thalauthor=J.+Corey-Bloom&title=The+importance+of+neuritic+plaques+and+tangles+to+the+development+and+evolution+of+AD&doi=10.1212%2F01.WNL.0000129697.01779.0A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of neuritic plaques and tangles to the development and evolution of AD</span></div><div class="casAuthors">Tiraboschi P; Hansen L A; Thal L J; Corey-Bloom J</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1984-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine the relation of neuritic plaques (NPs) and neurofibrillary tangles (NFTs) to the development and evolution of Alzheimer disease (AD).  METHODS:  An autopsy series of 102 patients with dementia and pathologically confirmed AD and 29 normal control subjects (NCs) was studied.  AD cases were stratified according to their last Mini-Mental State Examination (MMSE) before death as mild, moderate, severe, or very severe.  NPs and NFTs were enumerated in the midfrontal (MF), inferior parietal (IP), superior temporal (ST), hippocampal (Hip), or entorhinal cortices using thioflavin-S preparations.  RESULTS:  Most (87%) of the NCs had allocortical NFTs, whereas only a minority (37%) displayed neocortical NPs, and even fewer (19%) showed Hip NPs.  In contrast, none of the NCs exhibited neocortical NFTs, except one case with a single ST tangle.  However, neocortical NFTs were not detected in even 10% of the patients with AD and, in particular, were absent in nearly 50% of those with mild disease at death.  Thus, their sensitivity as a marker of AD was lower than that of NPs, which, conversely, were found in all patients with AD.  Comparing NCs and patients with mild AD, significant differences were found for numbers of NPs only.  Across the AD groups, in contrast, although NP and NFT density increased with dementia severity, significant differences consistently emerged for NFTs alone.  CONCLUSIONS:  Deterioration in Alzheimer disease appears to be driven by neuritic plaques and neurofibrillary tangles at different stages of the disease.  The significant increase in neuritic plaques, but not neurofibrillary tangles, in patients with even mild Alzheimer disease at death compared with normal control subjects suggests that only neuritic plaques are associated with the earliest symptoms of Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtbOFsmd0HcJVVjGoY74BafW6udTcc2ea6usHBuoPu27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3osVCmsA%253D%253D&md5=9cb1dea591db3220956389aa8cfd73db</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1212%2F01.WNL.0000129697.01779.0A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.WNL.0000129697.01779.0A%26sid%3Dliteratum%253Aachs%26aulast%3DTiraboschi%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DL.%2BA.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26aulast%3DCorey-Bloom%26aufirst%3DJ.%26atitle%3DThe%2520importance%2520of%2520neuritic%2520plaques%2520and%2520tangles%2520to%2520the%2520development%2520and%2520evolution%2520of%2520AD%26jtitle%3DNeurology%26date%3D2004%26volume%3D62%26spage%3D1984%26epage%3D1989%26doi%3D10.1212%2F01.WNL.0000129697.01779.0A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gotz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennanen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eersel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schild, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ittner, L. M.</span></span> <span> </span><span class="NLM_article-title">Animal models reveal role for tau phosphorylation in human disease</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1802</i></span>,  <span class="NLM_fpage">860</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2009.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bbadis.2009.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=19751831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1802&publication_year=2010&pages=860-871&author=J.+Gotzauthor=A.+Gladbachauthor=L.+Pennanenauthor=J.+van+Eerselauthor=A.+Schildauthor=D.+Davidauthor=L.+M.+Ittner&title=Animal+models+reveal+role+for+tau+phosphorylation+in+human+disease&doi=10.1016%2Fj.bbadis.2009.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models reveal role for tau phosphorylation in human disease</span></div><div class="casAuthors">Gotz, Jurgen; Gladbach, Amadeus; Pennanen, Luis; van Eersel, Janet; Schild, Andreas; David, Della; Ittner, Lars M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1802</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">860-871</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Many proteins that are implicated in human disease are post-translationally modified.  This includes the microtubule-assocd. protein tau that is deposited in a hyperphosphorylated form in brains of Alzheimer's disease patients.  The focus of this review article is on the physiol. and pathol. phosphorylation of tau; the relevance of aberrant phosphorylation for disease; the role of kinases and phosphatases in this process; its modeling in transgenic mice, flies, and worms; and implications of phosphorylation for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCmQpme0Wu1LVg90H21EOLACvtfcHk0lg6wTgc4FQh_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsrzI&md5=fd569479d7942ffb8f9f3eadce1e4b78</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2009.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2009.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DGotz%26aufirst%3DJ.%26aulast%3DGladbach%26aufirst%3DA.%26aulast%3DPennanen%26aufirst%3DL.%26aulast%3Dvan%2BEersel%26aufirst%3DJ.%26aulast%3DSchild%26aufirst%3DA.%26aulast%3DDavid%26aufirst%3DD.%26aulast%3DIttner%26aufirst%3DL.%2BM.%26atitle%3DAnimal%2520models%2520reveal%2520role%2520for%2520tau%2520phosphorylation%2520in%2520human%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2010%26volume%3D1802%26spage%3D860%26epage%3D871%26doi%3D10.1016%2Fj.bbadis.2009.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuripa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akatsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funakoshi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishitomi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uema, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span> <span> </span><span class="NLM_article-title">The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between β-amyloid production and tau phosphorylation in Alzheimer disease</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddl437</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1093%2Fhmg%2Fddl437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17135279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=15-23&author=R.+Kimuraauthor=K.+Kaminoauthor=M.+Yamamotoauthor=A.+Nuripaauthor=T.+Kidaauthor=H.+Kazuiauthor=R.+Hashimotoauthor=T.+Tanakaauthor=T.+Kudoauthor=H.+Yamagataauthor=Y.+Tabaraauthor=T.+Mikiauthor=H.+Akatsuauthor=K.+Kosakaauthor=E.+Funakoshiauthor=K.+Nishitomiauthor=G.+Sakaguchiauthor=A.+Katoauthor=H.+Hattoriauthor=T.+Uemaauthor=M.+Takeda&title=The+DYRK1A+gene%2C+encoded+in+chromosome+21+Down+syndrome+critical+region%2C+bridges+between+%CE%B2-amyloid+production+and+tau+phosphorylation+in+Alzheimer+disease&doi=10.1093%2Fhmg%2Fddl437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between β-amyloid production and tau phosphorylation in Alzheimer disease</span></div><div class="casAuthors">Kimura, Ryo; Kamino, Kouzin; Yamamoto, Mitsuko; Nuripa, Aidaralieva; Kida, Tomoyuki; Kazui, Hiroaki; Hashimoto, Ryota; Tanaka, Toshihisa; Kudo, Takashi; Yamagata, Hidehisa; Tabara, Yasuharu; Miki, Tetsuro; Akatsu, Hiroyasu; Kosaka, Kenji; Funakoshi, Eishi; Nishitomi, Kouhei; Sakaguchi, Gaku; Kato, Akira; Hattori, Hideyuki; Uema, Takeshi; Takeda, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-23</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We scanned throughout chromosome 21 to assess genetic assocns. with late-onset Alzheimer disease (AD) using 374 Japanese patients and 375 population-based controls, because trisomy 21 is known to be assocd. with early deposition of β-amyloid (Aβ) in the brain.  Among 417 markers spanning 33 Mb, 22 markers showed assocns. with either the allele or the genotype frequency (P < 0.05).  Logistic regression anal. with age, sex and apolipoprotein E (APOE)-ε4 dose supported genetic risk of 17 markers, of which eight markers were linked to the SAMSN1, PRSS7, NCAM2, RUNX1, DYRK1A and KCNJ6 genes.  In logistic regression, the DYRK1A (dual-specificity tyrosine-regulated kinase 1A) gene, located in the Down syndrome crit. region, showed the highest significance [OR = 2.99 (95% CI: 1.72-5.19), P = 0.001], whereas the RUNX1 gene showed a high odds ratio [OR = 23.3 (95% CI: 2.76-196.5), P = 0.038].  DYRK1A mRNA level in the hippocampus was significantly elevated in patients with AD when compared with pathol. controls (P < 0.01).  DYRK1A mRNA level was upregulated along with an increase in the Aβ-level in the brain of transgenic mice, overproducing Aβ at 9 mo of age.  In neuroblastoma cells, Aβ induced an increase in the DYRK1A transcript, which also led to tau phosphorylation at Thr212 under the overexpression of tau.  Therefore, the upregulation of DYRK1A transcription results from Aβ loading, further leading to tau phosphorylation.  These result indicates that DYRK1A could be a key mol. bridging between β-amyloid prodn. and tau phosphorylation in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpETsvyVeafabVg90H21EOLACvtfcHk0li5Mj542JdLiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVWksA%253D%253D&md5=5aa7f15a92ce6328d33cb5cb179b2be2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddl437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddl437%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DR.%26aulast%3DKamino%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DNuripa%26aufirst%3DA.%26aulast%3DKida%26aufirst%3DT.%26aulast%3DKazui%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKudo%26aufirst%3DT.%26aulast%3DYamagata%26aufirst%3DH.%26aulast%3DTabara%26aufirst%3DY.%26aulast%3DMiki%26aufirst%3DT.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DKosaka%26aufirst%3DK.%26aulast%3DFunakoshi%26aufirst%3DE.%26aulast%3DNishitomi%26aufirst%3DK.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DHattori%26aufirst%3DH.%26aulast%3DUema%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DM.%26atitle%3DThe%2520DYRK1A%2520gene%252C%2520encoded%2520in%2520chromosome%252021%2520Down%2520syndrome%2520critical%2520region%252C%2520bridges%2520between%2520%25CE%25B2-amyloid%2520production%2520and%2520tau%2520phosphorylation%2520in%2520Alzheimer%2520disease%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2007%26volume%3D16%26spage%3D15%26epage%3D23%26doi%3D10.1093%2Fhmg%2Fddl437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryoo, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radnaabazar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Son, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span> <span> </span><span class="NLM_article-title">Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s disease</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2007.05075.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1471-4159.2007.05075.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=18005339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2008&pages=1333-1344&author=S.+R.+Ryooauthor=H.+J.+Choauthor=H.+W.+Leeauthor=H.+K.+Jeongauthor=C.+Radnaabazarauthor=Y.+S.+Kimauthor=M.+J.+Kimauthor=M.+Y.+Sonauthor=H.+Seoauthor=S.+H.+Chungauthor=W.+J.+Song&title=Dual-specificity+tyrosine%28Y%29-phosphorylation+regulated+kinase+1A-mediated+phosphorylation+of+amyloid+precursor+protein%3A+evidence+for+a+functional+link+between+Down+syndrome+and+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2007.05075.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease</span></div><div class="casAuthors">Ryoo, Soo-Ryoon; Cho, Hyun-Jeong; Lee, Hye-Won; Jeong, Hey Kyeong; Radnaabazar, Chinzorig; Kim, Yeun-Soo; Kim, Min-Jeong; Son, Mi-Young; Seo, Hyemyung; Chung, Sul-Hee; Song, Woo-Joo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1333-1344</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Most individuals with Down Syndrome (DS) show an early-onset of Alzheimer's disease (AD), which potentially results from the presence of an extra copy of a segment of chromosome 21.  Located on chromosome 21 are the genes that encode β-amyloid (Aβ) precursor protein (APP), a key protein involved in the pathogenesis of AD, and dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A (DYRK1A), a proline-directed protein kinase that plays a crit. role in neurodevelopment.  Here, the authors describe a potential mechanism for the regulation of AD pathol. in DS brains by DYRK1A-mediated phosphorylation of APP.  The authors show that APP is phosphorylated at Thr668 by DYRK1A in vitro and in mammalian cells.  The amts. of phospho-APP and Aβ are increased in the brains of transgenic mice that over-express the human DYRK1A protein.  Furthermore, we show that the amts. of phospho-APP as well as those of APP and DYRK1A are elevated in human DS brains.  Taken together, these results reveal a potential regulatory link between APP and DYRK1A in DS brains, and suggest that the overexpression of DYRK1A in DS may play a role in accelerating AD pathogenesis through phosphorylation of APP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5GqsDKfbC6bVg90H21EOLACvtfcHk0li5Mj542JdLiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCntLc%253D&md5=ab7a959cf5a06be742d89f1afb4f635d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.05075.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.05075.x%26sid%3Dliteratum%253Aachs%26aulast%3DRyoo%26aufirst%3DS.%2BR.%26aulast%3DCho%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BW.%26aulast%3DJeong%26aufirst%3DH.%2BK.%26aulast%3DRadnaabazar%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DSon%26aufirst%3DM.%2BY.%26aulast%3DSeo%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DS.%2BH.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26atitle%3DDual-specificity%2520tyrosine%2528Y%2529-phosphorylation%2520regulated%2520kinase%25201A-mediated%2520phosphorylation%2520of%2520amyloid%2520precursor%2520protein%253A%2520evidence%2520for%2520a%2520functional%2520link%2520between%2520Down%2520syndrome%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D104%26spage%3D1333%26epage%3D1344%26doi%3D10.1111%2Fj.1471-4159.2007.05075.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span> <span> </span><span class="NLM_article-title">Regulation of global gene expression and cell proliferation by APP</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22460</span>, <span class="refDoi"> DOI: 10.1038/srep22460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fsrep22460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26936520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1ehuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22460&author=Y.+Wuauthor=S.+Zhangauthor=Q.+Xuauthor=H.+Zouauthor=W.+Zhouauthor=F.+Caiauthor=T.+Liauthor=W.+Song&title=Regulation+of+global+gene+expression+and+cell+proliferation+by+APP&doi=10.1038%2Fsrep22460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of global gene expression and cell proliferation by APP</span></div><div class="casAuthors">Wu, Yili; Zhang, Si; Xu, Qin; Zou, Haiyan; Zhou, Weihui; Cai, Fang; Li, Tingyu; Song, Weihong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22460</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Down syndrome (DS), caused by trisomy of chromosome 21, is one of the most common genetic disorders.  Patients with DS display growth retardation and inevitably develop characteristic Alzheimer's disease (AD) neuropathol., including neurofibrillary tangles and neuritic plaques.  The expression of amyloid precursor protein (APP) is increased in both DS and AD patients.  To reveal the function of APP and elucidate the pathogenic role of increased APP expression in DS and AD, we performed gene expression profiling using microarray method in human cells overexpressing APP.  A set of genes are significantly altered, which are involved in cell cycle, cell proliferation and p53 signaling.  We found that overexpression of APP inhibits cell proliferation.  Furthermore, we confirmed that the downregulation of two validated genes, PSMA5 and PSMB7, inhibits cell proliferation, suggesting that the downregulation of PSMA5 and PSMB7 is involved in APP-induced cell proliferation impairment.  Taken together, this study suggests that APP regulates global gene expression and increased APP expression inhibits cell proliferation.  Our study provides a novel insight that APP overexpression may contribute to the growth impairment in DS patients and promote AD pathogenesis by inhibiting cell proliferation including neural stem cell proliferation and neurogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppfw8KFjhgAbVg90H21EOLACvtfcHk0lhJsbJ__0Yh4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1ehuro%253D&md5=7d067033a11b2fe039f132f09b61a462</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1038%2Fsrep22460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22460%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DW.%26atitle%3DRegulation%2520of%2520global%2520gene%2520expression%2520and%2520cell%2520proliferation%2520by%2520APP%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22460%26doi%3D10.1038%2Fsrep22460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gearhart, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oster-Granite, M. L.</span></span> <span> </span><span class="NLM_article-title">Expression of the amyloid precursor protein gene in mouse oocytes and embryos</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">1779</span>– <span class="NLM_lpage">1782</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.5.1779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1073%2Fpnas.88.5.1779" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=1779-1782&author=S.+Fisherauthor=J.+D.+Gearhartauthor=M.+L.+Oster-Granite&title=Expression+of+the+amyloid+precursor+protein+gene+in+mouse+oocytes+and+embryos&doi=10.1073%2Fpnas.88.5.1779"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.5.1779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.5.1779%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DGearhart%26aufirst%3DJ.%2BD.%26aulast%3DOster-Granite%26aufirst%3DM.%2BL.%26atitle%3DExpression%2520of%2520the%2520amyloid%2520precursor%2520protein%2520gene%2520in%2520mouse%2520oocytes%2520and%2520embryos%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26spage%3D1779%26epage%3D1782%26doi%3D10.1073%2Fpnas.88.5.1779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meechoovet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gately, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shcherbakova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span> <span> </span><span class="NLM_article-title">β-Carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer’s disease-related sites</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e19264</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0019264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1371%2Fjournal.pone.0019264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21573099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e19264&author=D.+Frostauthor=B.+Meechoovetauthor=T.+Wangauthor=S.+Gatelyauthor=M.+Giorgettiauthor=I.+Shcherbakovaauthor=T.+Dunckley&title=%CE%B2-Carboline+compounds%2C+including+harmine%2C+inhibit+DYRK1A+and+tau+phosphorylation+at+multiple+Alzheimer%E2%80%99s+disease-related+sites&doi=10.1371%2Fjournal.pone.0019264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites</span></div><div class="casAuthors">Frost, Danielle; Meechoovet, Bessie; Wang, Tong; Gately, Stephen; Giorgetti, Marco; Shcherbakova, Irina; Dunckley, Travis</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e19264</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Harmine, a β-carboline alkaloid, is a high affinity inhibitor of the dual specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) protein.  The DYRK1A gene is located within the Down Syndrome Crit. Region (DSCR) on chromosome 21.  We and others have implicated DYRK1A in the phosphorylation of tau protein on multiple sites assocd. with tau pathol. in Down Syndrome and in Alzheimer's disease (AD).  Pharmacol. inhibition of this kinase may provide an opportunity to intervene therapeutically to alter the onset or progression of tau pathol. in AD.  Here we test the ability of harmine, and numerous addnl. β-carboline compds., to inhibit the DYRK1A dependent phosphorylation of tau protein on serine 396, serine 262/serine 356 (12E8 epitope), and threonine 231 in cell culture assays and in vitro phosphorylation assays.  Results demonstrate that the β-carboline compds. (1) potently reduce the expression of all three phosphorylated forms of tau protein, and (2) inhibit the DYRK1A catalyzed direct phosphorylation of tau protein on serine 396.  By assaying several β-carboline compds., we define certain chem. groups that modulate the affinity of this class of compds. for inhibition of tau phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIyW3w-np5NrVg90H21EOLACvtfcHk0lhJsbJ__0Yh4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D&md5=586705088397bfee8f58955b94bcc1db</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019264%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DD.%26aulast%3DMeechoovet%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGately%26aufirst%3DS.%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DDunckley%26aufirst%3DT.%26atitle%3D%25CE%25B2-Carboline%2520compounds%252C%2520including%2520harmine%252C%2520inhibit%2520DYRK1A%2520and%2520tau%2520phosphorylation%2520at%2520multiple%2520Alzheimer%25E2%2580%2599s%2520disease-related%2520sites%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De19264%26doi%3D10.1371%2Fjournal.pone.0019264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rachidi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, C.</span></span> <span> </span><span class="NLM_article-title">Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways</span>. <i>Eur. J. Paediatr. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1016/j.ejpn.2007.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejpn.2007.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17933568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A280%3ADC%252BD1c3mvF2lsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=168-182&author=M.+Rachidiauthor=C.+Lopes&title=Mental+retardation+and+associated+neurological+dysfunctions+in+Down+syndrome%3A+a+consequence+of+dysregulation+in+critical+chromosome+21+genes+and+associated+molecular+pathways&doi=10.1016%2Fj.ejpn.2007.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways</span></div><div class="casAuthors">Rachidi Mohammed; Lopes Carmela</div><div class="citationInfo"><span class="NLM_cas:title">European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">168-82</span>
        ISSN:<span class="NLM_cas:issn">1090-3798</span>.
    </div><div class="casAbstract">Down syndrome (DS), affecting 1/700 live births, is the major genetic cause of mental retardation (MR), a cognitive disorder with hard impact on public health.  DS brain is characterized by a reduced cerebellar volume and number of granular cells, defective cortical lamination and reduced cortical neurons, malformed dendritic trees and spines, and abnormal synapses.  These neurological alterations, also found in trisomic mouse models, result from gene-dosage effects of Human Chromosome 21 (HC21) on the expression of critical developmental genes.  HC21 sequencing, mouse ortholog gene identification and DS mouse model generation lead to determine HC21 gene functions and the effects of protein-dosage alterations in neurodevelopmental and metabolic pathways in DS individuals.  Trisomic brain transcriptome of DS patients and trisomic mouse models identified some molecular changes determined by gene-overdosage and associated dysregulation of some disomic gene expression in DS brains.  These transcriptional variations cause developmental alterations in neural patterning and signal transduction pathways that may lead to defective neuronal circuits responsible for the pathogenesis of MR in DS.  Recently, the first altered molecular pathway responsible of some DS phenotypes, including neurological and cognitive disorders has been identified.  In this pathway, two critical HC21 genes (DYRK1A and DSCR1) act synergistically to control the phosphorylation levels of NFATc and NFATc-regulated gene expression.  Interestingly, the NFATc mice show neurological dysfunctions similar to those seen in DS patients and trisomic mouse models.  Treatment of DS mouse model Ts65Dn with GABA(A) antagonists allowed post-drug rescue of cognitive defects, indicating a hopeful direction in clinical therapies for MR in children with DS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTC_YleMWvr1rt7lRqEFUJVfW6udTcc2eYzURL8lCTBhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3mvF2lsQ%253D%253D&md5=8103c577a5e480eaa427bb98cabe4c53</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpn.2007.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpn.2007.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DRachidi%26aufirst%3DM.%26aulast%3DLopes%26aufirst%3DC.%26atitle%3DMental%2520retardation%2520and%2520associated%2520neurological%2520dysfunctions%2520in%2520Down%2520syndrome%253A%2520a%2520consequence%2520of%2520dysregulation%2520in%2520critical%2520chromosome%252021%2520genes%2520and%2520associated%2520molecular%2520pathways%26jtitle%3DEur.%2520J.%2520Paediatr.%2520Neurol.%26date%3D2008%26volume%3D12%26spage%3D168%26epage%3D182%26doi%3D10.1016%2Fj.ejpn.2007.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternberg, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasten-Sportes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keuren, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glover, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurnit, D. M.</span></span> <span> </span><span class="NLM_article-title">Isolation of human and murine homologues of the <i>Drosophila</i> minibrain gene: human homologue maps to 21q22.2 in the Down syndrome “critical region</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1006/geno.1996.0636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1006%2Fgeno.1996.0636" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=331-339&author=W.+J.+Songauthor=L.+R.+Sternbergauthor=C.+Kasten-Sportesauthor=M.+L.+Keurenauthor=S.+H.+Chungauthor=A.+C.+Slackauthor=D.+E.+Millerauthor=T.+W.+Gloverauthor=P.+W.+Chiangauthor=L.+Louauthor=D.+M.+Kurnit&title=Isolation+of+human+and+murine+homologues+of+the+Drosophila+minibrain+gene%3A+human+homologue+maps+to+21q22.2+in+the+Down+syndrome+%E2%80%9Ccritical+region&doi=10.1006%2Fgeno.1996.0636"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1996.0636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1996.0636%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DW.%2BJ.%26aulast%3DSternberg%26aufirst%3DL.%2BR.%26aulast%3DKasten-Sportes%26aufirst%3DC.%26aulast%3DKeuren%26aufirst%3DM.%2BL.%26aulast%3DChung%26aufirst%3DS.%2BH.%26aulast%3DSlack%26aufirst%3DA.%2BC.%26aulast%3DMiller%26aufirst%3DD.%2BE.%26aulast%3DGlover%26aufirst%3DT.%2BW.%26aulast%3DChiang%26aufirst%3DP.%2BW.%26aulast%3DLou%26aufirst%3DL.%26aulast%3DKurnit%26aufirst%3DD.%2BM.%26atitle%3DIsolation%2520of%2520human%2520and%2520murine%2520homologues%2520of%2520the%2520Drosophila%2520minibrain%2520gene%253A%2520human%2520homologue%2520maps%2520to%252021q22.2%2520in%2520the%2520Down%2520syndrome%2520%25E2%2580%259Ccritical%2520region%26jtitle%3DGenomics%26date%3D1996%26volume%3D38%26spage%3D331%26epage%3D339%26doi%3D10.1006%2Fgeno.1996.0636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toiber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azkona, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Ari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torán, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soreq, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierssen, M.</span></span> <span> </span><span class="NLM_article-title">Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2010.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.nbd.2010.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=20600907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=348-359&author=D.+Toiberauthor=G.+Azkonaauthor=S.+Ben-Ariauthor=N.+Tor%C3%A1nauthor=H.+Soreqauthor=M.+Dierssen&title=Engineering+DYRK1A+overdosage+yields+Down+syndrome-characteristic+cortical+splicing+aberrations&doi=10.1016%2Fj.nbd.2010.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations</span></div><div class="casAuthors">Toiber, Debra; Azkona, Garikoitz; Ben-Ari, Shani; Toran, Nuria; Soreq, Hermona; Dierssen, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">348-359</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Down syndrome (DS) assocs. with impaired brain functions, but the underlying mechanism(s) are yet unclear.  The "gene dosage" hypothesis predicts that in DS, overexpression of a single gene can impair multiple brain functions through a signal amplification effect due to impaired regulatory mechanism(s).  Here, we report findings attributing to impairments in the splicing process such a regulatory role.  We have used DS fetal brain samples in search for initial evidence and employed engineered mice with MMU16 partial trisomy (Ts65Dn) or direct excess of the splicing-assocd. nuclear kinase Dyrk1A, overdosed in DS for further analyses.  We present specific albeit modest changes in the DS brain's splicing machinery with subsequently amplified effects in target transcripts; and we demonstrate that engineered excess of Dyrk1A can largely recapitulate these changes.  Specifically, in both the fetal DS brains and the Dyrk1A overdose models, we found ample modestly modified splicing-assocd. transcripts which apparently induced secondary enhancement in exon inclusion of key synaptic transcripts.  Thus, DS-reduced levels of the dominant-neg. TRKBT1 transcript, but not other TRKB mRNA transcripts, were accompanied by corresponding decreases in BDNF.  In addn., the DS brains and Dyrk1A overdosage models showed selective changes in the transcripts compn. of neuroligin mRNAs as well as redns. in the "synaptic" acetylcholinesterase variant AChE-S mRNA and corresponding increases in the stress-inducible AChE-R mRNA variant, yielding key synaptic proteins with unusual features.  In cotransfected cells, Dyrk1A overdosage caused parallel changes in the splicing pattern of an AChE mini-gene, suggesting that Dyrk1A overdosage is both essential and sufficient to induce the obsd. change in the compn. of AChE mRNA variants.  Furthermore, the Dyrk1A overdosage animal models showed pronounced changes in the structure of neuronal nuclear speckles, where splicing events take place and in SR proteins phosphorylation known to be required for the splicing process.  Together, our findings demonstrate DS-like brain splicing machinery malfunctioning in Dyrk1A overexpressing mice.  Since individual splicing choices may alter cell fate detn., axon guidance, and synaptogenesis, these findings suggest the retrieval of balanced splicing as a goal for DS therapeutic manipulations early in DS development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLpyIlkfn_WrVg90H21EOLACvtfcHk0ljU3G3khcC1Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7rO&md5=185113212f1323f82c2fad8425a88651</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2010.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2010.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DToiber%26aufirst%3DD.%26aulast%3DAzkona%26aufirst%3DG.%26aulast%3DBen-Ari%26aufirst%3DS.%26aulast%3DTor%25C3%25A1n%26aufirst%3DN.%26aulast%3DSoreq%26aufirst%3DH.%26aulast%3DDierssen%26aufirst%3DM.%26atitle%3DEngineering%2520DYRK1A%2520overdosage%2520yields%2520Down%2520syndrome-characteristic%2520cortical%2520splicing%2520aberrations%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D40%26spage%3D348%26epage%3D359%26doi%3D10.1016%2Fj.nbd.2010.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aranda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laguna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de La Luna, S.</span></span> <span> </span><span class="NLM_article-title">Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">5899</span>– <span class="NLM_lpage">5911</span>, <span class="refDoi"> DOI: 10.1128/MCB.00394-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1128%2FMCB.00394-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=18678649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2gt73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=5899-5911&author=S.+Arandaauthor=M.+Alvarezauthor=S.+Turroauthor=A.+Lagunaauthor=S.+de+La+Luna&title=Sprouty2-mediated+inhibition+of+fibroblast+growth+factor+signaling+is+modulated+by+the+protein+kinase+DYRK1A&doi=10.1128%2FMCB.00394-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A</span></div><div class="casAuthors">Aranda, Sergi; Alvarez, Monica; Turro, Silvia; Laguna, Ariadna; de la Luna, Susana</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5899-5911</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Raf-MEK-extracellular signal-regulated kinase (Erk) signaling initiated by growth factor-engaged receptor tyrosine kinases (RTKs) is modulated by an intricate network of pos. and neg. feedback loops which det. the specificity and spatiotemporal characteristics of the intracellular signal.  Well-known antagonists of RTK signaling are the Sprouty proteins.  The activity of Sprouty proteins is modulated by phosphorylation.  However, little is known about the kinases responsible for these posttranslational modifications.  We identify DYRK1A as one of the protein kinases of Sprouty2.  We show that DYRK1A interacts with and regulates the phosphorylation status of Sprouty2.  Moreover, we identify Thr75 on Sprouty2 as a DYRK1A phosphorylation site in vitro and in vivo.  This site is functional, since its mutation enhanced the repressive function of Sprouty2 on fibroblast growth factor (FGF)-induced Erk signaling.  Further supporting the idea of a functional interaction, DYRK1A and Sprouty2 are present in protein complexes in mouse brain, where their expression overlaps in several structures.  Moreover, both proteins copurify with the synaptic plasma membrane fraction of a crude synaptosomal prepn. and colocalize in growth cones, pointing to a role in nerve terminals.  Our results suggest, therefore, that DYRK1A pos. regulates FGF-mitogen-activated protein kinase signaling by phosphorylation-dependent impairment of the inhibitory activity of Sprouty2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof664Ahh528LVg90H21EOLACvtfcHk0liBGGmMM04Nsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2gt73F&md5=735de015391f4b58c2f73ebf493823cc</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FMCB.00394-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00394-08%26sid%3Dliteratum%253Aachs%26aulast%3DAranda%26aufirst%3DS.%26aulast%3DAlvarez%26aufirst%3DM.%26aulast%3DTurro%26aufirst%3DS.%26aulast%3DLaguna%26aufirst%3DA.%26aulast%3Dde%2BLa%2BLuna%26aufirst%3DS.%26atitle%3DSprouty2-mediated%2520inhibition%2520of%2520fibroblast%2520growth%2520factor%2520signaling%2520is%2520modulated%2520by%2520the%2520protein%2520kinase%2520DYRK1A%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D5899%26epage%3D5911%26doi%3D10.1128%2FMCB.00394-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misteli, T.</span></span> <span> </span><span class="NLM_article-title">Small molecule modulators of pre-mRNA splicing in cancer therapy</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2015.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.molmed.2015.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26700537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGitr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=28-37&author=M.+Saltonauthor=T.+Misteli&title=Small+molecule+modulators+of+pre-mRNA+splicing+in+cancer+therapy&doi=10.1016%2Fj.molmed.2015.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy</span></div><div class="casAuthors">Salton, Maayan; Misteli, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-37</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pre-mRNA splicing is a fundamental process in mammalian gene expression and alternative RNA splicing plays a considerable role in generating protein diversity.  RNA splicing events are also key to the pathol. of numerous diseases, particularly cancers.  Some tumors are molecularly addicted to specific RNA splicing isoforms making interference with pre-mRNA processing a viable therapeutic strategy.  Several RNA splicing modulators have recently been characterized, some showing promise in preclin. studies.  While the targets of most splicing modulators are constitutive RNA processing components, possibly leading to undesirable side effects, selectivity for individual splicing events has been obsd.  Given the high prevalence of splicing defects in cancer, small mol. modulators of RNA processing represent a potentially promising novel therapeutic strategy in cancer treatment.  Here, we review their reported effects, mechanisms, and limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeM5XnpAvEVLVg90H21EOLACvtfcHk0liBGGmMM04Nsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGitr%252FK&md5=b1c76eb9e583e3e1da2e2c5918a020d7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2015.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2015.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DSalton%26aufirst%3DM.%26aulast%3DMisteli%26aufirst%3DT.%26atitle%3DSmall%2520molecule%2520modulators%2520of%2520pre-mRNA%2520splicing%2520in%2520cancer%2520therapy%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D28%26epage%3D37%26doi%3D10.1016%2Fj.molmed.2015.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soppa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florencio Ortiz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasqualon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">The Down syndrome-related protein kinase DYRK1A phosphorylates p27<sup>Kip1</sup> and cyclin D1 and induces cell cycle exit and neuronal differentiation</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2084</span>– <span class="NLM_lpage">2100</span>, <span class="refDoi"> DOI: 10.4161/cc.29104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.4161%2Fcc.29104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=2084-2100&author=U.+Soppaauthor=J.+Schumacherauthor=V.+Florencio+Ortizauthor=T.+Pasqualonauthor=F.+J.+Tejedorauthor=W.+Becker&title=The+Down+syndrome-related+protein+kinase+DYRK1A+phosphorylates+p27Kip1+and+cyclin+D1+and+induces+cell+cycle+exit+and+neuronal+differentiation&doi=10.4161%2Fcc.29104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.4161%2Fcc.29104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.29104%26sid%3Dliteratum%253Aachs%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DSchumacher%26aufirst%3DJ.%26aulast%3DFlorencio%2BOrtiz%26aufirst%3DV.%26aulast%3DPasqualon%26aufirst%3DT.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DThe%2520Down%2520syndrome-related%2520protein%2520kinase%2520DYRK1A%2520phosphorylates%2520p27Kip1%2520and%2520cyclin%2520D1%2520and%2520induces%2520cell%2520cycle%2520exit%2520and%2520neuronal%2520differentiation%26jtitle%3DCell%2520Cycle%26date%3D2014%26volume%3D13%26spage%3D2084%26epage%3D2100%26doi%3D10.4161%2Fcc.29104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. R.</span></span> <span> </span><span class="NLM_article-title">DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">6268</span>– <span class="NLM_lpage">6280</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2008.06751.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1742-4658.2008.06751.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2008&pages=6268-6280&author=A.+Seifertauthor=L.+A.+Allanauthor=P.+R.+Clarke&title=DYRK1A+phosphorylates+caspase+9+at+an+inhibitory+site+and+is+potently+inhibited+in+human+cells+by+harmine&doi=10.1111%2Fj.1742-4658.2008.06751.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2008.06751.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2008.06751.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeifert%26aufirst%3DA.%26aulast%3DAllan%26aufirst%3DL.%2BA.%26aulast%3DClarke%26aufirst%3DP.%2BR.%26atitle%3DDYRK1A%2520phosphorylates%2520caspase%25209%2520at%2520an%2520inhibitory%2520site%2520and%2520is%2520potently%2520inhibited%2520in%2520human%2520cells%2520by%2520harmine%26jtitle%3DFEBS%2520J.%26date%3D2008%26volume%3D275%26spage%3D6268%26epage%3D6280%26doi%3D10.1111%2Fj.1742-4658.2008.06751.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Perez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felsenfeld, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivendran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocaña, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span> <span> </span><span class="NLM_article-title">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1038/nm.3820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fnm.3820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25751815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=383-388&author=P.+Wangauthor=J.+C.+Alvarez-Perezauthor=D.+P.+Felsenfeldauthor=H.+Liuauthor=S.+Sivendranauthor=A.+Benderauthor=A.+Kumarauthor=R.+Sanchezauthor=D.+K.+Scottauthor=A.+Garcia-Oca%C3%B1aauthor=A.+F.+Stewart&title=A+high-throughput+chemical+screen+reveals+that+harmine-mediated+inhibition+of+DYRK1A+increases+human+pancreatic+beta+cell+replication&doi=10.1038%2Fnm.3820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication</span></div><div class="casAuthors">Wang, Peng; Alvarez-Perez, Juan-Carlos; Felsenfeld, Dan P.; Liu, Hongtao; Sivendran, Sharmila; Bender, Aaron; Kumar, Anil; Sanchez, Roberto; Scott, Donald K.; Garcia-Ocana, Adolfo; Stewart, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-388</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Types 1 and 2 diabetes affect some 380 million people worldwide.  Both ultimately result from a deficiency of functional pancreatic insulin-producing beta cells.  Beta cells proliferate in humans during a brief temporal window beginning around the time of birth, with a peak percentage (∼2%) engaged in the cell cycle in the first year of life.  In embryonic life and after early childhood, beta cell replication is barely detectable.  Whereas beta cell expansion seems an obvious therapeutic approach to beta cell deficiency, adult human beta cells have proven recalcitrant to such efforts.  Hence, there remains an urgent need for antidiabetic therapeutic agents that can induce regeneration and expansion of adult human beta cells in vivo or ex vivo.  Here, using a high-throughput small-mol. screen (HTS), we find that analogs of the small mol. harmine function as a new class of human beta cell mitogenic compds.  We also define dual-specificity tyrosine-regulated kinase-1a (DYRK1A) as the likely target of harmine and the nuclear factors of activated T cells (NFAT) family of transcription factors as likely mediators of human beta cell proliferation and differentiation.  Using three different mouse and human islet in vivo-based models, we show that harmine is able to induce beta cell proliferation, increase islet mass and improve glycemic control.  These observations suggest that harmine analogs may have unique therapeutic promise for human diabetes therapy.  Enhancing the potency and beta cell specificity of these compds. are important future challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp11xY4tql3VbVg90H21EOLACvtfcHk0libQsOGyqp-GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFOnsr8%253D&md5=32a02c393defd14b8922ac9efff63389</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnm.3820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3820%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DAlvarez-Perez%26aufirst%3DJ.%2BC.%26aulast%3DFelsenfeld%26aufirst%3DD.%2BP.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSivendran%26aufirst%3DS.%26aulast%3DBender%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DD.%2BK.%26aulast%3DGarcia-Oca%25C3%25B1a%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26atitle%3DA%2520high-throughput%2520chemical%2520screen%2520reveals%2520that%2520harmine-mediated%2520inhibition%2520of%2520DYRK1A%2520increases%2520human%2520pancreatic%2520beta%2520cell%2520replication%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D383%26epage%3D388%26doi%3D10.1038%2Fnm.3820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kentrup, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heukelbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilmes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schurmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppertz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kainulainen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span> <span> </span><span class="NLM_article-title">Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residue between subdomains VII and VIII</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">3488</span>– <span class="NLM_lpage">3495</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.7.3488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1074%2Fjbc.271.7.3488" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=3488-3495&author=H.+Kentrupauthor=W.+Beckerauthor=J.+Heukelbachauthor=A.+Wilmesauthor=A.+Schurmannauthor=C.+Huppertzauthor=H.+Kainulainenauthor=H.+G.+Joost&title=Dyrk%2C+a+dual+specificity+protein+kinase+with+unique+structural+features+whose+activity+is+dependent+on+tyrosine+residue+between+subdomains+VII+and+VIII&doi=10.1074%2Fjbc.271.7.3488"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.7.3488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.7.3488%26sid%3Dliteratum%253Aachs%26aulast%3DKentrup%26aufirst%3DH.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DHeukelbach%26aufirst%3DJ.%26aulast%3DWilmes%26aufirst%3DA.%26aulast%3DSchurmann%26aufirst%3DA.%26aulast%3DHuppertz%26aufirst%3DC.%26aulast%3DKainulainen%26aufirst%3DH.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26atitle%3DDyrk%252C%2520a%2520dual%2520specificity%2520protein%2520kinase%2520with%2520unique%2520structural%2520features%2520whose%2520activity%2520is%2520dependent%2520on%2520tyrosine%2520residue%2520between%2520subdomains%2520VII%2520and%2520VIII%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D3488%26epage%3D3495%26doi%3D10.1074%2Fjbc.271.7.3488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roos, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savitsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettenbach, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eswaran, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span> <span> </span><span class="NLM_article-title">Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">986</span>– <span class="NLM_lpage">996</span>, <span class="refDoi"> DOI: 10.1016/j.str.2013.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.str.2013.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=23665168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=986-996&author=M.+Soundararajanauthor=A.+K.+Roosauthor=P.+Savitskyauthor=P.+Filippakopoulosauthor=A.+N.+Kettenbachauthor=J.+V.+Olsenauthor=S.+A.+Gerberauthor=J.+Eswaranauthor=S.+Knappauthor=J.+M.+Elkins&title=Structures+of+Down+syndrome+kinases%2C+DYRKs%2C+reveal+mechanisms+of+kinase+activation+and+substrate+recognition&doi=10.1016%2Fj.str.2013.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition</span></div><div class="casAuthors">Soundararajan, Meera; Roos, Annette K.; Savitsky, Pavel; Filippakopoulos, Panagis; Kettenbach, Arminja N.; Olsen, Jesper V.; Gerber, Scott A.; Eswaran, Jeyanthy; Knapp, Stefan; Elkins, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">986-996</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine-(Y)-phosphorylation-regulated kinases (DYRKs) play key roles in brain development, regulation of splicing, and apoptosis, and are potential drug targets for neurodegenerative diseases and cancer.  We present crystal structures of one representative member of each DYRK subfamily: DYRK1A with an ATP-mimetic inhibitor and consensus peptide, and DYRK2 including NAPA and DH (DYRK homol.) box regions.  The current activation model suggests that DYRKs are Ser/Thr kinases that only autophosphorylate the second tyrosine of the activation loop YxY motif during protein translation.  The structures explain the roles of this tyrosine and of the DH box in DYRK activation and provide a structural model for DYRK substrate recognition.  Phosphorylation of a library of naturally occurring peptides identified substrate motifs that lack proline in the P+1 position, suggesting that DYRK1A is not a strictly proline-directed kinase.  Our data also show that DYRK1A wild-type and Y321F mutant retain tyrosine autophosphorylation activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDShaymgKcfLVg90H21EOLACvtfcHk0libQsOGyqp-GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVygtL0%253D&md5=f101707a987083c7d3d637b39332db35</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2013.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2013.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DRoos%26aufirst%3DA.%2BK.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKettenbach%26aufirst%3DA.%2BN.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DEswaran%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26atitle%3DStructures%2520of%2520Down%2520syndrome%2520kinases%252C%2520DYRKs%252C%2520reveal%2520mechanisms%2520of%2520kinase%2520activation%2520and%2520substrate%2520recognition%26jtitle%3DStructure%26date%3D2013%26volume%3D21%26spage%3D986%26epage%3D996%26doi%3D10.1016%2Fj.str.2013.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adayev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen-Hwang, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolton, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span> <span> </span><span class="NLM_article-title">Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity <i>in vitro</i></span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7614</span>– <span class="NLM_lpage">7624</span>, <span class="refDoi"> DOI: 10.1021/bi700251n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi700251n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=7614-7624&author=T.+Adayevauthor=M.+C.+Chen-Hwangauthor=N.+Murakamiauthor=E.+Leeauthor=D.+C.+Boltonauthor=Y.+W.+Hwang&title=Dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A+does+not+require+tyrosine+phosphorylation+for+activity+in+vitro&doi=10.1021%2Fbi700251n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fbi700251n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700251n%26sid%3Dliteratum%253Aachs%26aulast%3DAdayev%26aufirst%3DT.%26aulast%3DChen-Hwang%26aufirst%3DM.%2BC.%26aulast%3DMurakami%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DBolton%26aufirst%3DD.%2BC.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DDual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2520does%2520not%2520require%2520tyrosine%2520phosphorylation%2520for%2520activity%2520in%2520vitro%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D7614%26epage%3D7624%26doi%3D10.1021%2Fbi700251n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Himpel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tegge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Specificity determinants of substrate recognition by the protein kinase DYRK1A</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">2431</span>– <span class="NLM_lpage">2438</span>, <span class="refDoi"> DOI: 10.1074/jbc.275.4.2431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1074%2Fjbc.275.4.2431" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=2431-2438&author=S.+Himpelauthor=W.+Teggeauthor=R.+Frankauthor=S.+Lederauthor=H.+G.+Joostauthor=W.+Becker&title=Specificity+determinants+of+substrate+recognition+by+the+protein+kinase+DYRK1A&doi=10.1074%2Fjbc.275.4.2431"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.4.2431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.4.2431%26sid%3Dliteratum%253Aachs%26aulast%3DHimpel%26aufirst%3DS.%26aulast%3DTegge%26aufirst%3DW.%26aulast%3DFrank%26aufirst%3DR.%26aulast%3DLeder%26aufirst%3DS.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DSpecificity%2520determinants%2520of%2520substrate%2520recognition%2520by%2520the%2520protein%2520kinase%2520DYRK1A%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D2431%26epage%3D2438%26doi%3D10.1074%2Fjbc.275.4.2431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiechmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czajkowska, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Unusual function of the activation loop in the protein kinase DYRK1A</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(03)00148-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2FS0006-291X%2803%2900148-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=403-408&author=S.+Wiechmannauthor=H.+Czajkowskaauthor=K.+de+Graafauthor=J.+Grotzingerauthor=H.+G.+Joostauthor=W.+Becker&title=Unusual+function+of+the+activation+loop+in+the+protein+kinase+DYRK1A&doi=10.1016%2FS0006-291X%2803%2900148-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2900148-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252900148-7%26sid%3Dliteratum%253Aachs%26aulast%3DWiechmann%26aufirst%3DS.%26aulast%3DCzajkowska%26aufirst%3DH.%26aulast%3Dde%2BGraaf%26aufirst%3DK.%26aulast%3DGrotzinger%26aufirst%3DJ.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DUnusual%2520function%2520of%2520the%2520activation%2520loop%2520in%2520the%2520protein%2520kinase%2520DYRK1A%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D302%26spage%3D403%26epage%3D408%26doi%3D10.1016%2FS0006-291X%2803%2900148-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hérault, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">Dual-specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1183</span>– <span class="NLM_lpage">1199</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1360285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1080%2F13543776.2017.1360285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=28766366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ojs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1183-1199&author=T.+L.+Nguyenauthor=C.+Fruitauthor=Y.+H%C3%A9raultauthor=L.+Meijerauthor=T.+Besson&title=Dual-specificity+tyrosine+phosphorylation+regulated+kinase+1A+%28DYRK1A%29+inhibitors%3A+a+survey+of+recent+patent+literature&doi=10.1080%2F13543776.2017.1360285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature</span></div><div class="casAuthors">Nguyen, Thu Lan; Fruit, Corinne; Herault, Yann; Meijer, Laurent; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1183-1199</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a eukaryotic serine-threonine protein kinase belonging to the CMGC group.  DYRK1A hyperactivity appears to contribute to the development of a no. of human malignancies and to cognitive deficits obsd. in Down syndrome and Alzheimer's disease.  As a result, the DYRK1A kinase represents an attractive target for the synthesis and optimization of pharmacol. inhibitors of potential therapeutic interest.  Like most tyrosine kinase inhibitors developed up to the market, DYRK1A inhibitors are essentially acting by competing with ATP for binding at the catalytic site of the kinase.  This paper reviews patent activity assocd. with the discovery of synthetic novel heterocyclic mols. inhibiting the catalytic activity of DYRK1A.  Despite the important role of DYRK1A in biol. processes and the growing interest in the design of new therapeutic drugs, there are only few patented synthetic DYRK1A inhibitors and most of them were and are still developed by academic research groups, sometimes with industrial partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotMS30KxawIbVg90H21EOLACvtfcHk0liCdInPSDkxwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ojs7jO&md5=3cdf56f9f96f917133b4625dd5d4d09c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1360285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1360285%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DFruit%26aufirst%3DC.%26aulast%3DH%25C3%25A9rault%26aufirst%3DY.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DDual-specificity%2520tyrosine%2520phosphorylation%2520regulated%2520kinase%25201A%2520%2528DYRK1A%2529%2520inhibitors%253A%2520a%2520survey%2520of%2520recent%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D1183%26epage%3D1199%26doi%3D10.1080%2F13543776.2017.1360285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, C.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer’s?</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">872</span>, <span class="refDoi"> DOI: 10.1021/cn300094k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300094k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=857-872&author=B.+Smithauthor=F.+Meddaauthor=V.+Gokhaleauthor=T.+Dunckleyauthor=C.+Hulme&title=Recent+advances+in+the+design%2C+synthesis%2C+and+biological+evaluation+of+selective+DYRK1A+inhibitors%3A+a+new+avenue+for+a+disease+modifying+treatment+of+Alzheimer%E2%80%99s%3F&doi=10.1021%2Fcn300094k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer's?</span></div><div class="casAuthors">Smith, Breland; Medda, Federico; Gokhale, Vijay; Dunckley, Travis; Hulme, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">857-872</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  With 24.3 million people affected in 2005 and an estd. rise to 42.3 million in 2020, dementia is currently a leading unmet medical need and costly burden on public health.  Seventy percent of these cases have been attributed to Alzheimer's disease (AD), a neurodegenerative pathol. whose most evident symptom is a progressive decline in cognitive functions.  Dual specificity tyrosine phosphorylation regulated kinase-1A (DYRK1A) is important in neuronal development and plays a variety of functional roles within the adult central nervous system.  The DYRK1A gene is located within the Down syndrome crit. region (DSCR) on human chromosome 21 and current research suggests that overexpression of DYRK1A may be a significant factor leading to cognitive deficits in people with Alzheimer's disease (AD) and Down syndrome (DS).  Currently, treatment options for cognitive deficiencies assocd. with Down syndrome, as well as Alzheimer's disease, are extremely limited and represent a major unmet therapeutic need.  Small mol. inhibition of DYRK1A activity in the brain may provide an avenue for pharmaceutical intervention of mental impairment assocd. with AD and other neurodegenerative diseases.  We herein review the current state of the art in the development of DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqSAw8CXNiP7Vg90H21EOLACvtfcHk0liCdInPSDkxwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KmsL3K&md5=2009c25bc00389971cd71f64ead2da4a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fcn300094k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300094k%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DGokhale%26aufirst%3DV.%26aulast%3DDunckley%26aufirst%3DT.%26aulast%3DHulme%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520selective%2520DYRK1A%2520inhibitors%253A%2520a%2520new%2520avenue%2520for%2520a%2520disease%2520modifying%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%253F%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D857%26epage%3D872%26doi%3D10.1021%2Fcn300094k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span> <span> </span><span class="NLM_article-title">Activation, regulation and inhibition of DYRK1A</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2010.07956.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1742-4658.2010.07956.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=246-256&author=W.+Beckerauthor=W.+Sippl&title=Activation%2C+regulation+and+inhibition+of+DYRK1A&doi=10.1111%2Fj.1742-4658.2010.07956.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07956.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07956.x%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DActivation%252C%2520regulation%2520and%2520inhibition%2520of%2520DYRK1A%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D246%26epage%3D256%26doi%3D10.1111%2Fj.1742-4658.2010.07956.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adayev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.-W.</span></span> <span> </span><span class="NLM_article-title">An ELISA DYRK1A non-radioactive assay suitable for the characterization of inhibitors</span>. <i>F1000Research</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">42</span>, <span class="refDoi"> DOI: 10.12688/f1000research.10582.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.12688%2Ff1000research.10582.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=28163906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlGrt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=42&author=Y.+Liuauthor=T.+Adayevauthor=Y.-W.+Hwang&title=An+ELISA+DYRK1A+non-radioactive+assay+suitable+for+the+characterization+of+inhibitors&doi=10.12688%2Ff1000research.10582.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">An ELISA DYRK1A non-radioactive assay suitable for the characterization of inhibitors [version 1; referees: 2 approved]</span></div><div class="casAuthors">Liu, Yong; Adayev, Tatyana; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">F1000Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42/1-42/12</span>CODEN:
                <span class="NLM_cas:coden">FRESJL</span>;
        ISSN:<span class="NLM_cas:issn">2046-1402</span>.
    
            (<span class="NLM_cas:orgname">F1000 Research Ltd.</span>)
        </div><div class="casAbstract">The DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) gene encodes a proline-directed Ser/Thr kinase.  Elevated expression and/or altered distribution of the kinase have been implicated in the neurol. impairments assocd. with Down syndrome (DS) and Alzheimer's disease (AD).  Consequently, DYRK1A inhibition has been of significant interest as a potential strategy for therapeutic intervention of DS and AD.  Many classes of novel inhibitors have been described in the past decade.  Although non-radioactive methods for analyzing DYRK1A inhibition have been developed, methods employing radioactive tracers are still commonly used for quant. characterization of DYRK1A inhibitors.  Here, we present a non-radioactive ELISA assay based on the detection of DYRK1A-phosphorylated dynamin 1a fragment using a phosphorylation site-specific antibody.  The assay was verified by the use of two well-characterized DYRK1A inhibitors, epigallocatechin gallate (EGCG) and harmine.  The IC s for EGCG and harmine detd. by the ELISA method were found to be comparable to those previously measured by radioactive tracing methods.  Furthermore, we detd. the mode of inhibition for EGCG and harmine by a modification of the ELISA assay.  This assay confirms the mode of inhibition of EGCG (non-ATP-competitive) and harmine (ATP-competitive), as previously detd.  We conclude that the ELISA platform demonstrated here is a viable alternative to the traditional radioactive tracer assays for analyzing DYRK1A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSKO0R1KokF7Vg90H21EOLACvtfcHk0limTS8mRHfHuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlGrt7fP&md5=019b81d5c3d19f5afb045d8dbc7e3c7b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.10582.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.10582.2%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAdayev%26aufirst%3DT.%26aulast%3DHwang%26aufirst%3DY.-W.%26atitle%3DAn%2520ELISA%2520DYRK1A%2520non-radioactive%2520assay%2520suitable%2520for%2520the%2520characterization%2520of%2520inhibitors%26jtitle%3DF1000Research%26date%3D2017%26volume%3D6%26spage%3D42%26doi%3D10.12688%2Ff1000research.10582.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onogi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">86</span>, <span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+Down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eY73zWGvHzcg7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520Down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adayev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen-Hwang, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span> <span> </span><span class="NLM_article-title">Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">12011</span>– <span class="NLM_lpage">12019</span>, <span class="refDoi"> DOI: 10.1021/bi060632j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi060632j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=12011-12019&author=T.+Adayevauthor=M.+C.+Chen-Hwangauthor=N.+Murakamiauthor=J.+Wegielauthor=Y.+W.+Hwang&title=Kinetic+properties+of+a+MNB%2FDYRK1A+mutant+suitable+for+the+elucidation+of+biochemical+pathways&doi=10.1021%2Fbi060632j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fbi060632j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060632j%26sid%3Dliteratum%253Aachs%26aulast%3DAdayev%26aufirst%3DT.%26aulast%3DChen-Hwang%26aufirst%3DM.%2BC.%26aulast%3DMurakami%26aufirst%3DN.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DKinetic%2520properties%2520of%2520a%2520MNB%252FDYRK1A%2520mutant%2520suitable%2520for%2520the%2520elucidation%2520of%2520biochemical%2520pathways%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D12011%26epage%3D12019%26doi%3D10.1021%2Fbi060632j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1042/bj20021535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update&doi=10.1042%2Fbj20021535"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204%26doi%3D10.1042%2Fbj20021535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamoral-Theys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pottier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufrasne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neve, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornienko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingrassia, L.</span></span> <span> </span><span class="NLM_article-title">Natural polyphenols that display anticancer properties through inhibition of kinase activity</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">812</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.2174/092986710790712183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.2174%2F092986710790712183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=20156174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFOhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=812-825&author=D.+Lamoral-Theysauthor=L.+Pottierauthor=F.+Dufrasneauthor=J.+Neveauthor=J.+Duboisauthor=A.+Kornienkoauthor=R.+Kissauthor=L.+Ingrassia&title=Natural+polyphenols+that+display+anticancer+properties+through+inhibition+of+kinase+activity&doi=10.2174%2F092986710790712183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Natural polyphenols that display anticancer properties through inhibition of kinase activity</span></div><div class="casAuthors">Lamoral-Theys, D.; Pottier, L.; Dufrasne, F.; Neve, J.; Dubois, J.; Kornienko, A.; Kiss, R.; Ingrassia, L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">812-825</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over eleven hundred publications reporting anticancer activities of polyphenols have appeared in the peer-reviewed literature.  In addn., a search of the PubMed database using "polyphenols - cancer - review" as keywords produced over 320 hits for review articles (July 2009).  Targeting specific protein kinases to combat cancer represents a major focus of oncol. research within the so-called targeted therapy approach.  An exhaustive search of the PubMed database (July 2009) using "polyphenols - cancer - kinases" as keywords resulted in more than 130 hits, half of them having been published within the past five years.  Furthermore, the PubMed database contains 25 reviews on the subject of anti-kinase activity of some specific polyphenols, including mainly curcumin and the green tea polyphenol (-)-epigallocatechin 3-gallate (EGCG).  However, no attempt has been made yet to review this area of research in a comprehensive, general manner.  The current review therefore aims to highlight those anticancer polyphenols that target specific kinases in various types of cancer.  The present review also provides an in-depth anal. of polyphenol structure-activity relationships in relation to their anticancer activities and specific kinase targeting.  Lastly, a no. of polyphenols are identified as potential antitumor agents that could be used to combat biol. aggressive cancers, including metastasizing cancers, through the targeting of specific kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9MlNLk928FrVg90H21EOLACvtfcHk0lh_0ICr2ciUxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFOhsr8%253D&md5=0054313c7fe542d4862b6c505318a228</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.2174%2F092986710790712183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710790712183%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DPottier%26aufirst%3DL.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DNeve%26aufirst%3DJ.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DIngrassia%26aufirst%3DL.%26atitle%3DNatural%2520polyphenols%2520that%2520display%2520anticancer%2520properties%2520through%2520inhibition%2520of%2520kinase%2520activity%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D812%26epage%3D825%26doi%3D10.2174%2F092986710790712183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guedj, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebrie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivals, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizot, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbones, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span> <span> </span><span class="NLM_article-title">Green tea polyphenols rescue of brain deficits induced by overexpression of DYRK1A</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e4606</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0004606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1371%2Fjournal.pone.0004606" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e4606&author=F.+Guedjauthor=C.+Sebrieauthor=I.+Rivalsauthor=A.+Ledruauthor=E.+Palyauthor=J.+C.+Bizotauthor=D.+Smithauthor=E.+Rubinauthor=B.+Gilletauthor=M.+Arbonesauthor=J.+M.+Delabar&title=Green+tea+polyphenols+rescue+of+brain+deficits+induced+by+overexpression+of+DYRK1A&doi=10.1371%2Fjournal.pone.0004606"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0004606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0004606%26sid%3Dliteratum%253Aachs%26aulast%3DGuedj%26aufirst%3DF.%26aulast%3DSebrie%26aufirst%3DC.%26aulast%3DRivals%26aufirst%3DI.%26aulast%3DLedru%26aufirst%3DA.%26aulast%3DPaly%26aufirst%3DE.%26aulast%3DBizot%26aufirst%3DJ.%2BC.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DRubin%26aufirst%3DE.%26aulast%3DGillet%26aufirst%3DB.%26aulast%3DArbones%26aufirst%3DM.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26atitle%3DGreen%2520tea%2520polyphenols%2520rescue%2520of%2520brain%2520deficits%2520induced%2520by%2520overexpression%2520of%2520DYRK1A%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De4606%26doi%3D10.1371%2Fjournal.pone.0004606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sueoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawangkan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suganuma, M.</span></span> <span> </span><span class="NLM_article-title">Cancer prevention with green tea and its principal constituent, EGCG: from early investigations to current focus on human cancer stem cells</span>. <i>Mol. Cells</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.14348/molcells.2018.2227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.14348%2Fmolcells.2018.2227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=29429153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFarurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=73-82&author=H.+Fujikiauthor=T.+Watanabeauthor=E.+Sueokaauthor=A.+Rawangkanauthor=M.+Suganuma&title=Cancer+prevention+with+green+tea+and+its+principal+constituent%2C+EGCG%3A+from+early+investigations+to+current+focus+on+human+cancer+stem+cells&doi=10.14348%2Fmolcells.2018.2227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53aR"><div class="casContent"><span class="casTitleNuber">53a</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer prevention with green tea and its principal constituent, EGCG: from early investigations to current focus on human cancer stem cells</span></div><div class="casAuthors">Fujiki, Hirota; Watanabe, Tatsuro; Sueoka, Eisaburo; Rawangkan, Anchalee; Suganuma, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Molecules and Cells</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-82</span>CODEN:
                <span class="NLM_cas:coden">MOCEEK</span>;
        ISSN:<span class="NLM_cas:issn">1016-8478</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Molecular and Cellular Biology</span>)
        </div><div class="casAbstract">Cancer preventive activities of green tea and its main constituent, (-)-epigallocatechin gallate (EGCG) have been extensively studied by scientists all over the world.  Since 1983, we have studied the cancer chemopreventive effects of EGCG as well as green tea ext. and underlying mol. mechanisms.  The first part of this review summarizes groundbreaking topics with EGCG and green tea ext.: (1) Delayed cancer onset as revealed by a 10-yr prospective cohort study, (2) Prevention of colorectal adenoma recurrence by a double-blind randomized clin. phase II trial, (3) Inhibition of metastasis of B16 melanoma cells to the lungs of mice, (4) Increase in the av. value of Young's moduli, i.e., cell stiffness, for human lung cancer cell lines and inhibition of cell motility and (5) Synergistic enhancement of anticancer activity against human cancer cell lines with the combination of EGCG and anticancer compds.  In the second part, we became interested in cancer stem cells (CSCs). (1) Cancer stem cells in mouse skin carcinogenesis by way of introduction, after which we discuss two subjects from our review on human CSCs reported by other investigators gathered from a search of PubMed, (2) Expression of stemness markers of human CSCs compared with their parental cells, and (3) EGCG decreases or increases the expression of mRNA and protein in human CSCs.  On this point, EGCG inhibited self-renewal and expression of pluripotency-maintaining transcription factors in human CSCs.  Human CSCs are thus a target for cancer prevention and treatment with EGCG and green tea catechins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHqgM9r05vt7Vg90H21EOLACvtfcHk0lh_0ICr2ciUxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFarurjN&md5=6ee60a289e7e8b4b4cdfc07f86690841</span></div><a href="/servlet/linkout?suffix=cit53a&amp;dbid=16384&amp;doi=10.14348%2Fmolcells.2018.2227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14348%252Fmolcells.2018.2227%26sid%3Dliteratum%253Aachs%26aulast%3DFujiki%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DSueoka%26aufirst%3DE.%26aulast%3DRawangkan%26aufirst%3DA.%26aulast%3DSuganuma%26aufirst%3DM.%26atitle%3DCancer%2520prevention%2520with%2520green%2520tea%2520and%2520its%2520principal%2520constituent%252C%2520EGCG%253A%2520from%2520early%2520investigations%2520to%2520current%2520focus%2520on%2520human%2520cancer%2520stem%2520cells%26jtitle%3DMol.%2520Cells%26date%3D2018%26volume%3D41%26spage%3D73%26epage%3D82%26doi%3D10.14348%2Fmolcells.2018.2227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit53b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rady, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rady, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhtar, H.</span></span> <span> </span><span class="NLM_article-title">Cancer preventive and therapeutic effects of EGCG, the major polyphenol in green tea</span>. <i>Egypt. J. Basic Appl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.ejbas.2017.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejbas.2017.12.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=1-23&author=I.+Radyauthor=H.+Mohamedauthor=M.+Radyauthor=I.+A.+Siddiquiauthor=H.+Mukhtar&title=Cancer+preventive+and+therapeutic+effects+of+EGCG%2C+the+major+polyphenol+in+green+tea&doi=10.1016%2Fj.ejbas.2017.12.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejbas.2017.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejbas.2017.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DRady%26aufirst%3DI.%26aulast%3DMohamed%26aufirst%3DH.%26aulast%3DRady%26aufirst%3DM.%26aulast%3DSiddiqui%26aufirst%3DI.%2BA.%26aulast%3DMukhtar%26aufirst%3DH.%26atitle%3DCancer%2520preventive%2520and%2520therapeutic%2520effects%2520of%2520EGCG%252C%2520the%2520major%2520polyphenol%2520in%2520green%2520tea%26jtitle%3DEgypt.%2520J.%2520Basic%2520Appl.%2520Sci.%26date%3D2018%26volume%3D5%26spage%3D1%26epage%3D23%26doi%3D10.1016%2Fj.ejbas.2017.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. S.</span></span> <span> </span><span class="NLM_article-title">Biotransformation of green tea polyphenols and the biological activities of those metabolites</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">819</span>– <span class="NLM_lpage">825</span>, <span class="refDoi"> DOI: 10.1021/mp700075m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp700075m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1altr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=819-825&author=J.+D.+Lambertauthor=S.+Sangauthor=C.+S.+Yang&title=Biotransformation+of+green+tea+polyphenols+and+the+biological+activities+of+those+metabolites&doi=10.1021%2Fmp700075m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation of Green Tea Polyphenols and the Biological Activities of Those Metabolites</span></div><div class="casAuthors">Lambert, Joshua D.; Sang, Shengmin; Yang, Chung S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">819-825</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Green tea (Camellia sinensis, Theaceae) and its major polyphenol constituents, the catechins, have been reported to have many health benefits including the prevention of cancer and heart disease.  Many mechanisms of action have been proposed based on in vitro models; however, the importance of most of these mechanisms remains to be detd. in vivo.  The bioavailability and biotransformation of tea catechins play a key role in detg. the importance of various mechanisms in vivo.  Likewise, the biol. activity and bioavailability of tea catechin metabolites, an understudied area, are important in understanding the potential beneficial effects of tea.  In this article, we review the data available on the biotransformation of the tea catechins and the limited data set available on the biol. activities of the catechin metabolites.  Careful interpretation of available data, carefully designed animal expts., and integration of bioavailability and biol. activity data are needed if the disease preventive activity of tea is to be understood.  We hope this article will spark research efforts on some of the important questions regarding tea polyphenol bioavailability, biotransformation, and the biol. activities of tea catechin metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVvvkPngliqLVg90H21EOLACvtfcHk0lh_0ICr2ciUxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1altr%252FK&md5=7437af46e569f47fcfe1cfede71ede2a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fmp700075m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp700075m%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DJ.%2BD.%26aulast%3DSang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%2BS.%26atitle%3DBiotransformation%2520of%2520green%2520tea%2520polyphenols%2520and%2520the%2520biological%2520activities%2520of%2520those%2520metabolites%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2007%26volume%3D4%26spage%3D819%26epage%3D825%26doi%3D10.1021%2Fmp700075m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodlett, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, R. J.</span></span> <span> </span><span class="NLM_article-title">Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits</span>. <i>Mol. Genet. Genomic Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">451</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1002/mgg3.334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1002%2Fmgg3.334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=28944229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOntL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=451-465&author=M.+Stringerauthor=C.+R.+Goodlettauthor=R.+J.+Roper&title=Targeting+trisomic+treatments%3A+optimizing+Dyrk1a+inhibition+to+improve+Down+syndrome+deficits&doi=10.1002%2Fmgg3.334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits</span></div><div class="casAuthors">Stringer, Megan; Goodlett, Charles R.; Roper, Randall J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics & Genomic Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">451-465</span>CODEN:
                <span class="NLM_cas:coden">MGGMC6</span>;
        ISSN:<span class="NLM_cas:issn">2324-9269</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Overexpression of Dual-specificity tyrosine-phosphorylated regulated kinase 1A (DYRK1A), located on human chromosome 21, may alter mol. processes linked to developmental deficits in Down syndrome (DS).  Trisomic DYRK1A is a rational therapeutic target, and although redns. in Dyrk1a genetic dosage have shown improvements in trisomic mouse models, attempts to reduce Dyrk1a activity by pharmacol. mechanisms and correct these DS-assocd. phenotypes have been largely unsuccessful.  Epigallocatechin-3-gallate (EGCG) inhibits DYRK1A activity in vitro and this action has been postulated to account for improvement of some DS-assocd. phenotypes that have been reported in preclin. studies and clin. trials.  However, the beneficial effects of EGCG are inconsistent and there is no direct evidence that any obsd. improvement actually occurs through Dyrk1a inhibition.  Inconclusive outcomes likely reflect a lack of knowledge about the tissue-specific patterns of spatial and temporal overexpression and elevated activity of Dyrk1a that may contribute to emerging DS traits during development.  Emerging evidence indicates that Dyrk1a expression varies over the life span in DS mouse models, yet preclin. therapeutic treatments targeting Dyrk1a have largely not considered these developmental changes.  Therapies intended to improve DS phenotypes through normalizing trisomic Dyrk1a need to optimize the timing and dose of treatment to match the spatiotemporal patterning of excessive Dyrk1a activity in relevant tissues.  This will require more precise identification of developmental periods of vulnerability to enduring adverse effects of elevated Dyrk1a, representing the concurrence of increased Dyrk1a expression together with hypothesized tissue-specific-sensitive periods when Dyrk1a regulates cellular processes that shape the long-term functional properties of the tissue.  Future efforts targeting inhibition of trisomic Dyrk1a should identify these putative spatiotemporally specific developmental sensitive periods and det. whether normalizing Dyrk1a activity then can lead to improved outcomes in DS phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7hKbmonKy97Vg90H21EOLACvtfcHk0lgmz_eusrubTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOntL%252FN&md5=5a99b154e1a12b6f8af4d73e391bb966</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fmgg3.334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmgg3.334%26sid%3Dliteratum%253Aachs%26aulast%3DStringer%26aufirst%3DM.%26aulast%3DGoodlett%26aufirst%3DC.%2BR.%26aulast%3DRoper%26aufirst%3DR.%2BJ.%26atitle%3DTargeting%2520trisomic%2520treatments%253A%2520optimizing%2520Dyrk1a%2520inhibition%2520to%2520improve%2520Down%2520syndrome%2520deficits%26jtitle%3DMol.%2520Genet.%2520Genomic%2520Med.%26date%3D2017%26volume%3D5%26spage%3D451%26epage%3D465%26doi%3D10.1002%2Fmgg3.334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeysekera, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaCombe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stancombe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dria, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodlett, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, R. J.</span></span> <span> </span><span class="NLM_article-title">Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes</span>. <i>Physiol. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/j.physbeh.2017.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.physbeh.2017.05.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2017&pages=230-241&author=M.+Stringerauthor=I.+Abeysekeraauthor=J.+Thomasauthor=J.+LaCombeauthor=K.+Stancombeauthor=R.+J.+Stewartauthor=K.+J.+Driaauthor=J.+M.+Wallaceauthor=C.+R.+Goodlettauthor=R.+J.+Roper&title=Epigallocatechin-3-gallate+%28EGCG%29+consumption+in+the+Ts65Dn+model+of+Down+syndrome+fails+to+improve+behavioral+deficits+and+is+detrimental+to+skeletal+phenotypes&doi=10.1016%2Fj.physbeh.2017.05.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.physbeh.2017.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.physbeh.2017.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DStringer%26aufirst%3DM.%26aulast%3DAbeysekera%26aufirst%3DI.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DLaCombe%26aufirst%3DJ.%26aulast%3DStancombe%26aufirst%3DK.%26aulast%3DStewart%26aufirst%3DR.%2BJ.%26aulast%3DDria%26aufirst%3DK.%2BJ.%26aulast%3DWallace%26aufirst%3DJ.%2BM.%26aulast%3DGoodlett%26aufirst%3DC.%2BR.%26aulast%3DRoper%26aufirst%3DR.%2BJ.%26atitle%3DEpigallocatechin-3-gallate%2520%2528EGCG%2529%2520consumption%2520in%2520the%2520Ts65Dn%2520model%2520of%2520Down%2520syndrome%2520fails%2520to%2520improve%2520behavioral%2520deficits%2520and%2520is%2520detrimental%2520to%2520skeletal%2520phenotypes%26jtitle%3DPhysiol.%2520Behav.%26date%3D2017%26volume%3D177%26spage%3D230%26epage%3D241%26doi%3D10.1016%2Fj.physbeh.2017.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abeysekera, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dria, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, R. J.</span></span> <span> </span><span class="NLM_article-title">Differential effects of epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/mnfr.201500781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1002%2Fmnfr.201500781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26748562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28Xitlyruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=717-726&author=I.+Abeysekeraauthor=J.+Thomasauthor=T.+M.+Georgiadisauthor=A.+G.+Bermanauthor=M.+A.+Hammondauthor=K.+J.+Driaauthor=J.+M.+Wallaceauthor=R.+J.+Roper&title=Differential+effects+of+epigallocatechin-3-gallate+containing+supplements+on+correcting+skeletal+defects+in+a+Down+syndrome+mouse+model&doi=10.1002%2Fmnfr.201500781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model</span></div><div class="casAuthors">Abeysekera, Irushi; Thomas, Jared; Georgiadis, Taxiarchis M.; Berman, Alycia G.; Hammond, Max A.; Dria, Karl J.; Wallace, Joseph M.; Roper, Randall J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Nutrition & Food Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">717-726</span>CODEN:
                <span class="NLM_cas:coden">MNFRCV</span>;
        ISSN:<span class="NLM_cas:issn">1613-4125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Scope : Down syndrome (DS), caused by trisomy of human chromosome 21 (Hsa21), is characterized by a spectrum of phenotypes including skeletal abnormalities.  The Ts65Dn DS mouse model exhibits similar skeletal phenotypes as humans with DS.  DYRK1A, a kinase encoded on Hsa21, has been linked to deficiencies in bone homeostasis in DS mice and individuals with DS.  Treatment with Epigallocatechin-3-gallate (EGCG), a known inhibitor of Dyrk1a, improves some skeletal abnormalities assocd. with DS in mice.  EGCG supplements are widely available but the effectiveness of different EGCG-contg. supplements has not been well studied.  Methods and results : Six com. available supplements contg. EGCG were analyzed, and two of these supplements were compared with pure EGCG for their impact on skeletal deficits in a DS mouse model.  The results demonstrate differential effects of com. supplements on correcting skeletal abnormalities in Ts65Dn mice.  Different EGCG-contg. supplements display differences in degrdn., polyphenol content, and effects on trisomic bone.  Conclusion : This work suggests that the dose of EGCG and compn. of EGCG-contg. supplements may be important in correcting skeletal deficits assocd. with DS.  Careful analyses of these parameters may lead to a better understanding of how to improve skeletal and other deficits that impair individuals with DS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU4omzUCj_cLVg90H21EOLACvtfcHk0lgmz_eusrubTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xitlyruro%253D&md5=9b05b7d1ffc4a90a815e002ae1569e5d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.201500781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.201500781%26sid%3Dliteratum%253Aachs%26aulast%3DAbeysekera%26aufirst%3DI.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DGeorgiadis%26aufirst%3DT.%2BM.%26aulast%3DBerman%26aufirst%3DA.%2BG.%26aulast%3DHammond%26aufirst%3DM.%2BA.%26aulast%3DDria%26aufirst%3DK.%2BJ.%26aulast%3DWallace%26aufirst%3DJ.%2BM.%26aulast%3DRoper%26aufirst%3DR.%2BJ.%26atitle%3DDifferential%2520effects%2520of%2520epigallocatechin-3-gallate%2520containing%2520supplements%2520on%2520correcting%2520skeletal%2520defects%2520in%2520a%2520Down%2520syndrome%2520mouse%2520model%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2016%26volume%3D60%26spage%3D717%26epage%3D726%26doi%3D10.1002%2Fmnfr.201500781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span> <span> </span><span class="NLM_article-title">Chemical con artists foil drug discovery</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1038/513481a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2F513481a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25254460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=481-483&author=J.+Baellauthor=M.+A.+Walters&title=Chemical+con+artists+foil+drug+discovery&doi=10.1038%2F513481a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58aR"><div class="casContent"><span class="casTitleNuber">58a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry: Chemical con artists foil drug discovery</span></div><div class="casAuthors">Baell, Jonathan; Walters, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">7519</span>),
    <span class="NLM_cas:pages">481-483</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Naivety about promiscuous, assay-duping mols. is polluting the literature and wasting resources, warn Jonathan Baell and Michael A. Walters.  Academic drug discoverers must be more vigilant.  Mols. that show the strongest activity in screening might not be the best starting points for drugs.  PAINS hits should almost always be ignored.  Even trained medicinal chemists have to be careful until they become experienced in screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFYQ0B4VVoLVg90H21EOLACvtfcHk0lhjlVHZY2Ulrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsL7M&md5=f5788d81d006460c688e4b78e6200503</span></div><a href="/servlet/linkout?suffix=cit58a&amp;dbid=16384&amp;doi=10.1038%2F513481a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F513481a%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26atitle%3DChemical%2520con%2520artists%2520foil%2520drug%2520discovery%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D481%26epage%3D483%26doi%3D10.1038%2F513481a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit58b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58bR"><div class="casContent"><span class="casTitleNuber">58b</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhjlVHZY2Ulrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit58b&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wataha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, S.</span></span> <span> </span><span class="NLM_article-title">Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>308</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1124/jpet.103.058891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1124%2Fjpet.103.058891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=14569057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsFentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2004&pages=317-323&author=T.+Yamamotoauthor=J.+Lewisauthor=J.+Watahaauthor=D.+Dickinsonauthor=B.+Singhauthor=W.+B.+Bollagauthor=E.+Uetaauthor=T.+Osakiauthor=M.+Atharauthor=G.+Schusterauthor=S.+Hsu&title=Roles+of+catalase+and+hydrogen+peroxide+in+green+tea+polyphenol-induced+chemopreventive+effects&doi=10.1124%2Fjpet.103.058891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59aR"><div class="casContent"><span class="casTitleNuber">59a</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects</span></div><div class="casAuthors">Yamamoto, Tetsuya; Lewis, Jill; Wataha, John; Dickinson, Douglas; Singh, Baldev; Bollag, Wendy B.; Ueta, Eisaku; Osaki, Tokio; Athar, Mohammad; Schuster, George; Hsu, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">317-323</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) possesses promising anticancer potential.  Although in vivo studies unveiled the metabolic routes and pharmacokinetics of EGCG and showed no adverse effects, in vitro studies at high concns. demonstrated oxidative stress.  EGCG causes differential oxidative environments in tumor vs. normal epithelial cells, but the roles that EGCG, hydrogen peroxide (H2O2), and intracellular catalase play in the epithelial system are largely unknown.  The current study employed enzyme activity assays, reactive oxygen species quantification, and immunoblotting to investigate whether, EGCG-induced differential effects correlate with levels of key antioxidant enzymes and H2O2.  It was found that normal human keratinocytes with high catalase activity are least susceptible to H2O2, whereas H2O2 caused significant cytotoxicity in oral carcinoma cell lines.  However, the EGCG-induced differential effects could not be duplicated by H2O2 alone.  The addn. of exogenous catalase failed to completely prevent the EGCG-induced cytotoxicity and rescue the EGCG-induced growth arrest in the tumor cells.  The antioxidant N-acetyl-L-cysteine rescued the tumor cells from H2O2-induced damage only, but not from EGCG-induced mitochondrial damage.  Finally, alterations in catalase or superoxide dismutase activities were not obsd. upon EGCG exposure.  In conclusion, although endogenous catalase may play a role in response to H2O2-induced cytotoxicity, the EGCG-induced cytotoxic effects on tumor cells mainly result from sources other than H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs-PXEbs2cibVg90H21EOLACvtfcHk0lhjlVHZY2Ulrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsFentA%253D%253D&md5=cb1d379ec5dfedb267ac4f76f012524e</span></div><a href="/servlet/linkout?suffix=cit59a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.058891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.058891%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DWataha%26aufirst%3DJ.%26aulast%3DDickinson%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DBollag%26aufirst%3DW.%2BB.%26aulast%3DUeta%26aufirst%3DE.%26aulast%3DOsaki%26aufirst%3DT.%26aulast%3DAthar%26aufirst%3DM.%26aulast%3DSchuster%26aufirst%3DG.%26aulast%3DHsu%26aufirst%3DS.%26atitle%3DRoles%2520of%2520catalase%2520and%2520hydrogen%2520peroxide%2520in%2520green%2520tea%2520polyphenol-induced%2520chemopreventive%2520effects%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D308%26spage%3D317%26epage%3D323%26doi%3D10.1124%2Fjpet.103.058891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit59b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Naasani, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh-hashi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh-hara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruo, T.</span></span> <span> </span><span class="NLM_article-title">Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=824-830&author=I.+Naasaniauthor=F.+Oh-hashiauthor=T.+Oh-haraauthor=W.+Y.+Fengauthor=J.+Johnstonauthor=K.+Chanauthor=T.+Tsuruo&title=Blocking+telomerase+by+dietary+polyphenols+is+a+major+mechanism+for+limiting+the+growth+of+human+cancer+cells+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaasani%26aufirst%3DI.%26aulast%3DOh-hashi%26aufirst%3DF.%26aulast%3DOh-hara%26aufirst%3DT.%26aulast%3DFeng%26aufirst%3DW.%2BY.%26aulast%3DJohnston%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DTsuruo%26aufirst%3DT.%26atitle%3DBlocking%2520telomerase%2520by%2520dietary%2520polyphenols%2520is%2520a%2520major%2520mechanism%2520for%2520limiting%2520the%2520growth%2520of%2520human%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D824%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">Feeling nature’s PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS)</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=616-628&author=J.+B.+Baell&title=Feeling+nature%E2%80%99s+PAINS%3A+natural+products%2C+natural+product+drugs%2C+and+pan+assay+interference+compounds+%28PAINS%29&doi=10.1021%2Facs.jnatprod.5b00947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60aR"><div class="casContent"><span class="casTitleNuber">60a</span><div class="casTitle"><span class="NLM_cas:atitle">Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)</span></div><div class="casAuthors">Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-628</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We have previously reported on classes of compds. that can interfere with bioassays via a no. of different mechanisms and termed such compds. Pan Assay INterference compds., or PAINS.  These compds. were defined on the basis of high-throughput data derived from vendor-supplied synthetics.  The question therefore arises whether the concept of PAINS is relevant to compds. of natural origin.  Here, it is shown that this is indeed the case, but that the context of the biol. readout is an important factor that must be brought into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFy3lN9vzSbVg90H21EOLACvtfcHk0lgOOPgrm5nf6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVWktrc%253D&md5=199b040b1f6f3d636521879acae0114d</span></div><a href="/servlet/linkout?suffix=cit60a&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00947%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DFeeling%2520nature%25E2%2580%2599s%2520PAINS%253A%2520natural%2520products%252C%2520natural%2520product%2520drugs%252C%2520and%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D616%26epage%3D628%26doi%3D10.1021%2Facs.jnatprod.5b00947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit60b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Subramony, J. A.</span></span> <span> </span><span class="NLM_article-title">Apomorphine in dopaminergic therapy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1021/mp060012c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp060012c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFShsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=380-385&author=J.+A.+Subramony&title=Apomorphine+in+dopaminergic+therapy&doi=10.1021%2Fmp060012c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60bR"><div class="casContent"><span class="casTitleNuber">60b</span><div class="casTitle"><span class="NLM_cas:atitle">Apomorphine in Dopaminergic Therapy</span></div><div class="casAuthors">Subramony, J. Anand</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">380-385</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Apomorphine is a potent mol. for the treatment of Parkinson's disease (PD).  It can be obtained in both the R and S forms, and it is the former that is the therapeutically active form.  Due to its structural similarity with 3,4-dihydroxyphenethylamine, dopamine, apomorphine can function as an agonist in the treatment of PD as it can stimulate both the D1 and D2 receptors of the striatum.  The clin. efficacy of apomorphine is similar to that of 3,4-dihydroxyphenylalanine, levodopa (L-dopa), the cornerstone drug in dopaminergic therapy.  (R)-Apomorphine is efficacious for one of the most challenging aspects in the management of PD, namely, managing the unpredictable "on-off" period as a rescue medication after oral administration of a therapeutic drug such as L-dopa.  The effectiveness is due to its rapid control of the wearing-off period of the orally administered medicine.  This short review will trace the progress of apomorphine use starting with its initial discovery and the first indications for which it was used, discovery of its "cure" for PD, and the studies that led to demonstrating its therapeutic efficacy.  The key structural features of apomorphine responsible for its activity are illustrated along with major issues of chem. stability.  From a drug delivery point of view, the current form of administration of apomorphine and some of the potential alternate methods of delivery are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopmXWNc0iSHbVg90H21EOLACvtfcHk0lgOOPgrm5nf6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFShsbY%253D&md5=f17c44ba82d572eaaf1f134fb545c1a1</span></div><a href="/servlet/linkout?suffix=cit60b&amp;dbid=16384&amp;doi=10.1021%2Fmp060012c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp060012c%26sid%3Dliteratum%253Aachs%26aulast%3DSubramony%26aufirst%3DJ.%2BA.%26atitle%3DApomorphine%2520in%2520dopaminergic%2520therapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2006%26volume%3D3%26spage%3D380%26epage%3D385%26doi%3D10.1021%2Fmp060012c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ingolfsson, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobart, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Periole, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yilmaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maretzky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmings, H. C.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrink, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, O. S.</span></span> <span> </span><span class="NLM_article-title">Phytochemicals perturb membranes and promiscuously alter protein function</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1788</span>– <span class="NLM_lpage">1798</span>, <span class="refDoi"> DOI: 10.1021/cb500086e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500086e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptlyqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1788-1798&author=H.+I.+Ingolfssonauthor=P.+Thakurauthor=K.+F.+Heroldauthor=E.+A.+Hobartauthor=N.+B.+Ramseyauthor=X.+Perioleauthor=D.+H.+de+Jongauthor=M.+Zwamaauthor=D.+Yilmazauthor=K.+Hallauthor=T.+Maretzkyauthor=H.+C.+Hemmingsauthor=C.+Blobelauthor=S.+J.+Marrinkauthor=A.+Kocerauthor=J.+T.+Sackauthor=O.+S.+Andersen&title=Phytochemicals+perturb+membranes+and+promiscuously+alter+protein+function&doi=10.1021%2Fcb500086e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Phytochemicals Perturb Membranes and Promiscuously Alter Protein Function</span></div><div class="casAuthors">Ingolfsson, Helgi I.; Thakur, Pratima; Herold, Karl F.; Hobart, E. Ashley; Ramsey, Nicole B.; Periole, Xavier; de Jong, Djurre H.; Zwama, Martijn; Yilmaz, Duygu; Hall, Katherine; Maretzky, Thorsten; Hemmings, Hugh C.; Blobel, Carl; Marrink, Siewert J.; Kocer, Armagan; Sack, Jon T.; Andersen, Olaf S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1788-1798</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A wide variety of phytochems. are consumed for their perceived health benefits.  Many of these phytochems. have been found to alter numerous cell functions, but the mechanisms underlying their biol. activity tend to be poorly understood.  Phenolic phytochems. are particularly promiscuous modifiers of membrane protein function, suggesting that some of their actions may be due to a common, membrane bilayer-mediated mechanism.  To test whether bilayer perturbation may underlie this diversity of actions, we examd. five bioactive phenols reported to have medicinal value: capsaicin from chili peppers, curcumin from turmeric, EGCG from green tea, genistein from soybeans, and resveratrol from grapes.  We find that each of these widely consumed phytochems. alters lipid bilayer properties and the function of diverse membrane proteins.  Mol. dynamics simulations show that these phytochems. modify bilayer properties by localizing to the bilayer/soln. interface.  Bilayer-modifying propensity was verified using a gramicidin-based assay, and indiscriminate modulation of membrane protein function was demonstrated using four proteins: membrane-anchored metalloproteases, mechanosensitive ion channels, and voltage-dependent potassium and sodium channels.  Each protein exhibited similar responses to multiple phytochems., consistent with a common, bilayer-mediated mechanism.  Our results suggest that many effects of amphiphilic phytochems. are due to cell membrane perturbations, rather than specific protein binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL0NNb8_Q6qrVg90H21EOLACvtfcHk0lgOOPgrm5nf6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptlyqt7s%253D&md5=b61876239e926b652adea2e130627bc3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fcb500086e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500086e%26sid%3Dliteratum%253Aachs%26aulast%3DIngolfsson%26aufirst%3DH.%2BI.%26aulast%3DThakur%26aufirst%3DP.%26aulast%3DHerold%26aufirst%3DK.%2BF.%26aulast%3DHobart%26aufirst%3DE.%2BA.%26aulast%3DRamsey%26aufirst%3DN.%2BB.%26aulast%3DPeriole%26aufirst%3DX.%26aulast%3Dde%2BJong%26aufirst%3DD.%2BH.%26aulast%3DZwama%26aufirst%3DM.%26aulast%3DYilmaz%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DK.%26aulast%3DMaretzky%26aufirst%3DT.%26aulast%3DHemmings%26aufirst%3DH.%2BC.%26aulast%3DBlobel%26aufirst%3DC.%26aulast%3DMarrink%26aufirst%3DS.%2BJ.%26aulast%3DKocer%26aufirst%3DA.%26aulast%3DSack%26aufirst%3DJ.%2BT.%26aulast%3DAndersen%26aufirst%3DO.%2BS.%26atitle%3DPhytochemicals%2520perturb%2520membranes%2520and%2520promiscuously%2520alter%2520protein%2520function%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1788%26epage%3D1798%26doi%3D10.1021%2Fcb500086e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mclauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevernic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+Mclauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lhQ_9uoJ3PjaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMclauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adayev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. W.</span></span> <span> </span><span class="NLM_article-title">Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>507</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2010.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.abb.2010.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21185805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit12jsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2011&pages=212-218&author=T.+Adayevauthor=J.+Wegielauthor=Y.+W.+Hwang&title=Harmine+is+an+ATP-competitive+inhibitor+for+dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A+%28Dyrk1A%29&doi=10.1016%2Fj.abb.2010.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)</span></div><div class="casAuthors">Adayev, Tatyana; Wegiel, Jerzy; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-218</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Harmine is a β-carboline alkaloid.  The compd. is a potent inhibitor of dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A), a kinase implicated in Down syndrome.  In this study, we show that harmine functions as an ATP-competitive inhibitor against Dyrk1A.  Our conclusion is supported by kinetic anal. of harmine inhibition as well as by the characterization of a Dyrk1A mutation conferring significant resistance to harmine.  The mutation, V306A, is located next to the highly conserved D307 residue in kinases known to coordinate the phosphate groups of ATP through a Mg2+ ion.  The V306A mutation offers harmine resistance by differentially altering Dyrk1A affinity for harmine and ATP.  The V306A mutation causes no apparent alteration to Dyrk1A activity except for the redn. in ATP affinity.  This deficiency could be fully compensated by supplying ATP with a concn. in the physiol. range.  Our results reveal that harmine inhibits Dyrk1A activity by interacting with residues in the ATP-binding pocket and displacing ATP.  Our results also suggest that harmine will be a good lead compd. for further designing of selective ATP-competitive Dyrk1A inhibitors through exploration of the ATP-binding pocket of Dyrk1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-plj_OO0trVg90H21EOLACvtfcHk0lhQ_9uoJ3PjaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit12jsbo%253D&md5=bd3cd9608d332bc43b5b04f56059b62e</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2010.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2010.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DAdayev%26aufirst%3DT.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DHarmine%2520is%2520an%2520ATP-competitive%2520inhibitor%2520for%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2520%2528Dyrk1A%2529%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2011%26volume%3D507%26spage%3D212%26epage%3D218%26doi%3D10.1016%2Fj.abb.2010.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Göckler, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jofre, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soppa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">6324</span>– <span class="NLM_lpage">6337</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fj.1742-4658.2009.07346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=19796173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+G%C3%B6cklerauthor=G.+Jofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+DYRK1A+and+interferes+with+neurite+formation&doi=10.1111%2Fj.1742-4658.2009.07346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span></div><div class="casAuthors">Gockler Nora; Jofre Guillermo; Papadopoulos Chrisovalantis; Soppa Ulf; Tejedor Francisco J; Becker Walter</div><div class="citationInfo"><span class="NLM_cas:title">The FEBS journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6324-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">DYRK1A is a dual-specificity protein kinase that autophosphorylates a conserved tyrosine residue in the activation loop but phosphorylates exogenous substrates only at serine or threonine residues.  Tyrosine autophosphorylation of DYRKs is a one-off event that takes place during translation and induces the activation of the kinase.  Here we characterize the beta-carboline alkaloid harmine as a potent and specific inhibitor of DYRK1A both in vitro and in cultured cells.  Comparative in vitro assays of four kinases of the DYRK family showed that harmine inhibited substrate phosphorylation by DYRK1A more potently than it inhibited substrate phosphorylation by the closely related kinase DYRK1B [half maximal inhibitory concentrations (IC(50)) of 33 nm versus 166 nm, respectively] and by the more distant members of the family, DYRK2 and DYRK4 (1.9 microm and 80 microm, respectively).  Much higher concentrations of harmine were required to suppress tyrosine autophosphorylation of the translational intermediate of DYRK1A in a bacterial in vitro translation system (IC(50) = 1.9 microm).  Importantly, harmine inhibited the phosphorylation of a specific substrate by DYRK1A in cultured cells with a potency similar to that observed in vitro (IC(50) = 48 nm), without negative effects on the viability of the cells.  Overexpression of the DYRK1A gene on chromosome 21 has been implicated in the altered neuronal development observed in Down syndrome.  Here, we show that harmine interferes with neuritogenesis in cultured hippocampal neurons.  In summary, our data show that harmine inhibits DYRK1A substrate phosphorylation more potently than it inhibits tyrosine autophosphorylation, and provide evidence for a role of DYRK1A in the regulation of neurite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYQnyD9o3hqhe4jJGKT5N0fW6udTcc2eYo2Hq9KiI8L7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D&md5=f59bc35eb74546f6351a4705f2d5fda7</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07346.x%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ckler%26aufirst%3DN.%26aulast%3DJofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520DYRK1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337%26doi%3D10.1111%2Fj.1742-4658.2009.07346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span> <span> </span><span class="NLM_article-title">Anticancer activities of harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2017.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.phymed.2017.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=28478808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFygsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=10-18&author=C.+Liauthor=Y.+Wangauthor=C.+Wangauthor=X.+Yiauthor=M.+Liauthor=X.+He&title=Anticancer+activities+of+harmine+by+inducing+a+pro-death+autophagy+and+apoptosis+in+human+gastric+cancer+cells&doi=10.1016%2Fj.phymed.2017.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65aR"><div class="casContent"><span class="casTitleNuber">65a</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer activities of harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells</span></div><div class="casAuthors">Li, Chuan; Wang, Yihai; Wang, Chunhua; Yi, Xiaomin; Li, Mingya; He, Xiangjiu</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10-18</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Harmine, a β-carboline alkaloid from Peganum harmala, has multiple anti-tumor activities, esp. for its folk therapy for digestive system neoplasm.  However, the underlying mechanism of harmine on gastric cancer remains unclear.  To illuminate the potential anti-tumor activity and mechanism of harmine against gastric cancer cells.  The anti-proliferative activity of harmine in vitro was evaluated by MTT assay.  The autophagic activity induced by harmine was assessed using GFP-LC3 transfection.  FITC/PI double staining was applied for the apoptosis inspection.  The mitochondrial membrane potential was detected by JC-1 fluorescence probe.  The potential mechanisms for proteins level in autophagy and apoptosis were analyzed by Western blot.  Harmine exhibited potent effects on both autophagy and apoptosis.  Treatment with harmine could enhance dots of GFP-LC3 in cells.  Meanwhile, the process had connection with Beclin-1, LC3-II, and p62 by the inhibition of Akt/mTOR/p70S6K signaling.  However, high concn. of harmine led to apoptosis characterized by the propidium/Annexin V-pos. cell pollution, cell shrunk and the collapse of mitochondrial membrane potential.  The regulation of Bcl-2, Bax and the gathering of cleaved-PARP, cleaved-caspase 3 and cleaved-caspase 9 contributed to the induction of apoptosis.  In addn., 10 μM LY294002 (a specific inhibitor of PI3K/Akt) combination with 40 μM harmine significantly increased the cytotoxicity to the gastric cancer cells and up-regulated both the apoptosis-related protein (cleaved-PARP, cleaved-caspase-3) and autophagy-related protein (Beclin-1, LC3-II, and p62).  Adding the inhibitor of autophagy, 3-MA or BafA1, increased the viability of harmine-exposured gastric cancer cells, which confirmed the role of autophagy played in the gastric cancer cell death induced by harmine.  Harmine might be a potent inducer of apoptosis and autophagy, which offered evidences to therapy of harmine in gastric carcinoma in the folk medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb4bB5rtowvLVg90H21EOLACvtfcHk0ljO8Xh1zHPlZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFygsrk%253D&md5=566aade0aa66a553312a2af413dc2ea1</span></div><a href="/servlet/linkout?suffix=cit65a&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2017.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2017.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DX.%26atitle%3DAnticancer%2520activities%2520of%2520harmine%2520by%2520inducing%2520a%2520pro-death%2520autophagy%2520and%2520apoptosis%2520in%2520human%2520gastric%2520cancer%2520cells%26jtitle%3DPhytomedicine%26date%3D2017%26volume%3D28%26spage%3D10%26epage%3D18%26doi%3D10.1016%2Fj.phymed.2017.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit65b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Malinge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliss-Moreau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirsammer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diebold, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chlon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurbuxani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispino, J. D.</span></span> <span> </span><span class="NLM_article-title">Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">948</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1172/JCI60455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1172%2FJCI60455" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=948-962&author=S.+Malingeauthor=M.+Bliss-Moreauauthor=G.+Kirsammerauthor=L.+Dieboldauthor=T.+Chlonauthor=S.+Gurbuxaniauthor=J.+D.+Crispino&title=Increased+dosage+of+the+chromosome+21+ortholog+Dyrk1a+promotes+megakaryoblastic+leukemia+in+a+murine+model+of+Down+syndrome&doi=10.1172%2FJCI60455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65b&amp;dbid=16384&amp;doi=10.1172%2FJCI60455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI60455%26sid%3Dliteratum%253Aachs%26aulast%3DMalinge%26aufirst%3DS.%26aulast%3DBliss-Moreau%26aufirst%3DM.%26aulast%3DKirsammer%26aufirst%3DG.%26aulast%3DDiebold%26aufirst%3DL.%26aulast%3DChlon%26aufirst%3DT.%26aulast%3DGurbuxani%26aufirst%3DS.%26aulast%3DCrispino%26aufirst%3DJ.%2BD.%26atitle%3DIncreased%2520dosage%2520of%2520the%2520chromosome%252021%2520ortholog%2520Dyrk1a%2520promotes%2520megakaryoblastic%2520leukemia%2520in%2520a%2520murine%2520model%2520of%2520Down%2520syndrome%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26spage%3D948%26epage%3D962%26doi%3D10.1172%2FJCI60455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit65c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pozo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahonero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linares, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricoy, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Lain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepulveda, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Gomez, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of DYRK1A destabilizes EGFR and reduces EGFR dependent glioblastoma growth</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">2475</span>– <span class="NLM_lpage">2487</span>, <span class="refDoi"> DOI: 10.1172/JCI63623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1172%2FJCI63623" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=2475-2487&author=N.+Pozoauthor=C.+Zahoneroauthor=P.+Fernandezauthor=J.+M.+Linaresauthor=A.+Ayusoauthor=M.+Hagiwaraauthor=A.+Perezauthor=J.+R.+Ricoyauthor=A.+Hernandez-Lainauthor=J.+M.+Sepulvedaauthor=P.+Sanchez-Gomez&title=Inhibition+of+DYRK1A+destabilizes+EGFR+and+reduces+EGFR+dependent+glioblastoma+growth&doi=10.1172%2FJCI63623"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65c&amp;dbid=16384&amp;doi=10.1172%2FJCI63623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI63623%26sid%3Dliteratum%253Aachs%26aulast%3DPozo%26aufirst%3DN.%26aulast%3DZahonero%26aufirst%3DC.%26aulast%3DFernandez%26aufirst%3DP.%26aulast%3DLinares%26aufirst%3DJ.%2BM.%26aulast%3DAyuso%26aufirst%3DA.%26aulast%3DHagiwara%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DA.%26aulast%3DRicoy%26aufirst%3DJ.%2BR.%26aulast%3DHernandez-Lain%26aufirst%3DA.%26aulast%3DSepulveda%26aufirst%3DJ.%2BM.%26aulast%3DSanchez-Gomez%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520DYRK1A%2520destabilizes%2520EGFR%2520and%2520reduces%2520EGFR%2520dependent%2520glioblastoma%2520growth%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D2475%26epage%3D2487%26doi%3D10.1172%2FJCI63623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zaker, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oody, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arjmand, A.</span></span> <span> </span><span class="NLM_article-title">A Study on the antitumoral and differentiation effects of peganum harmala derivatives in combination with ATRA on leukemic cells</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">844</span>– <span class="NLM_lpage">849</span>, <span class="refDoi"> DOI: 10.1007/BF02978835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1007%2FBF02978835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17703736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFensbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=844-849&author=F.+Zakerauthor=A.+Oodyauthor=A.+Arjmand&title=A+Study+on+the+antitumoral+and+differentiation+effects+of+peganum+harmala+derivatives+in+combination+with+ATRA+on+leukemic+cells&doi=10.1007%2FBF02978835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66aR"><div class="casContent"><span class="casTitleNuber">66a</span><div class="casTitle"><span class="NLM_cas:atitle">A study on the antitumoral and differentiation effects of Peganum harmala derivatives in combination with ATRA on leukaemic cells</span></div><div class="casAuthors">Zaker, Farhad; Oody, Arezo; Arjmand, Alireza</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">844-849</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Plant derived agents may exert a new approach to the treatment of leukemia.  The present study was an evaluation of proliferation, cytotoxicity and differentiation of harmine and harmaline on HL60 cells, alone or in combination with ATRA and G-CSF.  Counting of cells, viability, MTT assay, morphol., NBT redn. and flow cytometry anal. were performed using CD11b and CD 14 monoclonal antibodies.  The data showed that harmine and harmaline reduced proliferation in dose and time dependent manner.  Optimal antiproliferative concn. of these agents was chosen.  However, both agents in higher doses were cytotoxic.  Combination of ATRA, G-CSF and each agent alone, particularly harmaline in optimal dose, resulted in partially additive decrease in cell proliferation.  Cells treated with both harmaline and ATRA demonstrated some morphol. changes and NBT positivity, but the extent of changes obsd. following treatment with harmaline was less than ATRA.  Flow cytometric anal. showed that ATRA induced a neutrophilic differentiation, while harmaline led to a predominantly monocytic differentiation.  Combination of harmine and harmaline with ATRA and G-CSF did not change the extent of differentiation, and the cells differentiated into the neutrophilic lineage.  This shows that the direction of differentiation is dominantly detd. by ATRA.  These preliminary data implies a new approach in treatment of leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg1ZM-rdb87rVg90H21EOLACvtfcHk0ljO8Xh1zHPlZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFensbo%253D&md5=411ec4a220294ca62931e59dcec54f80</span></div><a href="/servlet/linkout?suffix=cit66a&amp;dbid=16384&amp;doi=10.1007%2FBF02978835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02978835%26sid%3Dliteratum%253Aachs%26aulast%3DZaker%26aufirst%3DF.%26aulast%3DOody%26aufirst%3DA.%26aulast%3DArjmand%26aufirst%3DA.%26atitle%3DA%2520Study%2520on%2520the%2520antitumoral%2520and%2520differentiation%2520effects%2520of%2520peganum%2520harmala%2520derivatives%2520in%2520combination%2520with%2520ATRA%2520on%2520leukemic%2520cells%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2007%26volume%3D30%26spage%3D844%26epage%3D849%26doi%3D10.1007%2FBF02978835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit66b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span> <span> </span><span class="NLM_article-title">Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2013.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.phymed.2013.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=24176842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslehsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=348-355&author=H.+Zhangauthor=K.+Sunauthor=J.+Dingauthor=H.+Xuauthor=L.+Zhuauthor=K.+Zhangauthor=X.+Liauthor=W.+Sun&title=Harmine+induces+apoptosis+and+inhibits+tumor+cell+proliferation%2C+migration+and+invasion+through+down-regulation+of+cyclooxygenase-2+expression+in+gastric+cancer&doi=10.1016%2Fj.phymed.2013.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66bR"><div class="casContent"><span class="casTitleNuber">66b</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer</span></div><div class="casAuthors">Zhang, Hao; Sun, Kun; Ding, Jing; Xu, Huae; Zhu, Lingjun; Zhang, Kai; Li, Xiaolin; Sun, Weihao</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">348-355</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Cyclooxygenase-2 (COX-2) plays an important role in the carcinogenesis and progression of gastric cancer.  Harmine is reported as a promising drug candidate for cancer therapy; however, effects and action mechanism of harmine on the human gastric cancer cells remain unclear.  This study evaluated the anti-tumor effects of harmine on human gastric cancer both in vitro and in vivo.  The cell proliferation was detd. using MTT colorimetric assay.  Apoptosis was measured by DAPI staining and flow cytometry anal.  The wound healing and transwell invasion assays were performed to evaluate the effects of harmine on the migration and invasion of gastric cancer cells.  The expression of COX-2, proliferating cell nuclear antigen (PCNA), Bcl-2, Bax and matrix metalloproteinase-2 (MMP-2) was detected by Western blot anal.  Our results showed that harmine significantly inhibited cellular proliferation, migration, invasion and induced apoptosis in vitro, as well as inhibited tumor growth in vivo.  In addn., harmine significantly inhibited the expression of COX-2, PCNA, Bcl-2 and MMP-2 as well as increased Bax expression in gastric cancer cells.  These results collectively indicate that harmine induces apoptosis and inhibits proliferation, migration and invasion of human gastric cancer cells, which may be mediated by down-regulation of COX-2 expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5qPnBMAG2k7Vg90H21EOLACvtfcHk0ljucVRj2gMITA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslehsrzF&md5=0c0e8e2014f751c9b602bd7eb5b2b216</span></div><a href="/servlet/linkout?suffix=cit66b&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2013.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2013.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DK.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DW.%26atitle%3DHarmine%2520induces%2520apoptosis%2520and%2520inhibits%2520tumor%2520cell%2520proliferation%252C%2520migration%2520and%2520invasion%2520through%2520down-regulation%2520of%2520cyclooxygenase-2%2520expression%2520in%2520gastric%2520cancer%26jtitle%3DPhytomedicine%26date%3D2014%26volume%3D21%26spage%3D348%26epage%3D355%26doi%3D10.1016%2Fj.phymed.2013.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Waki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damoiseaux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilpitz, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontonoz, P.</span></span> <span> </span><span class="NLM_article-title">The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ expression</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2007.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.cmet.2007.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17488638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=357-370&author=H.+Wakiauthor=K.+W.+Parkauthor=N.+Mitroauthor=L.+Peiauthor=R.+Damoiseauxauthor=D.+C.+Wilpitzauthor=K.+Reueauthor=E.+Saezauthor=P.+Tontonoz&title=The+small+molecule+harmine+is+an+antidiabetic+cell-type-specific+regulator+of+PPAR%CE%B3+expression&doi=10.1016%2Fj.cmet.2007.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67aR"><div class="casContent"><span class="casTitleNuber">67a</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ expression</span></div><div class="casAuthors">Waki, Hironori; Park, Kye Won; Mitro, Nico; Pei, Liming; Damoiseaux, Robert; Wilpitz, Damien C.; Reue, Karen; Saez, Enrique; Tontonoz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-370</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PPARγ is the master regulator of adipogenesis and the mol. target of the thiazolidinedione antidiabetic drugs.  By screening for compds. that promote adipogenesis, we identified a small mol. that targets the PPARγ pathway by a distinct mechanism.  This mol., harmine, is not a ligand for the receptor; rather, it acts as a cell-type-specific regulator of PPARγ expression.  Administration of harmine to diabetic mice mimics the effects of PPARγ ligands on adipocyte gene expression and insulin sensitivity.  Unlike thiazolidinediones, however, harmine does not cause significant wt. gain or hepatic lipid accumulation.  Mol. studies indicate that harmine controls PPARγ expression through inhibition of the Wnt signaling pathway.  This work validates phenotypic screening of adipocytes as a promising strategy for the identification of bioactive small mols. and suggests that regulators of PPARγ expression may represent a complementary approach to PPARγ ligands in the treatment of insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Im5tRGS5LbVg90H21EOLACvtfcHk0ljucVRj2gMITA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqu7s%253D&md5=a2b9ff7b3eb65a8eef51d848d185b386</span></div><a href="/servlet/linkout?suffix=cit67a&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DWaki%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DK.%2BW.%26aulast%3DMitro%26aufirst%3DN.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DDamoiseaux%26aufirst%3DR.%26aulast%3DWilpitz%26aufirst%3DD.%2BC.%26aulast%3DReue%26aufirst%3DK.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DTontonoz%26aufirst%3DP.%26atitle%3DThe%2520small%2520molecule%2520harmine%2520is%2520an%2520antidiabetic%2520cell-type-specific%2520regulator%2520of%2520PPAR%25CE%25B3%2520expression%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D5%26spage%3D357%26epage%3D370%26doi%3D10.1016%2Fj.cmet.2007.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit67b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villanueva, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monticelli, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDougald, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldrath, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontonoz, P.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-gamma expression and adipocyte differentiation</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2038</span>– <span class="NLM_lpage">2048</span>, <span class="refDoi"> DOI: 10.1210/me.2007-0454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1210%2Fme.2007-0454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=18562627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2itL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=2038-2048&author=K.+W.+Parkauthor=H.+Wakiauthor=C.+J.+Villanuevaauthor=L.+A.+Monticelliauthor=C.+Hongauthor=S.+Kangauthor=O.+A.+MacDougaldauthor=A.+W.+Goldrathauthor=P.+Tontonoz&title=Inhibitor+of+DNA+binding+2+is+a+small+molecule-inducible+modulator+of+peroxisome+proliferator-activated+receptor-gamma+expression+and+adipocyte+differentiation&doi=10.1210%2Fme.2007-0454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67bR"><div class="casContent"><span class="casTitleNuber">67b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-γ expression and adipocyte differentiation</span></div><div class="casAuthors">Park, Kye Won; Waki, Hironori; Villanueva, Claudio J.; Monticelli, Laurel A.; Hong, Cynthia; Kang, Sona; MacDougald, Ormond A.; Goldrath, Ananda W.; Tontonoz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2038-2048</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The authors previously identified the small mol. harmine as a regulator of peroxisome proliferator activated-receptor γ (PPARγ) and adipocyte differentiation.  In an effort to identify signaling pathways mediating harmine's effects, the authors performed transcriptional profiling of 3T3-F442A preadipocytes.  Inhibitor of DNA biding 2 (Id2) was identified as a gene rapidly induced by harmine but not by PPARγ agonists.  Id2 is also induced in 3T3-L1 preadipocytes treated with dexamethasone, 3-isobutyl-1-methylxanthine, and insulin, suggesting that Id2 regulation is a common feature of the adipogenic program.  Stable overexpression of Id2 in preadipocytes promotes expression of PPARγ and enhances morphol. differentiation and lipid accumulation.  Conversely, small interfering RNA-mediated knockdown of Id2 antagonizes adipocyte differentiation.  Mice lacking Id2 expression display reduced adiposity, and embryonic fibroblasts derived from these mice exhibit reduced PPARγ expression and a diminished capacity for adipocyte differentiation.  Finally, Id2 expression is elevated in adipose tissues of obese mice and humans.  These results outline a role for Id2 in the modulation of PPARγ expression and adipogenesis and underscore the utility of adipogenic small mols. as tools to dissect adipocyte biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYPeLsKlo07LVg90H21EOLACvtfcHk0lgFTQwBcst1HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2itL%252FM&md5=cd3985530abf57aab9b6fa80805449f4</span></div><a href="/servlet/linkout?suffix=cit67b&amp;dbid=16384&amp;doi=10.1210%2Fme.2007-0454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2007-0454%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%2BW.%26aulast%3DWaki%26aufirst%3DH.%26aulast%3DVillanueva%26aufirst%3DC.%2BJ.%26aulast%3DMonticelli%26aufirst%3DL.%2BA.%26aulast%3DHong%26aufirst%3DC.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DMacDougald%26aufirst%3DO.%2BA.%26aulast%3DGoldrath%26aufirst%3DA.%2BW.%26aulast%3DTontonoz%26aufirst%3DP.%26atitle%3DInhibitor%2520of%2520DNA%2520binding%25202%2520is%2520a%2520small%2520molecule-inducible%2520modulator%2520of%2520peroxisome%2520proliferator-activated%2520receptor-gamma%2520expression%2520and%2520adipocyte%2520differentiation%26jtitle%3DMol.%2520Endocrinol.%26date%3D2008%26volume%3D22%26spage%3D2038%26epage%3D2048%26doi%3D10.1210%2Fme.2007-0454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablin, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase A by β-carboline derivatives</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1006/abbi.1996.9771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1006%2Fabbi.1996.9771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=8990278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADyaK2sXktlGitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1997&pages=137-142&author=H.+Kimauthor=S.+O.+Sablinauthor=R.+R.+Ramsay&title=Inhibition+of+monoamine+oxidase+A+by+%CE%B2-carboline+derivatives&doi=10.1006%2Fabbi.1996.9771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68aR"><div class="casContent"><span class="casTitleNuber">68a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase A by β-carboline derivatives</span></div><div class="casAuthors">Kim, Hoon; Sablin, Sergey O.; Ramsay, Rona R.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-142</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">β-Carbolines are endogenous inhibitors of monoamine oxidase (MAO).  The interaction of nine β-carboline derivs. and four 3,4-dihydro forms with purified MAO A was investigated.  All the compds. tested were reversible competitive inhibitors selective for MAO A, in agreement with previous studies on membrane prepns.  The oxidn. of kynuramine by MAO A in the presence of the more effective inhibitors showed a lag period before reaching the steady state.  In general, the 1-Me and 7-methoxy substituents increased the potency.  Harmine, 2-methylharminium, 2,9-dimethylharminium, and harmaline were the most effective inhibitors of the purified MAO A, with low Ki values of 5,69, 15, and 48 nM, resp.  The inhibitors interacted with the covalently bound flavin to induce distinct spectral changes, the magnitude of which correlated with the efficacy of the inhibition.  The more effective inhibitors could be in situ inhibitors of MAO A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkrxSogWwJzrVg90H21EOLACvtfcHk0lgFTQwBcst1HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlGitg%253D%253D&md5=04c6fecf6acc0097ab0ee54d0b6fb1e6</span></div><a href="/servlet/linkout?suffix=cit68a&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1996.9771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1996.9771%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DSablin%26aufirst%3DS.%2BO.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520A%2520by%2520%25CE%25B2-carboline%2520derivatives%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1997%26volume%3D337%26spage%3D137%26epage%3D142%26doi%3D10.1006%2Fabbi.1996.9771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit68b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Samoylenko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekwani, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, I.</span></span> <span> </span><span class="NLM_article-title"><i>Banisteriopsis caapi</i>, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson’s disease</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2009.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.jep.2009.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=19879939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot12msg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2010&pages=357-367&author=V.+Samoylenkoauthor=M.+Rahmanauthor=B.+L.+Tekwaniauthor=L.+M.+Tripathiauthor=Y.+H.+Wangauthor=S.+I.+Khanauthor=I.+A.+Khanauthor=L.+S.+Millerauthor=V.+C.+Joshiauthor=I.+Muhammad&title=Banisteriopsis+caapi%2C+a+unique+combination+of+MAO+inhibitory+and+antioxidative+constituents+for+the+activities+relevant+to+neurodegenerative+disorders+and+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.jep.2009.10.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68bR"><div class="casContent"><span class="casTitleNuber">68b</span><div class="casTitle"><span class="NLM_cas:atitle">Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease</span></div><div class="casAuthors">Samoylenko, Volodymyr; Rahman, Md. Mostafizur; Tekwani, Babu L.; Tripathi, Lalit M.; Wang, Yan-Hong; Khan, Shabana I.; Khan, Ikhlas A.; Miller, Loren S.; Joshi, Vaishali C.; Muhammad, Ilias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Aim of the study: Parkinson's disease is a neurol. disorder mostly effecting the elder population of the world.  Currently there is no definitive treatment or cure for this disease.  Therefore, in this study the compn. and constituents of the aq. ext. of Banisteriopsis caapi for monoamine oxidases (MAO) inhibitory and antioxidant activities were assessed, which are relevant to the prevention of neurol. disorders, including Parkinsonism.  Materials and methods: The aq. ext. of Banisteriopsis caapi stems was standardized and then fractionated using reversed-phase (RP) chromatog.  Pure compds. were isolated either by reversed-phase (RP) chromatog. or centrifugal preparative TLC, using a Chromatotron.  Structure elucidation was carried out by 1D and 2D NMR, Mass, IR and CD spectroscopy and chem. derivatization.  Chem. profiling of the ext. was carried out with RP-HPLC.  The inhibitory activity of MAO-A, MAO-B, acetylcholinesterase, butyrylcholinesterase and catechol-O-Me transferase enzymes, as well as antioxidant and cytotoxic activities of both Banisteriopsis caapi ext. and isolated compds. was evaluated.  Results: An examn. of the aq. exts. of Banisteriopsis caapi cultivar Da Vine yielded two new alkaloidal glycosides, named banistenoside A (1) and banistenoside B (2), contg. "azepino[1,2-a]tetrahydro-β-carboline" unique carbon framework.  One addnl. new natural tetrahydronorharmine (4), four known β-carbolines harmol (3), tetrahydroharmine (5), harmaline (6) and harmine (7), two known proanthocyanidines (-)-epicatechin (8) and (-)-procyanidin B2 (9), and a new disaccharide β--fructofuranosyl-(2 → 5)-fructopyranose (14) together with known saccharose (15) and β--glucose (16) were also isolated.  In addn., the acetates of 1, 2, 8, 9, 14 and 15 (compds. 10-13, 17, 18) were also prepd.  Harmaline (6) and harmine (7) showed potent in vitro inhibitory activity against recombinant human brain monoamine oxidase (MAO)-A and -B enzymes (IC50 2.5 and 2.0 nM, and 25 and 20 μM, resp.), and (-)-epicatechin (8) and (-)-procyanidin B2 (9) showed potent antioxidant and moderate MAO-B inhibitory activities (IC50 < 0.13 and 0.57 μg/mL, and 65 and 35 μM).  HPLC anal. revealed that most of the dominant chem. and bioactive markers (1, 2, 5, 7-9) were present in high concns. in dried bark of large branch.  Anal. of regular/com. Banisteriopsis caapi dried stems showed a similar qual. HPLC pattern, but relatively low content of dominant markers 1, 2, 7, and 9, which led to decreased MAO inhibitory and antioxidant potency.  Conclusion: Collectively, these results give addnl. basis to the existing claim of Banisteriopsis caapi stem ext. for the treatment of Parkinsonism, including other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaBgCrkOfxxrVg90H21EOLACvtfcHk0lhgxgGErp_hSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot12msg%253D%253D&md5=85cf0e8497c021bb6fb3107d6e72670a</span></div><a href="/servlet/linkout?suffix=cit68b&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2009.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2009.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DSamoylenko%26aufirst%3DV.%26aulast%3DRahman%26aufirst%3DM.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DTripathi%26aufirst%3DL.%2BM.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26aulast%3DMiller%26aufirst%3DL.%2BS.%26aulast%3DJoshi%26aufirst%3DV.%2BC.%26aulast%3DMuhammad%26aufirst%3DI.%26atitle%3DBanisteriopsis%2520caapi%252C%2520a%2520unique%2520combination%2520of%2520MAO%2520inhibitory%2520and%2520antioxidative%2520constituents%2520for%2520the%2520activities%2520relevant%2520to%2520neurodegenerative%2520disorders%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2010%26volume%3D127%26spage%3D357%26epage%3D367%26doi%3D10.1016%2Fj.jep.2009.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit68c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Reniers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masereel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmc.2010.11.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21183355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=134-144&author=J.+Reniersauthor=S.+Robertauthor=R.+Frederickauthor=B.+Masereelauthor=S.+Vincentauthor=J.+Wouters&title=Synthesis+and+evaluation+of+%CE%B2-carboline+derivatives+as+potential+monoamine+oxidase+inhibitors&doi=10.1016%2Fj.bmc.2010.11.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68cR"><div class="casContent"><span class="casTitleNuber">68c</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span></div><div class="casAuthors">Reniers, J.; Robert, S.; Frederick, R.; Masereel, B.; Vincent, S.; Wouters, J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-144</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies have shown that harmine is a reversible inhibitor of human monoamine oxidase A (MAO-A).  Moreover, the crystal structure of human MAO-A in complex with harmine has been recently solved.  This crystal structure shows that close to the methoxy group of the harmine moiety, a lipophilic pocket is left vacant within the binding site of human MAO-A.  Our objective was to optimize the β-carboline series against human MAO-A in order to explore this pocket.  Therefore, a series of β-carboline derivs. has been synthesized.  The compds. were evaluated for their human monoamine oxidase A and B inhibitory potency and their Ki values were estd.  The results show that O-alkylated compds. with lipophilic groups like cyclohexyl, Ph and aliph. chains increase the inhibition of MAO-A compared to harmine.  Compd. 3e (I), with the trifluorobutyloxy group, was the most active of this series, with a Ki against MAO-A of 3.6 nM.  Mol. docking studies show that the trifluorobutyloxy chain occupies the hydrophobic pocket vacant with harmine.  The O-alkylated compds. are less active on MAO-B than on MAO-A.  However, several compds. show a better inhibition on MAO-B compared to harmine.  Compd. 3f, with the cyclohexylmethoxy chain, displayed the best inhibitory activity against MAO-B with a Ki value of 221.6 nM.  This cyclohexyl bearing analog is also a potent MAO-A inhibitor with a Ki value of 4.3 nM.  Mol. docking studies show that the cyclohexyl chain also occupies a hydrophobic pocket but in different ways in MAO-A or MAO-B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz8NiKL6ru47Vg90H21EOLACvtfcHk0lhgxgGErp_hSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D&md5=8e6a16abe22ac5353add1a3eab31d4fb</span></div><a href="/servlet/linkout?suffix=cit68c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DReniers%26aufirst%3DJ.%26aulast%3DRobert%26aufirst%3DS.%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DS.%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%25CE%25B2-carboline%2520derivatives%2520as%2520potential%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D134%26epage%3D144%26doi%3D10.1016%2Fj.bmc.2010.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, D. J.</span></span> <span> </span><span class="NLM_article-title">Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2004.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.pharmthera.2004.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=15163593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVCitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2004&pages=111-129&author=D.+J.+McKenna&title=Clinical+investigations+of+the+therapeutic+potential+of+ayahuasca%3A+rationale+and+regulatory+challenges&doi=10.1016%2Fj.pharmthera.2004.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69aR"><div class="casContent"><span class="casTitleNuber">69a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges</span></div><div class="casAuthors">McKenna, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-129</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Ayahuasca is a hallucinogenic beverage that is prominent in the ethnomedicine and shamanism of indigenous Amazonian tribes.  Its unique pharmacol. depends on the oral activity of the hallucinogen, N,N-dimethyltryptamine (DMT), which results from inhibition of monoamine oxidase (MAO) by β-carboline alkaloids.  MAO is the enzyme that normally degrades DMT in the liver and gut.  Ayahuasca has long been integrated into mestizo folk medicine in the northwest Amazon.  In Brazil, it is used as a sacrament by several syncretic churches.  Some of these organizations have incorporated in the United States.  The recreational and religious use of ayahuasca in the United States, as well as "ayahuasca tourism" in the Amazon, is increasing.  The current legal status of ayahuasca or its source plants in the United States is unclear, although DMT is a Schedule I controlled substance.  One ayahuasca church has received favorable rulings in 2 federal courts in response to its petition to the Department of Justice for the right to use ayahuasca under the Religious Freedom Restoration Act.  A biomedical study of one of the churches, the Un~iao do Vegetal (UDV), indicated that ayahuasca may have therapeutic applications for the treatment of alcoholism, substance abuse, and possibly other disorders.  Clin. studies conducted in Spain have demonstrated that ayahuasca can be used safely in normal healthy adults, but have done little to clarify its potential therapeutic uses.  Because of ayahuasca's ill-defined legal status and variable botanical and chem. compn., clin. investigations in the United States, ideally under an approved Investigational New Drug (IND) protocol, are complicated by both regulatory and methodol. issues.  This article provides an overview of ayahuasca and discusses some of the challenges that must be overcome before it can be clin. investigated in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCoBn82YvdZ7Vg90H21EOLACvtfcHk0lgfYlqWrxrovw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVCitbk%253D&md5=f44206dc223bee9a44b26b12f7f56a7c</span></div><a href="/servlet/linkout?suffix=cit69a&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DMcKenna%26aufirst%3DD.%2BJ.%26atitle%3DClinical%2520investigations%2520of%2520the%2520therapeutic%2520potential%2520of%2520ayahuasca%253A%2520rationale%2520and%2520regulatory%2520challenges%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D102%26spage%3D111%26epage%3D129%26doi%3D10.1016%2Fj.pharmthera.2004.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit69b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastos, M. de L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guedes
de Pinho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, M.</span></span> <span> </span><span class="NLM_article-title">The hallucinogenic world of tryptamines: an updated review</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">1151</span>– <span class="NLM_lpage">1173</span>, <span class="refDoi"> DOI: 10.1007/s00204-015-1513-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1007%2Fs00204-015-1513-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25877327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXms1Grt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=1151-1173&author=A.+M.+Araujoauthor=F.+Carvalhoauthor=M.+de+L.+Bastosauthor=P.+Guedes%0Ade+Pinhoauthor=M.+Carvalho&title=The+hallucinogenic+world+of+tryptamines%3A+an+updated+review&doi=10.1007%2Fs00204-015-1513-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69bR"><div class="casContent"><span class="casTitleNuber">69b</span><div class="casTitle"><span class="NLM_cas:atitle">The hallucinogenic world of tryptamines: an updated review</span></div><div class="casAuthors">Araujo, Ana Margarida; Carvalho, Felix; Bastos, Maria de Lourdes; Guedes de Pinho, Paula; Carvalho, Marcia</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1151-1173</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In the area of psychotropic drugs, tryptamines are known to be a broad class of classical or serotonergic hallucinogens.  These drugs are capable of producing profound changes in sensory perception, mood and thought in humans and act primarily as agonists of the 5-HT2A receptor.  Well-known tryptamines such as psilocybin contained in Aztec sacred mushrooms and N,N-dimethyltryptamine (DMT), present in South American psychoactive beverage ayahuasca, have been restrictedly used since ancient times in sociocultural and ritual contexts.  However, with the discovery of hallucinogenic properties of lysergic acid diethylamide (LSD) in mid-1900s, tryptamines began to be used recreationally among young people.  More recently, new synthetically produced tryptamine hallucinogens, such as alpha-methyltryptamine (AMT), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), emerged in the recreational drug market, which have been claimed as the next-generation designer drugs to replace LSD ('legal' alternatives to LSD).  Tryptamine derivs. are widely accessible over the Internet through companies selling them as 'research chems.', but can also be sold in 'headshops' and street dealers.  Reports of intoxication and deaths related to the use of new tryptamines have been described over the last years, raising international concern over tryptamines.  However, the lack of literature pertaining to pharmacol. and toxicol. properties of new tryptamine hallucinogens hampers the assessment of their actual potential harm to general public health.  This review provides a comprehensive update on tryptamine hallucinogens, concerning their historical background, prevalence, patterns of use and legal status, chem., toxicokinetics, toxicodynamics and their physiol. and toxicol. effects on animals and humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSfClZKsa4RrVg90H21EOLACvtfcHk0lgElQn1lnUW4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXms1Grt7s%253D&md5=719ab1ac55f187d434d769efeaccfef9</span></div><a href="/servlet/linkout?suffix=cit69b&amp;dbid=16384&amp;doi=10.1007%2Fs00204-015-1513-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-015-1513-x%26sid%3Dliteratum%253Aachs%26aulast%3DAraujo%26aufirst%3DA.%2BM.%26aulast%3DCarvalho%26aufirst%3DF.%26aulast%3DBastos%26aufirst%3DM.%2Bde%2BL.%26aulast%3DGuedes%2Bde%2BPinho%26aufirst%3DP.%26aulast%3DCarvalho%26aufirst%3DM.%26atitle%3DThe%2520hallucinogenic%2520world%2520of%2520tryptamines%253A%2520an%2520updated%2520review%26jtitle%3DArch.%2520Toxicol.%26date%3D2015%26volume%3D89%26spage%3D1151%26epage%3D1173%26doi%3D10.1007%2Fs00204-015-1513-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balint, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzalegui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbridge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotschy, A. S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and synthesis of harmine derivatives with different selectivity profiles in kinase versus monoamine oxidase inhibition</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1002%2Fcmdc.201600539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=28264138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1Wisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=932-939&author=B.+Balintauthor=C.+Weberauthor=F.+Cruzaleguiauthor=M.+Burbridgeauthor=A.+S.+Kotschy&title=Structure-based+design+and+synthesis+of+harmine+derivatives+with+different+selectivity+profiles+in+kinase+versus+monoamine+oxidase+inhibition&doi=10.1002%2Fcmdc.201600539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Synthesis of Harmine Derivatives with Different Selectivity Profiles in Kinase versus Monoamine Oxidase Inhibition</span></div><div class="casAuthors">Balint, Balazs; Weber, Csaba; Cruzalegui, Francisco; Burbridge, Mike; Kotschy, Andras</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">932-939</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is an emerging biol. target with implications in diverse therapeutic areas such as neurol. disorders (Down syndrome, in particular), metab., and oncol.  Harmine, a natural product that selectively inhibits DYRK1A amongst kinases, could serve as a tool compd. to better understand the biol. processes that arise from DYRK1A inhibition.  On the other hand, harmine is also a potent inhibitor of monoamine oxidase A (MAO-A).  Using structure-based design, we synthesized a collection of harmine analogs with tunable selectivity toward these two enzymes.  Modifications at the 7-position typically decreased affinity for DYRK1A, whereas substitution at the 9-position had a similar effect on MAO-A inhibition but DYRK1A inhibition was maintained.  The resulting collection of compds. can help to understand the biol. role of DYRK1A and also to assess the interference in the biol. effect originating in MAO-A inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsY4lpVOJVlbVg90H21EOLACvtfcHk0lgElQn1lnUW4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1Wisro%253D&md5=f713602f24c608cbe5c97d965ea3727d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600539%26sid%3Dliteratum%253Aachs%26aulast%3DBalint%26aufirst%3DB.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DCruzalegui%26aufirst%3DF.%26aulast%3DBurbridge%26aufirst%3DM.%26aulast%3DKotschy%26aufirst%3DA.%2BS.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520harmine%2520derivatives%2520with%2520different%2520selectivity%2520profiles%2520in%2520kinase%2520versus%2520monoamine%2520oxidase%2520inhibition%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D932%26epage%3D939%26doi%3D10.1002%2Fcmdc.201600539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarragiotto, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span> <span> </span><span class="NLM_article-title">Computational and experimental evaluation of the structure/activity relationship of β-carbolines as DYRK1A inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4854</span>– <span class="NLM_lpage">4860</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2014.08.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4854-4860&author=B.+Drungauthor=C.+Scholzauthor=V.+Barbosaauthor=A.+Nazariauthor=M.+H.+Sarragiottoauthor=B.+Schmidt&title=Computational+and+experimental+evaluation+of+the+structure%2Factivity+relationship+of+%CE%B2-carbolines+as+DYRK1A+inhibitors&doi=10.1016%2Fj.bmcl.2014.08.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.054%26sid%3Dliteratum%253Aachs%26aulast%3DDrung%26aufirst%3DB.%26aulast%3DScholz%26aufirst%3DC.%26aulast%3DBarbosa%26aufirst%3DV.%26aulast%3DNazari%26aufirst%3DA.%26aulast%3DSarragiotto%26aufirst%3DM.%2BH.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DComputational%2520and%2520experimental%2520evaluation%2520of%2520the%2520structure%252Factivity%2520relationship%2520of%2520%25CE%25B2-carbolines%2520as%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4854%26epage%3D4860%26doi%3D10.1016%2Fj.bmcl.2014.08.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruben, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurzlbauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Selectivity profiling and biological activity of novel β-carbolines as potent and selective DYRK1 kinase inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0132453</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0132453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1371%2Fjournal.pone.0132453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26192590" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0132453&author=K.+Rubenauthor=A.+Wurzlbauerauthor=A.+Walteauthor=W.+Sipplauthor=F.+Bracherauthor=W.+Becker&title=Selectivity+profiling+and+biological+activity+of+novel+%CE%B2-carbolines+as+potent+and+selective+DYRK1+kinase+inhibitors&doi=10.1371%2Fjournal.pone.0132453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132453%26sid%3Dliteratum%253Aachs%26aulast%3DRuben%26aufirst%3DK.%26aulast%3DWurzlbauer%26aufirst%3DA.%26aulast%3DWalte%26aufirst%3DA.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DSelectivity%2520profiling%2520and%2520biological%2520activity%2520of%2520novel%2520%25CE%25B2-carbolines%2520as%2520potent%2520and%2520selective%2520DYRK1%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0132453%26doi%3D10.1371%2Fjournal.pone.0132453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruben, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birner-Gruenberger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preisinger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamberg-Lemper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Mechanism of dual specificity kinase activity of DYRK1A</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">4495</span>– <span class="NLM_lpage">4511</span>, <span class="refDoi"> DOI: 10.1111/febs.12411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Ffebs.12411" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=4495-4511&author=A.+Walteauthor=K.+Rubenauthor=R.+Birner-Gruenbergerauthor=C.+Preisingerauthor=S.+Bamberg-Lemperauthor=N.+Hilzauthor=F.+Bracherauthor=W.+Becker&title=Mechanism+of+dual+specificity+kinase+activity+of+DYRK1A&doi=10.1111%2Ffebs.12411"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12411%26sid%3Dliteratum%253Aachs%26aulast%3DWalte%26aufirst%3DA.%26aulast%3DRuben%26aufirst%3DK.%26aulast%3DBirner-Gruenberger%26aufirst%3DR.%26aulast%3DPreisinger%26aufirst%3DC.%26aulast%3DBamberg-Lemper%26aufirst%3DS.%26aulast%3DHilz%26aufirst%3DN.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DMechanism%2520of%2520dual%2520specificity%2520kinase%2520activity%2520of%2520DYRK1A%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D4495%26epage%3D4511%26doi%3D10.1111%2Ffebs.12411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beniddir, M.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Borgne, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iorga, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litaudon, M.</span></span> <span> </span><span class="NLM_article-title">Acridone alkaloids from <i>Glycosmis chlorosperma</i> as DYRK1A inhibitors</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1117</span>– <span class="NLM_lpage">1122</span>, <span class="refDoi"> DOI: 10.1021/np400856h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400856h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=1117-1122&author=M.%0AA.+Beniddirauthor=E.+Le+Borgneauthor=B.+I.+Iorgaauthor=N.+Loa%C3%ABcauthor=O.+Lozachauthor=L.+Meijerauthor=K.+Awangauthor=M.+Litaudon&title=Acridone+alkaloids+from+Glycosmis+chlorosperma+as+DYRK1A+inhibitors&doi=10.1021%2Fnp400856h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fnp400856h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400856h%26sid%3Dliteratum%253Aachs%26aulast%3DBeniddir%26aufirst%3DM.%2BA.%26aulast%3DLe%2BBorgne%26aufirst%3DE.%26aulast%3DIorga%26aufirst%3DB.%2BI.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAwang%26aufirst%3DK.%26aulast%3DLitaudon%26aufirst%3DM.%26atitle%3DAcridone%2520alkaloids%2520from%2520Glycosmis%2520chlorosperma%2520as%2520DYRK1A%2520inhibitors%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2014%26volume%3D77%26spage%3D1117%26epage%3D1122%26doi%3D10.1021%2Fnp400856h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemling, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offen, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Brosse, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarau, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westley, J. W.</span></span> <span> </span><span class="NLM_article-title">New leukotriene B4 receptor antagonist: leucettamine A and related imidazole alkaloids from the marine sponge <i>Leucetta microraphis</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1021/np50091a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50091a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1993&pages=116-121&author=G.+W.+Chanauthor=S.+Mongauthor=M.+E.+Hemlingauthor=A.+J.+Freyerauthor=P.+M.+Offenauthor=C.+W.+De+Brosseauthor=H.+M.+Sarauauthor=J.+W.+Westley&title=New+leukotriene+B4+receptor+antagonist%3A+leucettamine+A+and+related+imidazole+alkaloids+from+the+marine+sponge+Leucetta+microraphis&doi=10.1021%2Fnp50091a016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75a&amp;dbid=16384&amp;doi=10.1021%2Fnp50091a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50091a016%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%2BW.%26aulast%3DMong%26aufirst%3DS.%26aulast%3DHemling%26aufirst%3DM.%2BE.%26aulast%3DFreyer%26aufirst%3DA.%2BJ.%26aulast%3DOffen%26aufirst%3DP.%2BM.%26aulast%3DDe%2BBrosse%26aufirst%3DC.%2BW.%26aulast%3DSarau%26aufirst%3DH.%2BM.%26aulast%3DWestley%26aufirst%3DJ.%2BW.%26atitle%3DNew%2520leukotriene%2520B4%2520receptor%2520antagonist%253A%2520leucettamine%2520A%2520and%2520related%2520imidazole%2520alkaloids%2520from%2520the%2520marine%2520sponge%2520Leucetta%2520microraphis%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1993%26volume%3D56%26spage%3D116%26epage%3D121%26doi%3D10.1021%2Fnp50091a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit75b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwashima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iguchi, K.</span></span> <span> </span><span class="NLM_article-title">A new bioactive triene aldehyde from the marine sponge <i>Leucetta microraphis</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">258</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1021/np9903503</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np9903503" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2000&pages=258-260&author=K.+Watanabeauthor=Y.+Tsudaauthor=M.+Iwashimaauthor=K.+Iguchi&title=A+new+bioactive+triene+aldehyde+from+the+marine+sponge+Leucetta+microraphis&doi=10.1021%2Fnp9903503"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75b&amp;dbid=16384&amp;doi=10.1021%2Fnp9903503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp9903503%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DY.%26aulast%3DIwashima%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DK.%26atitle%3DA%2520new%2520bioactive%2520triene%2520aldehyde%2520from%2520the%2520marine%2520sponge%2520Leucetta%2520microraphis%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2000%26volume%3D63%26spage%3D258%26epage%3D260%26doi%3D10.1021%2Fnp9903503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attanasio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villiers, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alencar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roué, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguet-Kondracki, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proksch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limanton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiheneuf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klautau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Marine-derived 2-aminoimidazolone alkaloids. Leucettamine B-related polyandrocarpamines inhibit mammalian and protozoan DYRK & CLK kinases</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">316</span>, <span class="refDoi"> DOI: 10.3390/md15100316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.3390%2Fmd15100316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVKnt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=316&author=N.+Loa%C3%ABcauthor=E.+Attanasioauthor=B.+Villiersauthor=E.+Durieuauthor=T.+Tahtouhauthor=M.+Camauthor=R.+A.+Davisauthor=A.+Alencarauthor=M.+Rou%C3%A9author=M.-L.+Bourguet-Kondrackiauthor=P.+Prokschauthor=E.+Limantonauthor=S.+Guiheneufauthor=F.+Carreauxauthor=J.-P.+Bazureauauthor=M.+Klautauauthor=L.+Meijer&title=Marine-derived+2-aminoimidazolone+alkaloids.+Leucettamine+B-related+polyandrocarpamines+inhibit+mammalian+and+protozoan+DYRK+%26+CLK+kinases&doi=10.3390%2Fmd15100316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Marine-derived 2-aminoimidazolone alkaloids. leucettamine B-related polyandrocarpamines inhibit mammalian and protozoan DYRK & CLK kinases</span></div><div class="casAuthors">Loaec, Nadege; Attanasio, Eletta; Villiers, Benoit; Durieu, Emilie; Tahtouh, Tania; Cam, Morgane; Davis, Rohan A.; Alencar, Aline; Roue, Melanie; Bourguet-Kondracki, Marie-Lise; Proksch, Peter; Limanton, Emmanuelle; Guiheneuf, Olene; Carreaux, Francois; Bazureau, Jean-Pierre; Klautau, Michelle; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">316/1-316/15</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A large diversity of 2-aminoimidazolone alkaloids is produced by various marine invertebrates, esp. by the marine Calcareous sponges Leucetta and Clathrina.  The phylogeny of these sponges and the wide scope of 2-aminoimidazolone alkaloids they produce are reviewed in this article.  The origin (invertebrate cells, assocd. microorganisms, or filtered plankton), physiol. functions, and natural mol. targets of these alkaloids are largely unknown.  Following the identification of leucettamine B as an inhibitor of selected protein kinases, we synthesized a family of analogs, collectively named leucettines, as potent inhibitors of DYRKs (dual-specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) and potential pharmacol. leads for the treatment of several diseases, including Alzheimer's disease and Down syndrome.  We assembled a small library of marine sponge- and ascidian-derived 2-aminoimidazolone alkaloids, along with several synthetic analogs, and tested them on a panel of mammalian and protozoan kinases.  Polyandrocarpamines A and B were found to be potent and selective inhibitors of DYRKs and CLKs.  They inhibited cyclin D1 phosphorylation on a DYRK1A phosphosite in cultured cells. 2-Aminoimidazolones thus represent a promising chem. scaffold for the design of potential therapeutic drug candidates acting as specific inhibitors of disease-relevant kinases, and possibly other disease-relevant targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVUruCIbF4drVg90H21EOLACvtfcHk0lgBDRNTVlg8HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVKnt77J&md5=c3132730ae4c301918038bf0e4a13433</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.3390%2Fmd15100316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd15100316%26sid%3Dliteratum%253Aachs%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DAttanasio%26aufirst%3DE.%26aulast%3DVilliers%26aufirst%3DB.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DCam%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DR.%2BA.%26aulast%3DAlencar%26aufirst%3DA.%26aulast%3DRou%25C3%25A9%26aufirst%3DM.%26aulast%3DBourguet-Kondracki%26aufirst%3DM.-L.%26aulast%3DProksch%26aufirst%3DP.%26aulast%3DLimanton%26aufirst%3DE.%26aulast%3DGuiheneuf%26aufirst%3DS.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26aulast%3DKlautau%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DMarine-derived%25202-aminoimidazolone%2520alkaloids.%2520Leucettamine%2520B-related%2520polyandrocarpamines%2520inhibit%2520mammalian%2520and%2520protozoan%2520DYRK%2520%2526%2520CLK%2520kinases%26jtitle%3DMar.%2520Drugs%26date%3D2017%26volume%3D15%26spage%3D316%26doi%3D10.3390%2Fmd15100316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhommel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberholzer, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Selectivity, co-crystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9312</span>– <span class="NLM_lpage">9330</span>, <span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+co-crystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520co-crystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Naert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferré, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmstrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Givalois, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25–35 peptide administration in mice</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2170</span>– <span class="NLM_lpage">2182</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2015.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.euroneuro.2015.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26381812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2170-2182&author=G.+Naertauthor=V.+Ferr%C3%A9author=J.+Meunierauthor=E.+Kellerauthor=S.+Malmstromauthor=L.+Givaloisauthor=F.+Carreauxauthor=J.+P.+Bazureauauthor=T.+Maurice&title=Leucettine+L41%2C+a+DYRK1A-preferential+DYRKs%2FCLKs+inhibitor%2C+prevents+memory+impairments+and+neurotoxicity+induced+by+oligomeric+A%CE%B225%E2%80%9335+peptide+administration+in+mice&doi=10.1016%2Fj.euroneuro.2015.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78aR"><div class="casContent"><span class="casTitleNuber">78a</span><div class="casTitle"><span class="NLM_cas:atitle">Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice</span></div><div class="casAuthors">Naert, Gaelle; Ferre, Valentine; Meunier, Johann; Keller, Emeline; Malmstrom, Susanna; Givalois, Laurent; Carreaux, Francois; Bazureau, Jean-Pierre; Maurice, Tangui</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2170-2182</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) are implicated in the onset and progression of Down syndrome (DS) and Alzheimer's disease (AD).  DYRK1A has emerged as a possible link between amyloid-β (Aβ) and Tau, the major pathol. proteins in AD.  We here assessed the neuroprotective potential of a novel inhibitor of DYRKs/CLKs.  The Leucettine L41, acting preferentially on DYRK1A, was tested in Aβ25-35-treated mice, a nontransgenic model of AD-like toxicity.  We co-injected intracerebroventricularly oligomeric Aβ25-35 peptide and L41 in Swiss male mice.  After 7 days, they were submitted to behavioral tests addressing spatial and non-spatial, short- and long-term memories.  The oxidative stress, apoptotic markers, kinases involved in Tau phosphorylation, and synaptic integrity were analyzed by Western blot and ELISA in the hippocampus.  L41, tested at 0.4, 1.2, 4 μg, prevented the Aβ25-35-induced memory deficits in the Y-maze, passive avoidance and water-maze tests, with the most active dose being 4 μg.  The inhibitor prevented the Aβ25-35-induced oxidative stress, as revealed by measures of lipid peroxidn. levels and reactive oxygen species accumulation, and abolished Aβ25-35-induced expression of pro-apoptotic markers.  L41 prevented the Aβ25-35-induced decrease of AKT activation and increase of glycogen synthase kinase-3β (GSK-3β) activation, resulting in a decrease of Tau phosphorylation.  Finally, L41 restored Aβ25-35-reduced levels of synaptic markers.  The novel DYRK1A-preferential inhibitor L41 therefore prevented Aβ25-35-induced memory impairments and neurotoxicity in the mouse hippocampus.  These in vivo data highlighted particularly DYRK1A as a major kinase involved in Aβ pathol. and suggested therapeutic developments for DYRK1A inhibitors in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSRN-4HYiJs7Vg90H21EOLACvtfcHk0lgBDRNTVlg8HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFemsro%253D&md5=0ddd499193f1ef57d02b46a39f225abb</span></div><a href="/servlet/linkout?suffix=cit78a&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2015.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2015.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DNaert%26aufirst%3DG.%26aulast%3DFerr%25C3%25A9%26aufirst%3DV.%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DE.%26aulast%3DMalmstrom%26aufirst%3DS.%26aulast%3DGivalois%26aufirst%3DL.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DLeucettine%2520L41%252C%2520a%2520DYRK1A-preferential%2520DYRKs%252FCLKs%2520inhibitor%252C%2520prevents%2520memory%2520impairments%2520and%2520neurotoxicity%2520induced%2520by%2520oligomeric%2520A%25CE%25B225%25E2%2580%259335%2520peptide%2520administration%2520in%2520mice%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2015%26volume%3D25%26spage%3D2170%26epage%3D2182%26doi%3D10.1016%2Fj.euroneuro.2015.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit78b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Debdab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babault, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baratte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenreich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span> <span> </span><span class="NLM_article-title">Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4172</span>– <span class="NLM_lpage">4186</span>, <span class="refDoi"> DOI: 10.1021/jm200274d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200274d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4172-4186&author=M.+Debdabauthor=F.+Carreauxauthor=S.+Renaultauthor=M.+Soundararajanauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=O.+Lozachauthor=L.+Babaultauthor=T.+Tahtouhauthor=B.+Baratteauthor=Y.+Ogawaauthor=M.+Hagiwaraauthor=A.+Eisenreichauthor=U.+Rauchauthor=S.+Knappauthor=L.+Meijerauthor=J.+P.+Bazureau&title=Leucettines%2C+a+class+of+potent+inhibitors+of+cdc2-like+kinases+and+dual+specificity%2C+tyrosine+phosphorylation+regulated+kinases+derived+from+the+marine+sponge+leucettamine+B%3A+modulation+of+alternative+pre-RNA+splicing&doi=10.1021%2Fjm200274d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78b&amp;dbid=16384&amp;doi=10.1021%2Fjm200274d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200274d%26sid%3Dliteratum%253Aachs%26aulast%3DDebdab%26aufirst%3DM.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DRenault%26aufirst%3DS.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBabault%26aufirst%3DL.%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DHagiwara%26aufirst%3DM.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26atitle%3DLeucettines%252C%2520a%2520class%2520of%2520potent%2520inhibitors%2520of%2520cdc2-like%2520kinases%2520and%2520dual%2520specificity%252C%2520tyrosine%2520phosphorylation%2520regulated%2520kinases%2520derived%2520from%2520the%2520marine%2520sponge%2520leucettamine%2520B%253A%2520modulation%2520of%2520alternative%2520pre-RNA%2520splicing%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4172%26epage%3D4186%26doi%3D10.1021%2Fjm200274d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foll-Josselin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limanton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J. P.</span></span> <span> </span><span class="NLM_article-title">Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">737</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.01.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2013.01.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=728-737&author=G.+Burgyauthor=T.+Tahtouhauthor=E.+Durieuauthor=B.+Foll-Josselinauthor=E.+Limantonauthor=L.+Meijerauthor=F.+Carreauxauthor=J.+P.+Bazureau&title=Chemical+synthesis+and+biological+validation+of+immobilized+protein+kinase+inhibitory+Leucettines&doi=10.1016%2Fj.ejmech.2013.01.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.01.035%26sid%3Dliteratum%253Aachs%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DFoll-Josselin%26aufirst%3DB.%26aulast%3DLimanton%26aufirst%3DE.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.%2BP.%26atitle%3DChemical%2520synthesis%2520and%2520biological%2520validation%2520of%2520immobilized%2520protein%2520kinase%2520inhibitory%2520Leucettines%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D62%26spage%3D728%26epage%3D737%26doi%3D10.1016%2Fj.ejmech.2013.01.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterlin Masic, L. P.</span></span> <span> </span><span class="NLM_article-title">Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1517/17460441.2012.688743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1517%2F17460441.2012.688743" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=549-560&author=T.+Tomasicauthor=L.+P.+Peterlin+Masic&title=Rhodanine+as+a+scaffold+in+drug+discovery%3A+a+critical+review+of+its+biological+activities+and+mechanisms+of+target+modulation&doi=10.1517%2F17460441.2012.688743"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80a&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.688743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.688743%26sid%3Dliteratum%253Aachs%26aulast%3DTomasic%26aufirst%3DT.%26aulast%3DPeterlin%2BMasic%26aufirst%3DL.%2BP.%26atitle%3DRhodanine%2520as%2520a%2520scaffold%2520in%2520drug%2520discovery%253A%2520a%2520critical%2520review%2520of%2520its%2520biological%2520activities%2520and%2520mechanisms%2520of%2520target%2520modulation%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D549%26epage%3D560%26doi%3D10.1517%2F17460441.2012.688743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit80b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gilberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpfe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Activity profiles of analog series containing pan assay interference compounds</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">35638</span>– <span class="NLM_lpage">35647</span>, <span class="refDoi"> DOI: 10.1039/C7RA06736D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1039%2FC7RA06736D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFyhs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=35638-35647&author=E.+Gilbergauthor=D.+Stumpfeauthor=J.+Bajorath&title=Activity+profiles+of+analog+series+containing+pan+assay+interference+compounds&doi=10.1039%2FC7RA06736D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80bR"><div class="casContent"><span class="casTitleNuber">80b</span><div class="casTitle"><span class="NLM_cas:atitle">Activity profiles of analog series containing pan assay interference compounds</span></div><div class="casAuthors">Gilberg, Erik; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">57</span>),
    <span class="NLM_cas:pages">35638-35647</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Activity artifacts in assays present a major problem for biol. screening and medicinal chem.  Such artifacts are often caused by compds. that form aggregates or are reactive under assay conditions.  Many pan assay interference compds. (PAINS) have been proposed to cause false-pos. assay readouts.  PAINS are typically contained as substructures in larger mols.  They are used as computational filters to detect compds. with potential chem. liabilities.  Recent studies have shown that mols. contg. the same PAINS substructure often have greatly varying hit rates in screening assays.  Even the overall most frequently active PAINS substructures are found in compds. that are only rarely active or consistently inactive in many assays they are tested in.  These observations suggest that the structural context in which PAINS are presented may play an important role for eliciting false-pos. activities.  However, this assumption remains to be investigated.  Herein, we report the systematic identification of analog series of screening compds. that contain PAINS or exclusively consist of PAINS and the anal. of their activity profiles.  Comparison of analogs or different series of analogs contg. the same PAINS substructure provides structural context information.  For many PAINS, extensively tested series with distinct activity profiles were detected.  Furthermore, analogs within the same series often displayed significant differences in hit rates.  The analog series reported herein organize PAINS in different structural contexts.  Their activity profiles provide many opportunities for exptl. follow-up investigations to better understand PAINS characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4gvYh5SuHrLVg90H21EOLACvtfcHk0lhgN1iaYwNeIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFyhs7zP&md5=88d15494e03827a9e0ca2a920a97a09a</span></div><a href="/servlet/linkout?suffix=cit80b&amp;dbid=16384&amp;doi=10.1039%2FC7RA06736D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA06736D%26sid%3Dliteratum%253Aachs%26aulast%3DGilberg%26aufirst%3DE.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DActivity%2520profiles%2520of%2520analog%2520series%2520containing%2520pan%2520assay%2520interference%2520compounds%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D35638%26epage%3D35647%26doi%3D10.1039%2FC7RA06736D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joffe, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puricelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seldes, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, J. A.</span></span> <span> </span><span class="NLM_article-title">Indole alkaloids from the tunicate <i>Aplidum meridianum</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1130</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1021/np970493u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np970493u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1998&pages=1130-1132&author=L.+H.+Francoauthor=E.+B.+Joffeauthor=L.+Puricelliauthor=M.+Tatianauthor=A.+M.+Seldesauthor=J.+A.+Palermo&title=Indole+alkaloids+from+the+tunicate+Aplidum+meridianum&doi=10.1021%2Fnp970493u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=10.1021%2Fnp970493u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp970493u%26sid%3Dliteratum%253Aachs%26aulast%3DFranco%26aufirst%3DL.%2BH.%26aulast%3DJoffe%26aufirst%3DE.%2BB.%26aulast%3DPuricelli%26aufirst%3DL.%26aulast%3DTatian%26aufirst%3DM.%26aulast%3DSeldes%26aufirst%3DA.%2BM.%26aulast%3DPalermo%26aufirst%3DJ.%2BA.%26atitle%3DIndole%2520alkaloids%2520from%2520the%2520tunicate%2520Aplidum%2520meridianum%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1998%26volume%3D61%26spage%3D1130%26epage%3D1132%26doi%3D10.1021%2Fnp970493u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit81b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Seldes, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez Brasco, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez Franco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, J. A.</span></span> <span> </span><span class="NLM_article-title">Identification of two meridianins from the crude extract of the tunicate <i>Aplidium meridianum</i> by tandem mass spectrometry</span>. <i>Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1080/14786410601133517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1080%2F14786410601133517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=17497427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFSitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=555-563&author=A.+M.+Seldesauthor=M.+F.+Rodriguez+Brascoauthor=L.+Hernandez+Francoauthor=J.+A.+Palermo&title=Identification+of+two+meridianins+from+the+crude+extract+of+the+tunicate+Aplidium+meridianum+by+tandem+mass+spectrometry&doi=10.1080%2F14786410601133517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81bR"><div class="casContent"><span class="casTitleNuber">81b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of two meridianins from the crude extract of the tunicate Aplidium meridianum by tandem mass spectrometry</span></div><div class="casAuthors">Seldes, A. M.; Brasco, M. F. Rodriguez; Franco, L. Hernandez; Palermo, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">555-563</span>CODEN:
                <span class="NLM_cas:coden">NPRAAT</span>;
        ISSN:<span class="NLM_cas:issn">1478-6419</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">As part of the development of an anal. technique for the detection of meridianins and related compds. in biol. fluids, a crude ext. of the tunicate Aplidium meridianum was analyzed using neutral loss tandem mass spectrometry.  The 41 u neutral loss-EI(+) mass spectrum showed mol. ions corresponding to two previously undetected alkaloids.  We report the isolation and structure elucidation of the alkaloids, meridianins F and G.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmCqhJsIWLdrVg90H21EOLACvtfcHk0lgMxJTdsoi_sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFSitbk%253D&md5=6ca7a7595bde47385c0437fdbea4c2a4</span></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=10.1080%2F14786410601133517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14786410601133517%26sid%3Dliteratum%253Aachs%26aulast%3DSeldes%26aufirst%3DA.%2BM.%26aulast%3DRodriguez%2BBrasco%26aufirst%3DM.%2BF.%26aulast%3DHernandez%2BFranco%26aufirst%3DL.%26aulast%3DPalermo%26aufirst%3DJ.%2BA.%26atitle%3DIdentification%2520of%2520two%2520meridianins%2520from%2520the%2520crude%2520extract%2520of%2520the%2520tunicate%2520Aplidium%2520meridianum%2520by%2520tandem%2520mass%2520spectrometry%26jtitle%3DNat.%2520Prod.%2520Res.%26date%3D2007%26volume%3D21%26spage%3D555%26epage%3D563%26doi%3D10.1080%2F14786410601133517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gompel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leost, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Kier
Joffe, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puricelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernancez Franco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Meridianins, a new family of protein kinase inhibitors isolated from the ascidian <i>Aplidium meridianum</i></span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1703</span>– <span class="NLM_lpage">1707</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.01.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2004.01.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1703-1707&author=M.+Gompelauthor=M.+Leostauthor=E.+B.+De+Kier%0AJoffeauthor=L.+Puricelliauthor=L.+Hernancez+Francoauthor=J.+Palermoauthor=L.+Meijer&title=Meridianins%2C+a+new+family+of+protein+kinase+inhibitors+isolated+from+the+ascidian+Aplidium+meridianum&doi=10.1016%2Fj.bmcl.2004.01.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.01.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.01.050%26sid%3Dliteratum%253Aachs%26aulast%3DGompel%26aufirst%3DM.%26aulast%3DLeost%26aufirst%3DM.%26aulast%3DDe%2BKier%2BJoffe%26aufirst%3DE.%2BB.%26aulast%3DPuricelli%26aufirst%3DL.%26aulast%3DHernancez%2BFranco%26aufirst%3DL.%26aulast%3DPalermo%26aufirst%3DJ.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DMeridianins%252C%2520a%2520new%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520isolated%2520from%2520the%2520ascidian%2520Aplidium%2520meridianum%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1703%26epage%3D1707%26doi%3D10.1016%2Fj.bmcl.2004.01.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit82b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Radwan, M. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Sherbiny, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antitumor activity of indolylpyrimidines: marine natural product meridianin D analogues</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1206</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmc.2006.11.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=1206-1211&author=M.+A.+A.+Radwanauthor=M.+El-Sherbiny&title=Synthesis+and+antitumor+activity+of+indolylpyrimidines%3A+marine+natural+product+meridianin+D+analogues&doi=10.1016%2Fj.bmc.2006.11.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DRadwan%26aufirst%3DM.%2BA.%2BA.%26aulast%3DEl-Sherbiny%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520antitumor%2520activity%2520of%2520indolylpyrimidines%253A%2520marine%2520natural%2520product%2520meridianin%2520D%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D1206%26epage%3D1211%26doi%3D10.1016%2Fj.bmc.2006.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giraud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debiton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nauton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thery, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anizon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, protein kinase inhibitory potencies, and <i>in vitro</i> antiproliferative activities of meridianin derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4474</span>– <span class="NLM_lpage">4489</span>, <span class="refDoi"> DOI: 10.1021/jm200464w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200464w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4474-4489&author=F.+Giraudauthor=G.+Alvesauthor=E.+Debitonauthor=L.+Nautonauthor=V.+Theryauthor=E.+Durieuauthor=Y.+Ferandinauthor=O.+Lozachauthor=L.+Meijerauthor=F.+Anizonauthor=E.+Pereiraauthor=P.+Moreau&title=Synthesis%2C+protein+kinase+inhibitory+potencies%2C+and+in+vitro+antiproliferative+activities+of+meridianin+derivatives&doi=10.1021%2Fjm200464w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Protein Kinase Inhibitory Potencies, and in Vitro Antiproliferative Activities of Meridianin Derivatives</span></div><div class="casAuthors">Giraud, Francis; Alves, Georges; Debiton, Eric; Nauton, Lionel; Thery, Vincent; Durieu, Emilie; Ferandin, Yoan; Lozach, Olivier; Meijer, Laurent; Anizon, Fabrice; Pereira, Elisabeth; Moreau, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4474-4489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of new meridianin derivs., e.g., I (X = H, Y = 7-Br; X = I, Y = 6-Br, 7-Br) (II), is described.  The indolic ring system was substituted at the C-4 to C-7 positions either by a bromine atom or by nitro or amino groups.  Addnl., an iodine atom or various aryl groups were introduced at the C-5 position of the 2-aminopyrimidine ring.  These compds., as well as some of their synthetic intermediates, were tested for their kinase inhibitory potencies and for their in vitro antiproliferative activities.  We found that this series of compds. is particularly interesting in the development of new inhibitors of DYRK1A and CLK1 kinases.  The most effective compds. toward these two kinase families are the 6- and 7-bromo derivs. II that showed more than 45-fold selectivity toward DYRK1A/CLK1 kinases over the other kinases tested.  Meridianin derivs. could thus be developed toward potent and selective inhibitors of key RNA splicing regulators and potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBjkvRn0gdELVg90H21EOLACvtfcHk0lj472_xJR3w_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt12nsb4%253D&md5=7689b7e5afd91dd2dc1b1b1c3aec6a5d</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm200464w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200464w%26sid%3Dliteratum%253Aachs%26aulast%3DGiraud%26aufirst%3DF.%26aulast%3DAlves%26aufirst%3DG.%26aulast%3DDebiton%26aufirst%3DE.%26aulast%3DNauton%26aufirst%3DL.%26aulast%3DThery%26aufirst%3DV.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DPereira%26aufirst%3DE.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520protein%2520kinase%2520inhibitory%2520potencies%252C%2520and%2520in%2520vitro%2520antiproliferative%2520activities%2520of%2520meridianin%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4474%26epage%3D4489%26doi%3D10.1021%2Fjm200464w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perry, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettouati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litaudon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blunt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, M. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hope, H.</span></span> <span> </span><span class="NLM_article-title">Alkaloids from the antarctic sponge <i>Kirkpatrickia varialosa</i>. Part 1: variolin B, a new antitumour and antiviral compound</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3987</span>– <span class="NLM_lpage">3992</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)89673-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2FS0040-4020%2801%2989673-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=3987-3992&author=N.+B.+Perryauthor=L.+Ettouatiauthor=M.+Litaudonauthor=J.+W.+Bluntauthor=M.+H.+G.+Munroauthor=S.+Parkinauthor=H.+Hope&title=Alkaloids+from+the+antarctic+sponge+Kirkpatrickia+varialosa.+Part+1%3A+variolin+B%2C+a+new+antitumour+and+antiviral+compound&doi=10.1016%2FS0040-4020%2801%2989673-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2989673-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252989673-3%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DN.%2BB.%26aulast%3DEttouati%26aufirst%3DL.%26aulast%3DLitaudon%26aufirst%3DM.%26aulast%3DBlunt%26aufirst%3DJ.%2BW.%26aulast%3DMunro%26aufirst%3DM.%2BH.%2BG.%26aulast%3DParkin%26aufirst%3DS.%26aulast%3DHope%26aufirst%3DH.%26atitle%3DAlkaloids%2520from%2520the%2520antarctic%2520sponge%2520Kirkpatrickia%2520varialosa.%2520Part%25201%253A%2520variolin%2520B%252C%2520a%2520new%2520antitumour%2520and%2520antiviral%2520compound%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D3987%26epage%3D3992%26doi%3D10.1016%2FS0040-4020%2801%2989673-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Simone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erba, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vikhanskaya, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Francesco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuevas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez Sousa-Faro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Incalci, M.</span></span> <span> </span><span class="NLM_article-title">Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2366</span>– <span class="NLM_lpage">2377</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2005.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejca.2005.05.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=2366-2377&author=M.+Simoneauthor=E.+Erbaauthor=G.+Damiaauthor=F.+Vikhanskayaauthor=A.+M.+Di+Francescoauthor=R.+Riccardiauthor=C.+Baillyauthor=C.+Cuevasauthor=J.+M.+Fernandez+Sousa-Faroauthor=M.+D%E2%80%99Incalci&title=Variolin+B+and+its+derivate+deoxy-variolin+B%3A+new+marine+natural+compounds+with+cyclin-dependent+kinase+inhibitor+activity&doi=10.1016%2Fj.ejca.2005.05.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2005.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2005.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DSimone%26aufirst%3DM.%26aulast%3DErba%26aufirst%3DE.%26aulast%3DDamia%26aufirst%3DG.%26aulast%3DVikhanskaya%26aufirst%3DF.%26aulast%3DDi%2BFrancesco%26aufirst%3DA.%2BM.%26aulast%3DRiccardi%26aufirst%3DR.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DCuevas%26aufirst%3DC.%26aulast%3DFernandez%2BSousa-Faro%26aufirst%3DJ.%2BM.%26aulast%3DD%25E2%2580%2599Incalci%26aufirst%3DM.%26atitle%3DVariolin%2520B%2520and%2520its%2520derivate%2520deoxy-variolin%2520B%253A%2520new%2520marine%2520natural%2520compounds%2520with%2520cyclin-dependent%2520kinase%2520inhibitor%2520activity%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2005%26volume%3D41%26spage%3D2366%26epage%3D2377%26doi%3D10.1016%2Fj.ejca.2005.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit85b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Echalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettayeb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin complex</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1021/jm700940h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm700940h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=737-751&author=A.+Echalierauthor=K.+Bettayebauthor=Y.+Ferandinauthor=O.+Lozachauthor=M.+Clementauthor=A.+Valetteauthor=F.+Ligerauthor=B.+Marquetauthor=J.+C.+Morrisauthor=J.+A.+Endicottauthor=B.+Josephauthor=L.+Meijer&title=Meriolins+%283-%28pyrimidin-4-yl%29-7-azaindoles%29%3A+synthesis%2C+kinase+inhibitory+activity%2C+cellular+effects%2C+and+structure+of+a+CDK2%2Fcyclin+A%2Fmeriolin+complex&doi=10.1021%2Fjm700940h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85bR"><div class="casContent"><span class="casTitleNuber">85b</span><div class="casTitle"><span class="NLM_cas:atitle">Meriolins (3-(Pyrimidin-4-yl)-7-azaindoles): Synthesis, Kinase Inhibitory Activity, Cellular Effects, and Structure of a CDK2/Cyclin A/Meriolin Complex</span></div><div class="casAuthors">Echalier, Aude; Bettayeb, Karima; Ferandin, Yoan; Lozach, Olivier; Clelment, Monique; Valette, Annie; Liger, Francois; Marquet, Bernard; Morris, Jonathan C.; Endicott, Jane A.; Joseph, Benoit; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">737-751</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis and biol. characterization of 3-(pyrimidin-4-yl)-7-azaindoles (meriolins), a chem. hybrid between the natural products meridianins and variolins, derived from marine organisms.  Meriolins display potent inhibitory activities toward cyclin-dependent kinases (CDKs) and, to a lesser extent, other kinases (GSK-3, DYRK1A).  The crystal structures of I (meriolin 5) and variolin B in complex with CDK2/cyclin A reveal that the two inhibitors are oriented in very different ways inside the ATP-binding pocket of the kinase.  A structure-activity relationship provides further insight into the mol. mechanism of action of this family of kinase inhibitors.  Meriolins are also potent antiproliferative and proapoptotic agents in cells cultured either as monolayers or in spheroids.  Proapoptotic efficacy of meriolins correlates best with their CDK2 and CDK9 inhibitory activity.  Meriolins thus constitute a promising class of pharmacol. agents to be further evaluated against the numerous human diseases that imply abnormal regulation of CDKs including cancers, neurodegenerative disorders, and polycystic kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJgno3A1_7LVg90H21EOLACvtfcHk0lgb83IvXDCYww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msL8%253D&md5=1bfb3d02c6894c04237eee27bbccaa5b</span></div><a href="/servlet/linkout?suffix=cit85b&amp;dbid=16384&amp;doi=10.1021%2Fjm700940h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700940h%26sid%3Dliteratum%253Aachs%26aulast%3DEchalier%26aufirst%3DA.%26aulast%3DBettayeb%26aufirst%3DK.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DClement%26aufirst%3DM.%26aulast%3DValette%26aufirst%3DA.%26aulast%3DLiger%26aufirst%3DF.%26aulast%3DMarquet%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DMeriolins%2520%25283-%2528pyrimidin-4-yl%2529-7-azaindoles%2529%253A%2520synthesis%252C%2520kinase%2520inhibitory%2520activity%252C%2520cellular%2520effects%252C%2520and%2520structure%2520of%2520a%2520CDK2%252Fcyclin%2520A%252Fmeriolin%2520complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D737%26epage%3D751%26doi%3D10.1021%2Fjm700940h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span> <span> </span><span class="NLM_article-title">Variolins and related alkaloids</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3080</span>– <span class="NLM_lpage">3098</span>, <span class="refDoi"> DOI: 10.1021/cr900032s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr900032s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1ensL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=3080-3098&author=S.+R.+Walkerauthor=E.+J.+Carterauthor=B.+C.+Huffauthor=J.+C.+Morris&title=Variolins+and+related+alkaloids&doi=10.1021%2Fcr900032s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Variolins and Related Alkaloids</span></div><div class="casAuthors">Walker, Scott R.; Carter, Erin J.; Huff, Belinda C.; Morris, Jonathan C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3080-3098</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review was presented that summarized the isolation, structure detn., synthetic studies and biol. activities of the variolins, meridianins, and meriolins.  The identification and development of new cyclin-dependent kinase (CDK) inhibitors is an important area of research, particularly in the area of cancer chemotherapeutics.  The isolation of variolin B and the meridianins has resulted in a new scaffold being identified.  However, access to these compds. from their natural source, particularly in the case of variolin B, is very difficult, and as such, total synthesis was required to restore access.  This has allowed for more thorough biol. testing and allowed insights into the mode of action of these compds.  It is difficult to say whether variolin B or its deoxy analog will make it to clin. trials because there are issues with their soly. in water and their pharmacokinetic behavior.  However, work on these natural products has led to the discovery that the meriolins, synthetic hybrids that contain common structural features from each family, possess biol. activities that surpass those of either class of natural products.  Work by Meijer and co-workers suggests that the meriolins constitute a potent kinase inhibitory scaffold, and as such, these compds. may in turn inform the development of the next generation of cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHctKcp2TF0bVg90H21EOLACvtfcHk0lgb83IvXDCYww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1ensL8%253D&md5=7e617c38d72081988898dae97a40c3d8</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fcr900032s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900032s%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DS.%2BR.%26aulast%3DCarter%26aufirst%3DE.%2BJ.%26aulast%3DHuff%26aufirst%3DB.%2BC.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26atitle%3DVariolins%2520and%2520related%2520alkaloids%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D3080%26epage%3D3098%26doi%3D10.1021%2Fcr900032s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharate, S. B.</span></span> <span> </span><span class="NLM_article-title">Meridianin derivatives as potent Dyrk1A inhibitors and neuroprotective agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2948</span>– <span class="NLM_lpage">2952</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2015.05.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2948-2952&author=R.+R.+Yadavauthor=S.+Sharmaauthor=P.+Joshiauthor=A.+Waniauthor=R.+A.+Vishwakarmaauthor=A.+Kumarauthor=S.+B.+Bharate&title=Meridianin+derivatives+as+potent+Dyrk1A+inhibitors+and+neuroprotective+agents&doi=10.1016%2Fj.bmcl.2015.05.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.034%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DR.%2BR.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DWani%26aufirst%3DA.%26aulast%3DVishwakarma%26aufirst%3DR.%2BA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DBharate%26aufirst%3DS.%2BB.%26atitle%3DMeridianin%2520derivatives%2520as%2520potent%2520Dyrk1A%2520inhibitors%2520and%2520neuroprotective%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2948%26epage%3D2952%26doi%3D10.1016%2Fj.bmcl.2015.05.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brana, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda-Lucena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moris, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, J. A.</span></span> <span> </span><span class="NLM_article-title">Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_fpage">4118</span>– <span class="NLM_lpage">4120</span>, <span class="refDoi"> DOI: 10.1039/b905068j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1039%2Fb905068j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=19568652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvV2gu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=4118-4120&author=C.+Sanchezauthor=A.+P.+Salasauthor=A.+F.+Branaauthor=M.+Palominoauthor=A.+Pineda-Lucenaauthor=R.+J.+Carbajoauthor=C.+Mendezauthor=F.+Morisauthor=J.+A.+Salas&title=Generation+of+potent+and+selective+kinase+inhibitors+by+combinatorial+biosynthesis+of+glycosylated+indolocarbazoles&doi=10.1039%2Fb905068j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles</span></div><div class="casAuthors">Sanchez, Cesar; Salas, Aaroa P.; Brana, Alfredo F.; Palomino, Martina; Pineda-Lucena, Antonio; Carbajo, Rodrigo J.; Mendez, Carmen; Moris, Francisco; Salas, Jose A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">4118-4120</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report the generation of novel glycosylated indolocarbazoles by combinatorial biosynthesis, and the identification of two novel potent and selective compds. inhibitors of JAK2 and Ikkb kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB8EFvS1PgfrVg90H21EOLACvtfcHk0liUFrSq7TyVIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvV2gu7o%253D&md5=a79d52d492546915300b2b0d67230ffb</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1039%2Fb905068j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb905068j%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DC.%26aulast%3DSalas%26aufirst%3DA.%2BP.%26aulast%3DBrana%26aufirst%3DA.%2BF.%26aulast%3DPalomino%26aufirst%3DM.%26aulast%3DPineda-Lucena%26aufirst%3DA.%26aulast%3DCarbajo%26aufirst%3DR.%2BJ.%26aulast%3DMendez%26aufirst%3DC.%26aulast%3DMoris%26aufirst%3DF.%26aulast%3DSalas%26aufirst%3DJ.%2BA.%26atitle%3DGeneration%2520of%2520potent%2520and%2520selective%2520kinase%2520inhibitors%2520by%2520combinatorial%2520biosynthesis%2520of%2520glycosylated%2520indolocarbazoles%26jtitle%3DChem.%2520Commun.%26date%3D2009%26spage%3D4118%26epage%3D4120%26doi%3D10.1039%2Fb905068j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rothweiler, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandsdal, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svendsen, J. S.</span></span> <span> </span><span class="NLM_article-title">Probing the ATP-binding pocket of protein kinase DYRK1A with benzothiazole fragment molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9814</span>– <span class="NLM_lpage">9824</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01086</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01086" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9814-9824&author=U.+Rothweilerauthor=W.+Stensenauthor=B.+O.+Brandsdalauthor=J.+Isakssonauthor=F.+A.+Leesonauthor=R.+A.+Enghauthor=J.+S.+Svendsen&title=Probing+the+ATP-binding+pocket+of+protein+kinase+DYRK1A+with+benzothiazole+fragment+molecules&doi=10.1021%2Facs.jmedchem.6b01086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the ATP-Binding Pocket of Protein Kinase DYRK1A with Benzothiazole Fragment Molecules</span></div><div class="casAuthors">Rothweiler, Ulli; Stensen, Wenche; Brandsdal, Bjoern Olav; Isaksson, Johan; Leeson, Frederick Alan; Engh, Richard Alan; Svendsen, John S. Mjoeen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9814-9824</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRK1A has emerged as a potential target for therapies of Alzheimer's disease using small mols.  Based on the observation of selective DYRK1A inhibition by firefly D-luciferin, we have explored static and dynamic structural properties of fragment sized variants of the benzothiazole scaffold with respect to DYRK1A using X-ray crystallog. and NMR techniques.  The compds. have excellent ligand efficiencies and show a remarkable diversity of binding modes in dynamic equil.  Binding geometries are detd. in part by interactions often considered "weak", including "orthogonal multipolar" types represented by e.g. F-CO, sulfur-aromat, and halogen-aromat interactions, together with hydrogen bonds that are modulated by variation of electron withdrawing groups.  These studies show how the benzothiazole scaffold is highly promising for the development of therapeutic DYRK1A inhibitors.  In addn., the subtleties of the binding interactions, including dynamics, show how full structural studies are required to fully interpret the essential phys. determinants of binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYSQe1_5bEjLVg90H21EOLACvtfcHk0liUFrSq7TyVIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yksr7P&md5=edb850b232f53b3e161a5023915972e6</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01086%26sid%3Dliteratum%253Aachs%26aulast%3DRothweiler%26aufirst%3DU.%26aulast%3DStensen%26aufirst%3DW.%26aulast%3DBrandsdal%26aufirst%3DB.%2BO.%26aulast%3DIsaksson%26aufirst%3DJ.%26aulast%3DLeeson%26aufirst%3DF.%2BA.%26aulast%3DEngh%26aufirst%3DR.%2BA.%26aulast%3DSvendsen%26aufirst%3DJ.%2BS.%26atitle%3DProbing%2520the%2520ATP-binding%2520pocket%2520of%2520protein%2520kinase%2520DYRK1A%2520with%2520benzothiazole%2520fragment%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9814%26epage%3D9824%26doi%3D10.1021%2Facs.jmedchem.6b01086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Masaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4434</span>– <span class="NLM_lpage">4441</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmc.2015.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26145823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=4434-4441&author=S.+Masakiauthor=I.+Kiiauthor=Y.+Sumidaauthor=T.+Kato-Sumidaauthor=Y.+Ogawaauthor=N.+Itoauthor=M.+Nakamuraauthor=R.+Sonamotoauthor=N.+Kataokaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Design+and+synthesis+of+a+potent+inhibitor+of+class+1+DYRK+kinases+as+a+suppressor+of+adipogenesis&doi=10.1016%2Fj.bmc.2015.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90aR"><div class="casContent"><span class="casTitleNuber">90a</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis</span></div><div class="casAuthors">Masaki, So; Kii, Isao; Sumida, Yuto; Kato-Sumida, Tomoe; Ogawa, Yasushi; Ito, Nobutoshi; Nakamura, Mitsuhiro; Sonamoto, Rie; Kataoka, Naoyuki; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4434-4441</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dysregulation of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) has been demonstrated in several pathol. conditions, including Alzheimer's disease and cancer progression.  It has been recently reported that a gain of function-mutation in the human DYRK1B gene exacerbates metabolic syndrome by enhancing obesity.  In the previous study, we developed an inhibitor of DYRK family kinases (INDY) and demonstrated that INDY suppresses the pathol. phenotypes induced by overexpression of DYRK1A or DYRK1B in cellular and animal models.  In this study, we designed and synthesized a novel inhibitor of DYRK family kinases based on the crystal structure of the DYRK1A/INDY complex by replacing the phenol group of INDY with dibenzofuran to produce a deriv., named BINDY.  This compd. exhibited potent and selective inhibitory activity toward DYRK family kinases in an in vitro assay.  Furthermore, treatment of 3T3-L1 pre-adipocytes with BINDY hampered adipogenesis by suppressing gene expression of the crit. transcription factors PPARγ and C/EBPα.  This study indicates the possibility of BINDY as a potential drug for metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRt6yDW_MVw7Vg90H21EOLACvtfcHk0lgLHIdjT8BqCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fF&md5=7429d22909732d8ea03f373158969dfb</span></div><a href="/servlet/linkout?suffix=cit90a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DMasaki%26aufirst%3DS.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DKataoka%26aufirst%3DN.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520potent%2520inhibitor%2520of%2520class%25201%2520DYRK%2520kinases%2520as%2520a%2520suppressor%2520of%2520adipogenesis%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D4434%26epage%3D4441%26doi%3D10.1016%2Fj.bmc.2015.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit90b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span>; <span class="NLM_string-name">Kobayashi, A.</span></span> <span> </span><span class="NLM_article-title">Compound Pertaining to Neuropoiesis and Drug Composition</span>. <span class="NLM_patent">WO 2015083750</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Hagiwara&author=A.+Kobayashi&title=Compound+Pertaining+to+Neuropoiesis+and+Drug+Composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DCompound%2520Pertaining%2520to%2520Neuropoiesis%2520and%2520Drug%2520Composition%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the kinase DYRK1A by targeting its folding process</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11391</span>, <span class="refDoi"> DOI: 10.1038/ncomms11391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fncomms11391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27102360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11391&author=I.+Kiiauthor=Y.+Sumidaauthor=T.+Gotoauthor=R.+Sonamotoauthor=Y.+Okunoauthor=S.+Yoshidaauthor=T.+Kato-Sumidaauthor=Y.+Koikeauthor=M.+Abeauthor=Y.+Nonakaauthor=T.+Ikuraauthor=N.+Itoauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Selective+inhibition+of+the+kinase+DYRK1A+by+targeting+its+folding+process&doi=10.1038%2Fncomms11391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the kinase DYRK1A by targeting its folding process</span></div><div class="casAuthors">Kii, Isao; Sumida, Yuto; Goto, Toshiyasu; Sonamoto, Rie; Okuno, Yukiko; Yoshida, Suguru; Kato-Sumida, Tomoe; Koike, Yuka; Abe, Minako; Nonaka, Yosuke; Ikura, Teikichi; Ito, Nobutoshi; Shibuya, Hiroshi; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11391</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophosphorylation of amino-acid residues is part of the folding process of various protein kinases.  Conventional chem. screening of mature kinases has missed inhibitors that selectively interfere with the folding process.  Here we report a cell-based assay that evaluates inhibition of a kinase at a transitional state during the folding process and identify a folding intermediate-selective inhibitor of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), which we refer to as FINDY.  FINDY suppresses intramol. autophosphorylation of Ser97 in DYRK1A in cultured cells, leading to its degrdn., but does not inhibit substrate phosphorylation catalyzed by the mature kinase.  FINDY also suppresses Ser97 autophosphorylation of recombinant DYRK1A, suggesting direct inhibition, and shows high selectivity for DYRK1A over other DYRK family members.  In addn., FINDY rescues DYRK1A-induced developmental malformations in Xenopus laevis embryos.  Our study demonstrates that transitional folding intermediates of protein kinases can be targeted by small mols., and paves the way for developing novel types of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2gsAsp-YjLVg90H21EOLACvtfcHk0liXve2nShydng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslShtr8%253D&md5=5d64de412dd168a415a3da052d3afedc</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1038%2Fncomms11391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11391%26sid%3Dliteratum%253Aachs%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520kinase%2520DYRK1A%2520by%2520targeting%2520its%2520folding%2520process%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11391%26doi%3D10.1038%2Fncomms11391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sonamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Identification of a DYRK1A inhibitor that induces degradation of the target kinase using co-chaperone CDC37 fused with luciferase nanoKAZ</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">12728</span>, <span class="refDoi"> DOI: 10.1038/srep12728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fsrep12728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=26234946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKiur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=12728&author=R.+Sonamotoauthor=I.+Kiiauthor=Y.+Koikeauthor=Y.+Sumidaauthor=T.+Kato-Sumidaauthor=Y.+Okunoauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Identification+of+a+DYRK1A+inhibitor+that+induces+degradation+of+the+target+kinase+using+co-chaperone+CDC37+fused+with+luciferase+nanoKAZ&doi=10.1038%2Fsrep12728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a DYRK1A inhibitor that induces degradation of the target kinase using co-chaperone CDC37 fused with luciferase nanoKAZ</span></div><div class="casAuthors">Sonamoto, Rie; Kii, Isao; Koike, Yuka; Sumida, Yuto; Kato-Sumida, Tomoe; Okuno, Yukiko; Hosoya, Takamitsu; Hagiwara, Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12728</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The protein kinase family includes attractive targets for drug development.  Methods for screening of kinase inhibitors remain largely limited to in vitro catalytic assays.  It has been shown that ATP-competitive inhibitors antagonize interaction between the target kinase and kinase-specific co-chaperone CDC37 in living cells.  Here we show a cell-based method to screen kinase inhibitors using fusion protein of CDC37 with a mutated catalytic 19-kDa component of Oplophorus luciferase, nanoKAZ (CDC37-nanoKAZ).  A dual-specificity kinase DYRK1A, an importance of which has been highlighted in Alzheimer's disease, was targeted in this study.  We established 293T cells stably expressing CDC37-nanoKAZ, and analyzed interaction between CDC37-nanoKAZ and DYRK1A.  We revealed that DYRK1A interacted with CDC37-nanoKAZ.  Importantly, point mutations that affect autophosphorylation strengthened the interaction, thus improving signal/noise ratio of the interaction relative to non-specific binding of CDC37-nanoKAZ.  This high signal/noise ratio enabled screening of chem. library that resulted in identification of a potent inhibitor of DYRK1A, named CaNDY.  CaNDY induced selective degrdn. of DYRK1A, and inhibited catalytic activity of recombinant DYRK1A with IC50 value of 7.9 nM by competing with ATP.  This method based on a mutant target kinase and a bioluminescence-eliciting co-chaperone CDC37 could be applicable to evaluation and development of inhibitors targeting other kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQSIZOeUORKbVg90H21EOLACvtfcHk0liXve2nShydng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKiur%252FI&md5=de399d0f2c6e925396db0405c8eb0476</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1038%2Fsrep12728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep12728%26sid%3Dliteratum%253Aachs%26aulast%3DSonamoto%26aufirst%3DR.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DKato-Sumida%26aufirst%3DT.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520DYRK1A%2520inhibitor%2520that%2520induces%2520degradation%2520of%2520the%2520target%2520kinase%2520using%2520co-chaperone%2520CDC37%2520fused%2520with%2520luciferase%2520nanoKAZ%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D12728%26doi%3D10.1038%2Fsrep12728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huth, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black-Schaefer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorwin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladror, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severin, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartley, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span> <span> </span><span class="NLM_article-title">Toxicological evaluation of thiol-reactive compounds identified using a la assay to detect reactive molecules by nuclear magnetic resonance</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1752</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1021/tx700319t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700319t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSkurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1752-1759&author=J.+R.+Huthauthor=D.+Songauthor=R.+R.+Mendozaauthor=C.+L.+Black-Schaeferauthor=J.+C.+Mackauthor=S.+A.+Dorwinauthor=U.+S.+Ladrorauthor=J.+M.+Severinauthor=K.+A.+Walterauthor=D.+M.+Bartleyauthor=P.+J.+Hajduk&title=Toxicological+evaluation+of+thiol-reactive+compounds+identified+using+a+la+assay+to+detect+reactive+molecules+by+nuclear+magnetic+resonance&doi=10.1021%2Ftx700319t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicological Evaluation of Thiol-Reactive Compounds Identified Using a La Assay To Detect Reactive Molecules by Nuclear Magnetic Resonance</span></div><div class="casAuthors">Huth, Jeffrey R.; Song, Danying; Mendoza, Renaldo R.; Black-Schaefer, Candice L.; Mack, Jamey C.; Dorwin, Sarah A.; Ladror, Uri S.; Severin, Jean M.; Walter, Karl A.; Bartley, Diane M.; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1752-1759</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have recently reported on the development of a La assay to detect reactive mols. by NMR (ALARM NMR) to detect reactive false pos. hits from high-throughput screening, in which we obsd. a surprisingly large no. of compds. that can oxidize or form covalent adducts with protein thiols groups.  In the vast majority of these cases, the covalent interactions are largely nonspecific (e.g., affect many protein targets) and therefore unsuitable for drug development.  However, certain thiol-reactive species do appear to inhibit the target of interest in a specific manner.  The question then arises as to the potential toxicol. risks of developing a drug that can react with protein thiol groups.  Here, we report on the evaluation of a large set of ALARM-reactive and -nonreactive compds. against a panel of addnl. proteins (aldehyde dehydrogenase, superoxide dismutase, and three cytochrome P 450 enzymes).  It was obsd. that ALARM-reactive compds. have significantly increased risks of interacting with one or more of these enzymes in vitro.  Thus, ALARM NMR seems to be a sensitive tool to rapidly identify compds. with an enhanced risk of producing side effects in humans, including alc. intolerance, the formation of reactive oxygen species, and drug-drug interactions.  In conjunction with other toxicol. assays, ALARM NMR should be a valuable tool for prioritizing compds. for lead optimization and animal testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqli4LigspmibVg90H21EOLACvtfcHk0li8CS8ZF1-8rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSkurjP&md5=a70fc352f67e637753a3e5d410875a89</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Ftx700319t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700319t%26sid%3Dliteratum%253Aachs%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DMendoza%26aufirst%3DR.%2BR.%26aulast%3DBlack-Schaefer%26aufirst%3DC.%2BL.%26aulast%3DMack%26aufirst%3DJ.%2BC.%26aulast%3DDorwin%26aufirst%3DS.%2BA.%26aulast%3DLadror%26aufirst%3DU.%2BS.%26aulast%3DSeverin%26aufirst%3DJ.%2BM.%26aulast%3DWalter%26aufirst%3DK.%2BA.%26aulast%3DBartley%26aufirst%3DD.%2BM.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DToxicological%2520evaluation%2520of%2520thiol-reactive%2520compounds%2520identified%2520using%2520a%2520la%2520assay%2520to%2520detect%2520reactive%2520molecules%2520by%2520nuclear%2520magnetic%2520resonance%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1752%26epage%3D1759%26doi%3D10.1021%2Ftx700319t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenreich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szklarczyk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2010.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.chembiol.2010.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21276940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=67-76&author=O.+Fedorovauthor=K.+Huberauthor=A.+Eisenreichauthor=P.+Filippakopoulosauthor=O.+Kingauthor=A.+N.+Bullockauthor=D.+Szklarczykauthor=L.+J.+Jensenauthor=D.+Fabbroauthor=J.+Trappeauthor=U.+Rauchauthor=F.+Bracherauthor=S.+Knapp&title=Specific+CLK+inhibitors+from+a+novel+chemotype+for+regulation+of+alternative+splicing&doi=10.1016%2Fj.chembiol.2010.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing</span></div><div class="casAuthors">Fedorov, Oleg; Huber, Kilian; Eisenreich, Andreas; Filippakopoulos, Panagis; King, Oliver; Bullock, Alex N.; Szklarczyk, Damian; Jensen, Lars J.; Fabbro, Doriano; Trappe, Jorg; Rauch, Ursula; Bracher, Franz; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-76</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">There is a growing recognition of the importance of protein kinases in the control of alternative splicing.  To define the underlying regulatory mechanisms, highly selective inhibitors are needed.  Here, we report the discovery and characterization of the dichloroindolyl enaminonitrile KH-CB19, a potent and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4).  Cocrystal structures of KH-CB19 with CLK1 and CLK3 revealed a non-ATP mimetic binding mode, conformational changes in helix αC and the phosphate binding loop and halogen bonding to the kinase hinge region.  KH-CB19 effectively suppressed phosphorylation of SR (serine/arginine) proteins in cells, consistent with its expected mechanism of action.  Chem. inhibition of CLK1/CLK4 generated a unique pattern of splicing factor dephosphorylation and had at low nM concn. a profound effect on splicing of the two tissue factor isoforms flTF (full-length TF) and asHTF (alternatively spliced human TF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqnKjNEjPBHbVg90H21EOLACvtfcHk0li8CS8ZF1-8rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlarsLw%253D&md5=b2b17a9934f15f2d0d9a76a8d3179e95</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKing%26aufirst%3DO.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DSzklarczyk%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DL.%2BJ.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DSpecific%2520CLK%2520inhibitors%2520from%2520a%2520novel%2520chemotype%2520for%2520regulation%2520of%2520alternative%2520splicing%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D67%26epage%3D76%26doi%3D10.1016%2Fj.chembiol.2010.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, C.</span>; <span class="NLM_string-name">Labriere, C.</span>; <span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Kinase Inhibitors</span>. <span class="NLM_patent">WO 2014115071</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Guillou&author=C.+Labriere&author=L.+Meijer&title=Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuillou%26aufirst%3DC.%26atitle%3DKinase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labriere, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blairvacq, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, C.</span></span> <span> </span><span class="NLM_article-title">Further investigation of paprotrain: towards the conception of selective and multi-targeted CNS kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.08.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2016.08.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=920-934&author=C.+Labriereauthor=O.+Lozachauthor=M.+Blairvacqauthor=L.+Meijerauthor=C.+Guillou&title=Further+investigation+of+paprotrain%3A+towards+the+conception+of+selective+and+multi-targeted+CNS+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2016.08.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.08.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.08.069%26sid%3Dliteratum%253Aachs%26aulast%3DLabriere%26aufirst%3DC.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBlairvacq%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DGuillou%26aufirst%3DC.%26atitle%3DFurther%2520investigation%2520of%2520paprotrain%253A%2520towards%2520the%2520conception%2520of%2520selective%2520and%2520multi-targeted%2520CNS%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D920%26epage%3D934%26doi%3D10.1016%2Fj.ejmech.2016.08.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myrianthopoulos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kritsanida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriaud-Kolar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magiatis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaltsounis, A.-L.</span></span> <span> </span><span class="NLM_article-title">Novel inverse binding mode of indirubin derivatives yields improved selectivity for DYRK kinases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1021/ml300207a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300207a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=22-26&author=V.+Myrianthopoulosauthor=M.+Kritsanidaauthor=N.+Gaboriaud-Kolarauthor=P.+Magiatisauthor=Y.+Ferandinauthor=E.+Durieuauthor=O.+Lozachauthor=D.+Cappelauthor=M.+Soundararajanauthor=P.+Filippakopoulosauthor=W.+Shermanauthor=S.+Knappauthor=L.+Meijerauthor=E.+Mikrosauthor=A.-L.+Skaltsounis&title=Novel+inverse+binding+mode+of+indirubin+derivatives+yields+improved+selectivity+for+DYRK+kinases&doi=10.1021%2Fml300207a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases</span></div><div class="casAuthors">Myrianthopoulos, Vassilios; Kritsanida, Marina; Gaboriaud-Kolar, Nicolas; Magiatis, Prokopios; Ferandin, Yoan; Durieu, Emilie; Lozach, Olivier; Cappel, Daniel; Soundararajan, Meera; Filippakopoulos, Panagis; Sherman, Woody; Knapp, Stefan; Meijer, Laurent; Mikros, Emmanuel; Skaltsounis, Alexios-Leandros</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-26</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRK kinases are involved in alternative pre-mRNA splicing as well as in neuropathol. states such as Alzheimer's disease and Down syndrome.  In this study, we present the design, synthesis, and biol. evaluation of indirubins as DYRK inhibitors with enhanced selectivity.  Modifications of the bis-indole included polar or acidic functionalities at positions 5' and 6' and a bromine or a trifluoromethyl group at position 7, affording analogs that possess high activity and pronounced specificity.  Compd. 6i (I) carrying a 5'-carboxylate moiety demonstrated the best inhibitory profile.  A novel inverse binding mode, which forms the basis for the improved selectivity, was suggested by mol. modeling and confirmed by detg. the crystal structure of DYRK2 in complex with 6i.  Structure-activity relationships were further established, including a thermodn. anal. of binding site water mols., offering a structural explanation for the selective DYRK inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbTKuspwpHLrVg90H21EOLACvtfcHk0limFZ9OFHszxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrjJ&md5=4c98785d2d8264a1a46fa93cbb611e35</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fml300207a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300207a%26sid%3Dliteratum%253Aachs%26aulast%3DMyrianthopoulos%26aufirst%3DV.%26aulast%3DKritsanida%26aufirst%3DM.%26aulast%3DGaboriaud-Kolar%26aufirst%3DN.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DCappel%26aufirst%3DD.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DMikros%26aufirst%3DE.%26aulast%3DSkaltsounis%26aufirst%3DA.-L.%26atitle%3DNovel%2520inverse%2520binding%2520mode%2520of%2520indirubin%2520derivatives%2520yields%2520improved%2520selectivity%2520for%2520DYRK%2520kinases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D22%26epage%3D26%26doi%3D10.1021%2Fml300207a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Kinase inhibitors: not just for kinases anymore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1483</span>, <span class="refDoi"> DOI: 10.1021/jm020427b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020427b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1478-1483&author=S.+L.+McGovernauthor=B.+K.+Shoichet&title=Kinase+inhibitors%3A+not+just+for+kinases+anymore&doi=10.1021%2Fjm020427b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Inhibitors: Not Just for Kinases Anymore</span></div><div class="casAuthors">McGovern, Susan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1478-1483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinase inhibitors are widely employed as biol. reagents and as leads for drug design.  Their use is often complicated by their lack of specificity.  Although binding conserved ATP sites accounts for some of their nonspecificity, some compds. inhibit proteins not known to bind ATP.  It has been found that promiscuous hits from high-throughput screening may act as aggregates.  To explore whether this mechanism might explain the action of widely used nonspecific kinase inhibitors, 15 such compds. were studied.  Eight of these, rottlerin, quercetin, K-252c, bisindolylmaleimide I, bisindolylmaleimide IX, U0126, indirubin, and indigo, inhibited three diverse non-kinase enzymes.  Inhibition was time-dependent and sensitive to enzyme concn.; by light scattering, the compds. formed particles of 100-1000 nm diam.  These observations suggest that these eight kinase inhibitors, at least at micromolar concns., are promiscuous and act as aggregates.  Results obtained from the use of these compds. at micromolar or higher concns. against individual enzymes should be interpreted cautiously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-JSJ7FPf7e7Vg90H21EOLACvtfcHk0libLS_Gwgny3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D&md5=1d7e4e99a27be5ab279744aff92de26d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm020427b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020427b%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DKinase%2520inhibitors%253A%2520not%2520just%2520for%2520kinases%2520anymore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1478%26epage%3D1483%26doi%3D10.1021%2Fjm020427b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neagoie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedrenne, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merour, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldeyrou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansiaux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of chromeno[3,4-b]indoles as <i>Lamellarin</i> D analogues: a novel DYRK1A inhibitor class</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.01.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2012.01.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=22305342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFOrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2012&pages=379-396&author=C.+Neagoieauthor=E.+Vedrenneauthor=F.+Buronauthor=J.+Y.+Merourauthor=S.+Roscaauthor=S.+Bourgauthor=O.+Lozachauthor=L.+Meijerauthor=B.+Baldeyrouauthor=A.+Lansiauxauthor=S.+Routier&title=Synthesis+of+chromeno%5B3%2C4-b%5Dindoles+as+Lamellarin+D+analogues%3A+a+novel+DYRK1A+inhibitor+class&doi=10.1016%2Fj.ejmech.2012.01.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues : A novel DYRK1A inhibitor class</span></div><div class="casAuthors">Neagoie, Cleopatra; Vedrenne, Emeline; Buron, Frederic; Merour, Jean-Yves; Rosca, Sorin; Bourg, Stephane; Lozach, Olivier; Meijer, Laurent; Baldeyrou, Brigitte; Lansiaux, Amelie; Routier, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">379-396</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A library of substituted chromeno[3,4-b]indoles was developed as Lamellarin isosteres.  Synthesis was achieved from indoles after a four-step pathway sequence involving C-3 iodination, a Suzuki cross-coupling reaction, and a one pot deprotection/lactonization step.  Twenty final compds. were tested in order to det. their activity against topoisomerase I and kinases, the two major biol. activities of Lamellarins.  One newly synthesized deriv. exhibited a strong topoisomerase activity comparable to ref. compds. such as campthotecin and Lamellarin with only a weak kinase inhibition.  Two other lead compds. were identified as new nanomolar DYRK1A inhibitors and several other drugs affected the kinases in the sub-micromolar range.  These results will enable us to use the chromeno[3,4-b]indole as a pharmacophore to develop potent treatments for neurol. or oncol. disorders in which DYRK1A is fully involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopoVhDdU5tMbVg90H21EOLACvtfcHk0libLS_Gwgny3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFOrsLs%253D&md5=7d371529cde68f5fc4680c317a0d0a85</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DNeagoie%26aufirst%3DC.%26aulast%3DVedrenne%26aufirst%3DE.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DMerour%26aufirst%3DJ.%2BY.%26aulast%3DRosca%26aufirst%3DS.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBaldeyrou%26aufirst%3DB.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520chromeno%255B3%252C4-b%255Dindoles%2520as%2520Lamellarin%2520D%2520analogues%253A%2520a%2520novel%2520DYRK1A%2520inhibitor%2520class%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D49%26spage%3D379%26epage%3D396%26doi%3D10.1016%2Fj.ejmech.2012.01.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kassis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzeszcz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bénéteau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Guével, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillouzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewiński, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colliandre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J. Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(phenyl) pyridine or pyrazine V-shaped molecules as kinase inhibitors and cytotoxic agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5416</span>– <span class="NLM_lpage">5434</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.08.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2011.08.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21944287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=5416-5434&author=P.+Kassisauthor=J.+Brzeszczauthor=V.+B%C3%A9n%C3%A9teauauthor=O.+Lozachauthor=L.+Meijerauthor=R.+Le+Gu%C3%A9velauthor=C.+Guillouzoauthor=K.+Lewi%C5%84skiauthor=S.+Bourgauthor=L.+Colliandreauthor=S.+Routierauthor=J.+Y.+M%C3%A9rour&title=Synthesis+and+biological+evaluation+of+new+3-%286-hydroxyindol-2-yl%29-5-%28phenyl%29+pyridine+or+pyrazine+V-shaped+molecules+as+kinase+inhibitors+and+cytotoxic+agents&doi=10.1016%2Fj.ejmech.2011.08.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new 3-(6-hydroxyindol-2-yl)-5-(Phenyl) pyridine or pyrazine V-Shaped molecules as kinase inhibitors and cytotoxic agents</span></div><div class="casAuthors">Kassis, Pamela; Brzeszcz, Joanna; Beneteau, Valerie; Lozach, Olivier; Meijer, Laurent; Le Guevel, Remi; Guillouzo, Christiane; Lewinski, Krzysztof; Bourg, Stephane; Colliandre, Lionel; Routier, Sylvain; Merour, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5416-5434</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Herein is reported the synthesis and biol. evaluation of new 3-[(2-indolyl)]-5-phenyl-3,5-pyridine, 3-[(2-indolyl)]-5-phenyl-2,4-pyridine and 3-[(2-indolyl)]-5-phenyl-2,6-pyrazine derivs. designed as potential CDK inhibitors.  Indoles and phenyls were used to generate several substitutions of the pyridine and pyrazine rings.  The syntheses included Stille or Suzuki type reactions, which were carried out on the 3,5-dibromopyridine, 2,4-dichloropyridine and 2,6-dichloro-1-4-pyrazine moieties.  Cell effects of the V-shaped family were in the micromolar range.  Kinase assays were conducted and showed that compd. I inhibited CDK5 with an inhibitory concn. of 160 nM with a moderate selectivity over GSK3 compared to the ref. compd. II which exhibited a slightly lower activity on CDK5 (1.5 μM).  Compd. I was also found to be the most potent compd. in the series and was identified as a new lead for DYRK1A inhibitor discovery (IC50 = 60 nM).  Docking studies were carried out in order to investigate the inhibition of DYRK1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw8p7-Tg5B6LVg90H21EOLACvtfcHk0lhkzh_tZUGfLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbbJ&md5=1b960c962e74420cf3ddad26ffeeec94</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.08.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.08.048%26sid%3Dliteratum%253Aachs%26aulast%3DKassis%26aufirst%3DP.%26aulast%3DBrzeszcz%26aufirst%3DJ.%26aulast%3DB%25C3%25A9n%25C3%25A9teau%26aufirst%3DV.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DLe%2BGu%25C3%25A9vel%26aufirst%3DR.%26aulast%3DGuillouzo%26aufirst%3DC.%26aulast%3DLewi%25C5%2584ski%26aufirst%3DK.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DColliandre%26aufirst%3DL.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.%2BY.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%25203-%25286-hydroxyindol-2-yl%2529-5-%2528phenyl%2529%2520pyridine%2520or%2520pyrazine%2520V-shaped%2520molecules%2520as%2520kinase%2520inhibitors%2520and%2520cytotoxic%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D5416%26epage%3D5434%26doi%3D10.1016%2Fj.ejmech.2011.08.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakano-Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">10268</span>– <span class="NLM_lpage">10273</span>, <span class="refDoi"> DOI: 10.1073/pnas.1704143114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1073%2Fpnas.1704143114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=10268-10273&author=A.+Nakano-Kobayashiauthor=T.+Awayaauthor=I.+Kiiauthor=Y.+Sumidaauthor=Y.+Okunoauthor=S.+Yoshidaauthor=T.+Sumidaauthor=T.+Inoueauthor=T.+Hosoyaauthor=M.+Hagiwara&title=Prenatal+neurogenesis+induction+therapy+normalizes+brain+structure+and+function+in+Down+syndrome+mice&doi=10.1073%2Fpnas.1704143114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1704143114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1704143114%26sid%3Dliteratum%253Aachs%26aulast%3DNakano-Kobayashi%26aufirst%3DA.%26aulast%3DAwaya%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DSumida%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DPrenatal%2520neurogenesis%2520induction%2520therapy%2520normalizes%2520brain%2520structure%2520and%2520function%2520in%2520Down%2520syndrome%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D10268%26epage%3D10273%26doi%3D10.1073%2Fpnas.1704143114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazimierczuk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Maira, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orzeszko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">The selectivity of inhibitors of protein kinase CK2: an update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>415</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1042/BJ20080309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1042%2FBJ20080309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2008&pages=353-365&author=M.+A.+Paganoauthor=J.+Bainauthor=Z.+Kazimierczukauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=G.+Di+Mairaauthor=M.+Elliottauthor=A.+Orzeszkoauthor=G.+Cozzaauthor=F.+Meggioauthor=L.+A.+Pinna&title=The+selectivity+of+inhibitors+of+protein+kinase+CK2%3A+an+update&doi=10.1042%2FBJ20080309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102a&amp;dbid=16384&amp;doi=10.1042%2FBJ20080309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20080309%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DThe%2520selectivity%2520of%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D415%26spage%3D353%26epage%3D365%26doi%3D10.1042%2FBJ20080309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit102b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brzozka, K.</span>; <span class="NLM_string-name">Czardybon, W.</span>; <span class="NLM_string-name">Sabiniarz, A.</span>; <span class="NLM_string-name">Millik, M.</span>; <span class="NLM_string-name">Windak, R.</span>; <span class="NLM_string-name">Zarebski, A.</span>; <span class="NLM_string-name">Beuzen, N.</span></span> <span> </span><span class="NLM_article-title">A Compound, a Process for its Preparation, a Pharmaceutical Composition, Use of Compound, a Method for Modulating, or Regulating Serine/Threonine Kinases and a Serine/ Threonine Kinases Modulating Agent</span>. <span class="NLM_patent">WO 2011058139</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.+Brzozka&author=W.+Czardybon&author=A.+Sabiniarz&author=M.+Millik&author=R.+Windak&author=A.+Zarebski&author=N.+Beuzen&title=A+Compound%2C+a+Process+for+its+Preparation%2C+a+Pharmaceutical+Composition%2C+Use+of+Compound%2C+a+Method+for+Modulating%2C+or+Regulating+Serine%2FThreonine+Kinases+and+a+Serine%2F+Threonine+Kinases+Modulating+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrzozka%26aufirst%3DK.%26atitle%3DA%2520Compound%252C%2520a%2520Process%2520for%2520its%2520Preparation%252C%2520a%2520Pharmaceutical%2520Composition%252C%2520Use%2520of%2520Compound%252C%2520a%2520Method%2520for%2520Modulating%252C%2520or%2520Regulating%2520Serine%252FThreonine%2520Kinases%2520and%2520a%2520Serine%252F%2520Threonine%2520Kinases%2520Modulating%2520Agent%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit102c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Czardybon, W.</span>; <span class="NLM_string-name">Brzózka, K.</span>; <span class="NLM_string-name">Galezowski, M.</span>; <span class="NLM_string-name">Windak, R.</span>; <span class="NLM_string-name">Milik, M.</span>; <span class="NLM_string-name">Zawadzka, M.</span>; <span class="NLM_string-name">Guzik, P.</span>; <span class="NLM_string-name">Wincza, E.</span>; <span class="NLM_string-name">Prokop, M.</span>; <span class="NLM_string-name">Wiklik, K.</span>; <span class="NLM_string-name">Sabiniarz, A.</span>; <span class="NLM_string-name">Cholody, W. M.</span>; <span class="NLM_string-name">Horvath, R.</span>; <span class="NLM_string-name">Rzymski, T.</span></span> <span> </span><span class="NLM_article-title">Novel Benzimidazole Derivatives as Kinase Inhibitors</span>. <span class="NLM_patent">WO 2014096388</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=W.+Czardybon&author=K.+Brz%C3%B3zka&author=M.+Galezowski&author=R.+Windak&author=M.+Milik&author=M.+Zawadzka&author=P.+Guzik&author=E.+Wincza&author=M.+Prokop&author=K.+Wiklik&author=A.+Sabiniarz&author=W.+M.+Cholody&author=R.+Horvath&author=T.+Rzymski&title=Novel+Benzimidazole+Derivatives+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCzardybon%26aufirst%3DW.%26atitle%3DNovel%2520Benzimidazole%2520Derivatives%2520as%2520Kinase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hulme, C.</span>; <span class="NLM_string-name">Dunckley, T.</span>; <span class="NLM_string-name">Shaw, Y.
J.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Inhibitors of DYRK1A and Uses Thereof</span>. <span class="NLM_patent">WO 2017040993</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Hulme&author=T.+Dunckley&author=Y.%0AJ.+Shaw&title=Small+Molecule+Inhibitors+of+DYRK1A+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHulme%26aufirst%3DC.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520DYRK1A%2520and%2520Uses%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balint, B.</span>; <span class="NLM_string-name">Kotschy, A.</span>; <span class="NLM_string-name">Sipos, M.</span>; <span class="NLM_string-name">Weber, C.</span>; <span class="NLM_string-name">Foloppe, N.</span>; <span class="NLM_string-name">Walmsley, D.</span>; <span class="NLM_string-name">Burbridge, M. F.</span>; <span class="NLM_string-name">Cruzalegui, F. H.</span></span> <span> </span><span class="NLM_article-title">New Imidazo[4,5-<i>b</i>]pyridine Derivatives as Dual Dyrk1/clk1 Inhibitors</span>. <span class="NLM_patent">WO 2017055530A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=B.+Balint&author=A.+Kotschy&author=M.+Sipos&author=C.+Weber&author=N.+Foloppe&author=D.+Walmsley&author=M.+F.+Burbridge&author=F.+H.+Cruzalegui&title=New+Imidazo%5B4%2C5-b%5Dpyridine+Derivatives+as+Dual+Dyrk1%2Fclk1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBalint%26aufirst%3DB.%26atitle%3DNew%2520Imidazo%255B4%252C5-b%255Dpyridine%2520Derivatives%2520as%2520Dual%2520Dyrk1%252Fclk1%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gourdain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dairou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denhez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues-Lima, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cariou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. H.</span></span> <span> </span><span class="NLM_article-title">Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9569</span>– <span class="NLM_lpage">9585</span>, <span class="refDoi"> DOI: 10.1021/jm401049v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401049v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9569-9585&author=S.+Gourdainauthor=J.+Dairouauthor=C.+Denhezauthor=L.+C.+Buiauthor=F.+Rodrigues-Limaauthor=N.+Janelauthor=J.+M.+Delabarauthor=K.+Cariouauthor=R.+H.+Dodd&title=Development+of+DANDYs%2C+new+3%2C5-diaryl-7-azaindoles+demonstrating+potent+DYRK1A+kinase+inhibitory+activity&doi=10.1021%2Fjm401049v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Development of DANDYs, New 3,5-Diaryl-7-azaindoles Demonstrating Potent DYRK1A Kinase Inhibitory Activity</span></div><div class="casAuthors">Gourdain, Stephanie; Dairou, Julien; Denhez, Clement; Bui, Linh Chi; Rodrigues-Lima, Fernando; Janel, Nathalie; Delabar, Jean M.; Cariou, Kevin; Dodd, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9569-9585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3,5-diaryl-1H-pyrrolo[2,3-b]pyridines was synthesized and evaluated for inhibition of DYRK1A kinase in vitro.  Derivs. having hydroxy groups on the aryl moieties demonstrated high inhibitory potencies with Kis in the low nanomolar range.  Their methoxy analogs were up to 100 times less active.  Docking studies at the ATP binding site suggested that these compds. bind tightly to this site via a network of multiple H-bonds with the peptide backbone.  None of the active compds. was cytotoxic to KB cells at 10-6 M.  Kinase profiling revealed that compd. I showed 2-fold selectivity for DYRK1A with respect to DYRK2 and DYRK3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1vxODs_tGD7Vg90H21EOLACvtfcHk0liFplPZ7VXpKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrt77K&md5=27dcc77a1c0d413cf0ab5c999cf9a195</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm401049v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401049v%26sid%3Dliteratum%253Aachs%26aulast%3DGourdain%26aufirst%3DS.%26aulast%3DDairou%26aufirst%3DJ.%26aulast%3DDenhez%26aufirst%3DC.%26aulast%3DBui%26aufirst%3DL.%2BC.%26aulast%3DRodrigues-Lima%26aufirst%3DF.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3DCariou%26aufirst%3DK.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DDevelopment%2520of%2520DANDYs%252C%2520new%25203%252C5-diaryl-7-azaindoles%2520demonstrating%2520potent%2520DYRK1A%2520kinase%2520inhibitory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9569%26epage%3D9585%26doi%3D10.1021%2Fjm401049v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourdain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albac, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dairou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz-Afonso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues-Lima, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Caer, J-P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touboul, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delatour, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cariou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. H.</span></span> <span> </span><span class="NLM_article-title">DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2859</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-20984-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fs41598-018-20984-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=29434250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A280%3ADC%252BC1MrgslSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=2859&author=F.+Neumannauthor=S.+Gourdainauthor=C.+Albacauthor=A.+D.+Dekkerauthor=L.+C.+Buiauthor=J.+Dairouauthor=I.+Schmitz-Afonsoauthor=N.+Hueauthor=F.+Rodrigues-Limaauthor=J.+M.+Delabarauthor=M.-C.+Potierauthor=J-P.+L.+Le+Caerauthor=D.+Touboulauthor=B.+Delatourauthor=K.+Cariouauthor=R.+H.+Dodd&title=DYRK1A+inhibition+and+cognitive+rescue+in+a+Down+syndrome+mouse+model+are+induced+by+new+fluoro-DANDY+derivatives&doi=10.1038%2Fs41598-018-20984-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives</span></div><div class="casAuthors">Neumann Fernanda; Gourdain Stephanie; Schmitz-Afonso Isabelle; Hue Nathalie; Le Caer Jean-Pierre; Touboul David; Cariou Kevin; Dodd Robert H; Albac Christelle; Dekker Alain D; Delabar Jean M; Potier Marie-Claude; Delatour Benoit; Dekker Alain D; Bui Linh Chi; Rodrigues-Lima Fernando; Dairou Julien</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2859</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inhibition of DYRK1A kinase, produced by chromosome 21 and consequently overproduced in trisomy 21 subjects, has been suggested as a therapeutic approach to treating the cognitive deficiencies observed in Down syndrome (DS).  We now report the synthesis and potent DYRK1A inhibitory activities of fluoro derivatives of 3,5-di(polyhydroxyaryl)-7-azaindoles (F-DANDYs).  One of these compounds (3-(4-fluorophenyl)-5-(3,4-dihydroxyphenyl)-1H-pyrrolo[2,3-b]pyridine, 5a) was selected for in vivo studies of cognitive rescuing effects in a standard mouse model of DS (Ts65Dn line).  Using the Morris water maze task, Ts65Dn mice treated i.p. with 20 mg/kg of 5a performed significantly better than Ts65Dn mice treated with placebo, confirming the promnesiant effect of 5a in the trisomic mice.  Overall, these results demonstrate for the first time that selective and competitive inhibition of DYRK1A kinase by the F-DANDY derivative 5a may provide a viable treatment strategy for combating the memory and learning deficiencies encountered in DS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9xn_VdnX4CeR_TJajKxJDfW6udTcc2ebVcun2jK-7zLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MrgslSlsA%253D%253D&md5=2bfeabab1bcd8f8f661e8304a7bde167</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-20984-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-20984-z%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DF.%26aulast%3DGourdain%26aufirst%3DS.%26aulast%3DAlbac%26aufirst%3DC.%26aulast%3DDekker%26aufirst%3DA.%2BD.%26aulast%3DBui%26aufirst%3DL.%2BC.%26aulast%3DDairou%26aufirst%3DJ.%26aulast%3DSchmitz-Afonso%26aufirst%3DI.%26aulast%3DHue%26aufirst%3DN.%26aulast%3DRodrigues-Lima%26aufirst%3DF.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3DPotier%26aufirst%3DM.-C.%26aulast%3DLe%2BCaer%26aufirst%3DJ-P.%2BL.%26aulast%3DTouboul%26aufirst%3DD.%26aulast%3DDelatour%26aufirst%3DB.%26aulast%3DCariou%26aufirst%3DK.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DDYRK1A%2520inhibition%2520and%2520cognitive%2520rescue%2520in%2520a%2520Down%2520syndrome%2520mouse%2520model%2520are%2520induced%2520by%2520new%2520fluoro-DANDY%2520derivatives%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D2859%26doi%3D10.1038%2Fs41598-018-20984-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phoa, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbassi, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoque, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reekie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Font, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">Structural optimization and pharmacological evaluation of inhibitors targeting dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) and CDC-like kinases (CLK) in glioblastoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2052</span>– <span class="NLM_lpage">2070</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01840</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01840" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFSrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2052-2070&author=Q.+Zhouauthor=A.+F.+Phoaauthor=R.+H.+Abbassiauthor=M.+Hoqueauthor=T.+A.+Reekieauthor=J.+S.+Fontauthor=R.+M.+Ryanauthor=B.+W.+Stringerauthor=B.+W.+Dayauthor=T.+G.+Johnsauthor=L.+Munozauthor=M.+Kassiou&title=Structural+optimization+and+pharmacological+evaluation+of+inhibitors+targeting+dual-specificity+tyrosine+phosphorylation-regulated+kinases+%28DYRK%29+and+CDC-like+kinases+%28CLK%29+in+glioblastoma&doi=10.1021%2Facs.jmedchem.6b01840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma</span></div><div class="casAuthors">Zhou, Qingqing; Phoa, Athena F.; Abbassi, Ramzi H.; Hoque, Monira; Reekie, Tristan A.; Font, Josep S.; Ryan, Renae M.; Stringer, Brett W.; Day, Bryan W.; Johns, Terrance G.; Munoz, Lenka; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2052-2070</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The DYRK family contains kinases that are up-regulated in malignancy and control several cancer hallmarks.  To assess the anticancer potential of inhibitors targeting DYRK kinases, we developed a series of novel DYRK inhibitors based on the 7-azaindole scaffold.  All compds. were tested for their ability to inhibit DYRK1A, DYRK1B, DYRK2, and the structurally related CLK1.  The library was screened for anticancer efficacy in established and stem cell-like glioblastoma cell lines.  The most potent inhibitors (IC50 ≤ 50 nM) significantly decreased viability, clonogenic survival, migration, and invasion of glioblastoma cells.  Target engagement was confirmed with genetic knockdown and the cellular thermal shift assay.  We demonstrate that DYRK1A's thermal stability in cells is increased upon compd. treatment, confirming binding in cells.  In summary, we present synthesis, structure-activity relationship, and efficacy in glioblastoma-relevant models for a library of novel 7-azaindoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpju5xkVf0S5bVg90H21EOLACvtfcHk0lhs5woa4nps2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFSrtLc%253D&md5=953769f2edcb1e524ee73a84788f6e83</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01840%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DPhoa%26aufirst%3DA.%2BF.%26aulast%3DAbbassi%26aufirst%3DR.%2BH.%26aulast%3DHoque%26aufirst%3DM.%26aulast%3DReekie%26aufirst%3DT.%2BA.%26aulast%3DFont%26aufirst%3DJ.%2BS.%26aulast%3DRyan%26aufirst%3DR.%2BM.%26aulast%3DStringer%26aufirst%3DB.%2BW.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DJohns%26aufirst%3DT.%2BG.%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DStructural%2520optimization%2520and%2520pharmacological%2520evaluation%2520of%2520inhibitors%2520targeting%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinases%2520%2528DYRK%2529%2520and%2520CDC-like%2520kinases%2520%2528CLK%2529%2520in%2520glioblastoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2052%26epage%3D2070%26doi%3D10.1021%2Facs.jmedchem.6b01840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goff, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltgalvis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsella, T. M.</span></span> <span> </span><span class="NLM_article-title">Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2617</span>– <span class="NLM_lpage">2621</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2017.03.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2617-2621&author=S.+J.+Shawauthor=D.+A.+Goffauthor=N.+Linauthor=R.+Singhauthor=W.+Liauthor=J.+McLaughlinauthor=K.+A.+Baltgalvisauthor=D.+G.+Payanauthor=T.+M.+Kinsella&title=Developing+DYRK+inhibitors+derived+from+the+meridianins+as+a+means+of+increasing+levels+of+NFAT+in+the+nucleus&doi=10.1016%2Fj.bmcl.2017.03.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.037%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DS.%2BJ.%26aulast%3DGoff%26aufirst%3DD.%2BA.%26aulast%3DLin%26aufirst%3DN.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMcLaughlin%26aufirst%3DJ.%26aulast%3DBaltgalvis%26aufirst%3DK.%2BA.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DKinsella%26aufirst%3DT.%2BM.%26atitle%3DDeveloping%2520DYRK%2520inhibitors%2520derived%2520from%2520the%2520meridianins%2520as%2520a%2520means%2520of%2520increasing%2520levels%2520of%2520NFAT%2520in%2520the%2520nucleus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2617%26epage%3D2621%26doi%3D10.1016%2Fj.bmcl.2017.03.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arris, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardcastle, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewsbury, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesguiche, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitfield, H. J.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1038/nsb842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fnsb842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=745-749&author=T.+G.+Daviesauthor=J.+Bentleyauthor=C.+E.+Arrisauthor=F.+T.+Boyleauthor=N.+J.+Curtinauthor=J.+A.+Endicottauthor=A.+E.+Gibsonauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=I.+R.+Hardcastleauthor=P.+Jewsburyauthor=L.+N.+Johnsonauthor=V.+Mesguicheauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=J.+A.+Tuckerauthor=L.+Wangauthor=H.+J.+Whitfield&title=Structure-based+design+of+a+potent+purine-based+cyclin-dependent+kinase+inhibitor&doi=10.1038%2Fnsb842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fnsb842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb842%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWhitfield%26aufirst%3DH.%2BJ.%26atitle%3DStructure-based%2520design%2520of%2520a%2520potent%2520purine-based%2520cyclin-dependent%2520kinase%2520inhibitor%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D745%26epage%3D749%26doi%3D10.1038%2Fnsb842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scales, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goold, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon-Weeks, P. R.</span></span> <span> </span><span class="NLM_article-title">Nonprimed and DYRK1A-primed GSK3β-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">2424</span>– <span class="NLM_lpage">2435</span>, <span class="refDoi"> DOI: 10.1242/jcs.040162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1242%2Fjcs.040162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=19549690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFGmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=2424-2435&author=T.+M.+Scalesauthor=S.+Linauthor=M.+Krausauthor=R.+G.+Gooldauthor=P.+R.+Gordon-Weeks&title=Nonprimed+and+DYRK1A-primed+GSK3%CE%B2-phosphorylation+sites+on+MAP1B+regulate+microtubule+dynamics+in+growing+axons&doi=10.1242%2Fjcs.040162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Nonprimed and DYRK1A-primed GSK3β-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons</span></div><div class="casAuthors">Scales, Timothy M. E.; Lin, Shen; Kraus, Michaela; Goold, Robert G.; Gordon-Weeks, Phillip R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2424-2435</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">MAP1B is a developmentally regulated microtubule-assocd. phosphoprotein that regulates microtubule dynamics in growing axons and growth cones.  We used mass spectrometry to map 28 phosphorylation sites on MAP1B, and selected for further study a putative primed GSK3β site and compared it with two nonprimed GSK3β sites that we had previously characterized.  We raised a panel of phosphospecific antibodies to these sites on MAP1B and used it to assess the distribution of phosphorylated MAP1B in the developing nervous system.  This showed that the nonprimed sites are restricted to growing axons, whereas the primed sites are also expressed in the neuronal cell body.  To identify kinases phosphorylating MAP1B, we added kinase inhibitors to cultured embryonic cortical neurons and monitored MAP1B phosphorylation with our panel of phosphospecific antibodies.  These expts. identified dual-specificity tyrosine-phosphorylation-regulated kinase (DYRK1A) as the kinase that primes sites of GSK3β phosphorylation in MAP1B, and we confirmed this by knocking down DYRK1A in cultured embryonic cortical neurons by using shRNA.  DYRK1A knockdown compromised neuritogenesis and was assocd. with alterations in microtubule stability.  These expts. demonstrate that MAP1B has DYRK1A-primed and nonprimed GSK3β sites that are involved in the regulation of microtubule stability in growing axons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKRvNhhYBbLVg90H21EOLACvtfcHk0lin2y777s185Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFGmu7w%253D&md5=916cf24a8826a66240a64c96c90b76bf</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1242%2Fjcs.040162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.040162%26sid%3Dliteratum%253Aachs%26aulast%3DScales%26aufirst%3DT.%2BM.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DGoold%26aufirst%3DR.%2BG.%26aulast%3DGordon-Weeks%26aufirst%3DP.%2BR.%26atitle%3DNonprimed%2520and%2520DYRK1A-primed%2520GSK3%25CE%25B2-phosphorylation%2520sites%2520on%2520MAP1B%2520regulate%2520microtubule%2520dynamics%2520in%2520growing%2520axons%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2009%26volume%3D122%26spage%3D2424%26epage%3D2435%26doi%3D10.1242%2Fjcs.040162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bettayeb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sallam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popowycz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2713</span>– <span class="NLM_lpage">2724</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1158%2F1535-7163.MCT-08-0080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=18790752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSms7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2713-2724&author=K.+Bettayebauthor=H.+Sallamauthor=Y.+Ferandinauthor=F.+Popowyczauthor=G.+Fournetauthor=M.+Hassanauthor=A.+Echalierauthor=P.+Bernardauthor=J.+Endicottauthor=B.+Josephauthor=L.+Meijer&title=N-%26-N%2C+a+new+class+of+cell+death-inducing+kinase+inhibitors+derived+from+the+purine+roscovitine&doi=10.1158%2F1535-7163.MCT-08-0080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine</span></div><div class="casAuthors">Bettayeb, Karima; Sallam, Hatem; Ferandin, Yoan; Popowycz, Florence; Fournet, Guy; Hassan, Moustapha; Echalier, Aude; Bernard, Philippe; Endicott, Jane; Joseph, Benoit; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2713-2724</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) and their regulators show frequent abnormalities in tumors.  Ten low mol. wt. pharmacol. inhibitors of CDKs are currently in clin. trials against various cancers, including the 2,6,9-trisubstituted purine (R)-roscovitine (CYC202/Seliciclib).  We here report the characterization of N-&-N1, a bioisoster of roscovitine displaying improved antitumoral properties.  N-&-N1 shows exquisite selectivity for CDKs, with 2- to 3-fold enhanced potency compared with (R)-roscovitine.  Inhibition of retinoblastoma protein phosphorylation and RNA polymerase II Ser2 phosphorylation in neuroblastoma SH-SY5Y cells exposed to N-&-N1 indicates that N-&-N1 is able to inhibit CDKs in a cellular context.  N-&-N1 also down-regulates the expression of RNA polymerase.  Cocrystal structures of N-&-N1 and (R)-roscovitine in complex with CDK2/cyclin A reveal that both inhibitors adopt similar binding modes.  A competitive assay shows that, compared with (R)-roscovitine, N-&-N1 has reduced affinity for Erk2 and pyridoxal kinase.  N-&-N1 triggers cell death in a panel of diverse cell lines.  Cell death is accompanied by events characteristic of apoptosis: cytochrome c release, activation of effector caspases, and poly(ADP-ribose) polymerase cleavage.  Induction of p53 and p21CIP1 and down-regulation of the Mcl-1 antiapoptotic factor were also obsd.  Studies in mice show that N-&-N1 has pharmacokinetics properties similar to those of (R)-roscovitine.  Altogether, these results show that analogs of (R)-roscovitine can be designed with improved antitumor potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAdPDD672MabVg90H21EOLACvtfcHk0lin2y777s185Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSms7nL&md5=a2d1cc3e59c608be45064a2ace6f0426</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0080%26sid%3Dliteratum%253Aachs%26aulast%3DBettayeb%26aufirst%3DK.%26aulast%3DSallam%26aufirst%3DH.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DPopowycz%26aufirst%3DF.%26aulast%3DFournet%26aufirst%3DG.%26aulast%3DHassan%26aufirst%3DM.%26aulast%3DEchalier%26aufirst%3DA.%26aulast%3DBernard%26aufirst%3DP.%26aulast%3DEndicott%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DN-%2526-N%252C%2520a%2520new%2520class%2520of%2520cell%2520death-inducing%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520purine%2520roscovitine%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2713%26epage%3D2724%26doi%3D10.1158%2F1535-7163.MCT-08-0080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bettayeb, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oumata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferandin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galons, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5797</span>– <span class="NLM_lpage">5807</span>, <span class="refDoi"> DOI: 10.1038/onc.2008.191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1038%2Fonc.2008.191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=18574471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFyqtrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5797-5807&author=K.+Bettayebauthor=N.+Oumataauthor=A.+Echalierauthor=Y.+Ferandinauthor=J.+A.+Endicottauthor=H.+Galonsauthor=L.+Meijer&title=CR8%2C+a+potent+and+selective%2C+roscovitine-derived+inhibitor+of+cyclin-dependent+kinases&doi=10.1038%2Fonc.2008.191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases</span></div><div class="casAuthors">Bettayeb, K.; Oumata, N.; Echalier, A.; Ferandin, Y.; Endicott, J. A.; Galons, H.; Meijer, L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">5797-5807</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Among the ten pharmacol. inhibitors of cyclin-dependent kinases (CDKs) currently in clin. trials, the purine roscovitine (CYC202, Seliciclib) is undergoing phase 2 trials against non-small-cell lung and nasopharyngeal cancers.  An extensive medicinal chem. study, designed to generate more potent analogs of roscovitine, led to the identification of an optimal substitution at the N6 position (compd. CR8).  An extensive selectivity study (108 kinases) highlights the exquisite selectivity of CR8 for CDK1/2/3/5/7/9.  CR8 was 2- to 4-fold more potent than (R)-roscovitine at inhibiting these kinases.  Cocrystal structures of (R)-CR8 and (R)-roscovitine with pCDK2/cyclin A showed that both inhibitors adopt essentially identical positions.  The cellular effects of CR8 and (R)-roscovitine were investigated in human neuroblastoma SH-SY5Y cells.  CR8 inhibited the phosphorylation of CDK1 and 9 substrates, with a 25-50 times higher potency compared to (R)-roscovitine.  CR8 was consistently more potent than (R)-roscovitine at inducing apoptotic cell death parameters: 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium redn. (40-fold), lactate dehydrogenase release (35-fold), caspases activation (68-fold) and poly-(ADP-ribose)polymerase cleavage (50-fold).  This improved cell death-inducing activity of CR8 over (R)-roscovitine was obsd. in 25 different cell lines.  Altogether these results show that second-generation analogs of (R)-roscovitine can be designed with improved antitumor potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvXAJQBwEMJbVg90H21EOLACvtfcHk0lgXTZBNT-mH2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFyqtrfI&md5=31e226f8a2f23caf88e6c9422138d2d7</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fonc.2008.191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2008.191%26sid%3Dliteratum%253Aachs%26aulast%3DBettayeb%26aufirst%3DK.%26aulast%3DOumata%26aufirst%3DN.%26aulast%3DEchalier%26aufirst%3DA.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DCR8%252C%2520a%2520potent%2520and%2520selective%252C%2520roscovitine-derived%2520inhibitor%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5797%26epage%3D5807%26doi%3D10.1038%2Fonc.2008.191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span>; <span class="NLM_string-name">Bettayeb, K.</span>; <span class="NLM_string-name">Galons, H.</span>; <span class="NLM_string-name">Demange, L.</span>; <span class="NLM_string-name">Oumata, N.</span></span> <span> </span><span class="NLM_article-title">Perharidines as CDK Inhibitors</span>. <span class="NLM_patent">WO 2009034475A2</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=L.+Meijer&author=K.+Bettayeb&author=H.+Galons&author=L.+Demange&author=N.+Oumata&title=Perharidines+as+CDK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DPerharidines%2520as%2520CDK%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diharce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Désiré, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">An unusual binding model of the methyl 9-anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) confers high selectivity for dual-specificity tyrosine phosphorylation-regulated kinases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10315</span>– <span class="NLM_lpage">10321</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01083</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01083" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10315-10321&author=A.+Chaikuadauthor=J.+Diharceauthor=M.+Schr%C3%B6derauthor=A.+Foucourtauthor=B.+Leblondauthor=A.+S.+Casagrandeauthor=L.+D%C3%A9sir%C3%A9author=P.+Bonnetauthor=S.+Knappauthor=T.+Besson&title=An+unusual+binding+model+of+the+methyl+9-anilinothiazolo%5B5%2C4-f%5D+quinazoline-2-carbimidates+%28EHT+1610+and+EHT+5372%29+confers+high+selectivity+for+dual-specificity+tyrosine+phosphorylation-regulated+kinases&doi=10.1021%2Facs.jmedchem.6b01083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114aR"><div class="casContent"><span class="casTitleNuber">114a</span><div class="casTitle"><span class="NLM_cas:atitle">An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases</span></div><div class="casAuthors">Chaikuad, Apirat; Diharce, Julien; Schroder, Martin; Foucourt, Alicia; Leblond, Bertrand; Casagrande, Anne-Sophie; Desire, Laurent; Bonnet, Pascal; Knapp, Stefan; Besson, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10315-10321</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Me 9-anilinothiazolo[5,4-f]quinazoline-2-carbimidates 1 (EHT 5372) and 2 (EHT 1610) are strong inhibitors of DYRK's family kinases.  The crystal structures of the complex revealed a non-canonical binding mode of compd. 1 and 2 in DYRK2 explaining the remarkable selectivity and potency of these inhibitors.  The structural data and comparison presented here provide therefore a template for further improvement of this inhibitor class and for the development of novel inhibitors selectively targeting DYRK kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp91_JqCRXGqLVg90H21EOLACvtfcHk0lgXTZBNT-mH2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjtr%252FM&md5=856551b47ad21c90c55563b064001358</span></div><a href="/servlet/linkout?suffix=cit114a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01083%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DDiharce%26aufirst%3DJ.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DM.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DCasagrande%26aufirst%3DA.%2BS.%26aulast%3DD%25C3%25A9sir%25C3%25A9%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DAn%2520unusual%2520binding%2520model%2520of%2520the%2520methyl%25209-anilinothiazolo%255B5%252C4-f%255D%2520quinazoline-2-carbimidates%2520%2528EHT%25201610%2520and%2520EHT%25205372%2529%2520confers%2520high%2520selectivity%2520for%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10315%26epage%3D10321%26doi%3D10.1021%2Facs.jmedchem.6b01083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit114b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rosse, G.</span></span> <span> </span><span class="NLM_article-title">Tricyclic pyrimidines as inhibitors of DYRK1A/DYRK1B as potential treatment for Down’s syndrome or Alzheimer’s disease</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1021/ml400137s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400137s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=502-503&author=G.+Rosse&title=Tricyclic+pyrimidines+as+inhibitors+of+DYRK1A%2FDYRK1B+as+potential+treatment+for+Down%E2%80%99s+syndrome+or+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fml400137s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114b&amp;dbid=16384&amp;doi=10.1021%2Fml400137s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400137s%26sid%3Dliteratum%253Aachs%26aulast%3DRosse%26aufirst%3DG.%26atitle%3DTricyclic%2520pyrimidines%2520as%2520inhibitors%2520of%2520DYRK1A%252FDYRK1B%2520as%2520potential%2520treatment%2520for%2520Down%25E2%2580%2599s%2520syndrome%2520or%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D502%26epage%3D503%26doi%3D10.1021%2Fml400137s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit114c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span>; <span class="NLM_string-name">Casagrande, A.-S.</span>; <span class="NLM_string-name">Desire, L.</span>; <span class="NLM_string-name">Foucourt, A.</span>; <span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">DYRK1 Inhibitors and Uses Thereof</span>. <span class="NLM_patent">US 9446044B2</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=B.+Leblond&author=A.-S.+Casagrande&author=L.+Desire&author=A.+Foucourt&author=T.+Besson&title=DYRK1+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLeblond%26aufirst%3DB.%26atitle%3DDYRK1%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutadeur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benyamine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delalonde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucourt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taverne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pando, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desire, L.</span></span> <span> </span><span class="NLM_article-title">A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer’s disease: effect on Tau and amyloid pathologies <i>in vitro</i></span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1111/jnc.13018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1111%2Fjnc.13018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=25556849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2015&pages=440-451&author=S.+Coutadeurauthor=H.+Benyamineauthor=L.+Delalondeauthor=C.+de+Oliveiraauthor=B.+Leblondauthor=A.+Foucourtauthor=T.+Bessonauthor=A.+S.+Casagrandeauthor=T.+Taverneauthor=A.+Girardauthor=M.+P.+Pandoauthor=L.+Desire&title=A+novel+DYRK1A+%28dual+specificity+tyrosine+phosphorylation-regulated+kinase+1A%29+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+effect+on+Tau+and+amyloid+pathologies+in+vitro&doi=10.1111%2Fjnc.13018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro</span></div><div class="casAuthors">Coutadeur, Severine; Benyamine, Helene; Delalonde, Laurence; de Oliveira, Catherine; Leblond, Bertrand; Foucourt, Alicia; Besson, Thierry; Casagrande, Anne-Sophie; Taverne, Thierry; Girard, Angelique; Pando, Matthew P.; Desire, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-451</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene is located within the Down Syndrome (DS) crit. region on chromosome 21 and is implicated in the generation of Tau and amyloid pathologies that are assocd. with the early onset Alzheimer's Disease (AD) obsd. in DS.  DYRK1A is also found assocd. with neurofibrillary tangles in sporadic AD and phosphorylates key AD players (Tau, amyloid precursor, protein, etc).  Thus, DYRK1A may be an important therapeutic target to modify the course of Tau and amyloid beta (Aβ) pathologies.  Here, we describe EHT 5372 (Me 9-(2,4-dichlorophenylamino) thiazolo[5,4-f]quinazoline-2-carbimidate), a novel, highly potent (IC50 = 0.22 nM) DYRK1A inhibitor with a high degree of selectivity over 339 kinases.  Models in which inhibition of DYRK1A by siRNA reduced and DYRK1A over-expression induced Tau phosphorylation or Aβ prodn. were used.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation at multiple AD-relevant sites in biochem. and cellular assays.  EHT 5372 also normalizes both Aβ-induced Tau phosphorylation and DYRK1A-stimulated Aβ prodn.  DYRK1A is thus as a key element of Aβ-mediated Tau hyperphosphorylation, which links Tau and amyloid pathologies.  EHT 5372 and other compds. in its class warrant in vivo investigation as a novel, high-potential therapy for AD and other Tau opathies.  Inhibition of the dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is a new high-potential therapeutic approach for Alzheimer disease.  Here we describe EHT 5372, a novel potent and selective DYRK1A inhibitor.  EHT 5372 inhibits DYRK1A-induced Tau phosphorylation, Aβ prodn. and Aβ effects on phospho-Tau, including Tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVswt1MX4I7Vg90H21EOLACvtfcHk0lhJ2nOWbKjV4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlKitbY%253D&md5=5953fc5e56b7ea3c86ea414bd3de7863</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13018%26sid%3Dliteratum%253Aachs%26aulast%3DCoutadeur%26aufirst%3DS.%26aulast%3DBenyamine%26aufirst%3DH.%26aulast%3DDelalonde%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DFoucourt%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DCasagrande%26aufirst%3DA.%2BS.%26aulast%3DTaverne%26aufirst%3DT.%26aulast%3DGirard%26aufirst%3DA.%26aulast%3DPando%26aufirst%3DM.%2BP.%26aulast%3DDesire%26aufirst%3DL.%26atitle%3DA%2520novel%2520DYRK1A%2520%2528dual%2520specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520effect%2520on%2520Tau%2520and%2520amyloid%2520pathologies%2520in%2520vitro%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D133%26spage%3D440%26epage%3D451%26doi%3D10.1111%2Fjnc.13018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hédou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of thiazolo[5,4-f]quinazolin-9(8H)-ones as multi-target directed ligands of Ser/Thr kinases</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">578</span>, <span class="refDoi"> DOI: 10.3390/molecules21050578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.3390%2Fmolecules21050578" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=578&author=D.+H%C3%A9douauthor=J.+Godeauauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=C.+Fruitauthor=T.+Besson&title=Synthesis+of+thiazolo%5B5%2C4-f%5Dquinazolin-9%288H%29-ones+as+multi-target+directed+ligands+of+Ser%2FThr+kinases&doi=10.3390%2Fmolecules21050578"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21050578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21050578%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DGodeau%26aufirst%3DJ.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DFruit%26aufirst%3DC.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520thiazolo%255B5%252C4-f%255Dquinazolin-9%25288H%2529-ones%2520as%2520multi-target%2520directed%2520ligands%2520of%2520Ser%252FThr%2520kinases%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D578%26doi%3D10.3390%2Fmolecules21050578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeunynck, M.</span></span> <span> </span><span class="NLM_article-title">Catalyst-free synthesis of quinazolin-4-ones from (hetero)aryl-guanidines: application to the synthesis of pyrazolo[4,3-f]quinazolin-9-ones, a new family of DYRK1A inhibitors</span>. <i>Mol. Diversity</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1007/s11030-012-9397-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1007%2Fs11030-012-9397-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=659-667&author=J.+Debrayauthor=S.+Bonteauthor=O.+Lozachauthor=L.+Meijerauthor=M.+Demeunynck&title=Catalyst-free+synthesis+of+quinazolin-4-ones+from+%28hetero%29aryl-guanidines%3A+application+to+the+synthesis+of+pyrazolo%5B4%2C3-f%5Dquinazolin-9-ones%2C+a+new+family+of+DYRK1A+inhibitors&doi=10.1007%2Fs11030-012-9397-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1007%2Fs11030-012-9397-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11030-012-9397-7%26sid%3Dliteratum%253Aachs%26aulast%3DDebray%26aufirst%3DJ.%26aulast%3DBonte%26aufirst%3DS.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DDemeunynck%26aufirst%3DM.%26atitle%3DCatalyst-free%2520synthesis%2520of%2520quinazolin-4-ones%2520from%2520%2528hetero%2529aryl-guanidines%253A%2520application%2520to%2520the%2520synthesis%2520of%2520pyrazolo%255B4%252C3-f%255Dquinazolin-9-ones%252C%2520a%2520new%2520family%2520of%2520DYRK1A%2520inhibitors%26jtitle%3DMol.%2520Diversity%26date%3D2012%26volume%3D16%26spage%3D659%26epage%3D667%26doi%3D10.1007%2Fs11030-012-9397-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui-Jain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drygin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streiner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bliesath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huser, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proffitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwaebe, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderes, K.</span></span> <span> </span><span class="NLM_article-title">CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">10288</span>– <span class="NLM_lpage">10298</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1158%2F0008-5472.CAN-10-1893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21159648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10288-10298&author=A.+Siddiqui-Jainauthor=D.+Dryginauthor=N.+Streinerauthor=P.+Chuaauthor=F.+Pierreauthor=S.+E.+O%E2%80%99Brienauthor=J.+Bliesathauthor=M.+Omoriauthor=N.+Huserauthor=C.+Hoauthor=C.+Proffittauthor=M.+K.+Schwaebeauthor=D.+M.+Ryckmanauthor=W.+G.+Riceauthor=K.+Anderes&title=CX-4945%2C+an+orally+bioavailable+selective+inhibitor+of+protein+kinase+CK2%2C+inhibits+prosurvival+and+angiogenic+signaling+and+exhibits+antitumor+efficacy&doi=10.1158%2F0008-5472.CAN-10-1893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118aR"><div class="casContent"><span class="casTitleNuber">118a</span><div class="casTitle"><span class="NLM_cas:atitle">CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy</span></div><div class="casAuthors">Siddiqui-Jain, Adam; Drygin, Denis; Streiner, Nicole; Chua, Peter; Pierre, Fabrice; O'Brien, Sean E.; Bliesath, Josh; Omori, Mayuko; Huser, Nanni; Ho, Caroline; Proffitt, Chris; Schwaebe, Michael K.; Ryckman, David M.; Rice, William G.; Anderes, Kenna</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10288-10298</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Malignant transformation and maintenance of the malignant phenotype depends on oncogenic and non-oncogenic proteins that are essential to mediate oncogene signaling and to support the altered physiol. demands induced by transformation.  Protein kinase CK2 supports key prosurvival signaling pathways and represents a prototypical non-oncogene.  In this study, we describe CX-4945, a potent and selective orally bioavailable small mol. inhibitor of CK2.  The antiproliferative activity of CX-4945 against cancer cells correlated with expression levels of the CK2α catalytic subunit.  Attenuation of PI3K/Akt signaling by CX-4945 was evidenced by dephosphorylation of Akt on the CK2-specific S129 site and the canonical S473 and T308 regulatory sites.  CX-4945 caused cell-cycle arrest and selectively induced apoptosis in cancer cells relative to normal cells.  In models of angiogenesis, CX-4945 inhibited human umbilical vein endothelial cell migration, tube formation, and blocked CK2-dependent hypoxia-induced factor 1 alpha (HIF-1α) transcription in cancer cells.  When administered orally in murine xenograft models, CX-4945 was well tolerated and demonstrated robust antitumor activity with concomitant redns. of the mechanism-based biomarker phospho-p21 (T145).  The obsd. antiproliferative and anti-angiogenic responses to CX-4945 in tumor cells and endothelial cells collectively illustrate that this compd. exerts its antitumor effects through inhibition of CK2-dependent signaling in multiple pathways.  Finally, CX-4945 is the first orally bioavailable small mol. inhibitor of CK2 to advance into human clin. trials, thereby paving the way for an entirely new class of targeted treatment for cancer.  Cancer Res; 70(24); 10288-98.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8s0Sa3hOwtbVg90H21EOLACvtfcHk0lhJ2nOWbKjV4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7fK&md5=bfcfe06730e099719e752574a6636dfb</span></div><a href="/servlet/linkout?suffix=cit118a&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1893%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26aulast%3DDrygin%26aufirst%3DD.%26aulast%3DStreiner%26aufirst%3DN.%26aulast%3DChua%26aufirst%3DP.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DBliesath%26aufirst%3DJ.%26aulast%3DOmori%26aufirst%3DM.%26aulast%3DHuser%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DProffitt%26aufirst%3DC.%26aulast%3DSchwaebe%26aufirst%3DM.%2BK.%26aulast%3DRyckman%26aufirst%3DD.%2BM.%26aulast%3DRice%26aufirst%3DW.%2BG.%26aulast%3DAnderes%26aufirst%3DK.%26atitle%3DCX-4945%252C%2520an%2520orally%2520bioavailable%2520selective%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%252C%2520inhibits%2520prosurvival%2520and%2520angiogenic%2520signaling%2520and%2520exhibits%2520antitumor%2520efficacy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D10288%26epage%3D10298%26doi%3D10.1158%2F0008-5472.CAN-10-1893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit118b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel function of CX-4945 as a splicing regulator</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e94978</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0094978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1371%2Fjournal.pone.0094978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=24743259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e94978&author=H.+Kimauthor=K.+Choiauthor=H.+Kangauthor=S.+Y.+Leeauthor=S.+W.+Chiauthor=M.+S.+Leeauthor=J.+Songauthor=D.+Imauthor=Y.+Choiauthor=S.+Cho&title=Identification+of+a+novel+function+of+CX-4945+as+a+splicing+regulator&doi=10.1371%2Fjournal.pone.0094978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118bR"><div class="casContent"><span class="casTitleNuber">118b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel function of CX-4945 as a splicing regulator</span></div><div class="casAuthors">Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Lee, So-Young; Chi, Seung-wook; Lee, Min-sung; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e94978/1-e94978/8, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Alternative splicing is a nearly ubiquitous versatile process that controls gene expression and creates numerous protein isoforms with different functions from a single gene.  The significance of alternative splicing has been confirmed by the increasing no. of human diseases that are caused by misregulation of splicing events.  Very few compds., however, have been reported to act as inhibitors of alternative splicing, and their potential clin. use needs to be evaluated.  Here, we report that CX-4945, a previously well-characterized inhibitor of casein kinase 2 (CK2) and a mol. currently in clin. trials (Phase II) for cancer treatment, regulates splicing in mammalian cells in a CK2-independent manner.  Transcriptome-wide anal. using exon array also showed a widespread alteration in alternative splicing of numerous genes.  We found that CX-4945 potently inhibits the Cdc2-like kinases (Clks) in vitro and in turn, leads to suppression of the phosphorylation of serine/arginine-rich (SR) proteins in mammalian cells.  Surprisingly, the overall efficacy of CX-4945 on Clks (IC50 = 3-90 nM) was stronger than that of TG-003, the strongest inhibitor reported to date.  Of the Clks, Clk2 was most strongly inhibited by CX-4945 in an ATP-competitive manner.  Our research revealed an unexpected activity of the drug candidate CX-4945 as a potent splicing modulator and also suggested a potential application for therapy of diseases caused by abnormal splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEmZdGtUZUe7Vg90H21EOLACvtfcHk0lhZr8HW-VpHCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFemurzL&md5=5edb2338401d950cddbcba7d35e57c04</span></div><a href="/servlet/linkout?suffix=cit118b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0094978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0094978%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DChi%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DIm%26aufirst%3DD.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520novel%2520function%2520of%2520CX-4945%2520as%2520a%2520splicing%2520regulator%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De94978%26doi%3D10.1371%2Fjournal.pone.0094978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. C.</span>; <span class="NLM_string-name">Kim, H. K.</span>; <span class="NLM_string-name">Lee, K. S.</span>; <span class="NLM_string-name">Choi, K. M.</span>; <span class="NLM_string-name">Chi, S. W.</span>; <span class="NLM_string-name">Yu, K.</span>; <span class="NLM_string-name">Kim, A. K.</span>; <span class="NLM_string-name">Choi, M. R.</span>; <span class="NLM_string-name">Kang, H. J.</span>; <span class="NLM_string-name">Lee, J. S.</span>; <span class="NLM_string-name">Lee, M. S.</span></span> <span> </span><span class="NLM_article-title">Pharmaceutical Composition for Preventing and Treating Degenerative Brain Diseases, Containing CX-4945 as Active Ingredient</span>. <span class="NLM_patent">WO 2015199503</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+C.+Cho&author=H.+K.+Kim&author=K.+S.+Lee&author=K.+M.+Choi&author=S.+W.+Chi&author=K.+Yu&author=A.+K.+Kim&author=M.+R.+Choi&author=H.+J.+Kang&author=J.+S.+Lee&author=M.+S.+Lee&title=Pharmaceutical+Composition+for+Preventing+and+Treating+Degenerative+Brain+Diseases%2C+Containing+CX-4945+as+Active+Ingredient"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BC.%26atitle%3DPharmaceutical%2520Composition%2520for%2520Preventing%2520and%2520Treating%2520Degenerative%2520Brain%2520Diseases%252C%2520Containing%2520CX-4945%2520as%2520Active%2520Ingredient%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span> <span> </span><span class="NLM_article-title">A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition</span>. <i>Dis. Models &amp; Mech.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.1242/dmm.025668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1242%2Fdmm.025668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=27483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2hsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=839-848&author=H.+Kimauthor=K.+S.+Leeauthor=A.+K.+Kimauthor=M.+Choiauthor=K.+Choiauthor=M.+Kangauthor=S.+W.+Chiauthor=M.+S.+Leeauthor=J.+S.+Leeauthor=S.+Y.+Leeauthor=W.+J.+Songauthor=K.+Yuauthor=S.+Cho&title=A+chemical+with+proven+clinical+safety+rescues+Down-syndrome-related+phenotypes+in+through+DYRK1A+inhibition&doi=10.1242%2Fdmm.025668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical with proven clinical safety rescues Down-syndromerelated phenotypes in through DYRK1A inhibition</span></div><div class="casAuthors">Kim, Hyeongki; Lee, Kyu-Sun; Kim, Ae-Kyeong; Choi, Miri; Choi, Kwangman; Kang, Mingu; Chi, Seung-Wook; Lee, Min-Sung; Lee, Jeong-Soo; Lee, So-Young; Song, Woo-Joo; Yu, Kweon; Cho, Sungchan</div><div class="citationInfo"><span class="NLM_cas:title">Disease Models & Mechanisms</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">839-848</span>CODEN:
                <span class="NLM_cas:coden">DMMIAX</span>;
        ISSN:<span class="NLM_cas:issn">1754-8403</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">DYRK1A is important in neuronal development and function, and its excessive activity is considered a significant pathogenic factor in Down syndrome and Alzheimer's disease.  Thus, inhibition of DYRK1A has been suggested to be a new strategy to modify the disease.  Very few compds., however, have been reported to act as inhibitors, and their potential clin. uses require further evaluation.  Here,we newly identify CX-4945, the safety of which has been already proven in the clin. setting, as a potent inhibitor ofDYRK1A that acts in an ATP-competitive manner.  The inhibitory potency of CX-4945 on DYRK1A (IC50=6.8 nM) in vitro was higher than that of harmine, INDY or proINDY, which are well-known potent inhibitors of DYRK1A.  CX-4945 effectively reverses the aberrant phosphorylation of Tau, amyloid precursor protein (APP) and presenilin 1 (PS1) inmammalian cells.  To our surprise, feedingwith CX-4945 significantly restored the neurol. and phenotypic defects induced by the overexpression of minibrain, an ortholog of human DYRK1A, in the Drosophila model.  Moreover, oral administration of CX-4945 acutely suppressed Tau hyperphosphorylation in the hippocampus of DYRK1A-overexpressing mice.  Our research results demonstrate that CX-4945 is a potent DYRK1A inhibitor and also suggest that it has therapeutic potential for DYRK1A-assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwgsUZXI8Gj7Vg90H21EOLACvtfcHk0lhZr8HW-VpHCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2hsLbN&md5=bfc074ed6a4162a09435959405fa0529</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1242%2Fdmm.025668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.025668%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DA.%2BK.%26aulast%3DChoi%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DChi%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DCho%26aufirst%3DS.%26atitle%3DA%2520chemical%2520with%2520proven%2520clinical%2520safety%2520rescues%2520Down-syndrome-related%2520phenotypes%2520in%2520through%2520DYRK1A%2520inhibition%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2016%26volume%3D9%26spage%3D839%26epage%3D848%26doi%3D10.1242%2Fdmm.025668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luk, K. T.</span></span> <span> </span><span class="NLM_article-title">1,6- and 1,8-Naphthyridines Useful as Dyrk1 Inhibitors</span>. <span class="NLM_patent">WO 2012098066</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+T.+Luk&title=1%2C6-+and+1%2C8-Naphthyridines+Useful+as+Dyrk1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLuk%26aufirst%3DK.%2BT.%26atitle%3D1%252C6-%2520and%25201%252C8-Naphthyridines%2520Useful%2520as%2520Dyrk1%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu Jhaisha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunick, C.</span></span> <span> </span><span class="NLM_article-title">10-Iodo-11<i>H</i>-indolo[3,2-<i>c</i>]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3143</span>, <span class="refDoi"> DOI: 10.1021/jm501994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3131-3143&author=H.+Falkeauthor=A.+Chaikuadauthor=A.+Beckerauthor=N.+Loa%C3%ABcauthor=O.+Lozachauthor=S.+Abu+Jhaishaauthor=W.+Beckerauthor=P.+G.+Jonesauthor=L.+Preuauthor=K.+Baumannauthor=S.+Knappauthor=L.+Meijerauthor=C.+Kunick&title=10-Iodo-11H-indolo%5B3%2C2-c%5Dquinoline-6-carboxylic+acids+are+selective+inhibitors+of+DYRK1A&doi=10.1021%2Fjm501994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A</span></div><div class="casAuthors">Falke, Hannes; Chaikuad, Apirat; Becker, Anja; Loaec, Nadege; Lozach, Olivier; Abu Jhaisha, Samira; Becker, Walter; Jones, Peter G.; Preu, Lutz; Baumann, Knut; Knapp, Stefan; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3131-3143</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase DYRK1A has been suggested to act as one of the intracellular regulators contributing to neurol. alterations found in individuals with Down syndrome.  For an assessment of the role of DYRK1A, selective synthetic inhibitors are valuable pharmacol. tools.  However, the DYRK1A inhibitors described in the literature so far either are not sufficiently selective or have not been tested against closely related kinases from the DYRK and the CLK protein kinase families.  The aim of this study was the identification of DYRK1A inhibitors exhibiting selectivity vs. the structurally and functionally closely related DYRK and CLK isoforms.  Structure modification of the screening hit 11H-indolo[3,2-c]quinoline-6-carboxylic acid revealed structure-activity relationships for kinase inhibition and enabled the design of 10-iodo-substituted derivs. as very potent DYRK1A inhibitors with considerable selectivity against CLKs.  X-ray structure detn. of three 11H-indolo[3,2-c]quinoline-6-carboxylic acids cocrystd. with DYRK1A confirmed the predicted binding mode within the ATP binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4rHbgYJUsbVg90H21EOLACvtfcHk0lhrvegxH8wYfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtrY%253D&md5=70efbb6ad590a1240764ccc78af019ec</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm501994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501994d%26sid%3Dliteratum%253Aachs%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DAbu%2BJhaisha%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3D10-Iodo-11H-indolo%255B3%252C2-c%255Dquinoline-6-carboxylic%2520acids%2520are%2520selective%2520inhibitors%2520of%2520DYRK1A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3131%26epage%3D3143%26doi%3D10.1021%2Fjm501994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunick, C.</span></span> <span> </span><span class="NLM_article-title">Indole-3-carbonitriles as DYRK1A inhibitors by fragment-based drug design</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">64</span>, <span class="refDoi"> DOI: 10.3390/molecules23020064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.3390%2Fmolecules23020064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1OhurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=64&author=R.+Meineauthor=W.+Beckerauthor=H.+Falkeauthor=L.+Preuauthor=N.+Loaecauthor=L.+Meijerauthor=C.+Kunick&title=Indole-3-carbonitriles+as+DYRK1A+inhibitors+by+fragment-based+drug+design&doi=10.3390%2Fmolecules23020064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Indole-3-carbonitriles as DYRK1A inhibitors by fragment-based drug design</span></div><div class="casAuthors">Meine, Rosanna; Becker, Walter; Falke, Hannes; Preu, Lutz; Loaeec, Nadege; Meijer, Laurent; Kunick, Conrad</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">64/1-64/23</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a potential drug target because of its role in the development of Down syndrome and Alzheimer's disease.  The selective DYRK1A inhibitor 10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acid (KuFal194), a large, flat and lipophilic mol., suffers from poor water soly., limiting its use as chem. probe in cellular assays and animal models.  Based on the structure of KuFal194, 7-chloro-1H-indole-3-carbonitrile was selected as fragment template for the development of smaller and less lipophilic DYRK1A inhibitors.  By modification of this fragment, a series of indole-3-carbonitriles was designed and evaluated as potential DYRK1A ligands by mol. docking studies.  Synthesis and in vitro assays on DYRK1A and related protein kinases identified novel double-digit nanomolar inhibitors with submicromolar activity in cell culture assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkYtRPnACcGLVg90H21EOLACvtfcHk0lhrvegxH8wYfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1OhurfK&md5=3c41761df0f75e3f8a98c1ee3c057ff9</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23020064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23020064%26sid%3Dliteratum%253Aachs%26aulast%3DMeine%26aufirst%3DR.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DFalke%26aufirst%3DH.%26aulast%3DPreu%26aufirst%3DL.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKunick%26aufirst%3DC.%26atitle%3DIndole-3-carbonitriles%2520as%2520DYRK1A%2520inhibitors%2520by%2520fragment-based%2520drug%2520design%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D64%26doi%3D10.3390%2Fmolecules23020064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shcherbakova, I.</span>; <span class="NLM_string-name">Nikolich, K.</span>; <span class="NLM_string-name">Nikolyukin, Y.</span></span> <span> </span><span class="NLM_article-title">Compositions and Methods for Inhibiting DYRK1A to Treat Central Nervous System Diseases and Disorders</span>. <span class="NLM_patent">WO 2011068990</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=I.+Shcherbakova&author=K.+Nikolich&author=Y.+Nikolyukin&title=Compositions+and+Methods+for+Inhibiting+DYRK1A+to+Treat+Central+Nervous+System+Diseases+and+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26atitle%3DCompositions%2520and%2520Methods%2520for%2520Inhibiting%2520DYRK1A%2520to%2520Treat%2520Central%2520Nervous%2520System%2520Diseases%2520and%2520Disorders%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dominique, R.</span>; <span class="NLM_string-name">Luk, K.
T.</span>; <span class="NLM_string-name">Qiao, Q.</span>; <span class="NLM_string-name">Rossman, P. L.</span></span> <span> </span><span class="NLM_article-title">Quinoline DYRK1 Inhibitors</span>. <span class="NLM_patent">WO 2012098070</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Dominique&author=K.%0AT.+Luk&author=Q.+Qiao&author=P.+L.+Rossman&title=Quinoline+DYRK1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDominique%26aufirst%3DR.%26atitle%3DQuinoline%2520DYRK1%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sliman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blairvacq, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmaële, D.</span></span> <span> </span><span class="NLM_article-title">Identication and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1kinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2801</span>– <span class="NLM_lpage">2805</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2010.03.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2801-2805&author=F.+Slimanauthor=M.+Blairvacqauthor=E.+Durieuauthor=L.+Meijerauthor=J.+Rodrigoauthor=D.+Desma%C3%ABle&title=Identication+and+structure-activity+relationship+of+8-hydroxy-quinoline-7-carboxylic+acid+derivatives+as+inhibitors+of+Pim-1kinase&doi=10.1016%2Fj.bmcl.2010.03.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.061%26sid%3Dliteratum%253Aachs%26aulast%3DSliman%26aufirst%3DF.%26aulast%3DBlairvacq%26aufirst%3DM.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DDesma%25C3%25ABle%26aufirst%3DD.%26atitle%3DIdentication%2520and%2520structure-activity%2520relationship%2520of%25208-hydroxy-quinoline-7-carboxylic%2520acid%2520derivatives%2520as%2520inhibitors%2520of%2520Pim-1kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2801%26epage%3D2805%26doi%3D10.1016%2Fj.bmcl.2010.03.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chon, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. J.</span></span> <span> </span><span class="NLM_article-title">Putative therapeutic agents for the learning and memory deficits of people with Down syndrome</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3772</span>– <span class="NLM_lpage">3776</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2006.04.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=16698266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVykurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3772-3776&author=N.+D.+Kimauthor=J.+Yoonauthor=J.+H.+Kimauthor=J.+T.+Leeauthor=Y.+S.+Chonauthor=M.+K.+Hwangauthor=I.+Haauthor=W.+J.+Song&title=Putative+therapeutic+agents+for+the+learning+and+memory+deficits+of+people+with+Down+syndrome&doi=10.1016%2Fj.bmcl.2006.04.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Putative therapeutic agents for the learning and memory deficits of people with Down syndrome</span></div><div class="casAuthors">Kim, Nam Doo; Yoon, Jeonghyeok; Kim, Jung Ho; Lee, Jung Tae; Chon, Yong Sog; Hwang, Mi-Kyung; Ha, Ilho; Song, Woo-Joo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3772-3776</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mental retardation is the most common and debilitating condition for individuals with Down syndrome (DS).  The hyper-activation of DYRK1A by overexpression causes significant learning and memory deficits in DS-model mice.  Thus far, no mechanism-based drug has been developed to address this.  After a combination of in silico and in vitro screenings, two DYRK1A inhibitors were isolated that are active in a cell-based assay.  Further optimization could lead to a novel drug discovery that could address DS learning and memory deficits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCFzbIFHKqJbVg90H21EOLACvtfcHk0lhrvegxH8wYfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVykurw%253D&md5=5a6a306f3de1c958ac3d4b7f06d24c82</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.042%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DYoon%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DChon%26aufirst%3DY.%2BS.%26aulast%3DHwang%26aufirst%3DM.%2BK.%26aulast%3DHa%26aufirst%3DI.%26aulast%3DSong%26aufirst%3DW.%2BJ.%26atitle%3DPutative%2520therapeutic%2520agents%2520for%2520the%2520learning%2520and%2520memory%2520deficits%2520of%2520people%2520with%2520Down%2520syndrome%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3772%26epage%3D3776%26doi%3D10.1016%2Fj.bmcl.2006.04.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mott, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanega, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misteli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6700</span>– <span class="NLM_lpage">6705</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.09.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2009.09.121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6700-6705&author=B.+T.+Mottauthor=C.+Tanegaauthor=M.+Shenauthor=D.+J.+Maloneyauthor=P.+Shinnauthor=W.+Leisterauthor=J.+J.+Maruganauthor=J.+Ingleseauthor=C.+P.+Austinauthor=T.+Misteliauthor=D.+S.+Auldauthor=C.+J.+Thomas&title=Evaluation+of+substituted+6-arylquinazolin-4-amines+as+potent+and+selective+inhibitors+of+cdc2-like+kinases+%28Clk%29&doi=10.1016%2Fj.bmcl.2009.09.121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.121%26sid%3Dliteratum%253Aachs%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DShinn%26aufirst%3DP.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DEvaluation%2520of%2520substituted%25206-arylquinazolin-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520cdc2-like%2520kinases%2520%2528Clk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6700%26epage%3D6705%26doi%3D10.1016%2Fj.bmcl.2009.09.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span>; <span class="NLM_string-name">Mott, B. T.</span>; <span class="NLM_string-name">Tanega, C.</span>; <span class="NLM_string-name">Shen, M.</span>; <span class="NLM_string-name">Auld, D. S.</span>; <span class="NLM_string-name">Rosenthal, A. S.</span>; <span class="NLM_string-name">Maloney, D. J.</span></span> <span> </span><span class="NLM_article-title">Quinazolin-4-amine Derivatives; and Methods of Use</span>. <span class="NLM_patent">WO 2011041655A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+J.+Thomas&author=B.+T.+Mott&author=C.+Tanega&author=M.+Shen&author=D.+S.+Auld&author=A.+S.+Rosenthal&author=D.+J.+Maloney&title=Quinazolin-4-amine+Derivatives%3B+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DQuinazolin-4-amine%2520Derivatives%253B%2520and%2520Methods%2520of%2520Use%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit129b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanega, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mott, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougie, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misteli, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (DYRK)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3152</span>– <span class="NLM_lpage">3158</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2011.02.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21450467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3152-3158&author=A.+S.+Rosenthalauthor=C.+Tanegaauthor=M.+Shenauthor=B.+T.+Mottauthor=J.+M.+Bougieauthor=D.+T.+Nguyenauthor=T.+Misteliauthor=D.+S.+Auldauthor=D.+J.+Maloneyauthor=C.+J.+Thomas&title=Potent+and+selective+small+molecule+inhibitors+of+specific+isoforms+of+Cdc2-like+kinases+%28Clk%29+and+dual+specificity+tyrosine-phosphorylation-regulated+kinases+%28DYRK%29&doi=10.1016%2Fj.bmcl.2011.02.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129bR"><div class="casContent"><span class="casTitleNuber">129b</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)</span></div><div class="casAuthors">Rosenthal, Andrew S.; Tanega, Cordelle; Shen, Min; Mott, Bryan T.; Bougie, James M.; Nguyen, Dac-Trung; Misteli, Tom; Auld, Douglas S.; Maloney, David J.; Thomas, Craig J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3152-3158</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Continued examn. of substituted 6-arylquinazolin-4-amines as Clk4 kinase inhibitors resulted in selective inhibitors of Clk1, Clk4, Dyrk1A, and Dyrk1B kinases.  Several of the most potent inhibitors were validated as being highly selective within a comprehensive kinome scan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-t6jcT2g9qrVg90H21EOLACvtfcHk0li5KHsLiGxfuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCls7o%253D&md5=37a7ffa16767005c19c559bbe9c3ae71</span></div><a href="/servlet/linkout?suffix=cit129b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.114%26sid%3Dliteratum%253Aachs%26aulast%3DRosenthal%26aufirst%3DA.%2BS.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DMott%26aufirst%3DB.%2BT.%26aulast%3DBougie%26aufirst%3DJ.%2BM.%26aulast%3DNguyen%26aufirst%3DD.%2BT.%26aulast%3DMisteli%26aufirst%3DT.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DMaloney%26aufirst%3DD.%2BJ.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520small%2520molecule%2520inhibitors%2520of%2520specific%2520isoforms%2520of%2520Cdc2-like%2520kinases%2520%2528Clk%2529%2520and%2520dual%2520specificity%2520tyrosine-phosphorylation-regulated%2520kinases%2520%2528DYRK%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3152%26epage%3D3158%26doi%3D10.1016%2Fj.bmcl.2011.02.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esvan, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeinyeh, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boibessot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nauton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thery, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anizon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giraud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2016.04.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=170-177&author=Y.+J.+Esvanauthor=W.+Zeinyehauthor=T.+Boibessotauthor=L.+Nautonauthor=V.+Theryauthor=S.+Knappauthor=A.+Chaikuadauthor=N.+Loaecauthor=L.+Meijerauthor=F.+Anizonauthor=F.+Giraudauthor=P.+Moreau&title=Discovery+of+pyrido%5B3%2C4-g%5Dquinazoline+derivatives+as+CMGC+family+protein+kinase+inhibitors%3A+Design%2C+synthesis%2C+inhibitory+potency+and+X-ray+co-crystal+structure&doi=10.1016%2Fj.ejmech.2016.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DEsvan%26aufirst%3DY.%2BJ.%26aulast%3DZeinyeh%26aufirst%3DW.%26aulast%3DBoibessot%26aufirst%3DT.%26aulast%3DNauton%26aufirst%3DL.%26aulast%3DThery%26aufirst%3DV.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAnizon%26aufirst%3DF.%26aulast%3DGiraud%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520pyrido%255B3%252C4-g%255Dquinazoline%2520derivatives%2520as%2520CMGC%2520family%2520protein%2520kinase%2520inhibitors%253A%2520Design%252C%2520synthesis%252C%2520inhibitory%2520potency%2520and%2520X-ray%2520co-crystal%2520structure%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D118%26spage%3D170%26epage%3D177%26doi%3D10.1016%2Fj.ejmech.2016.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span>; <span class="NLM_string-name">Guillaumet, G.</span>; <span class="NLM_string-name">Tikad, A.</span>; <span class="NLM_string-name">Dehbi, O.</span></span> <span> </span><span class="NLM_article-title">Pyrido[3,2-<i>d</i>]pyrimidine Derivatives, Processes for Preparing Same and Therapeutic Uses Thereof</span>. <span class="NLM_patent">WO 2011135259A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Routier&author=G.+Guillaumet&author=A.+Tikad&author=O.+Dehbi&title=Pyrido%5B3%2C2-d%5Dpyrimidine+Derivatives%2C+Processes+for+Preparing+Same+and+Therapeutic+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DPyrido%255B3%252C2-d%255Dpyrimidine%2520Derivatives%252C%2520Processes%2520for%2520Preparing%2520Same%2520and%2520Therapeutic%2520Uses%2520Thereof%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit131b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dehbi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aadil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akssira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillaumet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and optimization of an original V-shaped collection of 4–7-disubstituted Pyrido[3,2-d] pyrimidines as CDK5 and DYRK1A inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.04.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2014.04.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2014&pages=352-363&author=O.+Dehbiauthor=A.+Tikadauthor=S.+Bourgauthor=P.+Bonnetauthor=O.+Lozachauthor=L.+Meijerauthor=M.+Aadilauthor=M.+Akssiraauthor=G.+Guillaumetauthor=S.+Routier&title=Synthesis+and+optimization+of+an+original+V-shaped+collection+of+4%E2%80%937-disubstituted+Pyrido%5B3%2C2-d%5D+pyrimidines+as+CDK5+and+DYRK1A+inhibitors&doi=10.1016%2Fj.ejmech.2014.04.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.04.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.04.055%26sid%3Dliteratum%253Aachs%26aulast%3DDehbi%26aufirst%3DO.%26aulast%3DTikad%26aufirst%3DA.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DAadil%26aufirst%3DM.%26aulast%3DAkssira%26aufirst%3DM.%26aulast%3DGuillaumet%26aufirst%3DG.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520optimization%2520of%2520an%2520original%2520V-shaped%2520collection%2520of%25204%25E2%2580%25937-disubstituted%2520Pyrido%255B3%252C2-d%255D%2520pyrimidines%2520as%2520CDK5%2520and%2520DYRK1A%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D80%26spage%3D352%26epage%3D363%26doi%3D10.1016%2Fj.ejmech.2014.04.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiumana, A.</span>; <span class="NLM_string-name">Foloppe, N.</span>; <span class="NLM_string-name">Ray, S.</span>; <span class="NLM_string-name">Walmsley, D.</span>; <span class="NLM_string-name">Kotschy, A.</span>; <span class="NLM_string-name">Burbridge, M. F.</span>; <span class="NLM_string-name">Cruzalegui, F. H.</span></span> <span> </span><span class="NLM_article-title">New Pyrrolo[2,3-<i>d</i>]pyrimidine Derivatives as Dual DYRK1/CLK1 Inhibitors</span>. <span class="NLM_patent">WO 2017055533</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+Fiumana&author=N.+Foloppe&author=S.+Ray&author=D.+Walmsley&author=A.+Kotschy&author=M.+F.+Burbridge&author=F.+H.+Cruzalegui&title=New+Pyrrolo%5B2%2C3-d%5Dpyrimidine+Derivatives+as+Dual+DYRK1%2FCLK1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFiumana%26aufirst%3DA.%26atitle%3DNew%2520Pyrrolo%255B2%252C3-d%255Dpyrimidine%2520Derivatives%2520as%2520Dual%2520DYRK1%252FCLK1%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span>; <span class="NLM_string-name">Luk, K.
T.</span>; <span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Pyrazolo Pyrimidines as Dyrk1a and Dyrk1b Inhibitors</span>. <span class="NLM_patent">WO 2012098068</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=W.+Liu&author=K.%0AT.+Luk&author=X.+Zhang&title=Pyrazolo+Pyrimidines+as+Dyrk1a+and+Dyrk1b+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DPyrazolo%2520Pyrimidines%2520as%2520Dyrk1a%2520and%2520Dyrk1b%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. W.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Luk, K. T.</span>; <span class="NLM_string-name">Rossman, P. L.</span>; <span class="NLM_string-name">Sun, H.</span>; <span class="NLM_string-name">Wovkulich, P. M.</span></span> <span> </span><span class="NLM_article-title">Pyrido Pyrimidines for Use as Dyrk1 Inhibitors</span>. <span class="NLM_patent">WO 2012098065A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+W.+Anderson&author=Y.+Chen&author=Z.+Chen&author=K.+T.+Luk&author=P.+L.+Rossman&author=H.+Sun&author=P.+M.+Wovkulich&title=Pyrido+Pyrimidines+for+Use+as+Dyrk1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%2BW.%26atitle%3DPyrido%2520Pyrimidines%2520for%2520Use%2520as%2520Dyrk1%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit134b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominique, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glenn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukacs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonskaia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Railkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilenchik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wovkulich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Pyrido[2,3-<i>d</i>]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6610</span>– <span class="NLM_lpage">6615</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2013.10.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6610-6615&author=K.+Andersonauthor=Y.+Chenauthor=Z.+Chenauthor=R.+Dominiqueauthor=K.+Glennauthor=Y.+Heauthor=C.+Jansonauthor=K.+C.+Lukauthor=C.+Lukacsauthor=A.+Polonskaiaauthor=Q.+Qiaoauthor=A.+Railkarauthor=P.+Rossmanauthor=H.+Sunauthor=Q.+Xiangauthor=M.+Vilenchikauthor=P.+Wovkulichauthor=X.+Zhang&title=Pyrido%5B2%2C3-d%5Dpyrimidines%3A+discovery+and+preliminary+SAR+of+a+novel+series+of+DYRK1B+and+DYRK1A+inhibitors&doi=10.1016%2Fj.bmcl.2013.10.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.055%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDominique%26aufirst%3DR.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DRossman%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidines%253A%2520discovery%2520and%2520preliminary%2520SAR%2520of%2520a%2520novel%2520series%2520of%2520DYRK1B%2520and%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6610%26epage%3D6615%26doi%3D10.1016%2Fj.bmcl.2013.10.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bendjeddou, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villiers, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spath, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galons, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oumata, N.</span></span> <span> </span><span class="NLM_article-title">Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">696</span>– <span class="NLM_lpage">709</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.ejmech.2016.09.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=696-709&author=L.+Z.+Bendjeddouauthor=N.+Loaecauthor=B.+Villiersauthor=E.+Prinaauthor=G.+F.+Spathauthor=H.+Galonsauthor=L.+Meijerauthor=N.+Oumata&title=Exploration+of+the+imidazo%5B1%2C2-b%5Dpyridazine+scaffold+as+a+protein+kinase+inhibitor&doi=10.1016%2Fj.ejmech.2016.09.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.064%26sid%3Dliteratum%253Aachs%26aulast%3DBendjeddou%26aufirst%3DL.%2BZ.%26aulast%3DLoaec%26aufirst%3DN.%26aulast%3DVilliers%26aufirst%3DB.%26aulast%3DPrina%26aufirst%3DE.%26aulast%3DSpath%26aufirst%3DG.%2BF.%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DOumata%26aufirst%3DN.%26atitle%3DExploration%2520of%2520the%2520imidazo%255B1%252C2-b%255Dpyridazine%2520scaffold%2520as%2520a%2520protein%2520kinase%2520inhibitor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D125%26spage%3D696%26epage%3D709%26doi%3D10.1016%2Fj.ejmech.2016.09.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bénéteau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabanne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Guevel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravache, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bénédetti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logé, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of new pyridazino[4,5-b]indol-4-ones and pyridazin-3 (2H)-one analogs as DYRK1A inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5037</span>– <span class="NLM_lpage">5040</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bmcl.2014.09.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5037-5040&author=A.+Bruelauthor=R.+B%C3%A9n%C3%A9teauauthor=M.+Chabanneauthor=O.+Lozachauthor=R.+Le+Guevelauthor=M.+Ravacheauthor=H.+B%C3%A9n%C3%A9dettiauthor=L.+Meijerauthor=C.+Log%C3%A9author=J.+M.+Robert&title=Synthesis+of+new+pyridazino%5B4%2C5-b%5Dindol-4-ones+and+pyridazin-3+%282H%29-one+analogs+as+DYRK1A+inhibitors&doi=10.1016%2Fj.bmcl.2014.09.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DBruel%26aufirst%3DA.%26aulast%3DB%25C3%25A9n%25C3%25A9teau%26aufirst%3DR.%26aulast%3DChabanne%26aufirst%3DM.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DLe%2BGuevel%26aufirst%3DR.%26aulast%3DRavache%26aufirst%3DM.%26aulast%3DB%25C3%25A9n%25C3%25A9detti%26aufirst%3DH.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DLog%25C3%25A9%26aufirst%3DC.%26aulast%3DRobert%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%2520new%2520pyridazino%255B4%252C5-b%255Dindol-4-ones%2520and%2520pyridazin-3%2520%25282H%2529-one%2520analogs%2520as%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5037%26epage%3D5040%26doi%3D10.1016%2Fj.bmcl.2014.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzorana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battistutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1007/s00018-011-0758-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1007%2Fs00018-011-0758-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=21720886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1GksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2012&pages=449-460&author=S.+Sarnoauthor=M.+Mazzoranaauthor=R.+Traynorauthor=M.+Ruzzeneauthor=G.+Cozzaauthor=M.+A.+Paganoauthor=F.+Meggioauthor=G.+Zagottoauthor=R.+Battistuttaauthor=L.+A.+Pinna&title=Structural+features+underlying+the+selectivity+of+the+kinase+inhibitors+NBC+and+dNBC%3A+role+of+a+nitro+group+that+discriminates+between+CK2+and+DYRK1A&doi=10.1007%2Fs00018-011-0758-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A</span></div><div class="casAuthors">Sarno, Stefania; Mazzorana, Marco; Traynor, Ryan; Ruzzene, Maria; Cozza, Giorgio; Pagano, Mario A.; Meggio, Flavio; Zagotto, Giuseppe; Battistutta, Roberto; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">449-460</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">8-Hydroxy-4-methyl-9-nitrobenzo(g)chromen-2-one (NBC) has been found to be a fairly potent ATP site-directed inhibitor of protein kinase CK2 (Ki = 0.22 μM).  Here, we show that NBC also inhibits PIM kinases, esp. PIM1 and PIM3, the latter as potently as CK2.  Upon removal of the nitro group, to give 8-hydroxy-4-methyl-benzo(g)chromen-2-one (here referred to as "denitro NBC", dNBC), the inhibitory power toward CK2 is almost entirely lost (IC50 > 30 μM) whereas that toward PIM1 and PIM3 is maintained; in addn., dNBC is a potent inhibitor of a no. of other kinases that are weakly inhibited or unaffected by NBC, with special ref. to DYRK1A whose IC50 values with NBC and dNBC are 15 and 0.60 μM, resp.  Therefore, the observation that NBC, unlike dNBC, is a potent inducer of apoptosis is consistent with the notion that this effect is mediated by inhibition of endogenous CK2.  The structural features underlying NBC selectivity have been revealed by inspecting its 3D structure in complex with the catalytic subunit of Z. mays CK2.  The crucial role of the nitro group is exerted both through a direct electrostatic interaction with the side chain of Lys68 and, indirectly, by enhancing the acidic dissocn. const. of the adjacent hydroxyl group which interacts with a conserved water mol. in the deepest part of the cavity.  By contrast, the very same nitro group is deleterious for the binding to the active site of DYRK1A, as disclosed by mol. docking.  This provides the rationale for preferential inhibition of DYRK1A by dNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPdF4WWERhM7Vg90H21EOLACvtfcHk0lhwVhaLAyFrqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1GksQ%253D%253D&md5=1105a1fc71bd6db43e10b23e073c1b37</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1007%2Fs00018-011-0758-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-011-0758-7%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DTraynor%26aufirst%3DR.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DStructural%2520features%2520underlying%2520the%2520selectivity%2520of%2520the%2520kinase%2520inhibitors%2520NBC%2520and%2520dNBC%253A%2520role%2520of%2520a%2520nitro%2520group%2520that%2520discriminates%2520between%2520CK2%2520and%2520DYRK1A%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2012%26volume%3D69%26spage%3D449%26epage%3D460%26doi%3D10.1007%2Fs00018-011-0758-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Folmer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasius, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morceau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabudravu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dicato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaspars, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of TNFα-induced activation of nuclear factor κB by kava (<i>Piper methysticum</i>) derivatives</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1206</span>– <span class="NLM_lpage">1218</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2005.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1016%2Fj.bcp.2005.12.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1206-1218&author=F.+Folmerauthor=R.+Blasiusauthor=F.+Morceauauthor=J.+Tabudravuauthor=M.+Dicatoauthor=M.+Jasparsauthor=M.+Diederich&title=Inhibition+of+TNF%CE%B1-induced+activation+of+nuclear+factor+%CE%BAB+by+kava+%28Piper+methysticum%29+derivatives&doi=10.1016%2Fj.bcp.2005.12.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2005.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2005.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DFolmer%26aufirst%3DF.%26aulast%3DBlasius%26aufirst%3DR.%26aulast%3DMorceau%26aufirst%3DF.%26aulast%3DTabudravu%26aufirst%3DJ.%26aulast%3DDicato%26aufirst%3DM.%26aulast%3DJaspars%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520TNF%25CE%25B1-induced%2520activation%2520of%2520nuclear%2520factor%2520%25CE%25BAB%2520by%2520kava%2520%2528Piper%2520methysticum%2529%2520derivatives%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D71%26spage%3D1206%26epage%3D1218%26doi%3D10.1016%2Fj.bcp.2005.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, H.</span>; <span class="NLM_string-name">Toyang, N. J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Agents Containing Cannabis Flavonoid Derivatives Targeting Kinases, Sirtuins and Oncogenic Agents for the Treatment of Cancers</span>. <span class="NLM_patent">WO 2016178713A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+Lowe&author=N.+J.+Toyang&title=Therapeutic+Agents+Containing+Cannabis+Flavonoid+Derivatives+Targeting+Kinases%2C+Sirtuins+and+Oncogenic+Agents+for+the+Treatment+of+Cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DH.%26atitle%3DTherapeutic%2520Agents%2520Containing%2520Cannabis%2520Flavonoid%2520Derivatives%2520Targeting%2520Kinases%252C%2520Sirtuins%2520and%2520Oncogenic%2520Agents%2520for%2520the%2520Treatment%2520of%2520Cancers%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralinaghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">Hydroxybenzothiophene ketones are efficient pre-mRNA splicing modulators due to dual inhibition of Dyrk1A and Clk1/4</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">963</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1021/ml500059y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500059y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=963-967&author=C.+Schmittauthor=P.+Miralinaghiauthor=M.+Marianoauthor=R.+W.+Hartmannauthor=M.+Engel&title=Hydroxybenzothiophene+ketones+are+efficient+pre-mRNA+splicing+modulators+due+to+dual+inhibition+of+Dyrk1A+and+Clk1%2F4&doi=10.1021%2Fml500059y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fml500059y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500059y%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DMiralinaghi%26aufirst%3DP.%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DHydroxybenzothiophene%2520ketones%2520are%2520efficient%2520pre-mRNA%2520splicing%2520modulators%2520due%2520to%2520dual%2520inhibition%2520of%2520Dyrk1A%2520and%2520Clk1%252F4%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D963%26epage%3D967%26doi%3D10.1021%2Fml500059y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span> <span> </span><span class="NLM_article-title">Focus on PAINS: false friends in the quest for selective anti-protozoal lead structures from Nature?</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1039/C5MD00481K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1039%2FC5MD00481K" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=214-223&author=J.+Glaserauthor=U.+Holzgrabe&title=Focus+on+PAINS%3A+false+friends+in+the+quest+for+selective+anti-protozoal+lead+structures+from+Nature%3F&doi=10.1039%2FC5MD00481K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1039%2FC5MD00481K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00481K%26sid%3Dliteratum%253Aachs%26aulast%3DGlaser%26aufirst%3DJ.%26aulast%3DHolzgrabe%26aufirst%3DU.%26atitle%3DFocus%2520on%2520PAINS%253A%2520false%2520friends%2520in%2520the%2520quest%2520for%2520selective%2520anti-protozoal%2520lead%2520structures%2520from%2520Nature%253F%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26spage%3D214%26epage%3D223%26doi%3D10.1039%2FC5MD00481K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altafaj, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estivill, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">474</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1998.9967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;key=10.1006%2Fbbrc.1998.9967" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1999&pages=474-479&author=S.+Lederauthor=Y.+Weberauthor=X.+Altafajauthor=X.+Estivillauthor=H.+G.+Joostauthor=W.+Becker&title=Cloning+and+characterization+of+DYRK1B%2C+a+novel+member+of+the+DYRK+family+of+protein+kinases&doi=10.1006%2Fbbrc.1998.9967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1998.9967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1998.9967%26sid%3Dliteratum%253Aachs%26aulast%3DLeder%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DY.%26aulast%3DAltafaj%26aufirst%3DX.%26aulast%3DEstivill%26aufirst%3DX.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DCloning%2520and%2520characterization%2520of%2520DYRK1B%252C%2520a%2520novel%2520member%2520of%2520the%2520DYRK%2520family%2520of%2520protein%2520kinases%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1999%26volume%3D254%26spage%3D474%26epage%3D479%26doi%3D10.1006%2Fbbrc.1998.9967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00185&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-22%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00185%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00185" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667980214a9dd1f3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
